data_2lcw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 0.5 OUTLIER -47.26 -30.07 2.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 96.9 m -61.33 125.55 24.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.465 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 40.2 pt -113.29 173.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.457 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.9 OUTLIER -126.36 112.98 16.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.266 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.01 122.48 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.626 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.471 ' HG3' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -128.89 129.98 46.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.018 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.57 46.76 0.52 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.3 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.7 OUTLIER -86.29 -84.59 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.5 0.191 . . . . 0.0 110.83 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 105.64 90.6 2.18 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.269 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 44.65 27.95 0.29 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.822 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.405 ' ND2' ' CD1' ' A' ' 359' ' ' PHE . 0.8 OUTLIER -142.31 -2.23 1.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.789 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 11.7 p -64.9 83.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.46 163.95 15.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.512 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 322' ' ' ILE . 13.8 mm -71.29 -49.1 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 111.366 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -34.1 76.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.5 t -63.58 -44.13 94.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.819 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.437 ' CG1' ' CG2' ' A' ' 339' ' ' VAL . 43.1 t -73.81 -38.44 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.401 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 306' ' ' LYS . . . -67.92 -30.44 69.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.053 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.55 -41.79 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.498 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -93.18 -21.43 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.527 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -104.71 37.56 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.808 0.337 . . . . 0.0 111.326 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.92 17.04 9.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.177 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.05 -43.27 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 109.987 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -35.56 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.5 -156.15 11.04 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.565 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 mt -101.93 134.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 2.2 mt -89.18 139.66 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 110.035 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.485 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -48.15 91.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.945 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.79 147.12 49.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.415 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.536 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -97.35 157.86 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.425 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -89.44 -8.25 53.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -45.55 8.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.431 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 61.0 p -107.5 -7.43 16.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 314' ' ' ASN . . . 61.72 18.84 57.48 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.678 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.5 163.69 35.04 Favored Pre-proline 0 C--O 1.227 -0.131 0 CA-C-O 120.677 0.275 . . . . 0.0 111.017 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.474 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 88.0 Cg_exo -46.86 154.55 1.05 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.789 2.326 . . . . 0.0 113.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.536 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -123.45 125.07 44.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.264 0.555 . . . . 0.0 110.959 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.422 ' O ' ' CD1' ' A' ' 298' ' ' ILE . 2.7 mp -140.11 140.51 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -95.56 115.8 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.747 0.308 . . . . 0.0 110.29 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.553 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -151.09 131.86 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.433 0.158 . . . . 0.0 110.663 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 324' ' ' LEU . . . -159.82 145.22 15.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 121.3 0.571 . . . . 0.0 112.298 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.457 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 7.6 p -98.0 134.9 40.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.793 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.437 ' CG2' ' CG1' ' A' ' 301' ' ' VAL . 57.2 t -107.84 128.69 62.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.405 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.485 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 50.3 m -90.4 142.78 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.374 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 146.0 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 111.269 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -79.28 -17.94 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.14 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.8 111.03 27.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.539 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -49.07 -52.19 9.19 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.469 2.113 . . . . 0.0 112.877 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.1 Cg_endo -59.07 -30.67 93.9 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.873 1.715 . . . . 0.0 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 36.4 t -65.66 -34.72 78.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.688 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.29 97.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.81 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 368' ' ' PHE . 0.6 OUTLIER -62.66 -50.91 69.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.262 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.35 53.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.75 -48.0 64.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.305 0.574 . . . . 0.0 109.863 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 355' ' ' ASP . 10.6 mt -57.44 -35.64 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.228 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -26.55 68.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.819 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.5 t90 -98.67 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.847 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 355' ' ' ASP . 60.6 m-85 -56.04 -74.17 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.562 ' C ' ' O ' ' A' ' 354' ' ' PHE . 22.6 t0 8.97 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.911 0.757 . . . . 0.0 111.624 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.02 22.35 4.25 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.259 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -78.72 -164.48 0.59 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.608 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 21.3 mm-40 -130.11 137.24 50.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 112.149 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -102.75 101.47 11.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.146 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.26 29.52 5.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.703 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 123.9 -37.9 2.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.443 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.7 OUTLIER -82.77 169.98 16.14 Favored Pre-proline 0 C--O 1.22 -0.474 0 CA-C-N 116.876 0.338 . . . . 0.0 110.659 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.76 144.46 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.441 2.761 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.434 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 3.6 pt -130.98 161.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-O 120.824 0.345 . . . . 0.0 111.667 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -130.42 100.95 5.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 23.3 t -85.64 130.79 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 p -127.75 -177.27 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.915 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.489 ' O ' ' ND2' ' A' ' 285' ' ' ASN . 13.8 m120 . . . . . 0 N--CA 1.458 -0.027 0 CA-C-O 120.621 0.248 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.0 OUTLIER 85.31 14.06 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.445 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 90.1 m -164.97 107.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.709 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.438 HD11 ' CE2' ' A' ' 305' ' ' PHE . 33.0 pt -92.75 170.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.172 0.51 . . . . 0.0 111.842 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.0 m-85 -119.75 110.92 17.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.553 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.15 119.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 336' ' ' GLU . 2.7 mm100 -128.31 130.03 47.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 126.26 20.18 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.154 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -71.19 -101.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 171.64 -100.44 0.15 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.139 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -131.95 33.55 3.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 296' ' ' VAL . 1.4 p-10 -130.46 -51.66 1.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.137 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.517 ' C ' ' O ' ' A' ' 295' ' ' ASN . 14.4 p -2.05 76.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.76 155.05 25.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.699 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 16.7 mt -61.12 -47.04 95.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -38.27 87.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -39.26 79.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.121 0.486 . . . . 0.0 110.484 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 87.2 t -73.41 -39.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.805 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.23 73.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.926 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -39.87 62.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.678 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -89.5 -21.64 22.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -102.19 30.09 4.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.142 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.3 19.36 17.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.159 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -101.83 -39.7 7.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 110.323 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.1 -38.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.119 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.99 -169.97 30.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.525 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.59 144.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 320' ' ' PRO . 4.1 mp -93.48 131.83 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.144 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 25.7 mtmt -48.91 93.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.765 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -64.56 145.46 56.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.463 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.465 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 5.8 m-20 -75.89 162.19 28.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.346 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -104.95 -7.72 19.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -104.48 -35.69 7.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.999 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 69.6 p -108.24 -9.57 15.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 60.51 14.72 36.35 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.718 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 159.18 52.41 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.984 0.392 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 311' ' ' ILE . 76.6 Cg_exo -44.68 151.15 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.007 2.471 . . . . 0.0 112.86 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.465 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 29.9 mtm -108.11 119.15 38.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.391 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 323' ' ' ASN . 4.8 mt -143.22 142.74 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.467 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 322' ' ' ILE . 8.9 m120 -117.95 133.19 56.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.885 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -125.41 164.04 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.209 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.821 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.403 ' HB3' ' NE2' ' A' ' 290' ' ' GLN . 2.7 mp0 -139.78 131.77 27.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.172 . . . . 0.0 110.866 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -162.65 145.54 11.01 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 121.089 0.471 . . . . 0.0 111.882 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 5.1 p -95.3 150.01 20.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.135 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.415 ' CG2' ' CG1' ' A' ' 301' ' ' VAL . 44.7 t -123.71 127.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 321' ' ' MET . 91.4 p -84.32 153.21 23.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.423 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 3.5 m-85 -127.08 133.41 50.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.022 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -62.46 -22.19 66.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.942 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -127.98 116.72 20.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.758 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.5 Cg_exo -45.23 -51.05 8.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.664 2.243 . . . . 0.0 113.017 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.2 Cg_endo -59.55 -30.48 92.52 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.85 1.7 . . . . 0.0 111.159 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.37 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.423 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -58.64 -42.75 89.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 368' ' ' PHE . 0.0 OUTLIER -62.86 -55.96 21.53 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.32 -31.74 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.792 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.61 -47.74 65.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.428 0.632 . . . . 0.0 109.39 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 355' ' ' ASP . 6.9 mt -61.91 -36.52 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.073 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -26.42 68.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.325 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.533 ' CE3' ' CZ ' ' A' ' 354' ' ' PHE . 3.5 t90 -91.08 -68.5 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.533 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 2.5 m-85 -68.84 -77.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 33.8 t0 25.27 50.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.033 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.7 26.98 1.21 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.804 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.489 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -102.47 -156.19 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.347 0.574 . . . . 0.0 110.778 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.4 mt-10 -113.5 128.65 56.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.349 0.595 . . . . 0.0 112.192 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.53 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.5 OUTLIER -108.01 103.19 12.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.981 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.5 t 63.36 28.07 15.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.619 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 104.62 -14.06 50.29 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.799 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.652 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 4.0 m-80 -106.92 170.94 5.14 Favored Pre-proline 0 C--O 1.219 -0.503 0 CA-C-N 117.246 0.523 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.1 139.14 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.82 2.346 . . . . 0.0 111.904 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.418 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 9.2 pt -132.33 172.78 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 106.16 4.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 288' ' ' PHE . 14.4 t -84.45 139.54 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.813 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -122.43 -175.0 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 111.885 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.447 ' CE1' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.431 ' OD1' ' CZ ' ' A' ' 368' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.08 -33.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.668 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 78.8 m -101.47 115.67 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.935 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.467 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 9.2 pt -91.08 173.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 2.4 m-85 -130.34 108.37 9.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.122 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.82 114.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 35.8 mm-40 -119.91 130.62 54.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.422 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.68 70.45 0.47 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.338 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.83 -78.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.877 0.339 . . . . 0.0 110.12 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.93 -81.62 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.665 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 294' ' ' GLU . 8.6 tp10 -140.93 41.5 1.82 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.249 0.547 . . . . 0.0 110.13 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -138.13 14.56 2.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.32 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.38 95.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 111.612 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 151.52 52.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.301 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.6 mm -65.21 -48.36 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.58 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.91 -35.11 79.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.761 0.315 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 55.2 m -70.89 -43.82 67.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 60.7 t -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 320' ' ' PRO . . . -63.0 -29.78 71.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.165 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.6 -38.84 64.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.889 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.428 ' OH ' ' CE2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -94.38 -22.36 18.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.618 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -93.22 5.26 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -97.06 23.93 6.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.89 -31.65 8.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.32 -39.39 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.767 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -150.96 -175.92 23.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.18 119.82 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 73.5 mt -85.83 125.02 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.244 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.71 103.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -62.02 148.8 42.82 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.641 178.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -106.8 140.08 40.21 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.73 0.3 . . . . 0.0 110.525 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -5.34 47.13 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -29.16 17.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.403 ' H ' ' ND2' ' A' ' 314' ' ' ASN . 28.9 p -122.13 -23.17 5.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 83.4 12.17 78.97 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.339 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.95 153.29 71.03 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.9 Cg_endo -44.79 153.24 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.048 2.499 . . . . 0.0 112.596 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.462 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 45.9 mtp -104.69 128.53 52.79 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 323' ' ' ASN . 3.1 mt -140.22 141.56 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.938 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 6.1 m-80 -97.37 148.38 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.98 135.9 24.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.842 0.353 . . . . 0.0 111.483 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.127 179.174 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.221 0 N-CA-C 113.627 0.211 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -160.23 167.29 27.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 0.0 111.217 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -158.0 147.14 19.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.144 0.497 . . . . 0.0 111.741 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 4.2 p -107.56 133.5 51.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.201 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 287' ' ' ILE . 49.8 t -100.91 124.29 54.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 18.3 p -94.67 112.16 23.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.199 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 311' ' ' ILE . 59.1 m-85 -91.27 159.46 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.953 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -88.91 -14.69 36.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -128.27 119.9 20.92 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.943 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.591 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.4 Cg_exo -47.56 -48.87 14.47 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.714 2.276 . . . . 0.0 113.027 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.9 Cg_endo -60.36 -30.6 91.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.858 1.705 . . . . 0.0 111.392 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -62.09 -34.91 77.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.645 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.428 ' HB2' ' CE1' ' A' ' 368' ' ' PHE . . . -59.71 -50.05 75.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.483 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.0 OUTLIER -60.75 -45.8 92.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.956 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.5 34.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.97 68.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 12.3 mt -59.64 -34.75 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.119 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -26.88 67.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.551 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.564 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.72 -68.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.049 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.39 -79.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.117 -177.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 37.6 t70 30.08 43.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 134.92 28.3 0.45 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.139 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.47 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -98.19 -163.6 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.9 pm0 -120.39 128.84 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.135 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -82.88 101.45 11.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.243 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 45.91 29.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.281 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.27 -43.36 1.26 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.925 -1.131 . . . . 0.0 114.256 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.636 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -92.49 162.64 29.11 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-N 117.242 0.521 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.93 141.85 7.48 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.135 2.557 . . . . 0.0 112.176 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 13.4 pt -124.77 177.6 4.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-O 121.105 0.479 . . . . 0.0 111.701 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -144.91 101.66 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.513 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 288' ' ' PHE . 25.7 t -84.76 135.17 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.053 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 m -136.85 172.61 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.428 . . . . 0.0 111.64 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.431 ' CZ ' ' OD1' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -21.74 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 61.4 m -71.61 102.29 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 341' ' ' PHE . 13.7 pt -104.02 162.04 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.991 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -125.22 127.54 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 112.202 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.7 t -107.12 117.5 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.3 mp0 -112.53 129.82 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.745 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.25 42.26 0.91 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.658 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.406 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.4 OUTLIER -71.19 -78.6 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.522 0.201 . . . . 0.0 110.81 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 111.41 87.09 1.71 Allowed Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.172 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 43.68 30.31 0.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.684 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.28 29.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.43 72.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.403 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -116.57 146.87 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mt -69.31 -43.66 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.479 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.15 -42.93 88.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.899 0.38 . . . . 0.0 110.666 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.9 p -65.0 -41.27 95.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 110.697 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 85.5 t -71.21 -42.7 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.266 0.555 . . . . 0.0 109.733 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.43 71.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.3 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -39.69 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.614 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -88.83 -24.33 22.6 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.614 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.6 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -94.14 19.1 9.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.662 0.268 . . . . 0.0 111.332 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.89 20.54 18.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 110.899 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -102.56 -39.36 7.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 tp -73.03 -34.98 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.05 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -167.25 -153.11 7.78 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.646 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -109.55 119.55 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.77 130.66 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.1 OUTLIER -48.68 92.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.62 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -69.81 137.49 51.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.432 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.5 OUTLIER -73.98 128.26 35.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.194 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -5.9 56.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.074 0.464 . . . . 0.0 110.071 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.44 -40.69 7.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.452 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.414 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.3 OUTLIER -105.13 -11.12 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.906 -179.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.07 11.92 59.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.498 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.414 ' HG2' HG21 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.16 152.2 66.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.902 0.351 . . . . 0.0 111.336 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 80.8 Cg_exo -47.68 158.47 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.795 2.33 . . . . 0.0 112.476 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.421 ' O ' ' OG ' ' A' ' 340' ' ' SER . 37.2 mmm -119.13 119.09 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 111.119 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 323' ' ' ASN . 59.6 mt -143.08 144.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.436 ' N ' HG22 ' A' ' 322' ' ' ILE . 3.2 m-80 -103.27 148.15 26.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 111.011 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 337' ' ' ALA . 3.6 mt -130.4 131.03 45.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 336' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 1.5 mt-10 -143.84 131.94 21.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.345 0.117 . . . . 0.0 110.8 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 324' ' ' LEU . . . -144.15 167.45 22.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.159 0.504 . . . . 0.0 111.913 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 288' ' ' PHE . 1.3 p -121.12 145.84 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.198 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 301' ' ' VAL . 92.0 t -125.4 134.37 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 0.0 111.385 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 321' ' ' MET . 59.2 p -98.37 131.02 45.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.016 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.433 ' CE2' HD11 ' A' ' 287' ' ' ILE . 2.8 m-85 -107.44 147.81 29.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.449 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.2 OUTLIER -79.08 -9.54 59.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 116.58 15.49 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.9 Cg_exo -45.13 -50.27 9.05 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.579 2.186 . . . . 0.0 112.798 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.0 Cg_endo -54.71 -30.56 67.29 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.924 1.749 . . . . 0.0 111.484 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.4 t -59.03 -42.17 89.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.868 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.84 74.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 0.0 110.387 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 348' ' ' LYS . 4.5 tppt? -61.98 -53.86 49.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.653 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.68 47.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.846 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.44 -47.92 65.93 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.595 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 7.7 mt -59.8 -36.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.66 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.166 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.514 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.16 -68.05 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.115 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.584 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -76.17 -80.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.595 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.1 p-10 26.62 45.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.399 0.437 . . . . 0.0 111.992 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 122.36 37.25 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.052 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -95.91 -155.99 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 13.4 mt-10 -113.27 128.27 56.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.62 . . . . 0.0 111.48 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.493 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -122.76 101.91 7.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.937 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 56.0 m 60.55 27.22 16.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 110.537 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.55 17.49 52.2 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.28 164.37 39.87 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.869 0.366 . . . . 0.0 111.306 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.55 132.54 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.816 2.344 . . . . 0.0 111.9 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 20.4 pt -120.84 174.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.04 0.448 . . . . 0.0 111.992 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -139.39 100.95 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.728 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 287' ' ' ILE . 26.0 t -97.64 115.92 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -140.54 -165.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.224 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 285' ' ' ASN . 33.7 m120 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.781 0.324 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 284' ' ' ASN . 6.4 p30 168.64 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.07 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 90.7 m -104.84 95.33 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.435 HD11 ' CZ ' ' A' ' 305' ' ' PHE . 50.3 pt -86.53 168.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.71 124.28 44.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.73 114.65 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.886 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -116.53 130.66 56.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.017 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 363' ' ' PRO . . . 127.96 20.7 1.63 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.615 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.459 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 12.3 mt -66.76 -103.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.95 0.35 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.97 34.5 5.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.459 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.41 30.74 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.715 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.97 81.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.582 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.6 146.27 30.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.37 -43.39 73.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.15 -40.62 90.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.64 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.8 t -63.45 -41.05 98.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 43.9 t -74.12 -41.17 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.295 0.569 . . . . 0.0 109.95 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.12 -29.85 68.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.937 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -74.14 -39.59 63.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -92.41 -24.49 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -96.78 32.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.236 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -116.18 16.62 15.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.288 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -98.77 -42.19 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.6 tp -71.07 -32.6 48.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.24 -163.66 27.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.6 mt -100.64 141.84 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.534 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.1 mt -100.83 125.22 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.411 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.76 107.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -73.42 152.38 40.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.133 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -105.27 138.16 41.91 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.827 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -1.95 25.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.428 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -96.9 -26.51 15.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 110.481 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.528 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 68.6 p -121.33 -20.41 6.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.58 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 75.79 13.96 82.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.976 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.528 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.86 164.03 35.66 Favored Pre-proline 0 C--N 1.333 -0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.376 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.508 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 71.3 Cg_exo -44.7 155.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.76 2.307 . . . . 0.0 112.384 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.471 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 51.7 mtp -109.34 119.8 40.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 111.636 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 323' ' ' ASN . 3.4 mt -142.83 145.19 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.977 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.408 ' N ' HG21 ' A' ' 322' ' ' ILE . 11.6 t-20 -119.15 116.4 26.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.805 0.336 . . . . 0.0 110.934 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.7 130.28 56.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' GLN . 6.8 mt-10 -140.97 131.54 25.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.596 0.236 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -139.28 169.69 17.31 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.917 0.389 . . . . 0.0 111.275 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 20.0 p -128.05 126.38 41.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.572 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.51 116.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.396 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 20.4 m -80.68 152.96 28.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 5.5 m-85 -136.29 139.15 42.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 -26.29 65.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -124.16 116.03 27.31 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.574 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.2 Cg_exo -42.72 -51.12 5.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.773 2.315 . . . . 0.0 113.094 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.4 Cg_endo -53.66 -30.37 55.39 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.817 1.678 . . . . 0.0 111.131 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.4 t -57.7 -46.15 84.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.16 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.52 -39.63 67.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.618 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.435 ' HD3' ' CZ ' ' A' ' 368' ' ' PHE . 4.3 tptp -64.91 -59.56 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.42 -30.71 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.758 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -50.25 52.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.469 0.652 . . . . 0.0 109.282 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 6.1 mt -59.48 -37.35 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.987 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.4 -26.3 66.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.946 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.4 t90 -98.9 -68.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.507 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 8.1 m-85 -63.86 -76.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 12.7 p-10 19.88 55.49 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.99 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 120.92 17.73 4.08 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.3 OUTLIER -76.14 -161.4 0.18 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.672 0.272 . . . . 0.0 111.323 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 3.3 mt-10 -113.48 152.92 29.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 111.523 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -142.08 101.3 3.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.514 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p 49.82 27.41 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.88 0.371 . . . . 0.0 110.665 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.43 17.33 22.24 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.245 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 359' ' ' PHE . 63.6 m-80 -129.3 152.2 79.09 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 121.002 0.429 . . . . 0.0 111.766 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.42 ' O ' ' HA3' ' A' ' 291' ' ' GLY . 90.7 Cg_endo -85.53 133.43 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.947 2.431 . . . . 0.0 111.451 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 5.1 pt -119.2 150.32 21.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.275 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 103.67 9.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.339 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 23.1 t -84.51 130.66 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.646 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.43 -174.45 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.701 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.435 ' CZ ' ' HD3' ' A' ' 348' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.418 ' ND2' ' N ' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.309 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -60.41 -23.6 64.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.997 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.4 m -70.13 139.56 52.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 39.1 pt -122.44 164.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.2 OUTLIER -113.24 109.1 18.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.69 114.66 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.592 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 2.0 mp0 -113.74 130.54 56.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.5 47.89 1.09 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.873 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.9 -70.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 102.79 77.48 1.22 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.632 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 42.01 31.53 0.24 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 29.29 2.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 110.512 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 324' ' ' LEU . 4.6 t -69.29 86.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.862 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.88 146.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 29.9 mm -70.88 -44.23 76.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.319 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.82 -43.1 84.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.782 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -41.59 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.7 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 72.6 t -72.05 -41.71 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.43 69.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.959 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.11 -35.37 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.845 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -88.71 -22.22 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.569 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 304' ' ' TYR . 1.2 m-85 -89.49 12.27 17.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 29.71 2.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.36 -35.51 5.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.415 HG12 ' CA ' ' A' ' 350' ' ' ALA . 5.0 tp -80.04 -33.88 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.336 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.67 -150.62 9.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.823 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.47 129.18 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 5.3 mt -84.34 125.9 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.05 0.452 . . . . 0.0 110.454 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -49.03 91.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.385 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -82.62 170.29 15.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.066 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.578 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -106.51 153.29 22.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -1.27 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.919 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -94.59 -47.38 6.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.607 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 58.4 p -104.62 -12.84 16.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.921 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.04 20.19 59.98 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.209 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.88 154.23 70.86 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.579 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 73.2 Cg_exo -51.16 149.87 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.226 1.951 . . . . 0.0 111.745 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.578 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -118.53 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.439 0.638 . . . . 0.0 112.208 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mt -140.9 143.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.618 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.37 115.6 28.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.439 ' CB ' ' CG1' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -116.14 153.66 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.847 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -148.29 131.26 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.777 0.322 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.06 170.33 22.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.066 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.459 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 76.1 p -127.2 114.58 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 305' ' ' PHE . 48.7 t -94.82 117.04 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.1 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.5 ' CB ' ' HB3' ' A' ' 312' ' ' LYS . 67.6 m -84.5 132.9 34.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 18.2 m-85 -104.95 142.62 34.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -19.5 62.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.7 OUTLIER -128.94 120.96 20.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.875 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.588 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -47.76 -48.63 15.43 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 113.069 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.8 Cg_endo -60.99 -30.63 90.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.858 1.705 . . . . 0.0 111.277 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -61.02 -32.6 72.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.372 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -61.68 -55.3 31.9 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.672 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -43.33 91.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.42 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.415 ' CA ' HG12 ' A' ' 308' ' ' ILE . . . -68.69 -49.35 59.66 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.429 0.633 . . . . 0.0 109.584 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.511 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 6.9 mt -59.45 -36.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.135 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -62.68 -26.4 68.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.618 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.56 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.2 t90 -100.32 -68.13 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.175 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.529 ' O ' ' C ' ' A' ' 355' ' ' ASP . 23.2 m-85 -61.33 -77.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 354' ' ' PHE . 17.4 p-10 17.29 59.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.71 22.11 2.54 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.739 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.424 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -81.22 -165.61 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.63 0.215 . . . . 0.0 110.799 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.9 OUTLIER -124.38 129.67 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 111.861 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -89.72 101.46 14.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.064 178.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.85 29.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.24 -48.71 0.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.93 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.649 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -82.8 169.95 16.22 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 117.034 0.417 . . . . 0.0 110.636 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.85 145.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 111.952 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 5.8 pt -127.37 -178.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.174 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -145.59 100.57 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.43 128.41 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -140.2 -165.55 1.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 368' ' ' PHE . 2.2 t-20 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.855 0.36 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER -123.44 -3.23 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.32 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.6 m -114.86 127.26 55.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 341' ' ' PHE . 29.7 pt -108.45 167.87 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.444 ' CD1' HG23 ' A' ' 338' ' ' THR . 18.0 m-30 -122.59 114.83 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.261 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.69 114.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.398 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -108.88 130.55 55.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 119.65 55.56 0.25 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.684 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.446 ' CD1' ' CE2' ' A' ' 359' ' ' PHE . 3.0 mm? -91.41 -77.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.749 0.309 . . . . 0.0 110.721 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.91 76.2 1.06 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.112 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 44.89 41.04 4.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 111.738 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.64 24.62 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.729 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 324' ' ' LEU . 4.0 t -73.89 88.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.519 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.63 146.54 42.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.793 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.419 HD13 HG23 ' A' ' 298' ' ' ILE . 54.2 mt -71.4 -43.49 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.443 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.44 -41.28 89.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.9 t -64.78 -43.4 93.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.725 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 59.6 t -72.98 -41.07 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.321 0.582 . . . . 0.0 109.649 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 311' ' ' ILE . . . -68.1 -29.69 68.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.982 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -73.5 -39.03 65.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.608 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.86 -22.47 16.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.0 OUTLIER -95.56 2.37 54.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 21.5 ptmt -96.37 30.2 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -34.31 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.11 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 350' ' ' ALA . 0.8 OUTLIER -80.31 -41.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.244 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -146.58 -168.24 13.45 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.7 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.14 106.71 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.593 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 10.8 mt -72.39 129.49 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 109.929 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 92.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -65.99 138.94 58.15 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.782 177.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.1 OUTLIER -89.78 165.75 13.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.171 0.51 . . . . 0.0 111.96 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -102.57 -4.41 25.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.3 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.435 ' HD3' ' CG2' ' A' ' 317' ' ' THR . 0.0 OUTLIER -96.33 -40.81 8.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.75 179.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.435 ' CG2' ' HD3' ' A' ' 316' ' ' LYS . 12.1 p -106.13 -18.33 14.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.304 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.44 8.13 85.62 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.161 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.413 ' OE1' ' HB ' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.54 157.89 66.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.743 0.272 . . . . 0.0 111.022 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.1 Cg_endo -45.45 162.18 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.904 2.403 . . . . 0.0 112.617 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.515 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.84 130.37 56.67 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.686 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.423 ' CG1' ' HA ' ' A' ' 339' ' ' VAL . 1.9 mp -143.22 140.02 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -105.23 115.82 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.415 ' HB3' ' CG1' ' A' ' 296' ' ' VAL . 0.2 OUTLIER -108.87 150.35 27.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.278 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 336' ' ' GLU . 14.2 m-85 . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.74 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.994 -0.042 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.421 ' HG2' ' CD1' ' A' ' 325' ' ' TYR . 0.1 OUTLIER -160.42 178.06 9.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.284 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.06 162.6 41.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.212 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.444 HG23 ' CD1' ' A' ' 288' ' ' PHE . 19.5 p -116.93 117.45 29.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.052 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 341' ' ' PHE . 50.8 t -92.73 123.06 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.586 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 1.2 m -101.33 131.87 47.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 339' ' ' VAL . 26.8 m-85 -115.37 158.54 22.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.063 0.458 . . . . 0.0 111.268 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.9 6.81 37.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.08 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.32 121.81 7.91 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.578 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 50.5 Cg_exo -52.88 -47.75 25.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.68 2.253 . . . . 0.0 113.326 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.8 Cg_endo -60.7 -30.12 89.72 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.729 1.619 . . . . 0.0 111.048 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -40.54 81.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.973 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.45 -50.87 72.24 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 348' ' ' LYS . 0.7 OUTLIER -62.17 -50.87 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.778 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.44 -34.16 33.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 308' ' ' ILE . . . -68.62 -46.81 68.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.421 0.629 . . . . 0.0 109.756 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.549 ' CD1' ' CE1' ' A' ' 368' ' ' PHE . 11.8 mt -58.69 -34.24 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.294 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.29 -26.8 68.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.796 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.537 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.07 -68.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 0.9 OUTLIER -77.63 -79.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.58 -176.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 28.74 45.7 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.799 0.333 . . . . 0.0 111.704 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 128.52 30.78 0.69 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -90.94 -160.32 0.71 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.51 0.195 . . . . 0.0 111.047 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 6.0 mp0 -113.36 153.13 29.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.291 0.567 . . . . 0.0 111.704 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -136.98 101.12 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.319 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.6 m 46.73 28.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.81 18.75 14.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.118 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 359' ' ' PHE . 72.0 m-80 -129.29 150.24 74.96 Favored Pre-proline 0 C--O 1.225 -0.186 0 CA-C-O 121.067 0.46 . . . . 0.0 111.71 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.93 127.83 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.766 2.311 . . . . 0.0 111.678 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.1 pt -111.43 165.2 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.912 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.34 100.99 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 287' ' ' ILE . 26.6 t -87.09 133.14 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 p -133.83 -176.49 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.653 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.55 ' CD1' ' OD1' ' A' ' 284' ' ' ASN . 26.6 m-85 . . . . . 0 C--O 1.233 0.188 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 121.014 0.435 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -28.41 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.4 m -64.82 145.13 56.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.441 HD13 ' CZ ' ' A' ' 305' ' ' PHE . 23.5 pt -125.39 173.42 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.421 ' CE1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -121.77 109.29 14.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.19 117.38 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.662 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.418 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -129.87 130.9 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.13 19.52 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.601 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 359' ' ' PHE . 39.6 mt -70.1 -101.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 159.08 -93.29 0.12 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.274 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -132.43 28.56 4.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.146 0.498 . . . . 0.0 110.136 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.09 -12.93 8.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.468 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.7 p -44.63 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 147.13 34.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.062 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.49 -47.37 93.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.712 0.291 . . . . 0.0 111.769 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.27 -39.47 89.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.2 t -68.44 -42.86 78.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 46.2 t -72.88 -38.82 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 109.625 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.425 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.38 -29.85 68.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.895 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.72 -40.54 66.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.812 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.2 -24.26 16.33 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.558 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -95.72 33.13 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.901 0.381 . . . . 0.0 110.977 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.31 21.0 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -103.92 -40.39 6.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.285 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.28 -27.84 27.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.5 -165.92 32.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.705 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.58 134.94 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.462 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.8 mt -94.68 127.73 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.422 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 321' ' ' MET . 14.7 mtmm -48.77 110.27 0.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -60.14 -179.64 0.11 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 315' ' ' LYS . 3.9 m-80 -95.98 -40.89 9.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 314' ' ' ASN . 0.2 OUTLIER 86.92 -31.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.411 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -41.23 11.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 67.0 p -100.23 -11.69 20.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.337 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 71.02 12.06 71.0 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 157.3 64.89 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.318 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 59.0 Cg_exo -44.59 161.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.259 2.64 . . . . 0.0 113.143 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 312' ' ' LYS . 21.5 mtp -120.67 124.65 45.72 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.585 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 7.1 mt -142.52 137.07 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.947 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.441 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 3.6 t30 -96.49 147.97 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.172 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -144.28 153.04 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 111.165 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 179.734 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 120.525 -0.042 . . . . 0.0 113.065 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.418 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 8.3 mp0 -121.51 133.23 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -160.19 149.95 17.95 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 288' ' ' PHE . 17.7 p -108.6 127.74 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.547 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.1 t -99.27 128.01 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.929 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 18.2 m -87.05 153.02 21.86 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.483 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 346' ' ' SER . 4.0 m-85 -136.14 141.58 44.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 111.273 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -9.35 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.212 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.46 117.88 13.47 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.779 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 62.0 Cg_exo -49.73 -49.67 15.27 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.6 2.2 . . . . 0.0 113.041 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.7 Cg_endo -59.81 -30.53 92.17 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 121.791 1.661 . . . . 0.0 111.048 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -59.84 -35.09 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.88 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -62.02 -52.89 62.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.342 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.0 OUTLIER -57.85 -46.48 84.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.095 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.444 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.71 -33.05 63.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.873 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -49.04 62.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 368' ' ' PHE . 15.9 mt -52.91 -34.52 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.946 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -61.09 -26.71 67.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.931 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -102.89 -63.73 1.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.869 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.558 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 10.3 m-85 -66.26 -77.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.591 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 354' ' ' PHE . 30.5 t0 9.41 62.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 107.08 35.09 2.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.226 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.96 -156.38 0.54 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -125.7 128.9 48.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.109 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.3 OUTLIER -89.41 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.842 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.58 28.39 0.76 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.655 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.04 -43.09 1.35 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.633 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 2.0 m-80 -81.83 169.99 16.7 Favored Pre-proline 0 C--O 1.22 -0.486 0 CA-C-N 116.974 0.387 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -97.88 142.05 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.514 2.81 . . . . 0.0 112.273 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 359' ' ' PHE . 3.4 pt -127.53 177.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.856 0.36 . . . . 0.0 111.512 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -145.03 101.61 3.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.752 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.473 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 61.2 t -88.92 138.15 19.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.761 0.315 . . . . 0.0 110.766 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.6 p -138.72 -164.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.331 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 5.2 m-85 . . . . . 0 C--N 1.333 -0.14 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.192 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 120.685 0.279 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -71.16 -37.02 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 m -90.57 136.63 32.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.417 HG12 ' CE2' ' A' ' 341' ' ' PHE . 6.1 pt -116.64 173.05 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CE2' ' CB ' ' A' ' 367' ' ' SER . 0.2 OUTLIER -135.66 120.99 19.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 111.051 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.37 127.1 55.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.802 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.13 130.49 52.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.031 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.79 72.28 0.67 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.909 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -135.71 -87.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.46 115.27 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.301 -0.952 . . . . 0.0 114.141 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 53.59 32.77 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 8.48 0.77 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.39 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 13.7 p -77.98 95.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 112.232 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.438 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.0 OUTLIER -136.4 146.81 46.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.083 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.98 -46.15 92.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.75 -41.82 87.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.901 0.382 . . . . 0.0 110.752 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.0 p -63.63 -41.65 98.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 34.1 t -73.56 -45.88 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -60.89 -29.96 69.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.564 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -74.3 -38.04 63.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.785 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.408 ' OH ' ' CE2' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.84 -21.82 20.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -91.89 11.42 24.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.5 24.05 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 111.079 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 -38.49 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.309 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.3 tp -75.66 -39.54 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.179 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -176.04 -166.9 34.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.82 139.41 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.745 0.307 . . . . 0.0 111.685 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.488 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 2.1 mt -94.16 138.69 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -48.0 91.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.239 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -68.34 145.37 54.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.839 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 8.4 m-20 -78.62 170.96 15.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.343 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 -16.18 12.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.957 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -99.6 -36.17 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.91 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 57.9 p -109.12 -5.95 15.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.032 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 56.42 17.94 20.6 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.268 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.94 154.92 53.27 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.649 0.262 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.488 ' HB3' ' CG2' ' A' ' 311' ' ' ILE . 68.1 Cg_exo -44.36 158.43 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.632 2.221 . . . . 0.0 112.712 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.5 OUTLIER -120.64 121.75 38.99 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.491 0.662 . . . . 0.0 111.674 -179.03 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 323' ' ' ASN . 2.3 mt -143.31 142.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.999 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 1.2 m-20 -103.19 148.5 25.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.138 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.402 ' CB ' ' CG2' ' A' ' 296' ' ' VAL . 0.9 OUTLIER -152.82 147.53 26.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.892 0.377 . . . . 0.0 111.072 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 179.84 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.4 ' CA ' ' HG ' ' A' ' 292' ' ' LEU . . . . . . . . 0 CA--C 1.517 0.2 0 N-CA-C 113.398 0.119 . . . . 0.0 113.398 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.445 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 12.3 mt-10 -141.99 131.38 23.68 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.752 -0.264 . . . . 0.0 111.165 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -161.65 140.51 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.781 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 288' ' ' PHE . 19.1 p -100.33 131.54 46.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.357 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 301' ' ' VAL . 75.1 t -110.64 122.04 64.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.586 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 67.0 m -98.41 147.33 24.82 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.161 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.492 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 63.1 m-85 -121.68 152.21 39.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.07 45.79 0.28 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.647 0.26 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 343' ' ' ASP . 2.7 p30 165.14 125.98 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.481 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.588 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 71.4 Cg_exo -50.89 -48.86 18.92 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.613 2.209 . . . . 0.0 113.671 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.2 Cg_endo -57.29 -30.8 88.89 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.921 1.748 . . . . 0.0 112.04 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.412 ' CB ' ' OD1' ' A' ' 343' ' ' ASP . 40.2 t -61.14 -40.31 93.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -56.04 -51.75 66.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.989 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.413 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.44 -45.26 95.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.112 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.08 -34.25 63.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.17 54.18 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.592 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 8.8 mt -55.74 -36.37 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.13 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.67 -26.59 67.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.744 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.52 ' CD1' ' CD2' ' A' ' 354' ' ' PHE . 1.3 t90 -82.41 -68.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.43 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.52 ' CD2' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.42 -78.54 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.536 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 31.13 51.11 0.12 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.86 22.09 1.84 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.096 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -84.63 -163.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.92 0.36 . . . . 0.0 110.093 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 10.8 mt-10 -119.17 130.87 55.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 364' ' ' ILE . 0.1 OUTLIER -90.81 101.22 13.97 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.649 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 44.41 29.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.026 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.58 -48.72 0.92 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.94 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -84.48 172.92 8.02 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 116.925 0.362 . . . . 0.0 110.668 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -94.1 145.02 1.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.218 2.612 . . . . 0.0 111.682 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 5.9 pt -116.69 178.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -148.28 100.89 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.068 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.44 131.08 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' SER . . . . . 0.517 ' CB ' ' CE2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -140.06 -164.0 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.923 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 351' ' ' ILE . 3.7 m-85 . . . . . 0 CA--C 1.529 0.145 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.637 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 5.5 p30 -102.14 -33.25 9.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 27.9 m -83.96 126.22 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.174 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 305' ' ' PHE . 13.6 pt -95.92 173.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.344 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.468 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -130.37 109.76 10.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.18 114.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -118.62 130.83 56.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.124 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 112.75 83.15 1.23 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.559 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 359' ' ' PHE . 1.9 mt -142.29 -78.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.828 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.21 -79.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.669 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -149.52 31.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.17 -17.97 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 292' ' ' LEU . 9.7 p -45.86 123.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.94 146.5 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.424 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.407 HG21 ' HB ' ' A' ' 322' ' ' ILE . 2.1 mp -64.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.151 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 18.5 pm0 -66.4 -34.76 78.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.121 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.0 m -73.65 -43.87 58.33 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.041 0.448 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 29.8 t -72.22 -36.4 55.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.338 0.589 . . . . 0.0 109.754 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.76 68.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.946 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.05 -41.25 62.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.773 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -97.39 -20.64 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.2 t80 -101.21 35.0 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.325 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 18.86 11.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -40.87 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.1 tp -72.35 -32.41 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.358 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . 0.405 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -161.08 -163.29 13.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.76 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.0 mt -111.08 115.69 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 2.2 mt -75.86 125.34 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -48.65 115.34 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 111.985 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -75.79 150.98 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.482 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -104.94 130.72 53.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -4.23 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 7.1 mptt -81.72 -36.64 28.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.443 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 0.4 OUTLIER -118.8 -30.98 4.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.21 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 96.78 14.39 43.47 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.882 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.472 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.18 162.03 44.03 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.901 0.351 . . . . 0.0 110.798 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 89.1 Cg_exo -44.56 162.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.78 2.32 . . . . 0.0 112.431 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.429 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -122.42 128.08 50.47 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.384 0.611 . . . . 0.0 111.758 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.407 ' HB ' HG21 ' A' ' 298' ' ' ILE . 4.9 mt -141.84 137.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -99.1 141.14 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.614 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.09 131.86 20.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 111.001 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.47 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.413 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -122.49 131.78 54.02 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -151.93 151.92 31.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.934 0.397 . . . . 0.0 111.965 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.468 HG22 ' CD1' ' A' ' 288' ' ' PHE . 22.3 p -106.05 126.4 52.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 73.3 t -99.49 128.61 51.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 83.5 p -85.44 152.45 23.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.53 148.71 52.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.64 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.52 -16.88 58.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.411 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.28 120.33 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.001 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.592 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.21 -51.07 7.13 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.655 2.237 . . . . 0.0 112.952 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.1 Cg_endo -53.69 -30.5 56.33 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.975 1.783 . . . . 0.0 111.241 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.405 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 14.2 t -57.24 -42.0 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.898 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 348' ' ' LYS . 0.3 OUTLIER -61.5 -53.02 61.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.5 18.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.97 -52.78 25.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.469 HD12 ' CZ ' ' A' ' 368' ' ' PHE . 11.4 mt -54.7 -36.66 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.367 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -26.18 66.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.816 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.1 t90 -98.29 -68.4 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 2.3 m-85 -66.68 -74.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 354' ' ' PHE . 25.7 t0 14.04 62.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.41 19.62 3.12 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.933 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 5.4 mtpt -87.05 -165.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.952 0.376 . . . . 0.0 110.687 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -121.74 142.47 50.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -111.13 101.68 10.18 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.824 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.75 28.74 6.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.32 -2.92 20.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.443 -0.885 . . . . 0.0 114.285 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.3 m-80 -117.79 170.07 6.74 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 117.594 0.697 . . . . 0.0 110.67 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -96.06 141.85 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.491 2.794 . . . . 0.0 111.77 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 3.4 pt -128.85 168.58 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.052 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.155 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 100.94 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.85 131.84 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.025 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -135.12 -173.91 3.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.469 ' CZ ' HD12 ' A' ' 351' ' ' ILE . 62.1 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.941 0.4 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 0.6 OUTLIER -50.97 -25.87 5.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.479 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -72.55 117.91 14.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.023 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 46.0 pt -107.7 169.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.406 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -134.0 122.4 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 111.094 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.441 HG21 ' CE2' ' A' ' 305' ' ' PHE . 2.4 t -110.02 127.64 66.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.6 mp0 -111.87 130.67 55.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.046 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.6 33.62 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.423 ' HA ' ' CD2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -59.71 -84.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 93.99 98.54 1.57 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.867 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.69 31.63 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.34 31.21 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 324' ' ' LEU . 4.0 t -75.91 70.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.403 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -129.37 146.61 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.587 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 298' ' ' ILE . 26.3 mm -71.45 -43.05 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.447 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.46 -40.67 89.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -42.65 83.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 66.4 t -71.43 -40.11 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.83 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.839 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -41.93 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.88 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.8 OUTLIER -88.02 -24.8 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.551 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.9 OUTLIER -97.43 30.54 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.121 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 306' ' ' LYS . 0.0 OUTLIER -114.77 1.81 14.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -85.4 -52.06 6.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.821 0.343 . . . . 0.0 111.144 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -28.19 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.0 -171.95 39.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.558 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 310' ' ' ILE . 4.4 mt -97.62 144.14 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 111.548 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 340' ' ' SER . 2.8 mt -97.86 127.01 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 29.0 mtmt -49.75 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.651 0.263 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -86.48 155.56 20.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.875 0.845 . . . . 0.0 111.504 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.552 ' HB3' ' OG1' ' A' ' 317' ' ' THR . 1.0 OUTLIER -71.12 98.37 1.66 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.195 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -46.4 -16.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.546 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 314' ' ' ASN . 20.3 mttm -92.5 -38.01 12.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 314' ' ' ASN . 47.9 p -103.62 -3.11 25.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 57.32 17.68 25.84 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.448 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -118.61 139.34 26.9 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.942 0.371 . . . . 0.0 111.252 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.3 Cg_exo -45.45 147.2 2.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.536 2.158 . . . . 0.0 112.406 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.4 mtp -107.74 123.07 47.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.42 0.629 . . . . 0.0 112.137 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 338' ' ' THR . 2.6 mp -143.02 139.74 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.567 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 5.1 m-80 -99.25 147.54 25.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.226 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.414 ' HB3' ' CG1' ' A' ' 296' ' ' VAL . 2.7 mt -128.08 150.22 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 179.849 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 9.5 pt-20 -153.14 157.33 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.642 0.258 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -160.87 156.91 25.74 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 111.762 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 288' ' ' PHE . 2.0 p -103.48 136.9 42.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.055 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.406 ' CG2' HG12 ' A' ' 301' ' ' VAL . 55.6 t -112.06 130.52 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 311' ' ' ILE . 16.5 m -86.32 153.1 22.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -129.35 135.89 49.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 111.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 19.2 m-20 -63.29 -35.89 81.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.327 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.44 118.97 33.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.586 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.3 Cg_exo -42.42 -51.02 5.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.87 2.38 . . . . 0.0 112.701 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.4 Cg_endo -56.08 -30.62 79.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.963 1.775 . . . . 0.0 111.282 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.2 t -60.99 -40.74 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.582 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 285' ' ' ASN . . . -56.32 -49.12 75.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.879 0.371 . . . . 0.0 110.468 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 348' ' ' LYS . 4.2 tppt? -59.42 -54.94 40.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.637 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.87 -35.37 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.699 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.81 35.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.33 0.586 . . . . 0.0 109.458 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 9.1 mt -54.08 -39.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.728 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.19 -26.64 18.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.77 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.543 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.3 t90 -106.85 -68.45 0.89 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.477 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 305' ' ' PHE . 4.8 m-85 -59.1 -9.96 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 41.6 t0 -71.87 62.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.276 0.489 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 128.07 35.75 0.5 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.906 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.496 ' HG3' ' CD1' ' A' ' 353' ' ' TRP . 36.4 mmtm -105.86 -173.83 2.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 5.7 mt-10 -116.66 133.1 56.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.134 0.492 . . . . 0.0 112.133 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.463 ' CZ ' ' CZ ' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -93.06 101.34 13.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.96 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 36.3 t 48.86 27.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.526 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.46 -45.01 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.737 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.9 OUTLIER -80.46 169.95 17.65 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 116.999 0.4 . . . . 0.0 111.037 -179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -94.63 145.16 1.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.397 2.731 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.4 pt -128.02 176.14 8.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.244 0.545 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -148.13 116.14 6.45 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' PHE . 40.5 t -109.53 135.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.949 0.404 . . . . 0.0 111.875 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' SER . . . . . 0.431 ' OG ' ' CE1' ' A' ' 288' ' ' PHE . 3.4 p -140.67 -163.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.951 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.902 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' ' 368' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.443 ' N ' ' ND2' ' A' ' 285' ' ' ASN . 0.1 OUTLIER -88.03 -31.59 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.282 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.6 m -88.04 134.2 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 305' ' ' PHE . 17.8 pt -110.79 173.38 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.476 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.418 ' CD2' ' OE1' ' A' ' 290' ' ' GLN . 1.4 t80 -127.8 108.15 10.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.5 114.81 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.5 mp0 -111.76 130.25 55.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 120.18 37.67 0.73 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.666 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 359' ' ' PHE . 2.8 mm? -79.04 -89.1 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.557 0.218 . . . . 0.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.34 104.93 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.293 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 77.01 43.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.784 0.325 . . . . 0.0 111.37 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -168.45 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 295' ' ' ASN . 8.7 p -19.06 94.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 295' ' ' ASN . 7.5 p -164.01 146.43 9.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.327 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.34 -42.27 74.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.986 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -43.15 86.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.9 p -65.03 -38.45 90.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 69.5 t -74.6 -40.62 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 109.729 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.43 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -74.35 -36.12 63.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.893 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.18 -24.23 16.36 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.586 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -95.47 27.78 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 111.283 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 22.09 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.085 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -105.33 -28.83 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.546 HD12 ' CE3' ' A' ' 353' ' ' TRP . 1.1 tp -83.91 -30.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -178.78 -162.33 28.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.4 mt -98.68 142.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.628 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.0 mp -98.43 136.11 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.569 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 321' ' ' MET . 2.7 mmtp -48.88 95.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.47 146.63 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.724 ' ND2' ' OG1' ' A' ' 317' ' ' THR . 0.1 OUTLIER -101.06 145.79 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 111.433 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -77.19 -7.59 56.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.904 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -83.16 -51.04 7.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.724 ' OG1' ' ND2' ' A' ' 314' ' ' ASN . 8.3 p -108.1 -7.31 16.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.526 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.63 15.69 66.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.393 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.415 ' H ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.9 164.37 23.89 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.807 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.517 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 57.7 Cg_exo -45.1 162.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.146 2.564 . . . . 0.0 113.456 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 17.4 mtm -123.29 118.68 28.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 49.3 mt -141.56 149.98 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.346 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -114.14 148.03 37.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 296' ' ' VAL . 2.1 mt -131.69 168.61 17.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.419 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 2.3 mp0 -131.59 134.4 46.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.965 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.17 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.958 0.409 . . . . 0.0 111.447 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.4 p -109.53 119.55 39.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 341' ' ' PHE . 1.2 t -93.91 123.04 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.86 129.97 41.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.824 0.345 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 339' ' ' VAL . 17.6 m-85 -109.71 150.26 28.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.57 -16.84 60.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.35 116.46 23.31 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 78.1 Cg_exo -44.82 -50.82 8.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.35 2.034 . . . . 0.0 112.602 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 9.7 Cg_endo -53.16 -30.42 50.38 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.016 1.811 . . . . 0.0 111.041 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 12.4 t -55.82 -48.75 74.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -53.32 -44.86 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.926 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 348' ' ' LYS . 0.2 OUTLIER -58.37 -54.28 48.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.063 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.5 -39.0 15.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.786 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.486 ' HA ' HD11 ' A' ' 308' ' ' ILE . . . -68.72 -45.82 70.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.362 0.601 . . . . 0.0 109.761 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 368' ' ' PHE . 7.9 mt -60.92 -32.39 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.433 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.67 -40.64 95.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.34 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.606 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -106.14 -45.54 4.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 356' ' ' GLY . 2.7 m-85 -59.22 -75.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.581 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.0 t0 1.04 63.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.211 0.944 . . . . 0.0 112.355 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 110.94 36.47 1.84 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.429 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 354' ' ' PHE . 7.9 ptmt -97.83 -158.37 0.66 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.576 0.227 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 33.0 mt-10 -113.89 128.88 56.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.045 0.45 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -122.89 105.72 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.299 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.3 m 59.76 30.09 19.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.75 57.86 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.04 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 7.2 m-80 -129.27 167.01 21.45 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.832 0.316 . . . . 0.0 111.037 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.36 128.8 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.924 2.416 . . . . 0.0 111.929 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 3.9 pt -124.68 168.58 17.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.599 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -139.1 102.42 4.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.068 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.13 134.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.02 -173.12 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.99 0.424 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 2.7 m-85 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.831 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.428 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.88 0.371 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 20.8 p30 -99.39 -18.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.979 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -71.06 117.56 12.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 287' ' ' ILE . 36.6 pt -105.15 164.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -126.34 117.22 22.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.146 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 364' ' ' ILE . 1.0 OUTLIER -110.0 114.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.131 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 288' ' ' PHE . 47.6 mm-40 -112.58 132.77 54.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.056 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.25 75.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.767 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.437 ' CD2' ' CE2' ' A' ' 359' ' ' PHE . 1.6 mp -124.48 -76.41 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.667 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 126.17 65.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.194 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 44.25 30.36 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.61 4.64 4.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.254 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 337' ' ' ALA . 11.1 p -66.51 109.45 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.99 0.424 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.0 OUTLIER -119.07 151.3 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.489 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.6 mm -63.18 -47.91 90.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.492 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.53 -42.18 87.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.8 p -65.81 -41.44 91.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.788 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 75.8 t -73.03 -40.51 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.14 -29.87 68.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.968 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -40.01 65.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.641 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.459 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.75 -22.46 29.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.42 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -90.12 7.13 39.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.423 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 14.86 15.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.644 0.259 . . . . 0.0 111.424 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.55 -31.98 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.11 -35.84 8.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.341 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.18 -169.61 35.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.8 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 13.0 mt -92.76 144.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 111.665 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.2 mt -97.64 125.13 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.482 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.7 OUTLIER -52.72 91.66 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.338 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -80.96 167.18 20.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.242 0.544 . . . . 0.0 110.715 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.597 ' OD1' ' OG1' ' A' ' 317' ' ' THR . 0.4 OUTLIER -90.13 143.29 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.878 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -80.45 -3.18 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -94.44 -45.35 7.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.493 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 81.4 p -108.45 -4.63 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.93 43.24 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.368 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.34 144.17 31.21 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.319 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.1 Cg_exo -45.06 147.97 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.523 2.149 . . . . 0.0 112.068 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.44 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 6.7 mtp -114.23 125.55 54.04 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 112.046 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 339' ' ' VAL . 74.4 mt -143.17 137.81 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.996 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -97.63 120.72 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.031 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 337' ' ' ALA . 0.6 OUTLIER -110.07 149.8 29.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.0 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.767 179.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.01 159.68 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 324' ' ' LEU . . . -165.19 150.9 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 56.3 p -95.59 128.34 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.654 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 322' ' ' ILE . 82.0 t -107.39 134.45 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.841 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 33.1 m -94.51 138.73 32.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.904 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 312' ' ' LYS . 3.3 m-85 -115.51 142.45 46.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 111.547 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 1.4 t70 -65.43 -20.75 66.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.753 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -128.69 115.32 19.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.567 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 73.7 Cg_exo -47.24 -51.58 9.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.538 2.158 . . . . 0.0 112.683 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.1 Cg_endo -57.69 -30.86 90.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.981 1.787 . . . . 0.0 111.19 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -36.41 81.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.569 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.54 93.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.658 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.407 ' C ' ' CD ' ' A' ' 348' ' ' LYS . 0.3 OUTLIER -61.89 -54.97 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.878 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.55 10.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.993 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.7 -49.33 59.8 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.439 0.638 . . . . 0.0 109.613 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 355' ' ' ASP . 11.7 mt -56.39 -36.17 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.363 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.87 -26.85 65.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.1 t90 -86.78 -68.21 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.063 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' A' ' 355' ' ' ASP . 10.6 m-85 -69.65 -77.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.614 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.9 t70 21.16 55.51 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.473 0.483 . . . . 0.0 111.401 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.2 22.16 1.95 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.446 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -80.11 -165.61 0.87 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.737 0.303 . . . . 0.0 111.416 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -114.93 142.11 47.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.669 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.504 ' HB2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -124.55 101.41 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.777 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.68 26.41 3.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.245 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 99.79 24.09 10.25 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.893 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 65.9 m-80 -129.95 153.65 81.03 Favored Pre-proline 0 C--O 1.225 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.776 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.02 136.01 8.98 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.577 2.185 . . . . 0.0 111.711 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 359' ' ' PHE . 9.1 pt -130.47 154.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -124.87 100.74 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.96 118.96 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.36 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' SER . . . . . 0.416 ' HA ' HG12 ' A' ' 351' ' ' ILE . 1.4 m -140.2 176.68 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.428 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 1.2 m-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.981 0.419 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 20.7 p30 -51.94 -28.38 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 86.1 m -76.0 132.24 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.439 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 37.0 pt -117.86 168.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.48 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 1.5 m-30 -117.39 106.73 13.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.71 114.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -132.1 132.17 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.647 0.261 . . . . 0.0 111.48 -179.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 364' ' ' ILE . . . 121.07 79.99 0.57 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.533 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -155.79 -90.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.801 -0.235 . . . . 0.0 111.116 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.441 ' H ' ' CG ' ' A' ' 292' ' ' LEU . . . 157.12 -92.5 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -126.0 28.07 6.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 297' ' ' THR . 0.8 OUTLIER -114.71 -14.48 12.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.04 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 9.8 p -52.24 88.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 295' ' ' ASN . 0.6 OUTLIER -128.88 147.16 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.21 -47.35 93.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.54 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -65.32 -39.36 92.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 24.7 p -68.59 -43.27 76.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.57 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 60.6 t -69.75 -37.84 74.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.495 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 306' ' ' LYS . . . -68.71 -30.86 69.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -35.73 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -103.81 -19.94 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.8 OUTLIER -99.43 -15.28 18.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -83.46 7.4 17.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.419 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -51.93 6.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 350' ' ' ALA . 0.6 OUTLIER -59.81 -33.53 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.587 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 308' ' ' ILE . . . -155.51 -177.84 29.15 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.251 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.84 105.86 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 52.5 mt -71.93 130.16 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 92.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -67.39 140.48 57.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.708 177.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -96.25 145.57 25.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 111.828 -179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -79.81 -4.12 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -90.57 -49.8 6.29 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.991 0.424 . . . . 0.0 110.197 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.2 p -104.98 -8.69 18.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.804 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 69.44 10.19 62.72 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.419 ' CA ' HG21 ' A' ' 313' ' ' THR . 0.0 OUTLIER -125.2 153.95 71.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 117.127 0.464 . . . . 0.0 110.99 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.7 Cg_endo -46.59 153.13 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.006 2.471 . . . . 0.0 112.77 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -105.03 120.96 42.77 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 111.262 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.406 HG21 ' N ' ' A' ' 323' ' ' ASN . 4.0 mt -139.55 142.01 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.031 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.406 ' N ' HG21 ' A' ' 322' ' ' ILE . 3.8 m-80 -104.5 148.22 26.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.17 114.85 12.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.705 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 336' ' ' GLU . 7.5 m-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 290' ' ' GLN . 29.7 mt-10 -147.2 131.61 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.665 0.269 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -150.14 145.55 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.48 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 16.2 p -108.8 118.85 37.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 78.9 t -94.26 126.77 46.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.246 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.72 121.93 37.95 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.876 0.37 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.48 155.44 16.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -25.86 40.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.644 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.7 117.05 22.6 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.565 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.8 Cg_exo -43.26 -51.43 5.79 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 113.107 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.3 Cg_endo -56.48 -30.63 82.95 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 121.956 1.771 . . . . 0.0 111.359 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.2 t -60.51 -37.63 81.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.883 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.21 70.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -59.86 -43.01 94.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 110.056 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.29 62.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 308' ' ' ILE . . . -68.59 -48.04 65.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 33.1 mt -52.46 -31.14 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.323 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -26.69 68.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -107.19 -61.93 1.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.514 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.523 ' O ' ' N ' ' A' ' 356' ' ' GLY . 66.3 m-85 -56.75 -74.85 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.029 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 354' ' ' PHE . 36.6 t0 2.94 65.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.046 0.841 . . . . 0.0 112.511 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 113.69 26.03 4.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.565 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 11.8 mm-40 -123.6 131.23 53.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -91.63 101.41 14.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.144 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 33.9 t 45.77 29.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.13 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.25 -46.98 1.01 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.0 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.3 OUTLIER -84.85 169.67 15.8 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 116.991 0.395 . . . . 0.0 110.697 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -96.31 138.86 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.391 2.727 . . . . 0.0 112.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 7.6 pt -116.97 -179.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 120.834 0.349 . . . . 0.0 111.426 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -148.31 100.51 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.01 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.92 128.03 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.708 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 92.5 p -140.51 -173.94 3.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.174 0.511 . . . . 0.0 112.048 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.35 179.449 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -61.61 -18.22 58.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.79 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -73.53 106.16 5.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 287' ' ' ILE . 16.2 pt -102.22 171.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.785 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.471 ' CZ ' ' CG2' ' A' ' 338' ' ' THR . 4.2 m-85 -125.33 113.54 17.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.35 114.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.223 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 30.9 mm-40 -111.6 130.76 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.351 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 114.08 81.45 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.348 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.407 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.3 OUTLIER -128.44 -74.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 124.52 -76.24 0.38 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.108 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.21 28.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.919 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.457 ' C ' ' ND2' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -116.28 -8.78 11.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.834 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 324' ' ' LEU . 13.1 p -47.73 107.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.88 146.78 9.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.016 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 11.3 mt -63.75 -46.03 95.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -66.68 -41.93 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.358 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.3 p -67.08 -40.97 87.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 60.7 t -73.94 -38.16 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.233 0.539 . . . . 0.0 109.662 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.66 72.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.82 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -74.33 -35.65 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.001 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.22 -24.38 19.91 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -98.21 26.65 5.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.6 25.68 10.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.877 0.37 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -107.15 -44.19 4.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.7 tp -74.1 -28.35 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -174.68 -164.68 29.91 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.759 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.97 132.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mp -81.53 128.01 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 321' ' ' MET . 5.0 mtmp? -55.35 100.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.182 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 1.7 m -63.94 154.5 33.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.259 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.551 ' HB2' ' HG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -93.6 138.95 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 3.73 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.921 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -111.65 -20.92 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.292 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.551 ' HG1' ' HB2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.27 -21.8 6.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.562 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.75 13.62 80.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.543 ' O ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -124.43 162.63 41.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.506 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 93.1 Cg_exo -47.63 148.26 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.533 2.155 . . . . 0.0 112.152 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 72.0 mtp -101.33 114.71 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.26 139.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.044 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.2 144.17 31.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 296' ' ' VAL . 0.3 OUTLIER -136.9 144.96 43.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.017 179.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.407 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 11.3 pt-20 -152.35 144.95 24.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 111.006 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.26 141.72 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.25 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.471 ' CG2' ' CZ ' ' A' ' 288' ' ' PHE . 3.7 p -92.1 138.83 31.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.706 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 301' ' ' VAL . 90.4 t -116.89 127.75 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 94.5 p -101.4 125.82 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.55 153.09 22.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.42 -26.49 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.326 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.96 111.16 48.25 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.954 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.584 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.4 Cg_exo -43.52 -51.04 6.38 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.53 2.153 . . . . 0.0 112.454 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.1 Cg_endo -55.35 -30.67 73.77 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.928 1.752 . . . . 0.0 111.149 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.7 t -58.98 -43.18 91.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.664 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.79 71.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.33 -52.7 62.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.708 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.79 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.819 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.99 74.02 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 8.1 mt -61.72 -35.79 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.99 -26.34 67.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.6 t90 -96.52 -68.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.939 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.536 ' O ' ' C ' ' A' ' 355' ' ' ASP . 16.3 m-85 -62.54 -74.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 354' ' ' PHE . 26.2 t70 11.86 63.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.811 0.694 . . . . 0.0 112.16 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 114.83 25.05 4.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.656 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 19.5 mmtt -87.54 -167.87 2.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -119.93 131.93 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 112.228 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.512 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -96.23 101.36 12.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.953 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.6 p 51.44 28.2 4.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.15 -42.49 1.55 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.28 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.643 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -78.05 172.32 10.15 Favored Pre-proline 0 C--O 1.221 -0.405 0 CA-C-N 116.667 0.233 . . . . 0.0 110.767 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -94.32 146.92 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.277 2.652 . . . . 0.0 112.054 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 3.1 pt -123.59 171.26 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 111.822 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -148.29 104.02 3.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.39 139.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.307 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.04 -172.1 3.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 351' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.68 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.171 0.51 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.467 ' ND2' ' CB ' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -52.87 -34.55 55.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.603 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 99.6 m -62.07 97.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 43.5 pt -86.55 170.59 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.1 OUTLIER -118.39 118.59 32.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 365' ' ' LYS . 0.2 OUTLIER -108.69 115.28 48.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.538 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -116.43 130.83 56.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.376 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.11 0.58 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.294 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -105.57 -83.55 0.51 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.905 0.352 . . . . 0.0 110.486 179.448 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.57 -50.14 2.83 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.214 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -107.75 40.0 1.81 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.186 0.493 . . . . 0.0 111.951 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -143.56 -42.28 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.039 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 295' ' ' ASN . 96.4 t 6.27 65.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 296' ' ' VAL . 39.4 p -161.92 145.58 12.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.731 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.77 -40.3 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.15 -42.81 88.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' SER . . . . . 0.422 ' HB3' ' OG1' ' A' ' 297' ' ' THR . 21.6 p -63.18 -41.49 99.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.473 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 34.9 t -70.72 -47.67 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.9 70.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.922 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.1 -40.67 71.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.756 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.69 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -88.83 9.99 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 20.99 13.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -102.32 -39.21 7.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.406 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.3 tp -76.81 -38.39 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.052 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -168.01 -162.97 21.12 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.528 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.6 mt -98.31 137.07 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.53 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.8 mt -96.73 136.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 4.1 mmtt -48.42 106.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.052 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -77.67 142.87 38.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.569 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.62 140.3 29.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 0.0 111.387 -179.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -77.86 -6.18 53.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.91 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -45.13 7.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.37 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 70.8 p -104.63 -8.25 19.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 63.95 14.22 55.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.235 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.14 164.08 34.01 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 120.485 0.183 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.563 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 79.3 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.44 2.093 . . . . 0.0 112.299 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.569 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.64 125.1 51.29 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.569 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 323' ' ' ASN . 4.6 mt -143.28 144.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.166 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.424 ' N ' HG21 ' A' ' 322' ' ' ILE . 1.2 m-20 -110.34 147.84 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.703 0.287 . . . . 0.0 110.455 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 324' ' ' LEU . 0.0 OUTLIER -145.48 130.14 18.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.111 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.511 179.679 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 0.6 OUTLIER -143.02 143.4 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.36 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.26 139.85 13.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.237 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.469 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 11.9 p -97.61 134.15 41.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 305' ' ' PHE . 95.0 t -112.0 126.06 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.522 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 312' ' ' LYS . 0.1 OUTLIER -86.18 153.26 22.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.467 ' CB ' ' ND2' ' A' ' 285' ' ' ASN . 4.5 m-85 -133.51 147.0 51.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.42 -33.22 48.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.65 118.07 41.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.648 0.261 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.552 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.5 Cg_exo -41.84 -51.69 4.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.876 2.384 . . . . 0.0 113.081 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.2 Cg_endo -55.6 -30.28 74.06 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.775 1.65 . . . . 0.0 111.089 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.8 t -56.64 -44.82 81.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.04 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -53.4 -50.34 65.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.63 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.48 ' C ' ' CD ' ' A' ' 348' ' ' LYS . 0.0 OUTLIER -63.9 -54.85 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.156 0.503 . . . . 0.0 109.749 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.92 14.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.58 -48.56 63.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 9.0 mt -58.93 -35.99 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.371 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -61.91 -26.2 68.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.242 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.6 t90 -94.37 -68.57 0.79 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.508 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 1.5 m-85 -69.79 -77.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.8 p-10 23.17 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.115 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.45 20.33 2.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.316 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.428 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 9.1 mtpp -87.02 -166.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.061 0.43 . . . . 0.0 110.472 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 13.3 mm-40 -120.02 128.91 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.419 . . . . 0.0 112.093 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -84.2 100.84 11.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.743 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.49 31.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 142.51 -51.62 0.67 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.186 -1.006 . . . . 0.0 114.048 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.4 OUTLIER -89.16 171.61 8.7 Favored Pre-proline 0 C--O 1.218 -0.59 0 CA-C-N 117.008 0.404 . . . . 0.0 110.743 -179.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.48 143.36 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.308 2.672 . . . . 0.0 112.193 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.492 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 3.9 pt -132.03 170.06 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 111.978 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -132.62 150.92 52.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.777 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 351' ' ' ILE . 11.6 t -131.6 127.74 59.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.8 p -140.24 172.92 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 351' ' ' ILE . 4.3 m-85 . . . . . 0 C--N 1.332 -0.154 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.088 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.487 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 3.8 p-10 -86.45 -19.14 30.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 74.6 m -80.42 144.98 32.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.769 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.2 pt -123.36 168.33 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.764 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.6 OUTLIER -124.06 114.95 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.174 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.63 114.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -112.74 144.18 42.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.678 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.51 4.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.731 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 7.2 mt -60.51 -76.76 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.618 0.247 . . . . 0.0 110.743 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.3 77.72 0.77 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.392 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 43.93 30.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.632 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.33 25.34 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.729 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 324' ' ' LEU . 21.5 t -68.17 83.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.7 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.44 147.99 49.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.588 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.4 mm -68.54 -47.02 79.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -38.64 87.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.7 t -63.96 -40.28 96.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 54.6 t -74.9 -41.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.862 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 306' ' ' LYS . . . -68.18 -29.93 68.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.837 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -74.11 -40.47 62.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.632 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -94.07 -21.83 18.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -105.33 38.13 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.02 19.11 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.305 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -36.45 8.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.301 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.0 tp -75.48 -30.1 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.465 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . 0.422 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -168.16 -167.38 28.73 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.91 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.69 116.71 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mt -76.81 124.02 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.313 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 321' ' ' MET . 23.9 mtmt -48.72 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -69.64 152.04 45.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.747 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.23 144.59 25.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.8 1.5 52.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.279 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.26 -32.1 7.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.845 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.403 ' HB ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -107.39 -20.67 13.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.752 179.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.37 8.59 71.15 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.776 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 314' ' ' ASN . 0.1 OUTLIER -125.12 167.42 16.3 Favored Pre-proline 0 C--O 1.224 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.538 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 66.8 Cg_exo -44.78 149.37 1.14 Allowed 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.708 2.272 . . . . 0.0 113.041 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 312' ' ' LYS . 36.7 mtp -101.94 121.56 42.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.835 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.434 HG21 ' O ' ' A' ' 338' ' ' THR . 1.2 mt -143.25 138.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.83 140.41 33.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.808 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 296' ' ' VAL . 5.2 mt -126.7 142.61 51.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.034 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.22 136.5 15.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 0.0 111.236 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.88 153.02 25.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.451 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -102.67 145.83 29.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.428 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.27 128.51 70.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.206 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 59.7 p -97.57 124.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.902 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -102.06 154.87 18.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.69 -21.09 38.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -125.98 118.36 23.9 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.683 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.589 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.1 Cg_exo -41.31 -50.81 4.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.733 2.289 . . . . 0.0 112.983 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.3 Cg_endo -53.03 -30.54 49.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.956 1.771 . . . . 0.0 111.219 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.422 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 25.6 t -57.26 -44.92 84.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.97 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 368' ' ' PHE . . . -56.35 -49.22 75.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.457 ' C ' ' HD3' ' A' ' 348' ' ' LYS . 0.7 OUTLIER -62.05 -49.97 73.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.003 0.43 . . . . 0.0 110.01 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.88 38.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.731 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.09 64.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.452 0.644 . . . . 0.0 109.382 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 10.5 mt -58.26 -35.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.158 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.17 -26.62 65.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.159 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.519 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -89.2 -68.01 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.334 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.601 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -75.64 -81.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.614 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.5 p-10 31.26 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.549 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 126.02 43.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.773 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.601 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.79 -157.2 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 27.7 tt0 -113.58 128.32 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.41 0.624 . . . . 0.0 111.518 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 304' ' ' TYR . 0.9 OUTLIER -112.46 101.66 9.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.957 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.7 t 55.43 26.55 8.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.068 0.461 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 94.66 24.83 16.89 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.74 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -129.94 148.57 70.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.822 0.344 . . . . 0.0 111.848 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.07 121.71 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.479 2.119 . . . . 0.0 111.447 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 8.7 pt -112.33 -178.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.961 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.12 101.04 3.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.673 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.407 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 40.8 t -88.64 133.52 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 86.6 p -127.53 -179.89 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.195 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . 0.487 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.693 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.8 p30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -58.41 -21.3 50.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.691 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 340' ' ' SER . 0.3 OUTLIER -84.56 143.04 29.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.59 HG12 HG13 ' A' ' 339' ' ' VAL . 2.0 pt -117.26 172.17 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.047 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 1.5 p90 -125.48 122.29 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.876 0.37 . . . . 0.0 111.459 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.34 114.86 45.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.93 131.0 57.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.06 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 106.75 43.15 1.46 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.976 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.5 OUTLIER -85.67 -79.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.791 0.296 . . . . 0.0 110.678 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 136.39 -81.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.546 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.13 29.74 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.92 0.39 . . . . 0.0 110.575 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -111.65 7.92 20.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.94 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 324' ' ' LEU . 10.0 t -55.52 89.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.529 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -147.52 146.44 29.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mm -71.43 -45.28 69.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.684 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.96 -43.09 84.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.073 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -40.0 82.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 54.2 t -73.58 -37.96 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.715 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 320' ' ' PRO . . . -68.61 -34.52 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.36 -38.02 71.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.092 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -85.54 -20.91 28.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.714 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -92.15 11.76 24.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 29.02 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.071 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -112.54 -33.8 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 7.8 tp -84.4 -31.8 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.71 -160.73 26.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.732 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.0 mt -92.85 134.63 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.562 0.22 . . . . 0.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 4.6 mt -92.93 134.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.378 0.608 . . . . 0.0 110.945 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.7 OUTLIER -48.56 100.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.411 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -76.21 154.25 35.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 318' ' ' GLY . 17.6 p30 -103.03 -178.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.018 0.437 . . . . 0.0 111.644 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.41 ' CD ' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -109.42 -12.46 14.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.172 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 -44.75 11.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.156 0.503 . . . . 0.0 109.999 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 8.5 p -106.37 -8.42 17.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.766 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 314' ' ' ASN . . . 61.23 17.39 52.36 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.671 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.7 168.03 14.32 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 120.776 0.322 . . . . 0.0 110.894 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.536 ' N ' ' HG2' ' A' ' 319' ' ' GLN . 80.4 Cg_exo -44.54 161.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.988 2.459 . . . . 0.0 112.726 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -123.08 129.43 51.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.296 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.45 HG12 ' CG2' ' A' ' 339' ' ' VAL . 3.7 mp -144.38 129.23 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.15 115.52 28.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.416 ' CD2' HG11 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -121.56 148.77 44.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.776 179.876 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.18 140.55 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.62 0.247 . . . . 0.0 110.703 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 324' ' ' LEU . . . -160.39 179.11 8.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.783 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 69.4 p -129.91 136.47 49.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.406 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.59 HG13 HG12 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -104.37 125.11 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.268 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 321' ' ' MET . 3.1 p -94.56 140.07 30.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.047 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.455 ' CE2' HD12 ' A' ' 287' ' ' ILE . 32.2 m-85 -115.5 160.16 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 111.069 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -80.63 -18.15 49.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.25 116.87 20.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.592 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.7 Cg_exo -44.77 -50.52 8.34 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.653 2.235 . . . . 0.0 112.907 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.1 Cg_endo -54.58 -30.51 65.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.003 1.802 . . . . 0.0 111.401 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.9 t -58.67 -41.21 85.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -56.05 -50.1 71.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.456 ' C ' ' HD3' ' A' ' 348' ' ' LYS . 0.4 OUTLIER -59.39 -50.64 73.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.175 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.56 -33.78 33.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.84 -48.33 63.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.433 0.635 . . . . 0.0 109.391 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 10.4 mt -56.87 -35.97 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.15 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -26.65 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.152 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.34 -68.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.054 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.504 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 5.1 m-85 -76.17 -79.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.483 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 354' ' ' PHE . 45.5 t0 21.44 51.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.439 0.462 . . . . 0.0 112.021 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 125.32 32.02 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.256 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -102.74 -162.87 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.087 0.443 . . . . 0.0 110.087 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 8.5 mt-10 -113.72 128.6 56.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.994 0.426 . . . . 0.0 111.866 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -102.79 101.72 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.266 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 41.0 t 60.01 28.38 17.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.486 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.32 -27.8 10.33 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.592 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 3.1 m-80 -91.76 169.54 11.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.956 0.378 . . . . 0.0 110.64 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -93.34 137.18 1.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 112.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 23.3 pt -134.36 164.52 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 120.977 0.417 . . . . 0.0 111.804 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 100.53 5.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 287' ' ' ILE . 19.5 t -90.02 118.66 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -140.53 -166.75 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.014 0.435 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -104.1 -25.15 13.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 58.9 m -70.52 116.23 10.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.8 pt -102.93 173.17 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.175 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.436 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.4 OUTLIER -122.46 107.69 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.421 ' O ' ' NE2' ' A' ' 290' ' ' GLN . 2.7 t -104.35 114.48 44.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.424 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 2.0 mp0 -116.78 130.5 56.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.98 25.77 1.64 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.849 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 292' ' ' LEU . 4.9 mp -88.05 -104.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.94 -39.7 1.82 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.594 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.93 31.82 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.654 0.727 . . . . 0.0 112.036 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.5 OUTLIER -162.51 -44.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 14.7 t 26.48 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.639 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -164.48 145.2 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.101 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 298' ' ' ILE . 1.2 mp -72.21 -42.1 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.998 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.44 -40.54 95.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.4 t -65.08 -43.99 90.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.468 . . . . 0.0 110.478 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 47.7 t -70.92 -40.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.353 0.597 . . . . 0.0 109.664 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.18 -29.82 68.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.024 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -37.7 65.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.685 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.438 ' OH ' ' CE1' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.57 -24.79 15.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.518 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -93.27 7.98 42.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -95.56 22.41 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 111.076 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.21 -44.35 6.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.94 -29.33 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.477 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.73 -170.52 35.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.943 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.29 113.85 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.689 0.281 . . . . 0.0 111.513 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 1.1 mt -71.65 135.16 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 0.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 321' ' ' MET . 6.1 mmmt -65.37 91.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -67.33 171.02 6.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 111.043 178.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 316' ' ' LYS . 0.4 OUTLIER -103.35 116.34 32.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.354 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -8.26 0.16 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.574 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -83.27 -34.49 25.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.064 0.459 . . . . 0.0 110.59 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.461 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.5 OUTLIER -121.62 -23.48 5.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.338 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.84 23.43 52.78 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.908 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.461 ' HG2' HG21 ' A' ' 317' ' ' THR . 2.7 pp0? -118.57 138.1 25.49 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.884 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 4.8 Cg_exo -44.01 131.04 8.32 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.999 2.466 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 0.0 OUTLIER -97.15 130.18 44.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.839 0.828 . . . . 0.0 112.929 -178.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 3.7 mt -143.14 140.22 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.428 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.439 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 6.2 t30 -98.8 148.38 23.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 337' ' ' ALA . 0.2 OUTLIER -154.42 128.17 8.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.943 0.401 . . . . 0.0 111.496 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.952 179.198 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 4.9 mp0 -130.16 132.16 45.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.502 0.191 . . . . 0.0 110.562 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -153.27 147.05 25.22 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.436 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 44.3 p -110.33 117.8 34.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.918 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.06 130.15 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.739 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 9.1 t -96.72 133.62 41.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.907 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.412 ' O ' ' HG3' ' A' ' 312' ' ' LYS . 3.0 m-85 -117.41 148.35 41.85 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -70.95 -34.32 71.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.49 109.45 60.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.584 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.28 -51.41 6.85 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.478 2.119 . . . . 0.0 112.496 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.3 Cg_endo -55.76 -30.58 76.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.945 1.763 . . . . 0.0 111.262 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -60.54 -44.21 96.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.21 81.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.287 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -60.16 -54.74 42.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.847 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.54 43.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.63 -49.68 57.28 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.543 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 9.9 mt -52.47 -36.66 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.763 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -58.38 -26.24 62.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.577 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.544 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.4 t90 -100.5 -68.6 0.8 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.518 ' CE2' ' CE1' ' A' ' 305' ' ' PHE . 47.2 m-85 -56.85 -74.48 0.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.4 p-10 9.35 59.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.973 0.796 . . . . 0.0 112.684 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.81 30.69 1.76 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.13 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.409 ' HG3' ' CG1' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -94.75 -164.45 1.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 7.7 mm-40 -119.4 129.38 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.621 -0.432 . . . . 0.0 112.122 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.3 OUTLIER -86.09 101.05 12.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 40.5 30.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.358 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 140.49 -49.72 0.78 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.28 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.0 OUTLIER -89.7 171.1 9.26 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 117.207 0.504 . . . . 0.0 110.958 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -95.15 140.17 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.468 2.779 . . . . 0.0 112.153 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 359' ' ' PHE . 5.1 pt -122.28 -179.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.865 0.364 . . . . 0.0 111.652 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.27 102.45 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.548 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.85 143.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.2 t -128.08 -168.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 9.9 p30 -63.9 -20.28 65.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 27.8 m -71.44 158.28 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 10.2 pt -142.94 173.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.1 OUTLIER -131.09 112.35 12.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.016 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.417 ' O ' ' NE2' ' A' ' 290' ' ' GLN . 0.5 OUTLIER -105.35 114.69 45.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.741 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.1 mp0 -113.37 130.59 56.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.034 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.03 0.89 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.387 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . 0.473 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.3 OUTLIER -84.56 -73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.108 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.27 105.12 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.392 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.18 46.6 19.74 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -165.69 26.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 110.796 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.415 ' CG1' ' CB ' ' A' ' 324' ' ' LEU . 18.0 t -79.17 100.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.564 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.36 147.0 25.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.585 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 298' ' ' ILE . 28.3 mm -70.93 -44.73 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.399 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.72 -39.19 87.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.7 t -68.22 -42.92 79.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.586 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 90.8 t -71.41 -40.01 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.564 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.46 -29.9 68.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.832 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.9 -38.73 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.721 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.81 -24.81 28.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.564 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 1.1 m-85 -85.67 1.13 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.769 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 12.81 15.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.622 0.248 . . . . 0.0 111.356 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.58 -45.11 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.043 0.449 . . . . 0.0 110.458 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.1 tp -76.32 -36.64 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.26 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -171.78 -158.72 16.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.913 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.48 144.16 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.742 0.306 . . . . 0.0 111.536 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.2 mt -96.15 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.86 93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.42 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -71.74 152.57 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.458 ' HB2' ' HG3' ' A' ' 321' ' ' MET . 0.7 OUTLIER -107.74 110.9 22.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.806 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -8.52 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.434 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 15.1 mmtt -89.35 -25.7 21.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.994 0.426 . . . . 0.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' THR . . . . . 0.534 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 74.9 p -122.06 -24.03 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.56 16.0 76.72 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.692 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLN . . . . . 0.534 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.58 160.08 57.57 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 0.0 111.619 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' PRO . . . . . 0.438 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 83.9 Cg_exo -50.5 156.9 3.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.776 2.317 . . . . 0.0 112.279 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.486 ' O ' ' OG ' ' A' ' 340' ' ' SER . 0.1 OUTLIER -121.35 122.94 40.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.224 0.535 . . . . 0.0 111.346 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 339' ' ' VAL . 47.9 mt -143.64 146.27 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.443 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.45 134.26 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.611 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.415 ' CB ' ' CG1' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -136.34 143.55 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.77 -179.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.74 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 37.8 mt-10 -148.5 131.99 16.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.686 0.279 . . . . 0.0 111.216 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.04 133.38 7.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 111.765 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' THR . . . . . 0.461 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 20.4 p -91.91 130.38 37.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.15 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 322' ' ' ILE . 60.4 t -111.26 132.38 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.683 0.278 . . . . 0.0 111.217 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 286' ' ' THR . 2.5 p -100.44 139.21 36.44 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.812 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.96 161.16 14.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.03 -27.77 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.756 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.76 120.53 22.95 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.506 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' PRO . . . . . 0.56 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.9 Cg_exo -41.91 -51.62 4.46 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.832 2.355 . . . . 0.0 112.963 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 14.4 Cg_endo -56.61 -30.67 84.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.914 1.742 . . . . 0.0 111.466 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.1 t -62.34 -39.23 92.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.33 78.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.38 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 349' ' ' ALA . 0.0 OUTLIER -61.73 -47.73 83.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.932 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.436 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.87 -31.96 63.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.97 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.09 67.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ILE . . . . . 0.519 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 10.8 mt -58.04 -35.46 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.943 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.23 -26.46 64.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.24 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.6 t90 -101.97 -65.87 0.96 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' PHE . . . . . 0.512 ' O ' ' C ' ' A' ' 355' ' ' ASP . 20.5 m-85 -61.11 -74.89 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 16.0 p-10 13.5 58.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.795 0.685 . . . . 0.0 112.345 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 113.27 35.02 1.68 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.727 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.23 -160.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.7 mm-40 -121.81 129.06 52.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 112.116 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' PHE . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -83.95 100.9 11.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 18.6 p 39.31 31.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.209 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.8 -47.83 0.92 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.91 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.8 m-80 -88.13 170.99 10.21 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.989 0.395 . . . . 0.0 110.604 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -96.24 141.71 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.251 2.634 . . . . 0.0 112.386 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ILE . . . . . 0.493 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 3.8 pt -126.82 -178.91 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.35 100.93 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 24.6 t -87.78 137.39 21.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.9 p -131.55 -165.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.963 0.411 . . . . 0.0 111.263 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.063 -179.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.771 0.32 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 60.62 66.16 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 8.5 t0 58.97 72.7 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -164.13 115.72 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.5 -17.63 19.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -96.87 27.46 3.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 111.121 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -44.95 110.92 0.26 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.367 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 0.5 OUTLIER -47.26 -30.07 2.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 96.9 m -61.33 125.55 24.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.465 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 40.2 pt -113.29 173.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.457 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.9 OUTLIER -126.36 112.98 16.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.266 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.01 122.48 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.626 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.471 ' HG3' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -128.89 129.98 46.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.018 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.57 46.76 0.52 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.3 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.7 OUTLIER -86.29 -84.59 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.5 0.191 . . . . 0.0 110.83 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 105.64 90.6 2.18 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.269 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 44.65 27.95 0.29 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.822 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.405 ' ND2' ' CD1' ' A' ' 359' ' ' PHE . 0.8 OUTLIER -142.31 -2.23 1.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.789 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 11.7 p -64.9 83.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.46 163.95 15.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.512 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 322' ' ' ILE . 13.8 mm -71.29 -49.1 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 111.366 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -34.1 76.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.5 t -63.58 -44.13 94.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.819 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.437 ' CG1' ' CG2' ' A' ' 339' ' ' VAL . 43.1 t -73.81 -38.44 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.401 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 306' ' ' LYS . . . -67.92 -30.44 69.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.053 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.55 -41.79 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.498 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -93.18 -21.43 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.527 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -104.71 37.56 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.808 0.337 . . . . 0.0 111.326 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.92 17.04 9.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.177 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.05 -43.27 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 109.987 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -35.56 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.5 -156.15 11.04 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.565 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 mt -101.93 134.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 2.2 mt -89.18 139.66 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 110.035 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.485 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -48.15 91.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.945 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.79 147.12 49.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.415 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.536 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -97.35 157.86 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.425 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -89.44 -8.25 53.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -45.55 8.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.431 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 61.0 p -107.5 -7.43 16.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 314' ' ' ASN . . . 61.72 18.84 57.48 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.678 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.438 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.5 163.69 35.04 Favored Pre-proline 0 C--O 1.227 -0.131 0 CA-C-O 120.677 0.275 . . . . 0.0 111.017 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.474 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 88.0 Cg_exo -46.86 154.55 1.05 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.789 2.326 . . . . 0.0 113.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.536 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -123.45 125.07 44.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.264 0.555 . . . . 0.0 110.959 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.422 ' O ' ' CD1' ' A' ' 298' ' ' ILE . 2.7 mp -140.11 140.51 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -95.56 115.8 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.747 0.308 . . . . 0.0 110.29 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.425 HD21 ' CB ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -108.26 116.77 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.553 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 9.9 p -120.89 156.37 32.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.63 145.12 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.799 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -110.23 -22.28 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.53 -46.33 55.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 5.2 t -99.27 -23.28 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.15 47.5 5.76 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.408 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -134.47 -165.27 1.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.605 0.24 . . . . 0.0 110.8 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 7.5 mt -108.82 166.26 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.09 -39.16 9.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 105.78 27.77 5.59 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -151.09 131.86 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.433 0.158 . . . . 0.0 110.663 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.425 ' CB ' HD21 ' A' ' 324' ' ' LEU . . . -159.82 145.22 15.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 121.3 0.571 . . . . 0.0 112.298 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.457 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 7.6 p -98.0 134.9 40.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.793 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.437 ' CG2' ' CG1' ' A' ' 301' ' ' VAL . 57.2 t -107.84 128.69 62.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.405 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.485 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 50.3 m -90.4 142.78 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.374 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 146.0 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 111.269 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -79.28 -17.94 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.14 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.8 111.03 27.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.539 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -49.07 -52.19 9.19 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.469 2.113 . . . . 0.0 112.877 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.1 Cg_endo -59.07 -30.67 93.9 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.873 1.715 . . . . 0.0 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 36.4 t -65.66 -34.72 78.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.688 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.29 97.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.81 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 368' ' ' PHE . 0.6 OUTLIER -62.66 -50.91 69.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.262 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.35 53.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.75 -48.0 64.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.305 0.574 . . . . 0.0 109.863 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 355' ' ' ASP . 10.6 mt -57.44 -35.64 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.228 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -26.55 68.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.819 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.5 t90 -98.67 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.847 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 355' ' ' ASP . 60.6 m-85 -56.04 -74.17 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.562 ' C ' ' O ' ' A' ' 354' ' ' PHE . 22.6 t0 8.97 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.911 0.757 . . . . 0.0 111.624 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.02 22.35 4.25 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.259 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -78.72 -164.48 0.59 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.608 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 21.3 mm-40 -130.11 137.24 50.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 112.149 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -102.75 101.47 11.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.146 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.26 29.52 5.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.703 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 123.9 -37.9 2.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.443 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.642 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.7 OUTLIER -82.77 169.98 16.14 Favored Pre-proline 0 C--O 1.22 -0.474 0 CA-C-N 116.876 0.338 . . . . 0.0 110.659 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.76 144.46 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.441 2.761 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.434 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 3.6 pt -130.98 161.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-O 120.824 0.345 . . . . 0.0 111.667 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -130.42 100.95 5.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 23.3 t -85.64 130.79 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 p -127.75 -177.27 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER -100.55 45.44 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.915 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 56.49 72.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 44.7 p -61.59 162.31 8.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.99 135.42 33.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.28 114.43 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -174.77 -171.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.85 -174.57 3.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 2.8 t80 63.65 84.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.41 112.5 5.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 60.74 53.36 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 167.23 115.01 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.7 -115.14 0.65 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.514 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -77.53 -51.07 6.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.14 -177.58 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 120.66 -19.57 9.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.645 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.8 166.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 111.097 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 163.63 69.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.551 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 62.22 -168.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.62 -32.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.96 98.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.021 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.28 -27.22 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.54 -35.23 6.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.526 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.489 ' O ' ' ND2' ' A' ' 285' ' ' ASN . 13.8 m120 -66.51 166.96 11.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.009 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.0 OUTLIER 85.31 14.06 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.445 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 369' ' ' ALA . 90.1 m -164.97 107.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.709 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.438 HD11 ' CE2' ' A' ' 305' ' ' PHE . 33.0 pt -92.75 170.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.172 0.51 . . . . 0.0 111.842 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.0 m-85 -119.75 110.92 17.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.553 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.15 119.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 336' ' ' GLU . 2.7 mm100 -128.31 130.03 47.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 126.26 20.18 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.154 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -71.19 -101.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 171.64 -100.44 0.15 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.139 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -131.95 33.55 3.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 296' ' ' VAL . 1.4 p-10 -130.46 -51.66 1.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.137 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.517 ' C ' ' O ' ' A' ' 295' ' ' ASN . 14.4 p -2.05 76.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.76 155.05 25.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.699 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 16.7 mt -61.12 -47.04 95.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -38.27 87.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -39.26 79.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.121 0.486 . . . . 0.0 110.484 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 87.2 t -73.41 -39.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.805 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.23 73.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.926 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -39.87 62.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.678 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -89.5 -21.64 22.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -102.19 30.09 4.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.142 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.3 19.36 17.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.159 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -101.83 -39.7 7.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 110.323 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.1 -38.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.119 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.99 -169.97 30.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.525 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.59 144.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 320' ' ' PRO . 4.1 mp -93.48 131.83 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.144 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 25.7 mtmt -48.91 93.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.765 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -64.56 145.46 56.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.463 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.465 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 5.8 m-20 -75.89 162.19 28.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.346 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -104.95 -7.72 19.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -104.48 -35.69 7.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.999 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 69.6 p -108.24 -9.57 15.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 60.51 14.72 36.35 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.718 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 159.18 52.41 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.984 0.392 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.427 ' HB3' HG22 ' A' ' 311' ' ' ILE . 76.6 Cg_exo -44.68 151.15 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.007 2.471 . . . . 0.0 112.86 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.465 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 29.9 mtm -108.11 119.15 38.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.391 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 323' ' ' ASN . 4.8 mt -143.22 142.74 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.467 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 322' ' ' ILE . 8.9 m120 -117.95 133.19 56.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.885 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -125.41 164.04 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.209 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.71 113.52 14.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.821 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 13.6 p -101.01 160.98 13.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.0 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.35 133.55 52.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.806 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 329' ' ' GLU . 0.0 OUTLIER -100.21 -7.19 24.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.416 ' N ' ' HD3' ' A' ' 328' ' ' ARG . 11.6 mt-10 -97.6 -36.68 10.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 110.747 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.4 t -110.86 -24.36 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 97.16 -22.7 39.35 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.408 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -176.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.382 . . . . 0.0 111.007 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.52 118.64 37.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.775 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -57.4 -21.2 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.353 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 80.61 38.58 16.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.915 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.403 ' HB3' ' NE2' ' A' ' 290' ' ' GLN . 2.7 mp0 -139.78 131.77 27.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.172 . . . . 0.0 110.866 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -162.65 145.54 11.01 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 121.089 0.471 . . . . 0.0 111.882 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.423 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 5.1 p -95.3 150.01 20.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.135 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.415 ' CG2' ' CG1' ' A' ' 301' ' ' VAL . 44.7 t -123.71 127.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 321' ' ' MET . 91.4 p -84.32 153.21 23.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.423 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 3.5 m-85 -127.08 133.41 50.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.022 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -62.46 -22.19 66.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.942 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -127.98 116.72 20.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.758 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.562 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.5 Cg_exo -45.23 -51.05 8.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.664 2.243 . . . . 0.0 113.017 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.2 Cg_endo -59.55 -30.48 92.52 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.85 1.7 . . . . 0.0 111.159 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.37 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.423 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -58.64 -42.75 89.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 368' ' ' PHE . 0.0 OUTLIER -62.86 -55.96 21.53 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.32 -31.74 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.792 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.61 -47.74 65.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.428 0.632 . . . . 0.0 109.39 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 355' ' ' ASP . 6.9 mt -61.91 -36.52 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.073 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -26.42 68.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.325 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.533 ' CE3' ' CZ ' ' A' ' 354' ' ' PHE . 3.5 t90 -91.08 -68.5 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.533 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 2.5 m-85 -68.84 -77.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 33.8 t0 25.27 50.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.033 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.7 26.98 1.21 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.804 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.489 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -102.47 -156.19 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.347 0.574 . . . . 0.0 110.778 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.652 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.4 mt-10 -113.5 128.65 56.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.349 0.595 . . . . 0.0 112.192 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.53 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.5 OUTLIER -108.01 103.19 12.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.981 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.5 t 63.36 28.07 15.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.619 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 104.62 -14.06 50.29 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.799 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.652 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 4.0 m-80 -106.92 170.94 5.14 Favored Pre-proline 0 C--O 1.219 -0.503 0 CA-C-N 117.246 0.523 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -92.1 139.14 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.82 2.346 . . . . 0.0 111.904 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.418 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 9.2 pt -132.33 172.78 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 106.16 4.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 288' ' ' PHE . 14.4 t -84.45 139.54 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.813 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -122.43 -175.0 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 111.885 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.447 ' CE1' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -103.43 40.27 1.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.635 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 286' ' ' THR . . . 61.14 108.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.208 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 63.7 p -74.16 133.29 42.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.63 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -42.92 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 59.87 155.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 177.33 45.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.25 55.97 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -177.07 56.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 45.0 t30 64.15 -77.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.29 148.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.857 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -134.64 -132.26 3.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.436 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.77 119.7 1.04 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 95.21 -175.4 33.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -97.32 -167.73 1.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.12 61.2 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.564 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -110.8 147.43 34.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.22 130.36 10.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.41 -1.217 . . . . 0.0 112.493 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.836 0.35 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -144.94 -178.32 5.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.18 94.88 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -149.22 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.1 t -105.06 24.19 12.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.77 -26.96 68.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.431 ' OD1' ' CZ ' ' A' ' 368' ' ' PHE . 0.4 OUTLIER -73.47 122.19 21.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.221 0.534 . . . . 0.0 110.921 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 166.08 -33.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.668 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 78.8 m -101.47 115.67 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.935 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.467 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 9.2 pt -91.08 173.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 2.4 m-85 -130.34 108.37 9.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.122 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.82 114.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 35.8 mm-40 -119.91 130.62 54.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.422 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 115.68 70.45 0.47 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.338 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.83 -78.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.877 0.339 . . . . 0.0 110.12 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.93 -81.62 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.665 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 294' ' ' GLU . 8.6 tp10 -140.93 41.5 1.82 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.249 0.547 . . . . 0.0 110.13 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -138.13 14.56 2.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.32 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 1.6 t -77.38 95.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 111.612 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.07 151.52 52.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.301 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.6 mm -65.21 -48.36 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.58 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.91 -35.11 79.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.761 0.315 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 55.2 m -70.89 -43.82 67.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 60.7 t -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 320' ' ' PRO . . . -63.0 -29.78 71.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.165 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.6 -38.84 64.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.889 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.428 ' OH ' ' CE2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -94.38 -22.36 18.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.618 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -93.22 5.26 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -97.06 23.93 6.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.89 -31.65 8.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.32 -39.39 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.767 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -150.96 -175.92 23.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.18 119.82 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 73.5 mt -85.83 125.02 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.244 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.71 103.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -62.02 148.8 42.82 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.641 178.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -106.8 140.08 40.21 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.73 0.3 . . . . 0.0 110.525 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -5.34 47.13 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -29.16 17.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.403 ' H ' ' ND2' ' A' ' 314' ' ' ASN . 28.9 p -122.13 -23.17 5.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 83.4 12.17 78.97 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.339 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.95 153.29 71.03 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.9 Cg_endo -44.79 153.24 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.048 2.499 . . . . 0.0 112.596 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.462 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 45.9 mtp -104.69 128.53 52.79 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 323' ' ' ASN . 3.1 mt -140.22 141.56 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.938 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 6.1 m-80 -97.37 148.38 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.404 ' HB2' ' CD2' ' A' ' 333' ' ' LEU . 0.2 OUTLIER -144.98 135.9 24.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.842 0.353 . . . . 0.0 111.483 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -80.35 87.81 5.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.127 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 15.6 p -83.43 167.73 17.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.397 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 329' ' ' GLU . 0.6 OUTLIER -64.01 99.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.426 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.46 -76.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.266 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 327' ' ' ASP . 13.3 mt-10 -147.69 -26.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 10.6 t -44.73 -29.67 0.81 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.821 0.343 . . . . 0.0 111.195 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.19 20.86 71.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.003 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.93 -25.8 67.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.568 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' A' ' 324' ' ' LEU . 2.2 mt 63.84 126.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.15 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.55 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.11 -69.03 0.13 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.627 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -160.23 167.29 27.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 0.0 111.217 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -158.0 147.14 19.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.144 0.497 . . . . 0.0 111.741 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.454 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 4.2 p -107.56 133.5 51.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.201 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 287' ' ' ILE . 49.8 t -100.91 124.29 54.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 18.3 p -94.67 112.16 23.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.199 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 311' ' ' ILE . 59.1 m-85 -91.27 159.46 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.953 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -88.91 -14.69 36.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -128.27 119.9 20.92 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.943 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.591 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.4 Cg_exo -47.56 -48.87 14.47 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.714 2.276 . . . . 0.0 113.027 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.9 Cg_endo -60.36 -30.6 91.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.858 1.705 . . . . 0.0 111.392 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -62.09 -34.91 77.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.645 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.428 ' HB2' ' CE1' ' A' ' 368' ' ' PHE . . . -59.71 -50.05 75.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.483 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.0 OUTLIER -60.75 -45.8 92.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.956 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.5 34.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.97 68.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 12.3 mt -59.64 -34.75 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.119 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -26.88 67.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.551 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.564 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.72 -68.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.049 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.39 -79.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.117 -177.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 37.6 t70 30.08 43.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 134.92 28.3 0.45 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.139 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.47 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -98.19 -163.6 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.9 pm0 -120.39 128.84 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.135 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.56 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -82.88 101.45 11.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.243 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 45.91 29.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.281 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.27 -43.36 1.26 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.925 -1.131 . . . . 0.0 114.256 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.636 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -92.49 162.64 29.11 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-N 117.242 0.521 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.93 141.85 7.48 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.135 2.557 . . . . 0.0 112.176 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 13.4 pt -124.77 177.6 4.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-O 121.105 0.479 . . . . 0.0 111.701 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -144.91 101.66 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.513 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 288' ' ' PHE . 25.7 t -84.76 135.17 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.053 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 m -136.85 172.61 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.428 . . . . 0.0 111.64 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.431 ' CZ ' ' OD1' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -93.03 63.68 3.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.744 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.429 ' HA ' ' CD1' ' A' ' 288' ' ' PHE . . . 57.92 165.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 47.9 m 57.96 165.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.77 88.47 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -84.04 -65.82 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -78.99 139.83 38.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.002 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -138.43 138.44 38.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.45 31.08 20.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -122.07 139.23 53.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 377' ' ' ARG . 0.0 OUTLIER -149.52 149.41 30.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 126.05 -179.64 16.16 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.597 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -111.5 56.74 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 144.04 112.95 0.86 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -94.21 -31.34 14.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 138.85 -31.2 2.41 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 112.04 19.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 0.0 110.927 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.69 -134.25 20.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.436 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.532 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.781 0.324 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.65 48.01 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.018 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -66.08 121.26 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -103.86 -70.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.948 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.14 28.62 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.8 115.53 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -21.74 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 61.4 m -71.61 102.29 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.433 HD11 ' CE2' ' A' ' 341' ' ' PHE . 13.7 pt -104.02 162.04 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.991 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -125.22 127.54 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 112.202 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.7 t -107.12 117.5 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.401 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.3 mp0 -112.53 129.82 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.745 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.25 42.26 0.91 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.658 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.406 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.4 OUTLIER -71.19 -78.6 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.522 0.201 . . . . 0.0 110.81 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 111.41 87.09 1.71 Allowed Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.172 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 43.68 30.31 0.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.684 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.28 29.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.43 72.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.403 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -116.57 146.87 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 35.8 mt -69.31 -43.66 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.479 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.15 -42.93 88.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.899 0.38 . . . . 0.0 110.666 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.9 p -65.0 -41.27 95.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 110.697 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 85.5 t -71.21 -42.7 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.266 0.555 . . . . 0.0 109.733 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.43 71.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.3 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -39.69 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.614 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -88.83 -24.33 22.6 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.614 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.6 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -94.14 19.1 9.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.662 0.268 . . . . 0.0 111.332 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.89 20.54 18.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 110.899 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -102.56 -39.36 7.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 tp -73.03 -34.98 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.05 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -167.25 -153.11 7.78 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.646 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -109.55 119.55 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.77 130.66 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.1 OUTLIER -48.68 92.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.62 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -69.81 137.49 51.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.432 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.5 OUTLIER -73.98 128.26 35.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.194 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -5.9 56.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.074 0.464 . . . . 0.0 110.071 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.44 -40.69 7.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.452 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.414 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.3 OUTLIER -105.13 -11.12 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.906 -179.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.07 11.92 59.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.498 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.414 ' HG2' HG21 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.16 152.2 66.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.902 0.351 . . . . 0.0 111.336 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 80.8 Cg_exo -47.68 158.47 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.795 2.33 . . . . 0.0 112.476 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.421 ' O ' ' OG ' ' A' ' 340' ' ' SER . 37.2 mmm -119.13 119.09 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 111.119 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 323' ' ' ASN . 59.6 mt -143.08 144.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.436 ' N ' HG22 ' A' ' 322' ' ' ILE . 3.2 m-80 -103.27 148.15 26.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 111.011 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 337' ' ' ALA . 3.6 mt -130.4 131.03 45.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.86 113.84 27.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 59.6 p -106.62 158.2 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.95 129.45 40.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.658 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.64 19.8 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.407 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.8 -41.57 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.8 p -110.68 -29.79 7.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 110.59 -24.65 16.93 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.82 -172.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 110.975 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.7 mt -100.49 133.25 45.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.821 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -68.77 -21.76 64.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 336' ' ' GLU . . . 87.56 29.09 22.57 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.369 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 1.5 mt-10 -143.84 131.94 21.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.345 0.117 . . . . 0.0 110.8 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 324' ' ' LEU . . . -144.15 167.45 22.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.159 0.504 . . . . 0.0 111.913 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 288' ' ' PHE . 1.3 p -121.12 145.84 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.198 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 301' ' ' VAL . 92.0 t -125.4 134.37 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 0.0 111.385 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 321' ' ' MET . 59.2 p -98.37 131.02 45.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.016 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.433 ' CE2' HD11 ' A' ' 287' ' ' ILE . 2.8 m-85 -107.44 147.81 29.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.449 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.2 OUTLIER -79.08 -9.54 59.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 116.58 15.49 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.9 Cg_exo -45.13 -50.27 9.05 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.579 2.186 . . . . 0.0 112.798 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.0 Cg_endo -54.71 -30.56 67.29 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.924 1.749 . . . . 0.0 111.484 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.4 t -59.03 -42.17 89.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.868 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.84 74.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 0.0 110.387 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 348' ' ' LYS . 4.5 tppt? -61.98 -53.86 49.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.653 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.68 47.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.846 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.44 -47.92 65.93 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.595 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 7.7 mt -59.8 -36.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.66 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.166 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.514 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.16 -68.05 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.115 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.584 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -76.17 -80.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.595 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.1 p-10 26.62 45.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.399 0.437 . . . . 0.0 111.992 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 122.36 37.25 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.052 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.584 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -95.91 -155.99 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 13.4 mt-10 -113.27 128.27 56.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.62 . . . . 0.0 111.48 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.493 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -122.76 101.91 7.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.937 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 56.0 m 60.55 27.22 16.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 110.537 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.55 17.49 52.2 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.28 164.37 39.87 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.869 0.366 . . . . 0.0 111.306 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -89.55 132.54 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.816 2.344 . . . . 0.0 111.9 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 20.4 pt -120.84 174.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.04 0.448 . . . . 0.0 111.992 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -139.39 100.95 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.728 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 287' ' ' ILE . 26.0 t -97.64 115.92 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.44 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -140.54 -165.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.224 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -80.54 117.52 21.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 288' ' ' PHE . . . -93.29 148.58 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.3 120.43 42.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -126.87 34.63 4.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 59.83 -87.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.979 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 42.95 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.632 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -122.07 94.53 4.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.972 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -142.94 -87.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 177.88 39.5 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.716 0.293 . . . . 0.0 110.711 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -178.58 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 153.21 -43.36 0.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.473 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 122.08 -92.68 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.501 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 113.5 29.85 2.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.518 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -111.34 31.17 6.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 0.0 110.818 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.7 80.5 1.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -124.91 127.29 46.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -92.65 -94.25 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.576 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 279' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.603 0.239 . . . . 0.0 111.156 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER 32.52 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.935 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -94.35 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -97.31 63.24 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.983 0.421 . . . . 0.0 110.811 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -41.08 11.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.45 17.29 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 285' ' ' ASN . 33.7 m120 -88.29 138.05 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.738 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 284' ' ' ASN . 6.4 p30 168.64 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.07 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 369' ' ' ALA . 90.7 m -104.84 95.33 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.435 HD11 ' CZ ' ' A' ' 305' ' ' PHE . 50.3 pt -86.53 168.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.416 ' CE1' ' HA ' ' A' ' 369' ' ' ALA . 31.4 m-85 -120.71 124.28 44.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.73 114.65 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.886 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -116.53 130.66 56.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.017 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 363' ' ' PRO . . . 127.96 20.7 1.63 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.615 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.459 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 12.3 mt -66.76 -103.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.95 0.35 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.97 34.5 5.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.459 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.41 30.74 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.715 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.97 81.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.582 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.6 146.27 30.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.37 -43.39 73.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.15 -40.62 90.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.64 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.8 t -63.45 -41.05 98.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 43.9 t -74.12 -41.17 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.295 0.569 . . . . 0.0 109.95 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.12 -29.85 68.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.937 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -74.14 -39.59 63.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -92.41 -24.49 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.3 OUTLIER -96.78 32.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.236 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -116.18 16.62 15.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.288 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -98.77 -42.19 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.6 tp -71.07 -32.6 48.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.24 -163.66 27.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.6 mt -100.64 141.84 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.534 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.1 mt -100.83 125.22 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.411 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.76 107.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -73.42 152.38 40.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.133 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -105.27 138.16 41.91 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.827 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -1.95 25.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.428 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -96.9 -26.51 15.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 110.481 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.528 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 68.6 p -121.33 -20.41 6.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.58 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 75.79 13.96 82.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.976 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.528 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.86 164.03 35.66 Favored Pre-proline 0 C--N 1.333 -0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.376 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.508 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 71.3 Cg_exo -44.7 155.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.76 2.307 . . . . 0.0 112.384 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.471 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 51.7 mtp -109.34 119.8 40.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 111.636 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 323' ' ' ASN . 3.4 mt -142.83 145.19 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.977 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.408 ' N ' HG21 ' A' ' 322' ' ' ILE . 11.6 t-20 -119.15 116.4 26.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.805 0.336 . . . . 0.0 110.934 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.7 130.28 56.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -109.07 91.79 3.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 69.7 p -147.01 165.17 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.431 ' HB2' HG22 ' A' ' 330' ' ' THR . 11.9 p30 -62.47 148.27 46.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.417 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -104.92 -20.99 13.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 178.75 30.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.233 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 327' ' ' ASP . 5.3 t -116.54 -35.99 4.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 107.72 10.14 27.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.452 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -69.73 -70.29 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.992 0.396 . . . . 0.0 110.825 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.9 mt 58.47 110.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.314 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 -15.96 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.906 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 57.8 47.77 86.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' GLN . 6.8 mt-10 -140.97 131.54 25.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.596 0.236 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -139.28 169.69 17.31 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.917 0.389 . . . . 0.0 111.275 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 20.0 p -128.05 126.38 41.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.572 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.51 116.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.396 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 20.4 m -80.68 152.96 28.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 5.5 m-85 -136.29 139.15 42.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 -26.29 65.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -124.16 116.03 27.31 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.574 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.2 Cg_exo -42.72 -51.12 5.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.773 2.315 . . . . 0.0 113.094 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.4 Cg_endo -53.66 -30.37 55.39 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.817 1.678 . . . . 0.0 111.131 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.4 t -57.7 -46.15 84.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.16 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.52 -39.63 67.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.618 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.435 ' HD3' ' CZ ' ' A' ' 368' ' ' PHE . 4.3 tptp -64.91 -59.56 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.42 -30.71 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.758 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -50.25 52.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.469 0.652 . . . . 0.0 109.282 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 6.1 mt -59.48 -37.35 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.987 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.4 -26.3 66.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.946 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.4 t90 -98.9 -68.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.507 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 8.1 m-85 -63.86 -76.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 12.7 p-10 19.88 55.49 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.99 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 120.92 17.73 4.08 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.463 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.3 OUTLIER -76.14 -161.4 0.18 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.672 0.272 . . . . 0.0 111.323 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 3.3 mt-10 -113.48 152.92 29.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 111.523 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.506 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -142.08 101.3 3.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.514 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p 49.82 27.41 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.88 0.371 . . . . 0.0 110.665 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.43 17.33 22.24 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.245 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 359' ' ' PHE . 63.6 m-80 -129.3 152.2 79.09 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 121.002 0.429 . . . . 0.0 111.766 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.42 ' O ' ' HA3' ' A' ' 291' ' ' GLY . 90.7 Cg_endo -85.53 133.43 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.947 2.431 . . . . 0.0 111.451 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 5.1 pt -119.2 150.32 21.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.275 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 103.67 9.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.339 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 23.1 t -84.51 130.66 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.646 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.43 -174.45 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.701 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.435 ' CZ ' ' HD3' ' A' ' 348' ' ' LYS . 0.2 OUTLIER -107.06 35.3 3.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.416 ' HA ' ' CE1' ' A' ' 288' ' ' PHE . . . 56.59 36.21 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.96 169.11 18.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.66 1.3 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 60.6 75.71 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.29 -171.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 375' ' ' PHE . 0.2 OUTLIER 79.36 -49.56 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.32 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 374' ' ' ASP . 0.2 OUTLIER 79.13 31.27 0.3 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.947 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.16 178.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.02 85.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.918 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 154.93 -81.18 0.17 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -128.89 -176.63 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.515 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 161.78 177.06 34.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.484 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 63.59 137.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -66.43 105.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -132.18 153.62 50.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 164.0 -115.24 0.64 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.504 179.925 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 43.37 74.84 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -101.06 36.15 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -100.53 33.2 2.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.48 -23.32 17.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -101.45 31.25 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.418 ' ND2' ' N ' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -44.39 110.78 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -60.41 -23.6 64.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.997 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.4 m -70.13 139.56 52.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 39.1 pt -122.44 164.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.459 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.2 OUTLIER -113.24 109.1 18.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.69 114.66 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.592 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 2.0 mp0 -113.74 130.54 56.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.5 47.89 1.09 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.873 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.9 -70.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.723 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 102.79 77.48 1.22 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.632 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 42.01 31.53 0.24 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 29.29 2.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 110.512 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 324' ' ' LEU . 4.6 t -69.29 86.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.862 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.88 146.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 29.9 mm -70.88 -44.23 76.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.319 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.82 -43.1 84.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.782 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -41.59 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.7 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 72.6 t -72.05 -41.71 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.43 69.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.959 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.11 -35.37 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.845 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -88.71 -22.22 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.569 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.512 ' CD2' ' CE1' ' A' ' 304' ' ' TYR . 1.2 m-85 -89.49 12.27 17.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 29.71 2.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.36 -35.51 5.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.415 HG12 ' CA ' ' A' ' 350' ' ' ALA . 5.0 tp -80.04 -33.88 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.336 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.67 -150.62 9.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.823 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.47 129.18 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 5.3 mt -84.34 125.9 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.05 0.452 . . . . 0.0 110.454 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -49.03 91.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.385 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -82.62 170.29 15.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.066 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.578 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -106.51 153.29 22.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -1.27 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.919 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -94.59 -47.38 6.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.607 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 58.4 p -104.62 -12.84 16.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.921 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.04 20.19 59.98 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.209 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.88 154.23 70.86 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.579 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 73.2 Cg_exo -51.16 149.87 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.226 1.951 . . . . 0.0 111.745 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.578 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -118.53 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.439 0.638 . . . . 0.0 112.208 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mt -140.9 143.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.618 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.37 115.6 28.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.439 ' CB ' ' CG1' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -116.14 153.66 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -128.45 119.74 25.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 62.2 p -113.28 114.32 26.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.214 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 332' ' ' LYS . 0.9 OUTLIER -173.02 99.76 0.13 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.402 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.99 -41.35 3.19 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 330' ' ' THR . 49.0 mt-10 -152.49 12.84 0.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.261 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.484 ' CB ' ' O ' ' A' ' 329' ' ' GLU . 1.4 t 155.13 45.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.7 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 326' ' ' THR . . . 89.06 32.18 11.06 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.624 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 327' ' ' ASP . 1.3 mttp -92.83 124.26 36.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 111.775 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 326' ' ' THR . 0.0 OUTLIER -46.28 118.17 1.83 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -96.62 30.24 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 49.66 53.22 22.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.659 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -148.29 131.26 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.777 0.322 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.06 170.33 22.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.066 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.459 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 76.1 p -127.2 114.58 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 305' ' ' PHE . 48.7 t -94.82 117.04 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.1 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.5 ' CB ' ' HB3' ' A' ' 312' ' ' LYS . 67.6 m -84.5 132.9 34.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 18.2 m-85 -104.95 142.62 34.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -19.5 62.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.7 OUTLIER -128.94 120.96 20.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.875 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.588 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -47.76 -48.63 15.43 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 113.069 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.8 Cg_endo -60.99 -30.63 90.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.858 1.705 . . . . 0.0 111.277 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -61.02 -32.6 72.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.372 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -61.68 -55.3 31.9 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.672 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -43.33 91.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.166 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.42 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.415 ' CA ' HG12 ' A' ' 308' ' ' ILE . . . -68.69 -49.35 59.66 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.429 0.633 . . . . 0.0 109.584 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.511 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 6.9 mt -59.45 -36.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.135 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -62.68 -26.4 68.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.618 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.56 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.2 t90 -100.32 -68.13 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.175 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.529 ' O ' ' C ' ' A' ' 355' ' ' ASP . 23.2 m-85 -61.33 -77.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 354' ' ' PHE . 17.4 p-10 17.29 59.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.71 22.11 2.54 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.739 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.424 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -81.22 -165.61 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.63 0.215 . . . . 0.0 110.799 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.9 OUTLIER -124.38 129.67 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 111.861 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -89.72 101.46 14.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.064 178.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.85 29.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.24 -48.71 0.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.93 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.649 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -82.8 169.95 16.22 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 117.034 0.417 . . . . 0.0 110.636 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -95.85 145.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 111.952 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 5.8 pt -127.37 -178.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.174 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -145.59 100.57 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.43 128.41 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -140.2 -165.55 1.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -93.2 113.51 25.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -69.96 175.19 4.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.74 -166.53 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.05 -41.55 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.53 -172.89 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.73 108.98 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.311 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -104.94 -31.32 9.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -58.24 -51.48 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -95.33 163.05 13.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -74.91 0.13 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.34 -138.68 13.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.559 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 139.3 79.91 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.409 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 161.77 -33.33 0.35 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.39 145.28 48.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 148.75 134.94 2.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.526 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.99 149.23 37.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 145.98 -108.67 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.527 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.463 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -169.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -141.08 87.86 2.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -144.93 119.96 10.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 21.6 p -105.01 -36.83 7.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -129.94 31.05 4.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.619 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 368' ' ' PHE . 2.2 t-20 -87.88 81.5 7.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.04 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER -123.44 -3.23 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.32 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.6 m -114.86 127.26 55.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.425 HG12 ' CE2' ' A' ' 341' ' ' PHE . 29.7 pt -108.45 167.87 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 369' ' ' ALA . 18.0 m-30 -122.59 114.83 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.261 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.69 114.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.398 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -108.88 130.55 55.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 119.65 55.56 0.25 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.684 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.446 ' CD1' ' CE2' ' A' ' 359' ' ' PHE . 3.0 mm? -91.41 -77.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.749 0.309 . . . . 0.0 110.721 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.91 76.2 1.06 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.112 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 44.89 41.04 4.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 111.738 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.64 24.62 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.729 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 324' ' ' LEU . 4.0 t -73.89 88.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.519 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.63 146.54 42.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.793 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.419 HD13 HG23 ' A' ' 298' ' ' ILE . 54.2 mt -71.4 -43.49 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.443 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.44 -41.28 89.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.9 t -64.78 -43.4 93.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.725 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 59.6 t -72.98 -41.07 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.321 0.582 . . . . 0.0 109.649 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 311' ' ' ILE . . . -68.1 -29.69 68.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.982 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -73.5 -39.03 65.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.608 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.86 -22.47 16.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.0 OUTLIER -95.56 2.37 54.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 21.5 ptmt -96.37 30.2 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -34.31 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.11 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 350' ' ' ALA . 0.8 OUTLIER -80.31 -41.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.244 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -146.58 -168.24 13.45 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.7 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.14 106.71 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.593 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 10.8 mt -72.39 129.49 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 109.929 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 92.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -65.99 138.94 58.15 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.782 177.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.1 OUTLIER -89.78 165.75 13.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.171 0.51 . . . . 0.0 111.96 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -102.57 -4.41 25.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.3 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.435 ' HD3' ' CG2' ' A' ' 317' ' ' THR . 0.0 OUTLIER -96.33 -40.81 8.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.75 179.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.435 ' CG2' ' HD3' ' A' ' 316' ' ' LYS . 12.1 p -106.13 -18.33 14.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.304 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.44 8.13 85.62 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.161 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.413 ' OE1' ' HB ' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.54 157.89 66.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.743 0.272 . . . . 0.0 111.022 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.1 Cg_endo -45.45 162.18 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.904 2.403 . . . . 0.0 112.617 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.515 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.84 130.37 56.67 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.686 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.423 ' CG1' ' HA ' ' A' ' 339' ' ' VAL . 1.9 mp -143.22 140.02 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -105.23 115.82 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.415 ' HB3' ' CG1' ' A' ' 296' ' ' VAL . 0.2 OUTLIER -108.87 150.35 27.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.278 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 336' ' ' GLU . 14.2 m-85 -92.29 101.81 14.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.74 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.413 HG21 ' HB3' ' A' ' 333' ' ' LEU . 2.9 p -108.03 158.96 16.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.04 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -78.85 148.28 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 17.79 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -108.34 -40.78 5.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.933 0.397 . . . . 0.0 110.668 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 9.0 p -119.69 -7.58 10.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.163 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 69.46 32.63 71.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.372 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.53 154.22 25.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -102.27 147.58 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.509 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.02 90.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.54 -76.43 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.994 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.421 ' HG2' ' CD1' ' A' ' 325' ' ' TYR . 0.1 OUTLIER -160.42 178.06 9.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.284 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -154.06 162.6 41.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.212 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.444 HG23 ' CD1' ' A' ' 288' ' ' PHE . 19.5 p -116.93 117.45 29.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.052 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 341' ' ' PHE . 50.8 t -92.73 123.06 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.586 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 1.2 m -101.33 131.87 47.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 339' ' ' VAL . 26.8 m-85 -115.37 158.54 22.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.063 0.458 . . . . 0.0 111.268 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.9 6.81 37.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.08 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.32 121.81 7.91 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.578 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 50.5 Cg_exo -52.88 -47.75 25.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.68 2.253 . . . . 0.0 113.326 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.8 Cg_endo -60.7 -30.12 89.72 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.729 1.619 . . . . 0.0 111.048 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -40.54 81.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.973 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.45 -50.87 72.24 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 348' ' ' LYS . 0.7 OUTLIER -62.17 -50.87 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.778 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.44 -34.16 33.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 308' ' ' ILE . . . -68.62 -46.81 68.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.421 0.629 . . . . 0.0 109.756 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.549 ' CD1' ' CE1' ' A' ' 368' ' ' PHE . 11.8 mt -58.69 -34.24 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.294 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.29 -26.8 68.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.796 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.537 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.07 -68.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 0.9 OUTLIER -77.63 -79.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.58 -176.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 28.74 45.7 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.799 0.333 . . . . 0.0 111.704 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 128.52 30.78 0.69 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -90.94 -160.32 0.71 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.51 0.195 . . . . 0.0 111.047 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 6.0 mp0 -113.36 153.13 29.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.291 0.567 . . . . 0.0 111.704 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -136.98 101.12 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.319 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.6 m 46.73 28.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.81 18.75 14.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.118 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 359' ' ' PHE . 72.0 m-80 -129.29 150.24 74.96 Favored Pre-proline 0 C--O 1.225 -0.186 0 CA-C-O 121.067 0.46 . . . . 0.0 111.71 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.93 127.83 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.766 2.311 . . . . 0.0 111.678 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.1 pt -111.43 165.2 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.912 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.34 100.99 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 287' ' ' ILE . 26.6 t -87.09 133.14 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 p -133.83 -176.49 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.653 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.55 ' CD1' ' OD1' ' A' ' 284' ' ' ASN . 26.6 m-85 -93.68 39.0 1.06 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.499 ' HA ' ' CD2' ' A' ' 288' ' ' PHE . . . 61.47 30.56 18.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.766 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.6 p -69.34 -162.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 74.31 134.51 0.05 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.989 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.4 -47.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.068 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -177.79 122.8 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.209 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.3 t70 58.22 -170.02 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 375' ' ' PHE . 0.1 OUTLIER -55.15 -178.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.65 160.57 14.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 161.86 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -58.84 89.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.392 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 76.98 -139.53 23.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.541 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 85.84 121.43 1.19 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -176.54 147.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -114.37 28.47 8.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -139.58 111.1 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 99.93 -89.12 0.83 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.398 -1.224 . . . . 0.0 112.533 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 58.59 176.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 282' ' ' SER . 5.1 m-20 -115.61 -85.89 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 56.09 -85.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.681 0.277 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 280' ' ' ASP . 10.0 t -104.93 -19.66 13.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.949 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -75.61 -22.39 56.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.081 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.77 119.14 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.729 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -28.41 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.4 m -64.82 145.13 56.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.441 HD13 ' CZ ' ' A' ' 305' ' ' PHE . 23.5 pt -125.39 173.42 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.421 ' CE1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -121.77 109.29 14.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.19 117.38 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.662 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.418 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -129.87 130.9 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.13 19.52 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.601 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 359' ' ' PHE . 39.6 mt -70.1 -101.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 159.08 -93.29 0.12 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.274 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -132.43 28.56 4.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.146 0.498 . . . . 0.0 110.136 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.09 -12.93 8.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.468 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 9.7 p -44.63 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 147.13 34.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.062 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.49 -47.37 93.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.712 0.291 . . . . 0.0 111.769 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.27 -39.47 89.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.2 t -68.44 -42.86 78.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 46.2 t -72.88 -38.82 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 109.625 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.425 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.38 -29.85 68.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.895 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.72 -40.54 66.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.812 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.2 -24.26 16.33 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.558 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -95.72 33.13 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.901 0.381 . . . . 0.0 110.977 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.31 21.0 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -103.92 -40.39 6.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.285 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.28 -27.84 27.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.5 -165.92 32.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.705 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.58 134.94 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.462 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.8 mt -94.68 127.73 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.422 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 321' ' ' MET . 14.7 mtmm -48.77 110.27 0.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -60.14 -179.64 0.11 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 315' ' ' LYS . 3.9 m-80 -95.98 -40.89 9.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 314' ' ' ASN . 0.2 OUTLIER 86.92 -31.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.411 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -41.23 11.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 67.0 p -100.23 -11.69 20.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.337 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 71.02 12.06 71.0 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 157.3 64.89 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.318 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 59.0 Cg_exo -44.59 161.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.259 2.64 . . . . 0.0 113.143 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 312' ' ' LYS . 21.5 mtp -120.67 124.65 45.72 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.585 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 7.1 mt -142.52 137.07 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.947 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.441 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 3.6 t30 -96.49 147.97 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.172 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -144.28 153.04 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 111.165 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -108.99 103.43 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.5 p -95.72 151.8 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.97 116.08 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.666 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.32 3.11 37.17 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.412 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.83 -41.98 8.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 110.677 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 5.7 p -116.87 -20.96 9.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.16 -16.2 57.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -62.95 -176.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.023 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.16 171.53 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -121.45 -46.02 2.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 118.99 19.43 4.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.065 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.418 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 8.3 mp0 -121.51 133.23 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -160.19 149.95 17.95 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 288' ' ' PHE . 17.7 p -108.6 127.74 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.547 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 65.1 t -99.27 128.01 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.929 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 18.2 m -87.05 153.02 21.86 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.483 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 346' ' ' SER . 4.0 m-85 -136.14 141.58 44.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 111.273 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -9.35 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.212 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.46 117.88 13.47 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.779 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 62.0 Cg_exo -49.73 -49.67 15.27 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.6 2.2 . . . . 0.0 113.041 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.7 Cg_endo -59.81 -30.53 92.17 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 121.791 1.661 . . . . 0.0 111.048 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -59.84 -35.09 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.88 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -62.02 -52.89 62.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.342 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.0 OUTLIER -57.85 -46.48 84.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.095 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.444 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.71 -33.05 63.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.873 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -49.04 62.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 368' ' ' PHE . 15.9 mt -52.91 -34.52 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.946 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -61.09 -26.71 67.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.931 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -102.89 -63.73 1.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.869 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.558 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 10.3 m-85 -66.26 -77.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.591 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 354' ' ' PHE . 30.5 t0 9.41 62.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 107.08 35.09 2.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.226 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.96 -156.38 0.54 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -125.7 128.9 48.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.109 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.3 OUTLIER -89.41 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.842 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.58 28.39 0.76 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.655 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.04 -43.09 1.35 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.633 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 2.0 m-80 -81.83 169.99 16.7 Favored Pre-proline 0 C--O 1.22 -0.486 0 CA-C-N 116.974 0.387 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -97.88 142.05 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.514 2.81 . . . . 0.0 112.273 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 359' ' ' PHE . 3.4 pt -127.53 177.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.856 0.36 . . . . 0.0 111.512 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -145.03 101.61 3.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.752 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.473 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 61.2 t -88.92 138.15 19.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.761 0.315 . . . . 0.0 110.766 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.6 p -138.72 -164.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.331 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 5.2 m-85 -96.85 26.9 4.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.192 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 33.86 49.29 0.27 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.288 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 2.0 m -162.51 167.79 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.284 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.01 117.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.964 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.5 mtt85 -118.23 60.35 0.79 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 62.28 75.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -61.36 171.14 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -177.0 -178.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -156.36 35.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.34 158.54 21.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.813 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.71 26.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 72.94 163.1 7.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.491 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -89.78 109.15 3.58 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -159.08 -54.44 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 111.077 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 56.24 72.86 0.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.555 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.0 mtm-85 -60.9 152.74 26.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.2 99.73 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.544 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.435 -1.203 . . . . 0.0 112.493 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.758 0.314 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.92 129.59 40.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -73.63 132.69 43.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -158.99 -178.12 7.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.2 m -83.83 -33.04 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -69.14 -35.32 76.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 48.83 89.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 0.2 OUTLIER -71.16 -37.02 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 m -90.57 136.63 32.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.417 HG12 ' CE2' ' A' ' 341' ' ' PHE . 6.1 pt -116.64 173.05 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CE2' ' CB ' ' A' ' 367' ' ' SER . 0.2 OUTLIER -135.66 120.99 19.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 111.051 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.37 127.1 55.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.802 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.13 130.49 52.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.031 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 110.79 72.28 0.67 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.909 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -135.71 -87.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.46 115.27 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.301 -0.952 . . . . 0.0 114.141 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 53.59 32.77 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 8.48 0.77 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.39 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 13.7 p -77.98 95.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 112.232 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.438 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.0 OUTLIER -136.4 146.81 46.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.083 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.98 -46.15 92.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.75 -41.82 87.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.901 0.382 . . . . 0.0 110.752 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.0 p -63.63 -41.65 98.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 34.1 t -73.56 -45.88 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -60.89 -29.96 69.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.564 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -74.3 -38.04 63.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.785 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.408 ' OH ' ' CE2' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.84 -21.82 20.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -91.89 11.42 24.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.5 24.05 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 111.079 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 -38.49 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.309 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.3 tp -75.66 -39.54 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.179 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -176.04 -166.9 34.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.82 139.41 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.745 0.307 . . . . 0.0 111.685 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.488 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 2.1 mt -94.16 138.69 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -48.0 91.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.239 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -68.34 145.37 54.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.839 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 8.4 m-20 -78.62 170.96 15.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.343 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 -16.18 12.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.957 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -99.6 -36.17 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.91 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 57.9 p -109.12 -5.95 15.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.032 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 56.42 17.94 20.6 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.268 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.94 154.92 53.27 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.649 0.262 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.488 ' HB3' ' CG2' ' A' ' 311' ' ' ILE . 68.1 Cg_exo -44.36 158.43 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.632 2.221 . . . . 0.0 112.712 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.5 OUTLIER -120.64 121.75 38.99 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.491 0.662 . . . . 0.0 111.674 -179.03 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 323' ' ' ASN . 2.3 mt -143.31 142.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.999 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 1.2 m-20 -103.19 148.5 25.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.138 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.402 ' CB ' ' CG2' ' A' ' 296' ' ' VAL . 0.9 OUTLIER -152.82 147.53 26.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.892 0.377 . . . . 0.0 111.072 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.68 148.39 49.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -147.39 160.12 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.776 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.85 142.36 53.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.781 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 -22.45 12.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.207 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.38 -34.86 65.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 110.709 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.4 p -116.68 -19.37 9.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.94 28.42 50.28 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.11 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 128.6 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.663 0.268 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 326' ' ' THR . 1.1 mm? -59.89 139.2 57.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.766 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -93.22 20.83 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.304 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.4 ' CA ' ' HG ' ' A' ' 292' ' ' LEU . . . 44.9 51.81 8.16 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.259 -0.496 . . . . 0.0 113.398 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.445 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 12.3 mt-10 -141.99 131.38 23.68 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.752 -0.264 . . . . 0.0 111.165 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -161.65 140.51 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.781 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 288' ' ' PHE . 19.1 p -100.33 131.54 46.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.357 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 301' ' ' VAL . 75.1 t -110.64 122.04 64.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.586 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 67.0 m -98.41 147.33 24.82 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.161 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.492 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 63.1 m-85 -121.68 152.21 39.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.07 45.79 0.28 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.647 0.26 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 343' ' ' ASP . 2.7 p30 165.14 125.98 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.481 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.588 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 71.4 Cg_exo -50.89 -48.86 18.92 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.613 2.209 . . . . 0.0 113.671 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.2 Cg_endo -57.29 -30.8 88.89 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.921 1.748 . . . . 0.0 112.04 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.412 ' CB ' ' OD1' ' A' ' 343' ' ' ASP . 40.2 t -61.14 -40.31 93.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -56.04 -51.75 66.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.989 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.413 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.44 -45.26 95.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.112 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.08 -34.25 63.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.17 54.18 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.592 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 8.8 mt -55.74 -36.37 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.13 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.67 -26.59 67.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.744 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.52 ' CD1' ' CD2' ' A' ' 354' ' ' PHE . 1.3 t90 -82.41 -68.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.43 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.52 ' CD2' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.42 -78.54 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.536 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.592 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 31.13 51.11 0.12 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.86 22.09 1.84 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.096 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -84.63 -163.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.92 0.36 . . . . 0.0 110.093 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 10.8 mt-10 -119.17 130.87 55.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' A' ' 364' ' ' ILE . 0.1 OUTLIER -90.81 101.22 13.97 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.649 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 44.41 29.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.026 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.58 -48.72 0.92 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.94 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -84.48 172.92 8.02 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 116.925 0.362 . . . . 0.0 110.668 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -94.1 145.02 1.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.218 2.612 . . . . 0.0 111.682 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 5.9 pt -116.69 178.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -148.28 100.89 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.068 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 23.7 t -96.44 131.08 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.517 ' CB ' ' CE2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -140.06 -164.0 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.923 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.431 ' CD1' HD13 ' A' ' 351' ' ' ILE . 3.7 m-85 -89.27 54.43 2.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.637 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.514 ' O ' ' O ' ' A' ' 370' ' ' THR . . . 53.43 100.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.752 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 369' ' ' ALA . 0.2 OUTLIER 51.35 131.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.094 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . 0.503 ' C ' ' HG3' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -74.84 -170.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.503 ' HG3' ' C ' ' A' ' 371' ' ' ARG . 0.0 OUTLIER 42.83 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.383 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.4 26.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.64 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.36 -170.74 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 66.9 159.78 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.31 151.21 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 153.34 44.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -97.44 139.46 14.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.557 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.76 68.63 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.3 m120 60.63 93.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.41 -128.34 6.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.01 178.24 4.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -136.73 -95.2 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.47 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -176.42 174.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -93.2 80.18 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -176.58 37.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.26 24.32 11.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.04 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -139.07 -35.14 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.74 67.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 5.5 p30 -102.14 -33.25 9.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 27.9 m -83.96 126.22 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.174 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 305' ' ' PHE . 13.6 pt -95.92 173.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.344 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.468 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -130.37 109.76 10.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.18 114.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -118.62 130.83 56.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.124 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 112.75 83.15 1.23 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.559 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 359' ' ' PHE . 1.9 mt -142.29 -78.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.828 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.21 -79.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.669 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -149.52 31.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.17 -17.97 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 292' ' ' LEU . 9.7 p -45.86 123.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.94 146.5 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.424 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.407 HG21 ' HB ' ' A' ' 322' ' ' ILE . 2.1 mp -64.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.151 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 18.5 pm0 -66.4 -34.76 78.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.121 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.0 m -73.65 -43.87 58.33 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.041 0.448 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 29.8 t -72.22 -36.4 55.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.338 0.589 . . . . 0.0 109.754 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.33 -29.76 68.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.946 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.05 -41.25 62.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.773 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -97.39 -20.64 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.2 t80 -101.21 35.0 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.325 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 18.86 11.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -40.87 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.1 tp -72.35 -32.41 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.358 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . 0.405 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -161.08 -163.29 13.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.76 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.0 mt -111.08 115.69 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 2.2 mt -75.86 125.34 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -48.65 115.34 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 111.985 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -75.79 150.98 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.482 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -104.94 130.72 53.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -4.23 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 7.1 mptt -81.72 -36.64 28.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.443 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 0.4 OUTLIER -118.8 -30.98 4.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.21 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 96.78 14.39 43.47 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.882 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.472 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.18 162.03 44.03 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.901 0.351 . . . . 0.0 110.798 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 89.1 Cg_exo -44.56 162.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.78 2.32 . . . . 0.0 112.431 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.429 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -122.42 128.08 50.47 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.384 0.611 . . . . 0.0 111.758 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.407 ' HB ' HG21 ' A' ' 298' ' ' ILE . 4.9 mt -141.84 137.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -99.1 141.14 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.614 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.09 131.86 20.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 111.001 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.525 ' O ' ' HB2' ' A' ' 334' ' ' LYS . 9.8 m-30 -84.31 142.51 30.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 333' ' ' LEU . 1.3 p -147.85 152.65 37.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.12 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 332' ' ' LYS . 2.0 m-20 -80.44 148.29 30.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.387 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -43.11 -49.15 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.924 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -179.9 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.774 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 9.1 t -79.57 -21.34 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 126.27 -47.64 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.857 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 327' ' ' ASP . 0.5 OUTLIER -62.55 113.61 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 110.977 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 326' ' ' THR . 0.1 OUTLIER -99.37 25.86 6.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 110.778 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 336' ' ' GLU . 0.1 OUTLIER 40.02 96.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.17 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -65.83 33.67 0.14 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.74 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 334' ' ' LYS . 0.0 OUTLIER -122.49 131.78 54.02 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -151.93 151.92 31.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.934 0.397 . . . . 0.0 111.965 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.468 HG22 ' CD1' ' A' ' 288' ' ' PHE . 22.3 p -106.05 126.4 52.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 73.3 t -99.49 128.61 51.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.966 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 83.5 p -85.44 152.45 23.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.53 148.71 52.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.64 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.52 -16.88 58.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.411 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.28 120.33 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.001 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.592 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.21 -51.07 7.13 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.655 2.237 . . . . 0.0 112.952 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.1 Cg_endo -53.69 -30.5 56.33 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.975 1.783 . . . . 0.0 111.241 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.405 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 14.2 t -57.24 -42.0 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.898 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.85 -49.55 73.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 348' ' ' LYS . 0.3 OUTLIER -61.5 -53.02 61.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.5 18.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.97 -52.78 25.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.469 HD12 ' CZ ' ' A' ' 368' ' ' PHE . 11.4 mt -54.7 -36.66 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.367 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -26.18 66.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.816 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.1 t90 -98.29 -68.4 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 2.3 m-85 -66.68 -74.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 354' ' ' PHE . 25.7 t0 14.04 62.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.41 19.62 3.12 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.933 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 5.4 mtpt -87.05 -165.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.952 0.376 . . . . 0.0 110.687 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -121.74 142.47 50.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.502 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -111.13 101.68 10.18 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.824 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.75 28.74 6.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 116.32 -2.92 20.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.443 -0.885 . . . . 0.0 114.285 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.3 m-80 -117.79 170.07 6.74 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 117.594 0.697 . . . . 0.0 110.67 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -96.06 141.85 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.491 2.794 . . . . 0.0 111.77 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 3.4 pt -128.85 168.58 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.052 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.155 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 100.94 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.85 131.84 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.025 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -135.12 -173.91 3.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.469 ' CZ ' HD12 ' A' ' 351' ' ' ILE . 62.1 m-85 -90.67 54.24 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 47.02 73.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.942 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 53.1 m 65.93 164.44 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . 0.4 ' N ' ' CD ' ' A' ' 371' ' ' ARG . 0.0 OUTLIER -148.81 135.65 19.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.116 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.21 107.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.59 173.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.036 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.42 44.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.8 -73.78 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -175.33 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -176.87 -66.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -155.15 110.19 0.44 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.17 144.48 3.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.1 -140.96 6.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.451 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.66 27.76 8.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.703 0.287 . . . . 0.0 110.855 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 56.39 27.72 53.96 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.536 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -124.38 111.6 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.01 -48.81 3.0 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.517 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.338 -1.257 . . . . 0.0 112.538 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.41 130.56 47.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.921 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -107.2 76.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -114.85 77.08 1.04 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 65.1 m -103.67 24.15 11.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -124.66 21.43 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.31 121.02 8.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 0.6 OUTLIER -50.97 -25.87 5.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.479 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -72.55 117.91 14.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.023 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 46.0 pt -107.7 169.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.406 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -134.0 122.4 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 111.094 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.441 HG21 ' CE2' ' A' ' 305' ' ' PHE . 2.4 t -110.02 127.64 66.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.6 mp0 -111.87 130.67 55.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.046 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.6 33.62 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.423 ' HA ' ' CD2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -59.71 -84.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 93.99 98.54 1.57 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.867 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.69 31.63 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.34 31.21 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 324' ' ' LEU . 4.0 t -75.91 70.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.403 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -129.37 146.61 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.587 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 298' ' ' ILE . 26.3 mm -71.45 -43.05 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.447 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.46 -40.67 89.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -42.65 83.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 66.4 t -71.43 -40.11 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.83 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.839 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -41.93 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.88 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.8 OUTLIER -88.02 -24.8 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.551 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.9 OUTLIER -97.43 30.54 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.121 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 306' ' ' LYS . 0.0 OUTLIER -114.77 1.81 14.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -85.4 -52.06 6.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.821 0.343 . . . . 0.0 111.144 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -65.64 -28.19 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.0 -171.95 39.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.558 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 310' ' ' ILE . 4.4 mt -97.62 144.14 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 111.548 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 340' ' ' SER . 2.8 mt -97.86 127.01 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 29.0 mtmt -49.75 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.651 0.263 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -86.48 155.56 20.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.875 0.845 . . . . 0.0 111.504 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.552 ' HB3' ' OG1' ' A' ' 317' ' ' THR . 1.0 OUTLIER -71.12 98.37 1.66 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.195 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -46.4 -16.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.546 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 314' ' ' ASN . 20.3 mttm -92.5 -38.01 12.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 314' ' ' ASN . 47.9 p -103.62 -3.11 25.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 57.32 17.68 25.84 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.448 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -118.61 139.34 26.9 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.942 0.371 . . . . 0.0 111.252 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.3 Cg_exo -45.45 147.2 2.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.536 2.158 . . . . 0.0 112.406 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.4 mtp -107.74 123.07 47.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.42 0.629 . . . . 0.0 112.137 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 338' ' ' THR . 2.6 mp -143.02 139.74 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.567 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.42 ' O ' ' CB ' ' A' ' 337' ' ' ALA . 5.1 m-80 -99.25 147.54 25.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.226 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.414 ' HB3' ' CG1' ' A' ' 296' ' ' VAL . 2.7 mt -128.08 150.22 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -118.89 139.94 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 16.6 p -125.59 176.07 7.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.85 148.69 46.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.09 -56.08 2.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.094 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -151.94 -31.03 0.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 11.3 t -43.46 -29.89 0.5 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.652 0.263 . . . . 0.0 111.655 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.28 -27.65 12.25 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.826 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.95 -174.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 16.1 mt -127.4 135.35 50.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.971 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -63.87 -24.86 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.75 39.86 27.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 9.5 pt-20 -153.14 157.33 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.642 0.258 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 323' ' ' ASN . . . -160.87 156.91 25.74 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 111.762 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 288' ' ' PHE . 2.0 p -103.48 136.9 42.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.055 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.406 ' CG2' HG12 ' A' ' 301' ' ' VAL . 55.6 t -112.06 130.52 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 311' ' ' ILE . 16.5 m -86.32 153.1 22.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -129.35 135.89 49.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 111.058 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 19.2 m-20 -63.29 -35.89 81.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.327 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.44 118.97 33.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.586 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.3 Cg_exo -42.42 -51.02 5.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.87 2.38 . . . . 0.0 112.701 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.4 Cg_endo -56.08 -30.62 79.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.963 1.775 . . . . 0.0 111.282 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.2 t -60.99 -40.74 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.582 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 285' ' ' ASN . . . -56.32 -49.12 75.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.879 0.371 . . . . 0.0 110.468 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' A' ' 348' ' ' LYS . 4.2 tppt? -59.42 -54.94 40.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.637 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.87 -35.37 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.699 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.81 35.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.33 0.586 . . . . 0.0 109.458 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 9.1 mt -54.08 -39.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.728 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.19 -26.64 18.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.77 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.543 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.3 t90 -106.85 -68.45 0.89 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.477 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 305' ' ' PHE . 4.8 m-85 -59.1 -9.96 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 41.6 t0 -71.87 62.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.276 0.489 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 128.07 35.75 0.5 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.906 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.496 ' HG3' ' CD1' ' A' ' 353' ' ' TRP . 36.4 mmtm -105.86 -173.83 2.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 5.7 mt-10 -116.66 133.1 56.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.134 0.492 . . . . 0.0 112.133 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.463 ' CZ ' ' CZ ' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -93.06 101.34 13.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.96 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 36.3 t 48.86 27.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.526 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.46 -45.01 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.737 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.9 OUTLIER -80.46 169.95 17.65 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 116.999 0.4 . . . . 0.0 111.037 -179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -94.63 145.16 1.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.397 2.731 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.4 pt -128.02 176.14 8.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.244 0.545 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -148.13 116.14 6.45 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 288' ' ' PHE . 40.5 t -109.53 135.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.949 0.404 . . . . 0.0 111.875 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.431 ' OG ' ' CE1' ' A' ' 288' ' ' PHE . 3.4 p -140.67 -163.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.951 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -95.19 65.86 2.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 60.83 157.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.221 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 136.99 58.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.669 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -96.77 35.86 1.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.03 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.58 43.8 15.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.56 95.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.37 70.57 0.3 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -176.19 92.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.63 120.14 39.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -105.09 120.14 40.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.54 29.33 12.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -67.32 -59.86 6.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 142.51 -28.19 2.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -73.44 0.3 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.293 . . . . 0.0 110.949 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.96 -110.82 0.46 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.64 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 127.06 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -96.1 56.62 1.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.519 -1.156 . . . . 0.0 112.548 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -151.24 -176.89 5.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.19 -76.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.959 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 69.85 -60.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.396 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -42.38 -54.18 3.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.653 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.04 -35.46 2.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.284 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.429 ' HB3' ' CD1' ' A' ' 368' ' ' PHE . 0.6 OUTLIER 54.43 104.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.443 ' N ' ' ND2' ' A' ' 285' ' ' ASN . 0.1 OUTLIER -88.03 -31.59 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.282 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.6 m -88.04 134.2 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 305' ' ' PHE . 17.8 pt -110.79 173.38 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.476 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.418 ' CD2' ' OE1' ' A' ' 290' ' ' GLN . 1.4 t80 -127.8 108.15 10.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.5 114.81 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.5 mp0 -111.76 130.25 55.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 120.18 37.67 0.73 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.666 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.433 HD11 ' CD2' ' A' ' 359' ' ' PHE . 2.8 mm? -79.04 -89.1 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.557 0.218 . . . . 0.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.34 104.93 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.293 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 77.01 43.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.784 0.325 . . . . 0.0 111.37 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -168.45 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 295' ' ' ASN . 8.7 p -19.06 94.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 295' ' ' ASN . 7.5 p -164.01 146.43 9.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.327 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.34 -42.27 74.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.986 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -43.15 86.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.9 p -65.03 -38.45 90.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 69.5 t -74.6 -40.62 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 109.729 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.43 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -74.35 -36.12 63.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.893 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.18 -24.23 16.36 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.586 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -95.47 27.78 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 111.283 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 22.09 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.085 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -105.33 -28.83 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.546 HD12 ' CE3' ' A' ' 353' ' ' TRP . 1.1 tp -83.91 -30.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -178.78 -162.33 28.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.4 mt -98.68 142.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.628 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.0 mp -98.43 136.11 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.569 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 321' ' ' MET . 2.7 mmtp -48.88 95.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.47 146.63 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.724 ' ND2' ' OG1' ' A' ' 317' ' ' THR . 0.1 OUTLIER -101.06 145.79 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 111.433 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -77.19 -7.59 56.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.904 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -83.16 -51.04 7.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.724 ' OG1' ' ND2' ' A' ' 314' ' ' ASN . 8.3 p -108.1 -7.31 16.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.526 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.63 15.69 66.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.393 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.415 ' H ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.9 164.37 23.89 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.807 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.517 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 57.7 Cg_exo -45.1 162.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.146 2.564 . . . . 0.0 113.456 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 17.4 mtm -123.29 118.68 28.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 49.3 mt -141.56 149.98 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.346 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -114.14 148.03 37.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 296' ' ' VAL . 2.1 mt -131.69 168.61 17.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.51 103.36 8.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 67.0 p -130.41 143.79 50.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -76.98 106.0 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 7.72 33.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.414 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.51 -38.43 14.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.411 ' CG2' ' HG3' ' A' ' 332' ' ' LYS . 0.0 OUTLIER -118.79 -37.52 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 120.84 29.35 1.54 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.965 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.411 ' HG3' ' CG2' ' A' ' 330' ' ' THR . 0.6 OUTLIER -100.22 -169.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 110.674 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.51 128.8 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.503 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -69.48 -58.9 3.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.57 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 115.49 28.89 2.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.0 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.419 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 2.3 mp0 -131.59 134.4 46.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.965 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -148.19 143.17 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.958 0.409 . . . . 0.0 111.447 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 17.4 p -109.53 119.55 39.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 341' ' ' PHE . 1.2 t -93.91 123.04 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.86 129.97 41.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.824 0.345 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 339' ' ' VAL . 17.6 m-85 -109.71 150.26 28.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.57 -16.84 60.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.35 116.46 23.31 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.682 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 78.1 Cg_exo -44.82 -50.82 8.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.35 2.034 . . . . 0.0 112.602 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 9.7 Cg_endo -53.16 -30.42 50.38 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.016 1.811 . . . . 0.0 111.041 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 12.4 t -55.82 -48.75 74.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -53.32 -44.86 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.926 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 348' ' ' LYS . 0.2 OUTLIER -58.37 -54.28 48.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.063 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.5 -39.0 15.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.786 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.486 ' HA ' HD11 ' A' ' 308' ' ' ILE . . . -68.72 -45.82 70.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.362 0.601 . . . . 0.0 109.761 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 368' ' ' PHE . 7.9 mt -60.92 -32.39 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.433 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.67 -40.64 95.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.34 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.606 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -106.14 -45.54 4.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 356' ' ' GLY . 2.7 m-85 -59.22 -75.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.581 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.0 t0 1.04 63.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.211 0.944 . . . . 0.0 112.355 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 110.94 36.47 1.84 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.429 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 354' ' ' PHE . 7.9 ptmt -97.83 -158.37 0.66 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.576 0.227 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 33.0 mt-10 -113.89 128.88 56.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.045 0.45 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -122.89 105.72 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.299 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.3 m 59.76 30.09 19.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.75 57.86 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.04 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 7.2 m-80 -129.27 167.01 21.45 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.832 0.316 . . . . 0.0 111.037 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.36 128.8 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.924 2.416 . . . . 0.0 111.929 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 3.9 pt -124.68 168.58 17.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.599 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -139.1 102.42 4.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.068 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 26.3 t -85.13 134.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.02 -173.12 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.99 0.424 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 2.7 m-85 -94.46 56.68 2.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.831 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.418 ' HA ' ' HB2' ' A' ' 288' ' ' PHE . . . 52.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.975 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 31.7 m 60.91 164.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.734 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.48 -22.57 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.726 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 21.7 mmt-85 72.77 48.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.379 . . . . 0.0 110.815 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.35 109.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -177.56 178.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -134.2 39.05 3.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -98.02 83.09 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 62.17 119.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -177.88 167.12 37.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -64.99 158.33 45.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -148.84 -162.16 10.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.54 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.17 -61.68 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -60.98 98.08 0.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 151.27 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.823 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 106.04 28.41 5.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.455 -1.192 . . . . 0.0 112.503 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.857 0.361 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -175.63 3.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.661 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.92 99.56 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -177.23 -74.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.1 m -105.17 23.98 12.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -116.36 30.82 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.93 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.428 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.3 OUTLIER -170.32 118.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.099 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 20.8 p30 -99.39 -18.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.979 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 26.4 m -71.06 117.56 12.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.277 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 287' ' ' ILE . 36.6 pt -105.15 164.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -126.34 117.22 22.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.146 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 364' ' ' ILE . 1.0 OUTLIER -110.0 114.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.131 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 288' ' ' PHE . 47.6 mm-40 -112.58 132.77 54.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.056 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 113.25 75.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.767 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.437 ' CD2' ' CE2' ' A' ' 359' ' ' PHE . 1.6 mp -124.48 -76.41 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.667 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 126.17 65.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.194 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 44.25 30.36 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.61 4.64 4.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.254 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 337' ' ' ALA . 11.1 p -66.51 109.45 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.99 0.424 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.0 OUTLIER -119.07 151.3 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.489 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.6 mm -63.18 -47.91 90.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.492 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.53 -42.18 87.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.8 p -65.81 -41.44 91.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.788 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 75.8 t -73.03 -40.51 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.14 -29.87 68.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.968 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -40.01 65.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.641 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.459 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.75 -22.46 29.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.42 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -90.12 7.13 39.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.423 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 14.86 15.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.644 0.259 . . . . 0.0 111.424 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.55 -31.98 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.11 -35.84 8.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.341 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.18 -169.61 35.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.8 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 13.0 mt -92.76 144.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 111.665 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.2 mt -97.64 125.13 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.482 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.7 OUTLIER -52.72 91.66 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.338 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -80.96 167.18 20.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.242 0.544 . . . . 0.0 110.715 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.597 ' OD1' ' OG1' ' A' ' 317' ' ' THR . 0.4 OUTLIER -90.13 143.29 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.878 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -80.45 -3.18 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -94.44 -45.35 7.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.493 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 81.4 p -108.45 -4.63 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.93 43.24 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.368 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.34 144.17 31.21 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.319 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.1 Cg_exo -45.06 147.97 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.523 2.149 . . . . 0.0 112.068 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.44 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 6.7 mtp -114.23 125.55 54.04 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 112.046 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 339' ' ' VAL . 74.4 mt -143.17 137.81 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.996 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -97.63 120.72 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.031 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 337' ' ' ALA . 0.6 OUTLIER -110.07 149.8 29.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.0 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -105.06 148.2 27.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.767 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.13 161.32 41.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -76.23 119.71 20.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -5.5 46.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.638 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -98.4 -69.31 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.1 p -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 77.55 60.24 2.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -134.69 -104.4 0.23 Allowed 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.979 -0.13 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 85.8 mt -155.69 149.06 24.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.736 0.303 . . . . 0.0 110.814 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -41.94 23.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 111.068 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 109.82 24.3 5.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.01 159.68 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 324' ' ' LEU . . . -165.19 150.9 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 56.3 p -95.59 128.34 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.654 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 322' ' ' ILE . 82.0 t -107.39 134.45 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.841 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 33.1 m -94.51 138.73 32.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.904 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 312' ' ' LYS . 3.3 m-85 -115.51 142.45 46.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 111.547 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 1.4 t70 -65.43 -20.75 66.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.753 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -128.69 115.32 19.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.567 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 73.7 Cg_exo -47.24 -51.58 9.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.538 2.158 . . . . 0.0 112.683 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.1 Cg_endo -57.69 -30.86 90.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.981 1.787 . . . . 0.0 111.19 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -36.41 81.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.569 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.54 93.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.658 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.407 ' C ' ' CD ' ' A' ' 348' ' ' LYS . 0.3 OUTLIER -61.89 -54.97 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.878 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.55 10.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.993 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.7 -49.33 59.8 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.439 0.638 . . . . 0.0 109.613 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 355' ' ' ASP . 11.7 mt -56.39 -36.17 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.363 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.87 -26.85 65.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.1 t90 -86.78 -68.21 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.063 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' A' ' 355' ' ' ASP . 10.6 m-85 -69.65 -77.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.614 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.9 t70 21.16 55.51 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.473 0.483 . . . . 0.0 111.401 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.2 22.16 1.95 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.446 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -80.11 -165.61 0.87 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.737 0.303 . . . . 0.0 111.416 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -114.93 142.11 47.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.669 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.504 ' HB2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -124.55 101.41 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.777 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.68 26.41 3.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.245 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 99.79 24.09 10.25 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.893 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 65.9 m-80 -129.95 153.65 81.03 Favored Pre-proline 0 C--O 1.225 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.776 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.02 136.01 8.98 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.577 2.185 . . . . 0.0 111.711 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 359' ' ' PHE . 9.1 pt -130.47 154.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -124.87 100.74 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 37.7 t -95.96 118.96 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.36 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.416 ' HA ' HG12 ' A' ' 351' ' ' ILE . 1.4 m -140.2 176.68 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.428 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 1.2 m-85 -70.13 110.17 5.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -85.28 87.71 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.158 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.62 152.75 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.14 120.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.803 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -145.58 99.78 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 60.85 155.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.06 -177.03 4.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 66.59 172.32 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -144.61 -151.06 0.35 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.53 143.12 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.077 0 CA-C-O 120.858 0.361 . . . . 0.0 110.847 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 120.89 133.51 4.44 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.423 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 159.18 54.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.557 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -101.88 -40.81 2.6 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.409 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 58.26 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.522 0.201 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 45.83 82.77 0.03 OUTLIER Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 167.89 9.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 110.12 30.37 3.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.507 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.876 0.369 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 60.53 172.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.24 8.41 27.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.363 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.02 4.54 4.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.596 0.236 . . . . 0.0 111.54 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.6 t -105.1 24.12 12.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.688 0.28 . . . . 0.0 110.85 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -65.01 -35.03 79.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.31 100.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 20.7 p30 -51.94 -28.38 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 86.1 m -76.0 132.24 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.439 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 37.0 pt -117.86 168.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 369' ' ' ALA . 1.5 m-30 -117.39 106.73 13.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.71 114.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.437 ' HB3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -132.1 132.17 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.647 0.261 . . . . 0.0 111.48 -179.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 364' ' ' ILE . . . 121.07 79.99 0.57 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.533 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -155.79 -90.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.801 -0.235 . . . . 0.0 111.116 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.441 ' H ' ' CG ' ' A' ' 292' ' ' LEU . . . 157.12 -92.5 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -126.0 28.07 6.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 297' ' ' THR . 0.8 OUTLIER -114.71 -14.48 12.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.04 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 9.8 p -52.24 88.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 295' ' ' ASN . 0.6 OUTLIER -128.88 147.16 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 41.7 mt -61.21 -47.35 93.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.54 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -65.32 -39.36 92.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 24.7 p -68.59 -43.27 76.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.57 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 60.6 t -69.75 -37.84 74.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.495 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 306' ' ' LYS . . . -68.71 -30.86 69.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -35.73 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -103.81 -19.94 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.8 OUTLIER -99.43 -15.28 18.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -83.46 7.4 17.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.419 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -51.93 6.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 350' ' ' ALA . 0.6 OUTLIER -59.81 -33.53 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.587 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 308' ' ' ILE . . . -155.51 -177.84 29.15 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.251 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.84 105.86 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 52.5 mt -71.93 130.16 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.49 92.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -67.39 140.48 57.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.708 177.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -96.25 145.57 25.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 111.828 -179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -79.81 -4.12 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -90.57 -49.8 6.29 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.991 0.424 . . . . 0.0 110.197 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.2 p -104.98 -8.69 18.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.804 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 69.44 10.19 62.72 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.419 ' CA ' HG21 ' A' ' 313' ' ' THR . 0.0 OUTLIER -125.2 153.95 71.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 117.127 0.464 . . . . 0.0 110.99 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.7 Cg_endo -46.59 153.13 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.006 2.471 . . . . 0.0 112.77 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -105.03 120.96 42.77 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 111.262 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.406 HG21 ' N ' ' A' ' 323' ' ' ASN . 4.0 mt -139.55 142.01 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.031 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.406 ' N ' HG21 ' A' ' 322' ' ' ILE . 3.8 m-80 -104.5 148.22 26.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.17 114.85 12.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.705 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 336' ' ' GLU . 7.5 m-30 -69.71 104.49 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 17.0 p -132.39 154.78 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.843 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -103.65 103.32 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -15.31 62.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.365 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -40.2 93.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.628 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.9 t -124.62 8.27 8.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.114 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 58.8 24.71 57.93 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.546 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -104.42 133.88 48.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.914 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.8 mp -93.22 149.16 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.792 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -95.69 21.7 8.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 50.62 50.73 35.57 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.504 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 290' ' ' GLN . 29.7 mt-10 -147.2 131.61 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.665 0.269 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -150.14 145.55 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.48 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 16.2 p -108.8 118.85 37.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 78.9 t -94.26 126.77 46.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.246 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.72 121.93 37.95 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.876 0.37 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -96.48 155.44 16.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -25.86 40.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.644 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.7 117.05 22.6 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.565 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.8 Cg_exo -43.26 -51.43 5.79 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 113.107 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.3 Cg_endo -56.48 -30.63 82.95 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 121.956 1.771 . . . . 0.0 111.359 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.2 t -60.51 -37.63 81.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.883 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.21 70.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -59.86 -43.01 94.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 110.056 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.29 62.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 308' ' ' ILE . . . -68.59 -48.04 65.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 33.1 mt -52.46 -31.14 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.323 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -26.69 68.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -107.19 -61.93 1.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.514 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.523 ' O ' ' N ' ' A' ' 356' ' ' GLY . 66.3 m-85 -56.75 -74.85 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.029 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 354' ' ' PHE . 36.6 t0 2.94 65.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.046 0.841 . . . . 0.0 112.511 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 113.69 26.03 4.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.565 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 11.8 mm-40 -123.6 131.23 53.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -91.63 101.41 14.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.144 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 33.9 t 45.77 29.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.13 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.25 -46.98 1.01 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.0 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.3 OUTLIER -84.85 169.67 15.8 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 116.991 0.395 . . . . 0.0 110.697 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -96.31 138.86 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.391 2.727 . . . . 0.0 112.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 7.6 pt -116.97 -179.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 120.834 0.349 . . . . 0.0 111.426 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -148.31 100.51 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.01 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.92 128.03 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.708 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 92.5 p -140.51 -173.94 3.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.174 0.511 . . . . 0.0 112.048 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -83.28 106.2 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.35 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 288' ' ' PHE . . . -35.81 111.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.205 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 11.9 t -107.4 -155.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.16 146.23 0.67 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.875 0.369 . . . . 0.0 111.374 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -176.9 4.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -114.3 153.22 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.933 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -87.49 -89.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 17.3 t80 178.86 51.83 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.829 0.347 . . . . 0.0 110.766 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 45.17 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.67 151.55 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -156.17 58.63 0.37 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 61.53 -161.42 26.85 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.448 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 83.92 -118.67 4.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.49 160.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 114.95 -72.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.559 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.48 121.63 44.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 79.92 -124.1 6.37 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.515 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.294 -1.281 . . . . 0.0 112.464 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 61.18 83.66 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -95.26 57.82 2.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.53 -164.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 368' ' ' PHE . 2.9 m -95.27 24.26 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.95 -10.81 6.31 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.695 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -33.64 124.37 0.43 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -61.61 -18.22 58.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.79 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -73.53 106.16 5.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 287' ' ' ILE . 16.2 pt -102.22 171.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.785 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.471 ' CZ ' ' CG2' ' A' ' 338' ' ' THR . 4.2 m-85 -125.33 113.54 17.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.35 114.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.223 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 30.9 mm-40 -111.6 130.76 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.351 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 114.08 81.45 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.348 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.407 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.3 OUTLIER -128.44 -74.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 124.52 -76.24 0.38 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.108 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.21 28.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.919 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.457 ' C ' ' ND2' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -116.28 -8.78 11.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.834 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 324' ' ' LEU . 13.1 p -47.73 107.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.88 146.78 9.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.016 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 11.3 mt -63.75 -46.03 95.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.801 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -66.68 -41.93 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.358 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.3 p -67.08 -40.97 87.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 60.7 t -73.94 -38.16 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.233 0.539 . . . . 0.0 109.662 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.66 72.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.82 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -74.33 -35.65 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.001 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.22 -24.38 19.91 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -98.21 26.65 5.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.6 25.68 10.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.877 0.37 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -107.15 -44.19 4.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 1.7 tp -74.1 -28.35 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -174.68 -164.68 29.91 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.759 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.97 132.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mp -81.53 128.01 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 321' ' ' MET . 5.0 mtmp? -55.35 100.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.182 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 1.7 m -63.94 154.5 33.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.259 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.551 ' HB2' ' HG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -93.6 138.95 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 3.73 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.921 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -111.65 -20.92 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.292 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.551 ' HG1' ' HB2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.27 -21.8 6.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.562 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.75 13.62 80.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.543 ' O ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -124.43 162.63 41.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.506 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 93.1 Cg_exo -47.63 148.26 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.533 2.155 . . . . 0.0 112.152 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 72.0 mtp -101.33 114.71 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.26 139.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.044 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.2 144.17 31.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.432 ' HB3' ' CG2' ' A' ' 296' ' ' VAL . 0.3 OUTLIER -136.9 144.96 43.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.42 114.14 20.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 17.4 p -103.09 169.98 8.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.22 115.1 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 110.792 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.02 26.03 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -112.36 -34.59 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 5.9 t -129.2 -40.27 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.022 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 141.03 -26.13 2.5 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.467 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -58.4 -174.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 326' ' ' THR . 3.2 pp -125.28 138.35 54.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -53.03 -23.58 7.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.593 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 78.65 39.24 21.99 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.013 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.407 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 11.3 pt-20 -152.35 144.95 24.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 111.006 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -155.26 141.72 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.25 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.471 ' CG2' ' CZ ' ' A' ' 288' ' ' PHE . 3.7 p -92.1 138.83 31.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.706 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 301' ' ' VAL . 90.4 t -116.89 127.75 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 94.5 p -101.4 125.82 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.55 153.09 22.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -73.42 -26.49 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.326 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.96 111.16 48.25 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.954 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.584 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.4 Cg_exo -43.52 -51.04 6.38 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.53 2.153 . . . . 0.0 112.454 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.1 Cg_endo -55.35 -30.67 73.77 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.928 1.752 . . . . 0.0 111.149 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.7 t -58.98 -43.18 91.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.664 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.4 -49.79 71.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.33 -52.7 62.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.708 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.79 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.819 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.99 74.02 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 8.1 mt -61.72 -35.79 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.99 -26.34 67.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.6 t90 -96.52 -68.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.939 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.536 ' O ' ' C ' ' A' ' 355' ' ' ASP . 16.3 m-85 -62.54 -74.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 354' ' ' PHE . 26.2 t70 11.86 63.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.811 0.694 . . . . 0.0 112.16 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 114.83 25.05 4.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.656 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 19.5 mmtt -87.54 -167.87 2.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -119.93 131.93 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 112.228 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.512 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -96.23 101.36 12.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.953 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.6 p 51.44 28.2 4.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.15 -42.49 1.55 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.28 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.643 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -78.05 172.32 10.15 Favored Pre-proline 0 C--O 1.221 -0.405 0 CA-C-N 116.667 0.233 . . . . 0.0 110.767 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -94.32 146.92 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.277 2.652 . . . . 0.0 112.054 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.484 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 3.1 pt -123.59 171.26 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 111.822 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -148.29 104.02 3.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 37.0 t -91.39 139.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.307 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.04 -172.1 3.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 282' ' ' SER . 0.2 OUTLIER -108.64 76.5 1.03 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.68 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 288' ' ' PHE . . . 57.09 92.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.411 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 41.34 -161.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.44 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 14.4 mmp_? 63.06 133.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -93.66 59.04 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.74 167.05 2.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.014 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.71 -176.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.61 34.6 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.09 31.61 20.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.6 -172.3 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 133.97 107.13 0.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -59.57 -56.69 23.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.502 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 98.67 -59.48 0.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.43 -169.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 176.1 -116.53 0.57 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -110.42 114.26 27.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -77.47 -140.84 1.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.476 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 61.38 -176.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.07 49.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.233 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 284' ' ' ASN . 1.0 OUTLIER -58.69 125.55 23.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.543 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.5 p -105.4 -29.28 10.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.393 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.88 5.25 19.53 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.444 ' HA ' ' OD1' ' A' ' 281' ' ' ASN . 8.0 p30 45.45 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.171 0.51 . . . . 0.0 111.564 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.467 ' ND2' ' CB ' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -52.87 -34.55 55.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.603 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 99.6 m -62.07 97.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.468 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 43.5 pt -86.55 170.59 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.1 OUTLIER -118.39 118.59 32.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 365' ' ' LYS . 0.2 OUTLIER -108.69 115.28 48.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.538 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.449 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -116.43 130.83 56.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.376 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 111.78 51.11 0.58 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.294 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -105.57 -83.55 0.51 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.905 0.352 . . . . 0.0 110.486 179.448 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.57 -50.14 2.83 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.214 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -107.75 40.0 1.81 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.186 0.493 . . . . 0.0 111.951 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -143.56 -42.28 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.039 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 295' ' ' ASN . 96.4 t 6.27 65.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 296' ' ' VAL . 39.4 p -161.92 145.58 12.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.731 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.2 mm -71.77 -40.3 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.15 -42.81 88.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.422 ' HB3' ' OG1' ' A' ' 297' ' ' THR . 21.6 p -63.18 -41.49 99.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.473 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.501 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 34.9 t -70.72 -47.67 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.9 70.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.922 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.1 -40.67 71.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.756 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.69 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.507 ' CD2' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -88.83 9.99 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 20.99 13.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -102.32 -39.21 7.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.406 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.3 tp -76.81 -38.39 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.052 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -168.01 -162.97 21.12 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.528 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.6 mt -98.31 137.07 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.53 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.8 mt -96.73 136.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 340' ' ' SER . 4.1 mmtt -48.42 106.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.052 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -77.67 142.87 38.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.569 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.62 140.3 29.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 0.0 111.387 -179.031 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -77.86 -6.18 53.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.91 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -45.13 7.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.37 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 70.8 p -104.63 -8.25 19.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 63.95 14.22 55.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.235 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.14 164.08 34.01 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 120.485 0.183 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.563 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 79.3 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.44 2.093 . . . . 0.0 112.299 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.569 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.64 125.1 51.29 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.569 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 323' ' ' ASN . 4.6 mt -143.28 144.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.166 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.424 ' N ' HG21 ' A' ' 322' ' ' ILE . 1.2 m-20 -110.34 147.84 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.703 0.287 . . . . 0.0 110.455 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 324' ' ' LEU . 0.0 OUTLIER -145.48 130.14 18.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.111 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -91.14 139.36 30.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.511 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 63.1 p -146.19 174.8 11.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.55 147.99 31.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.418 ' HD3' ' N ' ' A' ' 328' ' ' ARG . 0.0 OUTLIER -111.15 15.85 21.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.409 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.51 49.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.072 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 171.75 -35.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.99 -29.45 9.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.321 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -57.98 170.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 110.775 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 326' ' ' THR . 0.0 OUTLIER -108.57 -177.16 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -101.75 -28.93 12.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 102.23 28.27 6.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.567 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 0.6 OUTLIER -143.02 143.4 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.36 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -158.26 139.85 13.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.237 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.469 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 11.9 p -97.61 134.15 41.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 305' ' ' PHE . 95.0 t -112.0 126.06 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.522 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 312' ' ' LYS . 0.1 OUTLIER -86.18 153.26 22.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.467 ' CB ' ' ND2' ' A' ' 285' ' ' ASN . 4.5 m-85 -133.51 147.0 51.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.42 -33.22 48.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.65 118.07 41.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.648 0.261 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.552 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.5 Cg_exo -41.84 -51.69 4.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.876 2.384 . . . . 0.0 113.081 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.2 Cg_endo -55.6 -30.28 74.06 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.775 1.65 . . . . 0.0 111.089 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.8 t -56.64 -44.82 81.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.04 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -53.4 -50.34 65.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.63 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.48 ' C ' ' CD ' ' A' ' 348' ' ' LYS . 0.0 OUTLIER -63.9 -54.85 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.156 0.503 . . . . 0.0 109.749 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.92 14.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.58 -48.56 63.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 9.0 mt -58.93 -35.99 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.371 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -61.91 -26.2 68.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.242 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.6 t90 -94.37 -68.57 0.79 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.508 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 1.5 m-85 -69.79 -77.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.8 p-10 23.17 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.115 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.45 20.33 2.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.316 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.428 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 9.1 mtpp -87.02 -166.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.061 0.43 . . . . 0.0 110.472 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 13.3 mm-40 -120.02 128.91 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.419 . . . . 0.0 112.093 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.544 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -84.2 100.84 11.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.743 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.49 31.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 142.51 -51.62 0.67 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.186 -1.006 . . . . 0.0 114.048 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.4 OUTLIER -89.16 171.61 8.7 Favored Pre-proline 0 C--O 1.218 -0.59 0 CA-C-N 117.008 0.404 . . . . 0.0 110.743 -179.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.48 143.36 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.308 2.672 . . . . 0.0 112.193 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.492 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 3.9 pt -132.03 170.06 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 111.978 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -132.62 150.92 52.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.777 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 351' ' ' ILE . 11.6 t -131.6 127.74 59.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.8 p -140.24 172.92 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 351' ' ' ILE . 4.3 m-85 -86.28 55.5 3.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.088 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 59.44 84.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.14 120.21 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.16 127.77 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.712 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.61 -165.76 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -90.86 61.61 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.071 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 -75.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.92 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -178.92 150.79 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 57.43 -119.91 18.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 136.12 -51.36 0.81 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -131.19 -83.45 0.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.589 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.5 m120 63.71 137.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.87 0.367 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 99.18 -27.79 18.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 152.87 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -83.85 -27.97 36.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.551 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 61.43 -170.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -75.16 68.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.405 ' O ' ' CZ ' ' A' ' 368' ' ' PHE . 1.4 m120 -118.4 88.06 2.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 15.9 p -96.71 24.22 6.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.96 -28.25 62.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.992 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.487 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.2 OUTLIER -123.17 119.19 29.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 3.8 p-10 -86.45 -19.14 30.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 74.6 m -80.42 144.98 32.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.769 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.2 pt -123.36 168.33 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.764 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.6 OUTLIER -124.06 114.95 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.174 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.63 114.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -112.74 144.18 42.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.678 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.51 4.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.731 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 7.2 mt -60.51 -76.76 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.618 0.247 . . . . 0.0 110.743 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.3 77.72 0.77 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.392 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 43.93 30.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.632 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.33 25.34 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.729 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 324' ' ' LEU . 21.5 t -68.17 83.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.7 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.44 147.99 49.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.588 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 32.4 mm -68.54 -47.02 79.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -38.64 87.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.7 t -63.96 -40.28 96.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 54.6 t -74.9 -41.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.862 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 306' ' ' LYS . . . -68.18 -29.93 68.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.837 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -74.11 -40.47 62.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.632 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -94.07 -21.83 18.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.523 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -105.33 38.13 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.02 19.11 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.305 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -36.45 8.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.301 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.0 tp -75.48 -30.1 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.465 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . 0.422 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -168.16 -167.38 28.73 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.91 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.69 116.71 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mt -76.81 124.02 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.313 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 321' ' ' MET . 23.9 mtmt -48.72 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 1.2 m -69.64 152.04 45.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.747 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.23 144.59 25.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.8 1.5 52.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.279 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.26 -32.1 7.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.845 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.403 ' HB ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -107.39 -20.67 13.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.752 179.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.37 8.59 71.15 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.776 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.468 ' O ' ' OD1' ' A' ' 314' ' ' ASN . 0.1 OUTLIER -125.12 167.42 16.3 Favored Pre-proline 0 C--O 1.224 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.538 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 66.8 Cg_exo -44.78 149.37 1.14 Allowed 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.708 2.272 . . . . 0.0 113.041 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 312' ' ' LYS . 36.7 mtp -101.94 121.56 42.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.835 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.434 HG21 ' O ' ' A' ' 338' ' ' THR . 1.2 mt -143.25 138.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.83 140.41 33.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.808 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 296' ' ' VAL . 5.2 mt -126.7 142.61 51.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.034 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -115.48 87.93 2.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.5 p -89.1 174.03 8.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 329' ' ' GLU . 11.5 m-20 -90.06 99.63 12.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 -83.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 327' ' ' ASP . 3.2 mt-10 167.58 31.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.88 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 8.8 t -96.23 -26.24 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.154 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.13 72.75 0.57 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.926 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 327' ' ' ASP . 2.8 mtpp -143.11 -46.32 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 110.758 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.3 mp 62.09 147.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.099 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -102.96 12.15 36.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.269 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 52.36 49.0 53.1 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.522 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.22 136.5 15.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 0.0 111.236 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -157.88 153.02 25.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.451 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -102.67 145.83 29.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.428 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.27 128.51 70.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.206 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 59.7 p -97.57 124.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.902 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -102.06 154.87 18.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.69 -21.09 38.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -125.98 118.36 23.9 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.683 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.589 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.1 Cg_exo -41.31 -50.81 4.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.733 2.289 . . . . 0.0 112.983 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.3 Cg_endo -53.03 -30.54 49.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.956 1.771 . . . . 0.0 111.219 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.422 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 25.6 t -57.26 -44.92 84.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.97 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 368' ' ' PHE . . . -56.35 -49.22 75.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.457 ' C ' ' HD3' ' A' ' 348' ' ' LYS . 0.7 OUTLIER -62.05 -49.97 73.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.003 0.43 . . . . 0.0 110.01 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.88 38.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.731 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.09 64.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.452 0.644 . . . . 0.0 109.382 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 10.5 mt -58.26 -35.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.158 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.17 -26.62 65.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.159 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.519 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -89.2 -68.01 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.334 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.601 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -75.64 -81.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.614 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.5 p-10 31.26 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.549 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 126.02 43.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.773 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.601 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.79 -157.2 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 27.7 tt0 -113.58 128.32 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.41 0.624 . . . . 0.0 111.518 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 304' ' ' TYR . 0.9 OUTLIER -112.46 101.66 9.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.957 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.7 t 55.43 26.55 8.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.068 0.461 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 94.66 24.83 16.89 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.74 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -129.94 148.57 70.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.822 0.344 . . . . 0.0 111.848 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.07 121.71 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.479 2.119 . . . . 0.0 111.447 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 8.7 pt -112.33 -178.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.961 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.12 101.04 3.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.673 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.407 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 40.8 t -88.64 133.52 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 86.6 p -127.53 -179.89 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.195 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . 0.487 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -95.5 51.45 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.693 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 65.67 159.71 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.011 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -74.76 166.98 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.881 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.9 -172.95 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -116.55 -40.05 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 62.84 134.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 28.8 t70 60.04 164.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.12 -158.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 70.25 -78.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.08 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -153.48 -79.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 79.3 -152.21 35.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.35 75.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.424 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -89.31 -170.48 44.89 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.558 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.51 -167.62 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.311 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 157.65 -26.67 0.46 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.58 118.3 4.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.994 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.97 -94.82 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.485 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.53 155.85 34.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.84 -29.07 13.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 10.6 m120 61.58 21.43 12.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.055 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.3 m -104.98 23.52 13.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.057 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.32 31.12 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -115.81 87.4 2.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -58.41 -21.3 50.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.691 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.515 ' CG2' ' CB ' ' A' ' 369' ' ' ALA . 0.3 OUTLIER -84.56 143.04 29.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.59 HG12 HG13 ' A' ' 339' ' ' VAL . 2.0 pt -117.26 172.17 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.047 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 1.5 p90 -125.48 122.29 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.876 0.37 . . . . 0.0 111.459 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.34 114.86 45.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.93 131.0 57.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.06 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 106.75 43.15 1.46 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.976 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.5 OUTLIER -85.67 -79.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.791 0.296 . . . . 0.0 110.678 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 136.39 -81.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.546 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.13 29.74 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.92 0.39 . . . . 0.0 110.575 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -111.65 7.92 20.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.94 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.434 ' HB ' ' HG ' ' A' ' 333' ' ' LEU . 10.0 t -55.52 89.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.529 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -147.52 146.44 29.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mm -71.43 -45.28 69.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.684 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.96 -43.09 84.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.073 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -40.0 82.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 54.2 t -73.58 -37.96 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.715 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 320' ' ' PRO . . . -68.61 -34.52 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.36 -38.02 71.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.092 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -85.54 -20.91 28.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.714 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.6 OUTLIER -92.15 11.76 24.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 29.02 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.071 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -112.54 -33.8 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 7.8 tp -84.4 -31.8 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.71 -160.73 26.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.732 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.0 mt -92.85 134.63 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.562 0.22 . . . . 0.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 4.6 mt -92.93 134.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.378 0.608 . . . . 0.0 110.945 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.7 OUTLIER -48.56 100.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.411 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -76.21 154.25 35.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 318' ' ' GLY . 17.6 p30 -103.03 -178.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.018 0.437 . . . . 0.0 111.644 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.41 ' CD ' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -109.42 -12.46 14.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.172 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 -44.75 11.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.156 0.503 . . . . 0.0 109.999 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 8.5 p -106.37 -8.42 17.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.766 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 314' ' ' ASN . . . 61.23 17.39 52.36 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.671 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.536 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.7 168.03 14.32 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 120.776 0.322 . . . . 0.0 110.894 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.536 ' N ' ' HG2' ' A' ' 319' ' ' GLN . 80.4 Cg_exo -44.54 161.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.988 2.459 . . . . 0.0 112.726 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -123.08 129.43 51.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.296 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.45 HG12 ' CG2' ' A' ' 339' ' ' VAL . 3.7 mp -144.38 129.23 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.15 115.52 28.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.416 ' CD2' HG11 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -121.56 148.77 44.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -101.22 130.33 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 13.8 p -132.92 145.59 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 118.75 7.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.755 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -7.6 59.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.451 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.17 -43.74 12.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 10.0 t -112.72 -29.61 7.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.055 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.09 28.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.623 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.22 135.36 56.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.888 0.375 . . . . 0.0 111.074 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -61.95 149.19 41.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.785 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -76.71 -26.04 54.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 94.63 31.83 7.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.18 140.55 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.62 0.247 . . . . 0.0 110.703 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 324' ' ' LEU . . . -160.39 179.11 8.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.783 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' THR . . . . . . . . . . . . . 69.4 p -129.91 136.47 49.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.406 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.59 HG13 HG12 ' A' ' 287' ' ' ILE . 0.4 OUTLIER -104.37 125.11 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.268 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 321' ' ' MET . 3.1 p -94.56 140.07 30.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.047 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.455 ' CE2' HD12 ' A' ' 287' ' ' ILE . 32.2 m-85 -115.5 160.16 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 111.069 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -80.63 -18.15 49.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.25 116.87 20.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.592 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.7 Cg_exo -44.77 -50.52 8.34 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.653 2.235 . . . . 0.0 112.907 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.1 Cg_endo -54.58 -30.51 65.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.003 1.802 . . . . 0.0 111.401 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.9 t -58.67 -41.21 85.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -56.05 -50.1 71.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.456 ' C ' ' HD3' ' A' ' 348' ' ' LYS . 0.4 OUTLIER -59.39 -50.64 73.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.175 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.56 -33.78 33.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.84 -48.33 63.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.433 0.635 . . . . 0.0 109.391 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 355' ' ' ASP . 10.4 mt -56.87 -35.97 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.15 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -26.65 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.152 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.34 -68.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.054 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.504 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 5.1 m-85 -76.17 -79.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.483 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 354' ' ' PHE . 45.5 t0 21.44 51.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.439 0.462 . . . . 0.0 112.021 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 125.32 32.02 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.256 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -102.74 -162.87 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.087 0.443 . . . . 0.0 110.087 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 8.5 mt-10 -113.72 128.6 56.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.994 0.426 . . . . 0.0 111.866 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.488 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -102.79 101.72 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.266 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 41.0 t 60.01 28.38 17.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.486 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.32 -27.8 10.33 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.592 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 3.1 m-80 -91.76 169.54 11.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.956 0.378 . . . . 0.0 110.64 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -93.34 137.18 1.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 112.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . . . . . . . . . 23.3 pt -134.36 164.52 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 120.977 0.417 . . . . 0.0 111.804 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 100.53 5.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 287' ' ' ILE . 19.5 t -90.02 118.66 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.424 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -140.53 -166.75 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -72.94 113.06 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . 0.515 ' CB ' ' CG2' ' A' ' 286' ' ' THR . . . -63.03 82.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.0 t -167.94 -172.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.66 120.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 99.25 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.986 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.86 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -161.12 -178.12 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.89 102.06 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -170.21 111.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -129.23 -70.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 82.23 -58.33 4.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.631 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.1 28.59 4.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 77.39 115.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -103.93 112.75 25.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 109.93 -56.51 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -68.75 149.92 48.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 104.42 -28.21 15.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.53 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.481 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.85 0.357 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.77 157.45 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -85.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.69 77.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.765 0.317 . . . . 0.0 111.197 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 59.6 p -86.61 5.73 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -112.95 -9.34 13.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.632 0.254 . . . . 0.0 111.056 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.32 120.23 23.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.783 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -104.1 -25.15 13.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 58.9 m -70.52 116.23 10.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.8 pt -102.93 173.17 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.175 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.436 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.4 OUTLIER -122.46 107.69 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.421 ' O ' ' NE2' ' A' ' 290' ' ' GLN . 2.7 t -104.35 114.48 44.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.424 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 2.0 mp0 -116.78 130.5 56.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.98 25.77 1.64 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.849 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 292' ' ' LEU . 4.9 mp -88.05 -104.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.94 -39.7 1.82 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.594 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.93 31.82 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.654 0.727 . . . . 0.0 112.036 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.5 OUTLIER -162.51 -44.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 296' ' ' VAL . 14.7 t 26.48 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.639 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -164.48 145.2 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.101 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 298' ' ' ILE . 1.2 mp -72.21 -42.1 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.998 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.44 -40.54 95.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.4 t -65.08 -43.99 90.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.468 . . . . 0.0 110.478 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 47.7 t -70.92 -40.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.353 0.597 . . . . 0.0 109.664 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.18 -29.82 68.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.024 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -37.7 65.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.685 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.438 ' OH ' ' CE1' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.57 -24.79 15.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.518 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -93.27 7.98 42.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -95.56 22.41 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 111.076 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.21 -44.35 6.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.94 -29.33 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.477 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.73 -170.52 35.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.943 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.29 113.85 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.689 0.281 . . . . 0.0 111.513 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 1.1 mt -71.65 135.16 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 0.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 321' ' ' MET . 6.1 mmmt -65.37 91.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -67.33 171.02 6.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 111.043 178.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 316' ' ' LYS . 0.4 OUTLIER -103.35 116.34 32.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.354 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -8.26 0.16 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.574 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -83.27 -34.49 25.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.064 0.459 . . . . 0.0 110.59 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.461 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.5 OUTLIER -121.62 -23.48 5.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.338 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.84 23.43 52.78 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.908 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.461 ' HG2' HG21 ' A' ' 317' ' ' THR . 2.7 pp0? -118.57 138.1 25.49 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.884 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.627 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 4.8 Cg_exo -44.01 131.04 8.32 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.999 2.466 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 0.0 OUTLIER -97.15 130.18 44.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.839 0.828 . . . . 0.0 112.929 -178.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 3.7 mt -143.14 140.22 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.428 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.439 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 6.2 t30 -98.8 148.38 23.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 337' ' ' ALA . 0.2 OUTLIER -154.42 128.17 8.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.943 0.401 . . . . 0.0 111.496 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -86.54 87.94 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.952 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.445 HG23 ' CG1' ' A' ' 296' ' ' VAL . 0.2 OUTLIER -143.22 150.38 39.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.007 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.9 108.01 19.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.555 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.24 13.19 12.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.733 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -97.97 -40.57 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 111.134 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 6.4 t -127.2 -1.8 6.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.82 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.83 49.61 6.4 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.416 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.0 24.51 6.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 111.174 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 19.1 mt -32.62 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.762 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.41 -31.37 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 90.11 32.42 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.617 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 4.9 mp0 -130.16 132.16 45.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.502 0.191 . . . . 0.0 110.562 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -153.27 147.05 25.22 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.436 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 44.3 p -110.33 117.8 34.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.918 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . . . . . . . . . 56.1 t -93.06 130.15 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.739 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 9.1 t -96.72 133.62 41.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.907 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.412 ' O ' ' HG3' ' A' ' 312' ' ' LYS . 3.0 m-85 -117.41 148.35 41.85 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -70.95 -34.32 71.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.49 109.45 60.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.584 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.28 -51.41 6.85 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.478 2.119 . . . . 0.0 112.496 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.3 Cg_endo -55.76 -30.58 76.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.945 1.763 . . . . 0.0 111.262 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -60.54 -44.21 96.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.65 -46.21 81.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.287 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -60.16 -54.74 42.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.847 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.54 43.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.63 -49.68 57.28 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.543 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 9.9 mt -52.47 -36.66 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.763 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -58.38 -26.24 62.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.577 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.544 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.4 t90 -100.5 -68.6 0.8 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.518 ' CE2' ' CE1' ' A' ' 305' ' ' PHE . 47.2 m-85 -56.85 -74.48 0.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.4 p-10 9.35 59.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.973 0.796 . . . . 0.0 112.684 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.81 30.69 1.76 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.13 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.409 ' HG3' ' CG1' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -94.75 -164.45 1.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 7.7 mm-40 -119.4 129.38 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.621 -0.432 . . . . 0.0 112.122 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 362' ' ' ASN . 0.3 OUTLIER -86.09 101.05 12.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 40.5 30.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.358 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 140.49 -49.72 0.78 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.28 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.0 OUTLIER -89.7 171.1 9.26 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 117.207 0.504 . . . . 0.0 110.958 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -95.15 140.17 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.468 2.779 . . . . 0.0 112.153 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 359' ' ' PHE . 5.1 pt -122.28 -179.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.865 0.364 . . . . 0.0 111.652 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.27 102.45 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.548 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 17.6 t -84.85 143.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.2 t -128.08 -168.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -121.2 65.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.23 177.06 0.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.455 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 -172.92 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 67.15 179.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.817 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -133.89 76.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.297 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 49.09 28.7 2.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 375' ' ' PHE . 1.9 t0 71.99 -146.97 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.216 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 375' ' ' PHE . 17.9 p90 42.26 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.385 0.612 . . . . 0.0 111.489 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 179.62 98.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.79 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -135.8 123.1 21.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 76.51 -104.49 1.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.524 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 61.93 51.99 53.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 115.14 170.55 16.34 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.435 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -100.35 -31.07 11.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 141.94 -163.5 26.97 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.45 150.7 41.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.953 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 163.7 131.21 1.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.418 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.358 -1.245 . . . . 0.0 112.475 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.793 0.33 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 60.81 -167.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.26 -30.56 62.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.76 87.82 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.4 t -71.9 -28.37 63.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 284' ' ' ASN . 25.7 m-20 -111.53 -2.37 15.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.412 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 283' ' ' ASP . 5.1 p30 48.98 108.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.71 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 9.9 p30 -63.9 -20.28 65.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 27.8 m -71.44 158.28 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 10.2 pt -142.94 173.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 338' ' ' THR . 0.1 OUTLIER -131.09 112.35 12.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.016 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.417 ' O ' ' NE2' ' A' ' 290' ' ' GLN . 0.5 OUTLIER -105.35 114.69 45.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.741 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.1 mp0 -113.37 130.59 56.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.034 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.03 0.89 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.387 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.473 ' HB3' ' ND2' ' A' ' 295' ' ' ASN . 0.3 OUTLIER -84.56 -73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.108 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.27 105.12 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.392 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.18 46.6 19.74 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -165.69 26.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 110.796 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.415 ' CG1' ' CB ' ' A' ' 324' ' ' LEU . 18.0 t -79.17 100.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.564 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.36 147.0 25.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.585 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 298' ' ' ILE . 28.3 mm -70.93 -44.73 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.399 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.72 -39.19 87.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.7 t -68.22 -42.92 79.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.586 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 305' ' ' PHE . 90.8 t -71.41 -40.01 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.564 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.46 -29.9 68.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.832 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.9 -38.73 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.721 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.81 -24.81 28.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.564 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 1.1 m-85 -85.67 1.13 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.769 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 12.81 15.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.622 0.248 . . . . 0.0 111.356 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.58 -45.11 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.043 0.449 . . . . 0.0 110.458 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 2.1 tp -76.32 -36.64 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.26 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -171.78 -158.72 16.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.913 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.48 144.16 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.742 0.306 . . . . 0.0 111.536 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.2 mt -96.15 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.86 93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.42 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -71.74 152.57 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.458 ' HB2' ' HG3' ' A' ' 321' ' ' MET . 0.7 OUTLIER -107.74 110.9 22.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.806 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -8.52 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.434 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 15.1 mmtt -89.35 -25.7 21.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.994 0.426 . . . . 0.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.534 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 74.9 p -122.06 -24.03 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.56 16.0 76.72 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.692 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLN . . . . . 0.534 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.58 160.08 57.57 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 0.0 111.619 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' PRO . . . . . 0.438 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 83.9 Cg_exo -50.5 156.9 3.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.776 2.317 . . . . 0.0 112.279 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.486 ' O ' ' OG ' ' A' ' 340' ' ' SER . 0.1 OUTLIER -121.35 122.94 40.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.224 0.535 . . . . 0.0 111.346 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 339' ' ' VAL . 47.9 mt -143.64 146.27 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.443 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.45 134.26 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.611 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.415 ' CB ' ' CG1' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -136.34 143.55 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.77 -179.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -111.18 119.52 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 20.7 p -136.67 148.94 47.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.27 115.27 17.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -15.84 37.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.59 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -72.58 -41.58 65.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 6.0 t -104.17 -24.92 13.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.805 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.4 55.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -82.21 -171.96 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.068 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 326' ' ' THR . 0.8 OUTLIER -142.77 161.25 38.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.816 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.64 12.7 20.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.441 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 50.82 50.41 37.81 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.643 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 37.8 mt-10 -148.5 131.99 16.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.686 0.279 . . . . 0.0 111.216 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -159.04 133.38 7.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 111.765 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' THR . . . . . 0.461 ' CG2' ' CE1' ' A' ' 288' ' ' PHE . 20.4 p -91.91 130.38 37.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.15 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' VAL . . . . . 0.41 ' HA ' HG12 ' A' ' 322' ' ' ILE . 60.4 t -111.26 132.38 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.683 0.278 . . . . 0.0 111.217 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 286' ' ' THR . 2.5 p -100.44 139.21 36.44 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.812 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.96 161.16 14.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.03 -27.77 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.756 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.76 120.53 22.95 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.506 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' PRO . . . . . 0.56 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.9 Cg_exo -41.91 -51.62 4.46 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.832 2.355 . . . . 0.0 112.963 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 14.4 Cg_endo -56.61 -30.67 84.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.914 1.742 . . . . 0.0 111.466 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.1 t -62.34 -39.23 92.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -63.12 -48.33 78.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.38 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 349' ' ' ALA . 0.0 OUTLIER -61.73 -47.73 83.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.932 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.436 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.87 -31.96 63.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.97 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.09 67.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ILE . . . . . 0.519 ' O ' ' HB3' ' A' ' 355' ' ' ASP . 10.8 mt -58.04 -35.46 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.943 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.23 -26.46 64.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.24 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.6 t90 -101.97 -65.87 0.96 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' PHE . . . . . 0.512 ' O ' ' C ' ' A' ' 355' ' ' ASP . 20.5 m-85 -61.11 -74.89 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 16.0 p-10 13.5 58.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.795 0.685 . . . . 0.0 112.345 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 113.27 35.02 1.68 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.727 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.23 -160.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.7 mm-40 -121.81 129.06 52.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 112.116 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' PHE . . . . . 0.525 ' CZ ' ' CE2' ' A' ' 304' ' ' TYR . 0.1 OUTLIER -83.95 100.9 11.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 18.6 p 39.31 31.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.209 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.8 -47.83 0.92 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.91 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.8 m-80 -88.13 170.99 10.21 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.989 0.395 . . . . 0.0 110.604 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -96.24 141.71 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.251 2.634 . . . . 0.0 112.386 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ILE . . . . . 0.493 ' O ' ' HA2' ' A' ' 356' ' ' GLY . 3.8 pt -126.82 -178.91 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.35 100.93 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 354' ' ' PHE . 24.6 t -87.78 137.39 21.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.9 p -131.55 -165.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.963 0.411 . . . . 0.0 111.263 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -96.78 28.92 3.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.063 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 48.95 -176.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.1 t -171.31 -179.2 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 47.71 91.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.21 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -70.98 72.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.788 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -111.12 -177.67 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 28.5 t0 60.22 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 76.6 t80 60.11 87.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -119.04 -66.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -67.66 -50.77 56.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 146.42 -87.81 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -141.59 28.45 2.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 173.74 109.61 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.595 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.5 110.86 3.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.763 0.315 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -59.42 -160.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.22 135.74 52.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.81 -42.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.559 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.524 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -47.26 -30.07 2.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 96.9 m -61.33 125.55 24.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 366' ' ' VAL . 40.2 pt -113.29 173.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.49 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.9 OUTLIER -126.36 112.98 16.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.266 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -107.01 122.48 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.626 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -128.89 129.98 46.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.018 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.57 46.76 0.52 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.3 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 359' ' ' PHE . 0.7 OUTLIER -86.29 -84.59 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.5 0.191 . . . . 0.0 110.83 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 105.64 90.6 2.18 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.269 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 44.65 27.95 0.29 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.822 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 293' ' ' GLY . 17.9 p30 -142.31 -2.23 1.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.789 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 296' ' ' VAL . 11.7 p -64.9 83.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.792 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -116.46 163.95 15.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.512 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.814 ' CD1' HD11 ' A' ' 324' ' ' LEU . 13.8 mm -71.29 -49.1 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 111.366 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -34.1 76.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.5 t -63.58 -44.13 94.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.819 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 339' ' ' VAL . 43.1 t -73.81 -38.44 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.401 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.747 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -67.92 -30.44 69.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.053 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.55 -41.79 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.498 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -93.18 -21.43 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.527 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -104.71 37.56 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.808 0.337 . . . . 0.0 111.326 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.92 17.04 9.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.177 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.05 -43.27 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 109.987 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 350' ' ' ALA . 0.6 OUTLIER -66.74 -35.56 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.5 -156.15 11.04 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.565 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 mt -101.93 134.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -89.18 139.66 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 110.035 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -48.15 91.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.945 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.421 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -70.79 147.12 49.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.415 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.536 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -97.35 157.86 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.425 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -89.44 -8.25 53.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -45.55 8.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.431 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 61.0 p -107.5 -7.43 16.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 314' ' ' ASN . . . 61.72 18.84 57.48 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.678 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 1.6 pt20 -124.5 163.69 35.04 Favored Pre-proline 0 C--O 1.227 -0.131 0 CA-C-O 120.677 0.275 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.747 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 88.0 Cg_exo -46.86 154.55 1.05 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.789 2.326 . . . . 0.0 113.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.536 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -123.45 125.07 44.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.264 0.555 . . . . 0.0 110.959 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 338' ' ' THR . 2.7 mp -140.11 140.51 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -95.56 115.8 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.747 0.308 . . . . 0.0 110.29 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.814 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.553 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -151.09 131.86 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.433 0.158 . . . . 0.0 110.663 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.82 145.22 15.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 121.3 0.571 . . . . 0.0 112.298 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 322' ' ' ILE . 7.6 p -98.0 134.9 40.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.793 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.831 ' CG2' HG11 ' A' ' 301' ' ' VAL . 57.2 t -107.84 128.69 62.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.405 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 50.3 m -90.4 142.78 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.374 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 146.0 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 111.269 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -79.28 -17.94 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.14 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.8 111.03 27.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.554 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -49.07 -52.19 9.19 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.469 2.113 . . . . 0.0 112.877 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.1 Cg_endo -59.07 -30.67 93.9 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.873 1.715 . . . . 0.0 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 36.4 t -65.66 -34.72 78.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.688 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.29 97.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.81 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.882 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -62.66 -50.91 69.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.262 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.35 53.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.65 ' HA ' HD13 ' A' ' 308' ' ' ILE . . . -68.75 -48.0 64.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.305 0.574 . . . . 0.0 109.863 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.6 mt -57.44 -35.64 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.228 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -26.55 68.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.819 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.5 t90 -98.67 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.847 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 355' ' ' ASP . 60.6 m-85 -56.04 -74.17 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.562 ' C ' ' O ' ' A' ' 354' ' ' PHE . 22.6 t0 8.97 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.911 0.757 . . . . 0.0 111.624 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.02 22.35 4.25 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.259 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -78.72 -164.48 0.59 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.608 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 21.3 mm-40 -130.11 137.24 50.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 112.149 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.713 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -102.75 101.47 11.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.146 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.26 29.52 5.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.703 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 123.9 -37.9 2.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.443 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.0 OUTLIER -82.77 169.98 16.14 Favored Pre-proline 0 C--O 1.22 -0.474 0 CA-C-N 116.876 0.338 . . . . 0.0 110.659 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.76 144.46 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.441 2.761 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.713 HG21 ' HD2' ' A' ' 359' ' ' PHE . 3.6 pt -130.98 161.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-O 120.824 0.345 . . . . 0.0 111.667 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -130.42 100.95 5.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 287' ' ' ILE . 23.3 t -85.64 130.79 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 p -127.75 -177.27 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.915 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.489 ' O ' ' ND2' ' A' ' 285' ' ' ASN . 67.0 m-20 . . . . . 0 N--CA 1.458 -0.027 0 CA-C-O 120.621 0.248 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.0 OUTLIER 85.31 14.06 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.445 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 90.1 m -164.97 107.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.709 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.821 HD11 ' CE2' ' A' ' 305' ' ' PHE . 33.0 pt -92.75 170.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.172 0.51 . . . . 0.0 111.842 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.54 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.0 m-85 -119.75 110.92 17.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.553 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 339' ' ' VAL . 0.4 OUTLIER -103.15 119.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -128.31 130.03 47.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.533 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 126.26 20.18 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.154 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -71.19 -101.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 171.64 -100.44 0.15 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.139 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -131.95 33.55 3.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 296' ' ' VAL . 1.4 p30 -130.46 -51.66 1.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.137 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 296' ' ' VAL . 14.4 p -2.05 76.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.803 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -112.76 155.05 25.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.699 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.636 HG23 ' HB ' ' A' ' 322' ' ' ILE . 16.7 mt -61.12 -47.04 95.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -38.27 87.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -39.26 79.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.121 0.486 . . . . 0.0 110.484 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 297' ' ' THR . 87.2 t -73.41 -39.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.805 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.23 73.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.926 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -39.87 62.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.678 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -89.5 -21.64 22.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -102.19 30.09 4.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.142 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.3 19.36 17.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.159 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -101.83 -39.7 7.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 110.323 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -79.1 -38.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.119 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.99 -169.97 30.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.525 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.59 144.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 340' ' ' SER . 4.1 mp -93.48 131.83 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.144 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 25.7 mtmt -48.91 93.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.765 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -64.56 145.46 56.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.463 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.424 ' ND2' ' SD ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -75.89 162.19 28.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.346 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -104.95 -7.72 19.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -104.48 -35.69 7.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.999 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 314' ' ' ASN . 69.6 p -108.24 -9.57 15.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 313' ' ' THR . . . 60.51 14.72 36.35 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.718 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 159.18 52.41 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.984 0.392 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 76.6 Cg_exo -44.68 151.15 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.007 2.471 . . . . 0.0 112.86 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.424 ' SD ' ' ND2' ' A' ' 314' ' ' ASN . 29.9 mtm -108.11 119.15 38.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.391 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.636 ' HB ' HG23 ' A' ' 298' ' ' ILE . 4.8 mt -143.22 142.74 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.467 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -117.95 133.19 56.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 324' ' ' LEU . 0.1 OUTLIER -125.41 164.04 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.209 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.821 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.655 ' O ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -139.78 131.77 27.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.172 . . . . 0.0 110.866 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -162.65 145.54 11.01 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 121.089 0.471 . . . . 0.0 111.882 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.54 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 5.1 p -95.3 150.01 20.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.135 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.762 ' CG2' HG11 ' A' ' 301' ' ' VAL . 44.7 t -123.71 127.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 311' ' ' ILE . 91.4 p -84.32 153.21 23.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 3.5 m-85 -127.08 133.41 50.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.022 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -62.46 -22.19 66.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.942 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -127.98 116.72 20.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.758 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.5 Cg_exo -45.23 -51.05 8.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.664 2.243 . . . . 0.0 113.017 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.2 Cg_endo -59.55 -30.48 92.52 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.85 1.7 . . . . 0.0 111.159 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.37 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' A' ' 287' ' ' ILE . . . -58.64 -42.75 89.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.915 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.86 -55.96 21.53 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.527 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -48.32 -31.74 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.792 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.61 -47.74 65.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.428 0.632 . . . . 0.0 109.39 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -61.91 -36.52 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.073 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -26.42 68.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.325 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.533 ' CE3' ' CZ ' ' A' ' 354' ' ' PHE . 3.5 t90 -91.08 -68.5 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.533 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 2.5 m-85 -68.84 -77.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 33.8 t0 25.27 50.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.033 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.7 26.98 1.21 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.804 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.505 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -102.47 -156.19 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.347 0.574 . . . . 0.0 110.778 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.4 mt-10 -113.5 128.65 56.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.349 0.595 . . . . 0.0 112.192 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.5 OUTLIER -108.01 103.19 12.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.981 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.5 t 63.36 28.07 15.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.619 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 104.62 -14.06 50.29 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.799 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 4.0 m-80 -106.92 170.94 5.14 Favored Pre-proline 0 C--O 1.219 -0.503 0 CA-C-N 117.246 0.523 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 89.7 Cg_endo -92.1 139.14 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.82 2.346 . . . . 0.0 111.904 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.533 HG22 HD13 ' A' ' 292' ' ' LEU . 9.2 pt -132.33 172.78 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 106.16 4.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.772 ' CG1' HD12 ' A' ' 287' ' ' ILE . 14.4 t -84.45 139.54 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.813 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -122.43 -175.0 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 111.885 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.431 ' OD1' ' CZ ' ' A' ' 368' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 3.4 p30 166.08 -33.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.668 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 78.8 m -101.47 115.67 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.935 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 366' ' ' VAL . 9.2 pt -91.08 173.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 338' ' ' THR . 2.4 m-85 -130.34 108.37 9.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.122 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.596 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -99.82 114.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 35.8 mm-40 -119.91 130.62 54.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.422 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.86 ' C ' HD13 ' A' ' 292' ' ' LEU . . . 115.68 70.45 0.47 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.338 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.931 HD21 ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.83 -78.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.877 0.339 . . . . 0.0 110.12 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.93 -81.62 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.665 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 294' ' ' GLU . 8.6 tp10 -140.93 41.5 1.82 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.249 0.547 . . . . 0.0 110.13 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.13 14.56 2.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.32 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 1.061 HG12 HD23 ' A' ' 324' ' ' LEU . 1.6 t -77.38 95.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 111.612 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.817 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.07 151.52 52.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.301 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 324' ' ' LEU . 26.6 mm -65.21 -48.36 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.58 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.91 -35.11 79.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.761 0.315 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 55.2 m -70.89 -43.82 67.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.577 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -63.0 -29.78 71.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.165 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.6 -38.84 64.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.889 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 -22.36 18.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -93.22 5.26 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.06 23.93 6.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.89 -31.65 8.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 353' ' ' TRP . 1.8 tp -91.32 -39.39 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.767 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -150.96 -175.92 23.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.18 119.82 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 305' ' ' PHE . 73.5 mt -85.83 125.02 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.244 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -48.71 103.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -62.02 148.8 42.82 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.641 178.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.805 HD21 HG23 ' A' ' 317' ' ' THR . 0.1 OUTLIER -106.8 140.08 40.21 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.73 0.3 . . . . 0.0 110.525 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -5.34 47.13 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -29.16 17.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.805 HG23 HD21 ' A' ' 314' ' ' ASN . 28.9 p -122.13 -23.17 5.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 83.4 12.17 78.97 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.339 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.95 153.29 71.03 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.9 Cg_endo -44.79 153.24 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.048 2.499 . . . . 0.0 112.596 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.492 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 45.9 mtp -104.69 128.53 52.79 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 338' ' ' THR . 3.1 mt -140.22 141.56 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.938 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 6.1 m-80 -97.37 148.38 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 1.061 HD23 HG12 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -144.98 135.9 24.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.842 0.353 . . . . 0.0 111.483 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.127 179.174 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.453 -0.221 0 N-CA-C 113.627 0.211 . . . . 0.0 113.627 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.931 ' HA ' HD21 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -160.23 167.29 27.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 0.0 111.217 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -158.0 147.14 19.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.144 0.497 . . . . 0.0 111.741 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 322' ' ' ILE . 4.2 p -107.56 133.5 51.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.201 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 322' ' ' ILE . 49.8 t -100.91 124.29 54.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.3 p -94.67 112.16 23.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.199 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 311' ' ' ILE . 59.1 m-85 -91.27 159.46 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.953 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -88.91 -14.69 36.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -128.27 119.9 20.92 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.943 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.607 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.4 Cg_exo -47.56 -48.87 14.47 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.714 2.276 . . . . 0.0 113.027 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.9 Cg_endo -60.36 -30.6 91.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.858 1.705 . . . . 0.0 111.392 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -62.09 -34.91 77.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.645 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.542 ' HB3' ' CE1' ' A' ' 368' ' ' PHE . . . -59.71 -50.05 75.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.483 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 1.007 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -60.75 -45.8 92.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.956 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.5 34.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.63 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.49 -46.97 68.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 1.007 HD12 ' HA ' ' A' ' 348' ' ' LYS . 12.3 mt -59.64 -34.75 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.119 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -26.88 67.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.551 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.564 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.72 -68.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.049 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.39 -79.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.117 -177.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 37.6 t70 30.08 43.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 134.92 28.3 0.45 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.139 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -98.19 -163.6 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.9 pm0 -120.39 128.84 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.135 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.724 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.2 OUTLIER -82.88 101.45 11.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.243 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 45.91 29.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.281 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.27 -43.36 1.26 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.925 -1.131 . . . . 0.0 114.256 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.4 m120 -92.49 162.64 29.11 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-N 117.242 0.521 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 84.4 Cg_endo -85.93 141.85 7.48 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.135 2.557 . . . . 0.0 112.176 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.447 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 13.4 pt -124.77 177.6 4.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-O 121.105 0.479 . . . . 0.0 111.701 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -144.91 101.66 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.513 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 289' ' ' VAL . 25.7 t -84.76 135.17 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.053 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 m -136.85 172.61 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.428 . . . . 0.0 111.64 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 347' ' ' ALA . 7.0 p30 -57.32 -21.74 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 61.4 m -71.61 102.29 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 305' ' ' PHE . 13.7 pt -104.02 162.04 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.991 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 338' ' ' THR . 0.1 OUTLIER -125.22 127.54 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 112.202 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.821 HG13 HG22 ' A' ' 366' ' ' VAL . 1.7 t -107.12 117.5 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.401 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.482 ' OE1' ' CD2' ' A' ' 288' ' ' PHE . 1.3 mp0 -112.53 129.82 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.745 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.4 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 42.26 0.91 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.658 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 335' ' ' GLY . 0.4 OUTLIER -71.19 -78.6 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.522 0.201 . . . . 0.0 110.81 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.504 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 111.41 87.09 1.71 Allowed Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.172 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 43.68 30.31 0.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.684 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 293' ' ' GLY . 17.1 p30 -145.28 29.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.779 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.863 ' O ' HD13 ' A' ' 324' ' ' LEU . 2.5 t -75.43 72.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -116.57 146.87 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 322' ' ' ILE . 35.8 mt -69.31 -43.66 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.479 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.15 -42.93 88.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.899 0.38 . . . . 0.0 110.666 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.9 p -65.0 -41.27 95.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 110.697 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 85.5 t -71.21 -42.7 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.266 0.555 . . . . 0.0 109.733 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -63.25 -30.43 71.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.3 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -39.69 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.614 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -88.83 -24.33 22.6 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.614 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.632 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -94.14 19.1 9.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.662 0.268 . . . . 0.0 111.332 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.89 20.54 18.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 110.899 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -102.56 -39.36 7.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 tp -73.03 -34.98 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.05 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -167.25 -153.11 7.78 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.646 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -109.55 119.55 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.9 mt -71.77 130.66 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.1 OUTLIER -48.68 92.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.62 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -69.81 137.49 51.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.432 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' GLY . 2.6 t30 -73.98 128.26 35.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.194 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -5.9 56.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.074 0.464 . . . . 0.0 110.071 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.44 -40.69 7.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.452 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.3 OUTLIER -105.13 -11.12 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.906 -179.389 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.07 11.92 59.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.498 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.672 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.16 152.2 66.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.902 0.351 . . . . 0.0 111.336 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 80.8 Cg_exo -47.68 158.47 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.795 2.33 . . . . 0.0 112.476 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.2 mmm -119.13 119.09 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 111.119 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.83 HG23 ' O ' ' A' ' 338' ' ' THR . 59.6 mt -143.08 144.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.736 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 8.5 m120 -103.27 148.15 26.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 111.011 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 296' ' ' VAL . 3.6 mt -130.4 131.03 45.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 1.5 mt-10 -143.84 131.94 21.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.345 0.117 . . . . 0.0 110.8 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -144.15 167.45 22.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.159 0.504 . . . . 0.0 111.913 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 322' ' ' ILE . 1.3 p -121.12 145.84 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.198 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 322' ' ' ILE . 92.0 t -125.4 134.37 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 0.0 111.385 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 312' ' ' LYS . 59.2 p -98.37 131.02 45.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.016 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.44 147.81 29.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.2 OUTLIER -79.08 -9.54 59.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 116.58 15.49 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.62 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.9 Cg_exo -45.13 -50.27 9.05 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.579 2.186 . . . . 0.0 112.798 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.0 Cg_endo -54.71 -30.56 67.29 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.924 1.749 . . . . 0.0 111.484 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.4 t -59.03 -42.17 89.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.868 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 285' ' ' ASN . . . -56.86 -49.84 74.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 0.0 110.387 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.88 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.5 tppt? -61.98 -53.86 49.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.653 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.68 47.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.846 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.44 -47.92 65.93 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.88 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.7 mt -59.8 -36.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.66 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.166 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.514 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.16 -68.05 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.115 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.61 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -76.17 -80.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.1 p-10 26.62 45.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.399 0.437 . . . . 0.0 111.992 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.36 37.25 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.052 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.61 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -95.91 -155.99 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 13.4 mt-10 -113.27 128.27 56.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.62 . . . . 0.0 111.48 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.493 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -122.76 101.91 7.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.937 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 56.0 m 60.55 27.22 16.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 110.537 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.55 17.49 52.2 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 20.3 m-80 -129.28 164.37 39.87 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.869 0.366 . . . . 0.0 111.306 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 90.5 Cg_endo -89.55 132.54 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.816 2.344 . . . . 0.0 111.9 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 289' ' ' VAL . 20.4 pt -120.84 174.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.04 0.448 . . . . 0.0 111.992 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -139.39 100.95 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.728 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.821 HG22 HG13 ' A' ' 289' ' ' VAL . 26.0 t -97.64 115.92 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -140.54 -165.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.224 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 285' ' ' ASN . 33.7 m120 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.781 0.324 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 284' ' ' ASN . 6.4 p30 168.64 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.07 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 90.7 m -104.84 95.33 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.996 HD12 HG13 ' A' ' 366' ' ' VAL . 50.3 pt -86.53 168.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.681 ' HD2' HG22 ' A' ' 338' ' ' THR . 31.4 m-85 -120.71 124.28 44.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.661 HG12 ' HB ' ' A' ' 364' ' ' ILE . 0.9 OUTLIER -109.73 114.65 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.886 178.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -116.53 130.66 56.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.017 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 363' ' ' PRO . . . 127.96 20.7 1.63 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.615 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.566 HD22 ' CD2' ' A' ' 359' ' ' PHE . 12.3 mt -66.76 -103.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.95 0.35 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.97 34.5 5.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -145.41 30.74 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.715 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.97 81.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.582 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -146.6 146.27 30.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.704 HG23 ' HB ' ' A' ' 322' ' ' ILE . 15.4 mt -71.37 -43.39 73.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.15 -40.62 90.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.64 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.8 t -63.45 -41.05 98.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 297' ' ' THR . 43.9 t -74.12 -41.17 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.295 0.569 . . . . 0.0 109.95 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.12 -29.85 68.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -74.14 -39.59 63.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -92.41 -24.49 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -96.78 32.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.236 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -116.18 16.62 15.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.288 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -98.77 -42.19 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.455 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.6 tp -71.07 -32.6 48.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.24 -163.66 27.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.6 mt -100.64 141.84 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.534 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.1 mt -100.83 125.22 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.411 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.76 107.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -73.42 152.38 40.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.133 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.567 HD21 HG23 ' A' ' 317' ' ' THR . 0.2 OUTLIER -105.27 138.16 41.91 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.827 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -1.95 25.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -96.9 -26.51 15.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 110.481 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.567 HG23 HD21 ' A' ' 314' ' ' ASN . 68.6 p -121.33 -20.41 6.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.58 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 75.79 13.96 82.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.976 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.536 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.86 164.03 35.66 Favored Pre-proline 0 C--N 1.333 -0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.376 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.616 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 71.3 Cg_exo -44.7 155.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.76 2.307 . . . . 0.0 112.384 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.501 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 51.7 mtp -109.34 119.8 40.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 111.636 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.704 ' HB ' HG23 ' A' ' 298' ' ' ILE . 3.4 mt -142.83 145.19 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.977 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 11.6 t-20 -119.15 116.4 26.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.805 0.336 . . . . 0.0 110.934 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.7 130.28 56.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 290' ' ' GLN . 6.8 mt-10 -140.97 131.54 25.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.596 0.236 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -139.28 169.69 17.31 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.917 0.389 . . . . 0.0 111.275 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.681 HG22 ' HD2' ' A' ' 288' ' ' PHE . 20.0 p -128.05 126.38 41.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.572 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 322' ' ' ILE . 42.3 t -106.51 116.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.396 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 311' ' ' ILE . 20.4 m -80.68 152.96 28.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 5.5 m-85 -136.29 139.15 42.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 -26.29 65.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -124.16 116.03 27.31 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.589 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.2 Cg_exo -42.72 -51.12 5.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.773 2.315 . . . . 0.0 113.094 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.4 Cg_endo -53.66 -30.37 55.39 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.817 1.678 . . . . 0.0 111.131 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.4 t -57.7 -46.15 84.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.16 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -54.52 -39.63 67.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.618 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.892 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.3 tptp -64.91 -59.56 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.45 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -46.42 -30.71 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.758 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -50.25 52.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.469 0.652 . . . . 0.0 109.282 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.1 mt -59.48 -37.35 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.987 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.4 -26.3 66.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.946 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.4 t90 -98.9 -68.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 366' ' ' VAL . 8.1 m-85 -63.86 -76.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 12.7 p-10 19.88 55.49 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.99 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 120.92 17.73 4.08 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.3 OUTLIER -76.14 -161.4 0.18 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.672 0.272 . . . . 0.0 111.323 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 3.3 mt-10 -113.48 152.92 29.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 111.523 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -142.08 101.3 3.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.514 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p 49.82 27.41 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.88 0.371 . . . . 0.0 110.665 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.43 17.33 22.24 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.245 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 359' ' ' PHE . 27.6 m120 -129.3 152.2 79.09 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 121.002 0.429 . . . . 0.0 111.766 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.434 ' O ' ' HA3' ' A' ' 291' ' ' GLY . 90.7 Cg_endo -85.53 133.43 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.947 2.431 . . . . 0.0 111.451 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.661 ' HB ' HG12 ' A' ' 289' ' ' VAL . 5.1 pt -119.2 150.32 21.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.275 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 103.67 9.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.339 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.996 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -84.51 130.66 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.646 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.43 -174.45 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.701 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.671 ' CD2' HD13 ' A' ' 351' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 17.1 p30 -60.41 -23.6 64.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.4 m -70.13 139.56 52.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 366' ' ' VAL . 39.1 pt -122.44 164.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.608 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.2 OUTLIER -113.24 109.1 18.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.69 114.66 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 2.0 mp0 -113.74 130.54 56.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.5 47.89 1.09 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.873 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.878 HD12 HG22 ' A' ' 296' ' ' VAL . 7.1 mt -68.9 -70.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.723 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 102.79 77.48 1.22 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.632 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 42.01 31.53 0.24 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.42 29.29 2.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 110.512 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.918 HG12 HD22 ' A' ' 324' ' ' LEU . 4.6 t -69.29 86.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.862 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.88 146.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.228 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 322' ' ' ILE . 29.9 mm -70.88 -44.23 76.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.319 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.82 -43.1 84.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.782 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -41.59 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.7 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 297' ' ' THR . 72.6 t -72.05 -41.71 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.722 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -30.43 69.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.959 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.11 -35.37 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.845 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -88.71 -22.22 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.569 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 339' ' ' VAL . 1.2 m-85 -89.49 12.27 17.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 29.71 2.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.36 -35.51 5.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 349' ' ' ALA . 5.0 tp -80.04 -33.88 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.336 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.67 -150.62 9.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.823 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.47 129.18 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 302' ' ' ALA . 5.3 mt -84.34 125.9 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.05 0.452 . . . . 0.0 110.454 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -49.03 91.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.385 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -82.62 170.29 15.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.066 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.578 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -106.51 153.29 22.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -1.27 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.919 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 317' ' ' THR . 1.1 tptp -94.59 -47.38 6.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.607 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.561 HG23 ' HG3' ' A' ' 316' ' ' LYS . 58.4 p -104.62 -12.84 16.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.921 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.04 20.19 59.98 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.209 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.46 ' NE2' ' HB ' ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.88 154.23 70.86 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.322 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 73.2 Cg_exo -51.16 149.87 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.226 1.951 . . . . 0.0 111.745 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.578 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -118.53 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.439 0.638 . . . . 0.0 112.208 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -140.9 143.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.618 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.37 115.6 28.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -116.14 153.66 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.847 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -148.29 131.26 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.777 0.322 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.06 170.33 22.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.066 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 322' ' ' ILE . 76.1 p -127.2 114.58 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 322' ' ' ILE . 48.7 t -94.82 117.04 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.1 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 312' ' ' LYS . 67.6 m -84.5 132.9 34.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.707 ' HE2' HD13 ' A' ' 287' ' ' ILE . 18.2 m-85 -104.95 142.62 34.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -19.5 62.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 346' ' ' SER . 0.7 OUTLIER -128.94 120.96 20.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.875 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -47.76 -48.63 15.43 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 113.069 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.8 Cg_endo -60.99 -30.63 90.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.858 1.705 . . . . 0.0 111.277 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -61.02 -32.6 72.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.372 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -61.68 -55.3 31.9 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.672 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -59.01 -43.33 91.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.166 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.38 -35.42 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.406 ' CA ' HG12 ' A' ' 308' ' ' ILE . . . -68.69 -49.35 59.66 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.429 0.633 . . . . 0.0 109.584 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -59.45 -36.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.135 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -62.68 -26.4 68.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.618 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.56 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.2 t90 -100.32 -68.13 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.175 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.529 ' O ' ' C ' ' A' ' 355' ' ' ASP . 23.2 m-85 -61.33 -77.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 354' ' ' PHE . 17.4 p-10 17.29 59.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.71 22.11 2.54 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.739 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.447 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -81.22 -165.61 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.63 0.215 . . . . 0.0 110.799 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.9 OUTLIER -124.38 129.67 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 111.861 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.82 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -89.72 101.46 14.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.064 178.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.85 29.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.24 -48.71 0.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.93 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -82.8 169.95 16.22 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 117.034 0.417 . . . . 0.0 110.636 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 87.4 Cg_endo -95.85 145.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 111.952 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.82 HG21 ' HD2' ' A' ' 359' ' ' PHE . 5.8 pt -127.37 -178.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.174 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -145.59 100.57 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 287' ' ' ILE . 21.7 t -87.43 128.41 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -140.2 -165.55 1.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 368' ' ' PHE . 2.2 t-20 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.855 0.36 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER -123.44 -3.23 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.32 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.6 m -114.86 127.26 55.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 1.005 HD12 HG13 ' A' ' 366' ' ' VAL . 29.7 pt -108.45 167.87 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.633 ' CD1' HG22 ' A' ' 338' ' ' THR . 18.0 m-30 -122.59 114.83 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.261 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -105.69 114.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.398 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -108.88 130.55 55.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 119.65 55.56 0.25 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.684 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 296' ' ' VAL . 3.0 mm? -91.41 -77.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.749 0.309 . . . . 0.0 110.721 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.91 76.2 1.06 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.112 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 44.89 41.04 4.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 111.738 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -153.64 24.62 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.729 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 292' ' ' LEU . 4.0 t -73.89 88.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.519 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -116.63 146.54 42.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.793 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 54.2 mt -71.4 -43.49 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.443 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.44 -41.28 89.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.9 t -64.78 -43.4 93.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.725 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 297' ' ' THR . 59.6 t -72.98 -41.07 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.321 0.582 . . . . 0.0 109.649 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.1 -29.69 68.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.982 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -73.5 -39.03 65.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.608 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.86 -22.47 16.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.0 OUTLIER -95.56 2.37 54.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 21.5 ptmt -96.37 30.2 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.588 HE21 ' HH2' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -108.23 -34.31 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.11 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.459 HD13 ' HB2' ' A' ' 353' ' ' TRP . 0.8 OUTLIER -80.31 -41.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.244 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -146.58 -168.24 13.45 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.7 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.14 106.71 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 10.8 mt -72.39 129.49 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 109.929 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 92.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -65.99 138.94 58.15 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.782 177.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.1 OUTLIER -89.78 165.75 13.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.171 0.51 . . . . 0.0 111.96 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -102.57 -4.41 25.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.3 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.959 ' HD3' HG23 ' A' ' 317' ' ' THR . 0.0 OUTLIER -96.33 -40.81 8.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.75 179.041 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.959 HG23 ' HD3' ' A' ' 316' ' ' LYS . 12.1 p -106.13 -18.33 14.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.304 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.44 8.13 85.62 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.161 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.522 ' NE2' ' HB ' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.54 157.89 66.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.743 0.272 . . . . 0.0 111.022 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.635 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 1.1 Cg_endo -45.45 162.18 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.904 2.403 . . . . 0.0 112.617 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.515 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.84 130.37 56.67 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.686 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 339' ' ' VAL . 1.9 mp -143.22 140.02 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -105.23 115.82 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 296' ' ' VAL . 0.2 OUTLIER -108.87 150.35 27.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.278 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 336' ' ' GLU . 14.2 m-85 . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.74 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.994 -0.042 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -160.42 178.06 9.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.284 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -154.06 162.6 41.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.633 HG22 ' CD1' ' A' ' 288' ' ' PHE . 19.5 p -116.93 117.45 29.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.052 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 322' ' ' ILE . 50.8 t -92.73 123.06 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.586 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 311' ' ' ILE . 1.2 m -101.33 131.87 47.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 339' ' ' VAL . 26.8 m-85 -115.37 158.54 22.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.063 0.458 . . . . 0.0 111.268 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.9 6.81 37.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.08 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.32 121.81 7.91 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 50.5 Cg_exo -52.88 -47.75 25.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.68 2.253 . . . . 0.0 113.326 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.8 Cg_endo -60.7 -30.12 89.72 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.729 1.619 . . . . 0.0 111.048 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -40.54 81.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.973 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.45 -50.87 72.24 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.17 -50.87 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.778 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.44 -34.16 33.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' A' ' 305' ' ' PHE . . . -68.62 -46.81 68.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.421 0.629 . . . . 0.0 109.756 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.8 mt -58.69 -34.24 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.294 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.29 -26.8 68.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.796 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.588 ' HH2' HE21 ' A' ' 307' ' ' GLN . 1.2 t90 -87.07 -68.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 0.9 OUTLIER -77.63 -79.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.58 -176.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 28.74 45.7 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.799 0.333 . . . . 0.0 111.704 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 128.52 30.78 0.69 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -90.94 -160.32 0.71 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.51 0.195 . . . . 0.0 111.047 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 6.0 mp0 -113.36 153.13 29.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.291 0.567 . . . . 0.0 111.704 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.535 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.0 OUTLIER -136.98 101.12 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.319 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.6 m 46.73 28.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.81 18.75 14.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.118 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 359' ' ' PHE . 33.3 m120 -129.29 150.24 74.96 Favored Pre-proline 0 C--O 1.225 -0.186 0 CA-C-O 121.067 0.46 . . . . 0.0 111.71 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.93 127.83 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.766 2.311 . . . . 0.0 111.678 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 289' ' ' VAL . 6.1 pt -111.43 165.2 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.912 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.34 100.99 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 1.005 HG13 HD12 ' A' ' 287' ' ' ILE . 26.6 t -87.09 133.14 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 p -133.83 -176.49 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.653 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.55 ' CD1' ' OD1' ' A' ' 284' ' ' ASN . 26.6 m-85 . . . . . 0 C--O 1.233 0.188 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 121.014 0.435 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.721 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.0 OUTLIER -104.95 -28.41 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.4 m -64.82 145.13 56.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.846 HD12 HG13 ' A' ' 366' ' ' VAL . 23.5 pt -125.39 173.42 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -121.77 109.29 14.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -103.19 117.38 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.662 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.422 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -129.87 130.9 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.13 19.52 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.601 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 359' ' ' PHE . 39.6 mt -70.1 -101.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 159.08 -93.29 0.12 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.274 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -132.43 28.56 4.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.146 0.498 . . . . 0.0 110.136 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -122.09 -12.93 8.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.468 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.673 ' CG2' ' HB2' ' A' ' 337' ' ' ALA . 9.7 p -44.63 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -143.5 147.13 34.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.062 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.49 -47.37 93.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.712 0.291 . . . . 0.0 111.769 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.27 -39.47 89.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.2 t -68.44 -42.86 78.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 297' ' ' THR . 46.2 t -72.88 -38.82 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 109.625 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.38 -29.85 68.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.895 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.72 -40.54 66.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.812 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.2 -24.26 16.33 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.579 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.6 OUTLIER -95.72 33.13 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.901 0.381 . . . . 0.0 110.977 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.31 21.0 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -103.92 -40.39 6.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.285 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -72.28 -27.84 27.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.5 -165.92 32.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.705 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.58 134.94 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.462 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -94.68 127.73 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.422 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 321' ' ' MET . 14.7 mtmm -48.77 110.27 0.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -60.14 -179.64 0.11 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 315' ' ' LYS . 3.9 m-80 -95.98 -40.89 9.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 314' ' ' ASN . 0.2 OUTLIER 86.92 -31.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.411 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -41.23 11.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 67.0 p -100.23 -11.69 20.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.337 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 71.02 12.06 71.0 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.25 157.3 64.89 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.318 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 59.0 Cg_exo -44.59 161.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.259 2.64 . . . . 0.0 113.143 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 312' ' ' LYS . 21.5 mtp -120.67 124.65 45.72 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.585 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 301' ' ' VAL . 7.1 mt -142.52 137.07 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.947 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.555 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.6 t30 -96.49 147.97 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.172 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -144.28 153.04 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 111.165 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 179.734 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 120.525 -0.042 . . . . 0.0 113.065 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.422 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 8.3 mp0 -121.51 133.23 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.673 ' HB2' ' CG2' ' A' ' 296' ' ' VAL . . . -160.19 149.95 17.95 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 288' ' ' PHE . 17.7 p -108.6 127.74 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.547 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.593 ' CG2' HG11 ' A' ' 301' ' ' VAL . 65.1 t -99.27 128.01 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.929 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.2 m -87.05 153.02 21.86 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.483 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 346' ' ' SER . 4.0 m-85 -136.14 141.58 44.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 111.273 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -9.35 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.212 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.46 117.88 13.47 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.779 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.595 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 62.0 Cg_exo -49.73 -49.67 15.27 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.6 2.2 . . . . 0.0 113.041 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.7 Cg_endo -59.81 -30.53 92.17 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 121.791 1.661 . . . . 0.0 111.048 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -59.84 -35.09 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.88 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -62.02 -52.89 62.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.342 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.97 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -57.85 -46.48 84.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.095 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.52 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.71 -33.05 63.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.873 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 354' ' ' PHE . . . -68.65 -49.04 62.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 348' ' ' LYS . 15.9 mt -52.91 -34.52 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.946 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 348' ' ' LYS . 8.9 t0 -61.09 -26.71 67.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.931 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -102.89 -63.73 1.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.869 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.738 ' HB2' HG21 ' A' ' 366' ' ' VAL . 10.3 m-85 -66.26 -77.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.591 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 351' ' ' ILE . 30.5 t0 9.41 62.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 107.08 35.09 2.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.226 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.96 -156.38 0.54 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -125.7 128.9 48.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.109 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.702 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -89.41 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.842 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.58 28.39 0.76 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.655 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.04 -43.09 1.35 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.633 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 2.0 m-80 -81.83 169.99 16.7 Favored Pre-proline 0 C--O 1.22 -0.486 0 CA-C-N 116.974 0.387 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -97.88 142.05 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.514 2.81 . . . . 0.0 112.273 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 359' ' ' PHE . 3.4 pt -127.53 177.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.856 0.36 . . . . 0.0 111.512 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -145.03 101.61 3.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.752 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.846 HG13 HD12 ' A' ' 287' ' ' ILE . 61.2 t -88.92 138.15 19.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.761 0.315 . . . . 0.0 110.766 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.6 p -138.72 -164.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.331 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 5.2 m-85 . . . . . 0 C--N 1.333 -0.14 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.192 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.404 ' HB2' ' CD2' ' A' ' 368' ' ' PHE . 1.8 m-80 . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 120.685 0.279 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.2 OUTLIER -71.16 -37.02 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 m -90.57 136.63 32.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.763 HD12 HG13 ' A' ' 366' ' ' VAL . 6.1 pt -116.64 173.05 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CE2' ' CB ' ' A' ' 367' ' ' SER . 0.2 OUTLIER -135.66 120.99 19.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 111.051 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.774 ' CG1' HD12 ' A' ' 364' ' ' ILE . 1.0 OUTLIER -101.37 127.1 55.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.802 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.13 130.49 52.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.031 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.441 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 110.79 72.28 0.67 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.909 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -135.71 -87.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.46 115.27 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.301 -0.952 . . . . 0.0 114.141 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 53.59 32.77 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 8.48 0.77 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.39 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG13 ' A' ' 296' ' ' VAL . 13.7 p -77.98 95.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 112.232 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.895 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -136.4 146.81 46.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.083 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 322' ' ' ILE . 28.2 mm -64.98 -46.15 92.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.75 -41.82 87.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.901 0.382 . . . . 0.0 110.752 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.0 p -63.63 -41.65 98.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 297' ' ' THR . 34.1 t -73.56 -45.88 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -60.89 -29.96 69.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.564 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 28.4 t0 -74.3 -38.04 63.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.785 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.84 -21.82 20.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -91.89 11.42 24.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -96.5 24.05 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 111.079 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 -38.49 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.309 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 349' ' ' ALA . 3.3 tp -75.66 -39.54 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.179 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -176.04 -166.9 34.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.583 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.82 139.41 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.745 0.307 . . . . 0.0 111.685 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 2.1 mt -94.16 138.69 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -48.0 91.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.239 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -68.34 145.37 54.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.839 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.517 ' ND2' ' CG ' ' A' ' 321' ' ' MET . 1.4 m120 -78.62 170.96 15.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.343 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 -16.18 12.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.957 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -99.6 -36.17 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.91 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 57.9 p -109.12 -5.95 15.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.032 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 56.42 17.94 20.6 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.268 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -118.94 154.92 53.27 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.649 0.262 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.504 ' HB3' ' CG2' ' A' ' 311' ' ' ILE . 68.1 Cg_exo -44.36 158.43 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.632 2.221 . . . . 0.0 112.712 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.5 OUTLIER -120.64 121.75 38.99 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.491 0.662 . . . . 0.0 111.674 -179.03 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 339' ' ' VAL . 2.3 mt -143.31 142.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.999 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 1.2 m-20 -103.19 148.5 25.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.138 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 296' ' ' VAL . 0.9 OUTLIER -152.82 147.53 26.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.892 0.377 . . . . 0.0 111.072 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 179.84 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.408 ' CA ' ' HG ' ' A' ' 292' ' ' LEU . . . . . . . . 0 CA--C 1.517 0.2 0 N-CA-C 113.398 0.119 . . . . 0.0 113.398 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 12.3 mt-10 -141.99 131.38 23.68 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.752 -0.264 . . . . 0.0 111.165 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -161.65 140.51 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.781 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 322' ' ' ILE . 19.1 p -100.33 131.54 46.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.357 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 322' ' ' ILE . 75.1 t -110.64 122.04 64.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.586 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 67.0 m -98.41 147.33 24.82 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.161 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 63.1 m-85 -121.68 152.21 39.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.07 45.79 0.28 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.647 0.26 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 343' ' ' ASP . 2.7 p30 165.14 125.98 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.481 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 71.4 Cg_exo -50.89 -48.86 18.92 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.613 2.209 . . . . 0.0 113.671 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.2 Cg_endo -57.29 -30.8 88.89 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.921 1.748 . . . . 0.0 112.04 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.412 ' CB ' ' OD1' ' A' ' 343' ' ' ASP . 40.2 t -61.14 -40.31 93.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.04 -51.75 66.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.989 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.932 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.44 -45.26 95.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.112 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.573 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.08 -34.25 63.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.537 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.51 -50.17 54.18 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.8 mt -55.74 -36.37 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.13 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.67 -26.59 67.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.744 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.52 ' CD1' ' CD2' ' A' ' 354' ' ' PHE . 1.3 t90 -82.41 -68.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.43 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.52 ' CD2' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.42 -78.54 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.536 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 31.13 51.11 0.12 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.86 22.09 1.84 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.096 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -84.63 -163.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.92 0.36 . . . . 0.0 110.093 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 10.8 mt-10 -119.17 130.87 55.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' A' ' 364' ' ' ILE . 0.1 OUTLIER -90.81 101.22 13.97 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.649 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 44.41 29.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.026 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.58 -48.72 0.92 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.94 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.8 OUTLIER -84.48 172.92 8.02 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 116.925 0.362 . . . . 0.0 110.668 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -94.1 145.02 1.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.218 2.612 . . . . 0.0 111.682 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.774 HD12 ' CG1' ' A' ' 289' ' ' VAL . 5.9 pt -116.69 178.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -148.28 100.89 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.068 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.763 HG13 HD12 ' A' ' 287' ' ' ILE . 23.7 t -96.44 131.08 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' SER . . . . . 0.517 ' CB ' ' CE2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -140.06 -164.0 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.923 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.776 ' CE1' HD13 ' A' ' 351' ' ' ILE . 3.7 m-85 . . . . . 0 CA--C 1.529 0.145 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.637 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 5.5 p30 -102.14 -33.25 9.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 27.9 m -83.96 126.22 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.174 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.739 HD12 HG13 ' A' ' 366' ' ' VAL . 13.6 pt -95.92 173.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.344 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.758 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -130.37 109.76 10.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -98.18 114.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.6 OUTLIER -118.62 130.83 56.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.124 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.831 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 112.75 83.15 1.23 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.559 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 359' ' ' PHE . 1.9 mt -142.29 -78.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.828 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.21 -79.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.669 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -149.52 31.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.17 -17.97 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.971 HG22 HD23 ' A' ' 324' ' ' LEU . 9.7 p -45.86 123.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.94 146.5 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.424 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.751 HG23 HD12 ' A' ' 322' ' ' ILE . 2.1 mp -64.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.151 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 18.5 pm0 -66.4 -34.76 78.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.121 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.0 m -73.65 -43.87 58.33 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.041 0.448 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 297' ' ' THR . 29.8 t -72.22 -36.4 55.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.338 0.589 . . . . 0.0 109.754 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.702 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.33 -29.76 68.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.946 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.05 -41.25 62.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.773 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -97.39 -20.64 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 311' ' ' ILE . 1.2 t80 -101.21 35.0 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.325 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 18.86 11.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -40.87 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -72.35 -32.41 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.358 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.419 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -161.08 -163.29 13.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.76 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.0 mt -111.08 115.69 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -75.86 125.34 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -48.65 115.34 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 111.985 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -75.79 150.98 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.482 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -104.94 130.72 53.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -4.23 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 7.1 mptt -81.72 -36.64 28.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.4 OUTLIER -118.8 -30.98 4.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.21 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 96.78 14.39 43.47 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.882 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.685 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.18 162.03 44.03 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.901 0.351 . . . . 0.0 110.798 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 89.1 Cg_exo -44.56 162.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.78 2.32 . . . . 0.0 112.431 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.457 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -122.42 128.08 50.47 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.384 0.611 . . . . 0.0 111.758 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.751 HD12 HG23 ' A' ' 298' ' ' ILE . 4.9 mt -141.84 137.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.646 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -99.1 141.14 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.614 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.971 HD23 HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -145.09 131.86 20.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 111.001 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 292' ' ' LEU . . . . . . . . 0 CA--C 1.522 0.47 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -122.49 131.78 54.02 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -151.93 151.92 31.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.934 0.397 . . . . 0.0 111.965 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.758 HG22 ' CD1' ' A' ' 288' ' ' PHE . 22.3 p -106.05 126.4 52.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 322' ' ' ILE . 73.3 t -99.49 128.61 51.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.966 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 311' ' ' ILE . 83.5 p -85.44 152.45 23.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.53 148.71 52.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.64 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.52 -16.88 58.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.411 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.2 OUTLIER -136.28 120.33 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.001 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.21 -51.07 7.13 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.655 2.237 . . . . 0.0 112.952 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.1 Cg_endo -53.69 -30.5 56.33 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.975 1.783 . . . . 0.0 111.241 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.419 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 14.2 t -57.24 -42.0 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.898 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -55.85 -49.55 73.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.81 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.5 -53.02 61.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.5 18.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.97 -52.78 25.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.4 mt -54.7 -36.66 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.367 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -26.18 66.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.816 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.553 ' HE3' HD13 ' A' ' 308' ' ' ILE . 3.1 t90 -98.29 -68.4 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 2.3 m-85 -66.68 -74.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 354' ' ' PHE . 25.7 t0 14.04 62.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.41 19.62 3.12 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.933 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.48 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 5.4 mtpt -87.05 -165.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.952 0.376 . . . . 0.0 110.687 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.735 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -121.74 142.47 50.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.79 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -111.13 101.68 10.18 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.824 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.75 28.74 6.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 358' ' ' GLU . . . 116.32 -2.92 20.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.443 -0.885 . . . . 0.0 114.285 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.4 m120 -117.79 170.07 6.74 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 117.594 0.697 . . . . 0.0 110.67 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -96.06 141.85 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.491 2.794 . . . . 0.0 111.77 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.831 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.4 pt -128.85 168.58 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.052 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.155 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 100.94 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.739 HG13 HD12 ' A' ' 287' ' ' ILE . 21.2 t -84.85 131.84 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -135.12 -173.91 3.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.459 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 62.1 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.941 0.4 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 4.7 p30 -50.97 -25.87 5.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.479 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -72.55 117.91 14.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.023 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.575 HD12 ' CG1' ' A' ' 366' ' ' VAL . 46.0 pt -107.7 169.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.406 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 338' ' ' THR . 0.1 OUTLIER -134.0 122.4 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 111.094 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 366' ' ' VAL . 2.4 t -110.02 127.64 66.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.6 mp0 -111.87 130.67 55.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.046 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.6 33.62 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 295' ' ' ASN . 0.1 OUTLIER -59.71 -84.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.48 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 93.99 98.54 1.57 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.867 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.69 31.63 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.647 HD22 ' C ' ' A' ' 292' ' ' LEU . 16.7 p30 -144.34 31.21 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 324' ' ' LEU . 4.0 t -75.91 70.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -129.37 146.61 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.587 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 322' ' ' ILE . 26.3 mm -71.45 -43.05 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.447 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.46 -40.67 89.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -42.65 83.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 66.4 t -71.43 -40.11 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.68 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.24 -29.83 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.839 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -41.93 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.88 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -88.02 -24.8 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.61 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -97.43 30.54 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.121 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 306' ' ' LYS . 0.0 OUTLIER -114.77 1.81 14.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -85.4 -52.06 6.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.821 0.343 . . . . 0.0 111.144 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.602 HG21 ' CE2' ' A' ' 354' ' ' PHE . 0.7 OUTLIER -65.64 -28.19 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.0 -171.95 39.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.558 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.4 mt -97.62 144.14 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.68 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.8 mt -97.86 127.01 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 29.0 mtmt -49.75 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.651 0.263 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -86.48 155.56 20.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.875 0.845 . . . . 0.0 111.504 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.577 ' HB3' ' OG1' ' A' ' 317' ' ' THR . 1.0 OUTLIER -71.12 98.37 1.66 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.195 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.587 ' HD2' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -46.4 -16.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.546 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 314' ' ' ASN . 20.3 mttm -92.5 -38.01 12.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 314' ' ' ASN . 47.9 p -103.62 -3.11 25.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 57.32 17.68 25.84 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.448 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -118.61 139.34 26.9 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.942 0.371 . . . . 0.0 111.252 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.3 Cg_exo -45.45 147.2 2.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.536 2.158 . . . . 0.0 112.406 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.4 mtp -107.74 123.07 47.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.42 0.629 . . . . 0.0 112.137 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 338' ' ' THR . 2.6 mp -143.02 139.74 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.567 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.745 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 5.1 m-80 -99.25 147.54 25.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.226 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 337' ' ' ALA . 2.7 mt -128.08 150.22 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 179.849 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 9.5 pt-20 -153.14 157.33 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.642 0.258 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -160.87 156.91 25.74 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 111.762 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 322' ' ' ILE . 2.0 p -103.48 136.9 42.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.055 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.626 HG22 HG12 ' A' ' 322' ' ' ILE . 55.6 t -112.06 130.52 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 311' ' ' ILE . 16.5 m -86.32 153.1 22.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.407 ' N ' ' HG3' ' A' ' 312' ' ' LYS . 2.6 m-85 -129.35 135.89 49.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 111.058 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.438 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 19.2 m-20 -63.29 -35.89 81.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.327 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.44 118.97 33.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.604 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.3 Cg_exo -42.42 -51.02 5.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.87 2.38 . . . . 0.0 112.701 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.4 Cg_endo -56.08 -30.62 79.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.963 1.775 . . . . 0.0 111.282 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.2 t -60.99 -40.74 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.582 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.32 -49.12 75.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.879 0.371 . . . . 0.0 110.468 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.2 tppt? -59.42 -54.94 40.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.637 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.87 -35.37 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.699 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 354' ' ' PHE . . . -68.95 -51.81 35.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.33 0.586 . . . . 0.0 109.458 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.1 mt -54.08 -39.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.728 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.19 -26.64 18.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.77 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.543 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.3 t90 -106.85 -68.45 0.89 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.477 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 366' ' ' VAL . 4.8 m-85 -59.1 -9.96 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 41.6 t0 -71.87 62.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.276 0.489 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 128.07 35.75 0.5 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.906 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 353' ' ' TRP . 36.4 mmtm -105.86 -173.83 2.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 5.7 mt-10 -116.66 133.1 56.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.134 0.492 . . . . 0.0 112.133 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.474 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -93.06 101.34 13.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.96 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 36.3 t 48.86 27.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.526 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.46 -45.01 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.737 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.9 OUTLIER -80.46 169.95 17.65 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 116.999 0.4 . . . . 0.0 111.037 -179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -94.63 145.16 1.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.397 2.731 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.4 pt -128.02 176.14 8.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.244 0.545 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -148.13 116.14 6.45 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.658 HG22 HG13 ' A' ' 289' ' ' VAL . 40.5 t -109.53 135.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.949 0.404 . . . . 0.0 111.875 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 p -140.67 -163.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.951 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.902 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 368' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -31.59 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.282 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.6 m -88.04 134.2 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 17.8 pt -110.79 173.38 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.476 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.73 ' HD1' HG22 ' A' ' 338' ' ' THR . 1.4 t80 -127.8 108.15 10.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 364' ' ' ILE . 2.1 t -104.5 114.81 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.5 mp0 -111.76 130.25 55.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 120.18 37.67 0.73 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.666 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.745 HD12 ' OD1' ' A' ' 295' ' ' ASN . 2.8 mm? -79.04 -89.1 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.557 0.218 . . . . 0.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.34 104.93 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.293 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 77.01 43.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.784 0.325 . . . . 0.0 111.37 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.745 ' OD1' HD12 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -168.45 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.79 HG22 HD13 ' A' ' 324' ' ' LEU . 8.7 p -19.06 94.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 301' ' ' VAL . 7.5 p -164.01 146.43 9.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.327 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.34 -42.27 74.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.986 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -43.15 86.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.9 p -65.03 -38.45 90.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 297' ' ' THR . 69.5 t -74.6 -40.62 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 109.729 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.26 -31.43 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.708 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -74.35 -36.12 63.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.893 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.18 -24.23 16.36 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -95.47 27.78 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 111.283 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 22.09 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.085 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -105.33 -28.83 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 350' ' ' ALA . 1.1 tp -83.91 -30.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -178.78 -162.33 28.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.4 mt -98.68 142.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.628 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 340' ' ' SER . 3.0 mp -98.43 136.11 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.569 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 321' ' ' MET . 2.7 mmtp -48.88 95.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -68.47 146.63 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.956 HD21 ' HG2' ' A' ' 321' ' ' MET . 0.2 OUTLIER -101.06 145.79 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 111.433 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -77.19 -7.59 56.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.904 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -83.16 -51.04 7.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.531 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 8.3 p -108.1 -7.31 16.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.526 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 313' ' ' THR . . . 67.63 15.69 66.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.393 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 164.37 23.89 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.807 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.523 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 57.7 Cg_exo -45.1 162.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.146 2.564 . . . . 0.0 113.456 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.956 ' HG2' HD21 ' A' ' 314' ' ' ASN . 17.4 mtm -123.29 118.68 28.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 339' ' ' VAL . 49.3 mt -141.56 149.98 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.346 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -114.14 148.03 37.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.79 HD13 HG22 ' A' ' 296' ' ' VAL . 2.1 mt -131.69 168.61 17.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 2.3 mp0 -131.59 134.4 46.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.965 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -148.19 143.17 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.958 0.409 . . . . 0.0 111.447 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.73 HG22 ' HD1' ' A' ' 288' ' ' PHE . 17.4 p -109.53 119.55 39.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 322' ' ' ILE . 1.2 t -93.91 123.04 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.596 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -94.86 129.97 41.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.824 0.345 . . . . 0.0 110.86 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 339' ' ' VAL . 17.6 m-85 -109.71 150.26 28.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.57 -16.84 60.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 346' ' ' SER . 5.1 m-20 -126.35 116.46 23.31 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.682 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.615 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 78.1 Cg_exo -44.82 -50.82 8.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.35 2.034 . . . . 0.0 112.602 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 9.7 Cg_endo -53.16 -30.42 50.38 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.016 1.811 . . . . 0.0 111.041 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 12.4 t -55.82 -48.75 74.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -53.32 -44.86 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.926 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.846 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -58.37 -54.28 48.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.063 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.437 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -47.5 -39.0 15.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.786 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.72 -45.82 70.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.362 0.601 . . . . 0.0 109.761 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.9 mt -60.92 -32.39 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.433 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.67 -40.64 95.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.34 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.606 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -106.14 -45.54 4.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 356' ' ' GLY . 2.7 m-85 -59.22 -75.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.581 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.0 t0 1.04 63.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.211 0.944 . . . . 0.0 112.355 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 110.94 36.47 1.84 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.429 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.501 ' HD3' ' CD2' ' A' ' 354' ' ' PHE . 7.9 ptmt -97.83 -158.37 0.66 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.576 0.227 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 33.0 mt-10 -113.89 128.88 56.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.045 0.45 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -122.89 105.72 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.299 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.3 m 59.76 30.09 19.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.75 57.86 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.04 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 7.2 m-80 -129.27 167.01 21.45 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.832 0.316 . . . . 0.0 111.037 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 96.3 Cg_endo -90.36 128.8 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.924 2.416 . . . . 0.0 111.929 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 3.9 pt -124.68 168.58 17.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.599 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -139.1 102.42 4.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.068 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 354' ' ' PHE . 26.3 t -85.13 134.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.02 -173.12 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.99 0.424 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 2.7 m-85 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.831 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.428 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.88 0.371 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 20.8 p30 -99.39 -18.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.979 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 26.4 m -71.06 117.56 12.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.277 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.713 HD12 ' CG1' ' A' ' 366' ' ' VAL . 36.6 pt -105.15 164.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -126.34 117.22 22.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.146 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 366' ' ' VAL . 1.0 OUTLIER -110.0 114.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.131 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 288' ' ' PHE . 47.6 mm-40 -112.58 132.77 54.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.056 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.679 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 75.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.767 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.848 HD21 ' CE2' ' A' ' 359' ' ' PHE . 1.6 mp -124.48 -76.41 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.667 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 126.17 65.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.194 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 44.25 30.36 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.61 4.64 4.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.254 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 292' ' ' LEU . 11.1 p -66.51 109.45 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.99 0.424 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -119.07 151.3 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.489 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.793 HD13 HD21 ' A' ' 324' ' ' LEU . 26.6 mm -63.18 -47.91 90.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.492 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.53 -42.18 87.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.8 p -65.81 -41.44 91.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.788 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 297' ' ' THR . 75.8 t -73.03 -40.51 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.14 -29.87 68.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.968 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -40.01 65.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.641 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.459 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.75 -22.46 29.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.42 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -90.12 7.13 39.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.423 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 14.86 15.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.644 0.259 . . . . 0.0 111.424 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.55 -31.98 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.489 HG23 ' CE2' ' A' ' 341' ' ' PHE . 2.6 tp -88.11 -35.84 8.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.341 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.18 -169.61 35.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.8 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 13.0 mt -92.76 144.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 111.665 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 340' ' ' SER . 3.2 mt -97.64 125.13 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.7 OUTLIER -52.72 91.66 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.338 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -80.96 167.18 20.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.242 0.544 . . . . 0.0 110.715 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.597 ' OD1' ' OG1' ' A' ' 317' ' ' THR . 0.4 OUTLIER -90.13 143.29 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.878 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -80.45 -3.18 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -94.44 -45.35 7.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.493 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 81.4 p -108.45 -4.63 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.93 43.24 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.368 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.34 144.17 31.21 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.319 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.1 Cg_exo -45.06 147.97 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.523 2.149 . . . . 0.0 112.068 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.46 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 6.7 mtp -114.23 125.55 54.04 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 112.046 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 338' ' ' THR . 74.4 mt -143.17 137.81 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.996 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.41 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.7 t30 -97.63 120.72 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.031 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.793 HD21 HD13 ' A' ' 298' ' ' ILE . 0.6 OUTLIER -110.07 149.8 29.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.0 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.767 179.802 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.01 159.68 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.617 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -165.19 150.9 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 322' ' ' ILE . 56.3 p -95.59 128.34 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.654 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.585 ' CG2' HG11 ' A' ' 301' ' ' VAL . 82.0 t -107.39 134.45 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.841 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 311' ' ' ILE . 33.1 m -94.51 138.73 32.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.904 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.3 m-85 -115.51 142.45 46.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 111.547 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 1.4 t70 -65.43 -20.75 66.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.753 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -128.69 115.32 19.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.583 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 73.7 Cg_exo -47.24 -51.58 9.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.538 2.158 . . . . 0.0 112.683 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.1 Cg_endo -57.69 -30.86 90.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.981 1.787 . . . . 0.0 111.19 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -36.41 81.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.569 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -59.48 -44.54 93.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.658 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.899 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.89 -54.97 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.878 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.55 10.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.993 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.7 -49.33 59.8 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.439 0.638 . . . . 0.0 109.613 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.7 mt -56.39 -36.17 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.363 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.87 -26.85 65.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.1 t90 -86.78 -68.21 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.063 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' A' ' 355' ' ' ASP . 10.6 m-85 -69.65 -77.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.614 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.9 t70 21.16 55.51 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.473 0.483 . . . . 0.0 111.401 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.2 22.16 1.95 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.446 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -80.11 -165.61 0.87 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.737 0.303 . . . . 0.0 111.416 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -114.93 142.11 47.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.669 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.848 ' CE2' HD21 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -124.55 101.41 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.777 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.68 26.41 3.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.245 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 99.79 24.09 10.25 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.893 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 65.9 m-80 -129.95 153.65 81.03 Favored Pre-proline 0 C--O 1.225 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.776 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.02 136.01 8.98 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.577 2.185 . . . . 0.0 111.711 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.689 ' HB ' HG12 ' A' ' 289' ' ' VAL . 9.1 pt -130.47 154.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -124.87 100.74 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 289' ' ' VAL . 37.7 t -95.96 118.96 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.36 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' SER . . . . . 0.411 ' HA ' HG12 ' A' ' 351' ' ' ILE . 1.4 m -140.2 176.68 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.428 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 1.2 m-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.981 0.419 . . . . 0.0 111.835 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 20.7 p30 -51.94 -28.38 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 86.1 m -76.0 132.24 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 366' ' ' VAL . 37.0 pt -117.86 168.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' ' 338' ' ' THR . 1.5 m-30 -117.39 106.73 13.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -99.71 114.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 336' ' ' GLU . 0.7 OUTLIER -132.1 132.17 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.647 0.261 . . . . 0.0 111.48 -179.098 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.782 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 121.07 79.99 0.57 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.533 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -155.79 -90.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.801 -0.235 . . . . 0.0 111.116 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 292' ' ' LEU . . . 157.12 -92.5 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -126.0 28.07 6.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 297' ' ' THR . 0.8 OUTLIER -114.71 -14.48 12.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.04 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.748 HG22 HD22 ' A' ' 324' ' ' LEU . 9.8 p -52.24 88.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -128.88 147.16 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 322' ' ' ILE . 41.7 mt -61.21 -47.35 93.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.54 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -65.32 -39.36 92.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 24.7 p -68.59 -43.27 76.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.57 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 297' ' ' THR . 60.6 t -69.75 -37.84 74.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.495 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -68.71 -30.86 69.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -35.73 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -103.81 -19.94 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.654 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.8 OUTLIER -99.43 -15.28 18.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -83.46 7.4 17.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.419 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -51.93 6.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -59.81 -33.53 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.587 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -155.51 -177.84 29.15 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.251 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.84 105.86 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 302' ' ' ALA . 52.5 mt -71.93 130.16 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 1.0 OUTLIER -48.49 92.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -67.39 140.48 57.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.708 177.543 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -96.25 145.57 25.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 111.828 -179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -79.81 -4.12 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -90.57 -49.8 6.29 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.991 0.424 . . . . 0.0 110.197 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.2 p -104.98 -8.69 18.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.804 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 313' ' ' THR . . . 69.44 10.19 62.72 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 153.95 71.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 117.127 0.464 . . . . 0.0 110.99 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.7 Cg_endo -46.59 153.13 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.006 2.471 . . . . 0.0 112.77 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -105.03 120.96 42.77 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 111.262 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.73 HD12 HG23 ' A' ' 298' ' ' ILE . 4.0 mt -139.55 142.01 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.031 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 7.8 m120 -104.5 148.22 26.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 296' ' ' VAL . 0.5 OUTLIER -135.17 114.85 12.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.705 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 336' ' ' GLU . 7.5 m-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 290' ' ' GLN . 29.7 mt-10 -147.2 131.61 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.665 0.269 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.663 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -150.14 145.55 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.519 HG22 ' CE1' ' A' ' 288' ' ' PHE . 16.2 p -108.8 118.85 37.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.631 ' CG2' HG11 ' A' ' 301' ' ' VAL . 78.9 t -94.26 126.77 46.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.246 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.3 OUTLIER -95.72 121.93 37.95 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.876 0.37 . . . . 0.0 111.138 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.51 ' HE2' HD13 ' A' ' 287' ' ' ILE . 9.9 m-85 -96.48 155.44 16.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -25.86 40.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.644 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.7 117.05 22.6 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.581 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.8 Cg_exo -43.26 -51.43 5.79 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 113.107 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.3 Cg_endo -56.48 -30.63 82.95 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 121.956 1.771 . . . . 0.0 111.359 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.2 t -60.51 -37.63 81.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.883 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -60.15 -51.21 70.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -59.86 -43.01 94.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 110.056 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.29 62.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 308' ' ' ILE . . . -68.59 -48.04 65.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 348' ' ' LYS . 33.1 mt -52.46 -31.14 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.323 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -26.69 68.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -107.19 -61.93 1.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.514 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.571 ' CB ' HG21 ' A' ' 366' ' ' VAL . 66.3 m-85 -56.75 -74.85 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.029 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 354' ' ' PHE . 36.6 t0 2.94 65.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.046 0.841 . . . . 0.0 112.511 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 113.69 26.03 4.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.565 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -87.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 11.8 mm-40 -123.6 131.23 53.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.716 ' HZ ' HG22 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -91.63 101.41 14.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.144 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 33.9 t 45.77 29.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.13 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.25 -46.98 1.01 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.0 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.3 OUTLIER -84.85 169.67 15.8 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 116.991 0.395 . . . . 0.0 110.697 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -96.31 138.86 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.391 2.727 . . . . 0.0 112.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 291' ' ' GLY . 7.6 pt -116.97 -179.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 120.834 0.349 . . . . 0.0 111.426 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -148.31 100.51 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.01 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -86.92 128.03 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.708 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 92.5 p -140.51 -173.94 3.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.174 0.511 . . . . 0.0 112.048 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.35 179.449 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -61.61 -18.22 58.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.79 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -73.53 106.16 5.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.675 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 16.2 pt -102.22 171.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.785 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.643 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.2 m-85 -125.33 113.54 17.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 366' ' ' VAL . 0.3 OUTLIER -102.35 114.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.223 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 30.9 mm-40 -111.6 130.76 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.351 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.634 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 114.08 81.45 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.348 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.3 OUTLIER -128.44 -74.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 124.52 -76.24 0.38 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.108 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.21 28.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.919 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -116.28 -8.78 11.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.834 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 296' ' ' VAL . 13.1 p -47.73 107.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.88 146.78 9.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.016 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.614 HG23 ' HB ' ' A' ' 322' ' ' ILE . 11.3 mt -63.75 -46.03 95.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.801 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -66.68 -41.93 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.358 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.3 p -67.08 -40.97 87.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -73.94 -38.16 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.233 0.539 . . . . 0.0 109.662 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.66 72.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.82 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -74.33 -35.65 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.001 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.22 -24.38 19.91 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -98.21 26.65 5.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.6 25.68 10.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.877 0.37 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -107.15 -44.19 4.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.402 HD13 ' HE3' ' A' ' 353' ' ' TRP . 1.7 tp -74.1 -28.35 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -174.68 -164.68 29.91 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.759 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.97 132.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mp -81.53 128.01 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 321' ' ' MET . 5.0 mtmp? -55.35 100.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.182 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.666 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.7 m -63.94 154.5 33.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.259 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.915 HD21 ' HG2' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.6 138.95 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 3.73 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.921 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -111.65 -20.92 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.292 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 -21.8 6.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.75 13.62 80.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.666 ' C ' HG23 ' A' ' 313' ' ' THR . 0.0 OUTLIER -124.43 162.63 41.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 93.1 Cg_exo -47.63 148.26 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.533 2.155 . . . . 0.0 112.152 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.915 ' HG2' HD21 ' A' ' 314' ' ' ASN . 72.0 mtp -101.33 114.71 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.667 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -143.26 139.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.8 OUTLIER -103.2 144.17 31.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 -179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.565 ' CD2' HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -136.9 144.96 43.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.017 179.902 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 11.3 pt-20 -152.35 144.95 24.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 111.006 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -155.26 141.72 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.25 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 3.7 p -92.1 138.83 31.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.706 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.667 HG22 HG12 ' A' ' 322' ' ' ILE . 90.4 t -116.89 127.75 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 311' ' ' ILE . 94.5 p -101.4 125.82 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.55 153.09 22.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 23.0 t0 -73.42 -26.49 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.326 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.96 111.16 48.25 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.954 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.6 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.4 Cg_exo -43.52 -51.04 6.38 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.53 2.153 . . . . 0.0 112.454 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.1 Cg_endo -55.35 -30.67 73.77 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.928 1.752 . . . . 0.0 111.149 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.7 t -58.98 -43.18 91.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.664 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.675 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -55.4 -49.79 71.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.958 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.33 -52.7 62.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.708 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.79 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.819 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.99 74.02 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.1 mt -61.72 -35.79 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.99 -26.34 67.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.6 t90 -96.52 -68.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.939 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 364' ' ' ILE . 16.3 m-85 -62.54 -74.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 354' ' ' PHE . 26.2 t70 11.86 63.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.811 0.694 . . . . 0.0 112.16 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 114.83 25.05 4.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.656 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 19.5 mmtt -87.54 -167.87 2.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -119.93 131.93 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 112.228 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -96.23 101.36 12.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.953 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.6 p 51.44 28.2 4.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.15 -42.49 1.55 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.28 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.3 m120 -78.05 172.32 10.15 Favored Pre-proline 0 C--O 1.221 -0.405 0 CA-C-N 116.667 0.233 . . . . 0.0 110.767 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -94.32 146.92 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.277 2.652 . . . . 0.0 112.054 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 354' ' ' PHE . 3.1 pt -123.59 171.26 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 111.822 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -148.29 104.02 3.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.807 HG22 HG13 ' A' ' 289' ' ' VAL . 37.0 t -91.39 139.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.04 -172.1 3.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 351' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.68 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.171 0.51 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -52.87 -34.55 55.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.603 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 99.6 m -62.07 97.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.666 HD12 HG13 ' A' ' 366' ' ' VAL . 43.5 pt -86.55 170.59 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -118.39 118.59 32.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 365' ' ' LYS . 0.2 OUTLIER -108.69 115.28 48.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.538 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -116.43 130.83 56.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.376 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.635 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 111.78 51.11 0.58 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.294 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.758 HD22 ' H ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -105.57 -83.55 0.51 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.905 0.352 . . . . 0.0 110.486 179.448 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.57 -50.14 2.83 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.214 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -107.75 40.0 1.81 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.186 0.493 . . . . 0.0 111.951 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -143.56 -42.28 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.039 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 296' ' ' VAL . 96.4 t 6.27 65.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.839 ' O ' HG23 ' A' ' 301' ' ' VAL . 39.4 p -161.92 145.58 12.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.731 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.732 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.2 mm -71.77 -40.3 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.15 -42.81 88.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.41 ' HB3' ' OG1' ' A' ' 297' ' ' THR . 21.6 p -63.18 -41.49 99.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.473 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 297' ' ' THR . 34.9 t -70.72 -47.67 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.728 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -62.62 -29.9 70.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.922 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.1 -40.67 71.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.756 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.69 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -88.83 9.99 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 20.99 13.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -102.32 -39.21 7.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.406 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.441 HD13 ' HE3' ' A' ' 353' ' ' TRP . 3.3 tp -76.81 -38.39 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.052 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -168.01 -162.97 21.12 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.528 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.6 mt -98.31 137.07 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.53 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -96.73 136.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 341' ' ' PHE . 4.1 mmtt -48.42 106.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.052 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -77.67 142.87 38.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.569 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.62 140.3 29.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 0.0 111.387 -179.031 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -77.86 -6.18 53.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.91 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -45.13 7.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.37 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 70.8 p -104.63 -8.25 19.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 63.95 14.22 55.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.235 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 2.1 pt20 -125.14 164.08 34.01 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 120.485 0.183 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.591 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 79.3 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.44 2.093 . . . . 0.0 112.299 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.569 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.64 125.1 51.29 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.569 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.717 HD13 ' HB ' ' A' ' 301' ' ' VAL . 4.6 mt -143.28 144.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.166 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.534 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.2 m-20 -110.34 147.84 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.703 0.287 . . . . 0.0 110.455 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.732 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -145.48 130.14 18.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.111 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 325' ' ' TYR . . . . . 0.402 ' HB2' ' CG ' ' A' ' 336' ' ' GLU . 51.2 m-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.511 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.401 ' C ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 325' ' ' TYR . 0.6 OUTLIER -143.02 143.4 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.36 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -158.26 139.85 13.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.237 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 288' ' ' PHE . 11.9 p -97.61 134.15 41.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.561 HG22 HG11 ' A' ' 301' ' ' VAL . 95.0 t -112.0 126.06 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.522 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.899 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -86.18 153.26 22.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.467 ' CB ' ' ND2' ' A' ' 285' ' ' ASN . 4.5 m-85 -133.51 147.0 51.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.42 -33.22 48.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.65 118.07 41.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.648 0.261 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.565 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.5 Cg_exo -41.84 -51.69 4.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.876 2.384 . . . . 0.0 113.081 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.2 Cg_endo -55.6 -30.28 74.06 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.775 1.65 . . . . 0.0 111.089 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.8 t -56.64 -44.82 81.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.04 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.66 ' HB2' HD22 ' A' ' 285' ' ' ASN . . . -53.4 -50.34 65.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.63 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.943 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -63.9 -54.85 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.156 0.503 . . . . 0.0 109.749 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.92 14.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.539 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.58 -48.56 63.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.0 mt -58.93 -35.99 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.371 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -61.91 -26.2 68.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.242 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.6 t90 -94.37 -68.57 0.79 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.586 ' HB2' HG21 ' A' ' 366' ' ' VAL . 1.5 m-85 -69.79 -77.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.8 p-10 23.17 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.115 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.45 20.33 2.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.316 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.446 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 9.1 mtpp -87.02 -166.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.061 0.43 . . . . 0.0 110.472 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 13.3 mm-40 -120.02 128.91 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.419 . . . . 0.0 112.093 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HD2' HD12 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -84.2 100.84 11.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.743 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.49 31.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 142.51 -51.62 0.67 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.186 -1.006 . . . . 0.0 114.048 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.5 OUTLIER -89.16 171.61 8.7 Favored Pre-proline 0 C--O 1.218 -0.59 0 CA-C-N 117.008 0.404 . . . . 0.0 110.743 -179.255 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 358' ' ' GLU . 85.9 Cg_endo -95.48 143.36 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.308 2.672 . . . . 0.0 112.193 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.9 pt -132.03 170.06 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 111.978 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -132.62 150.92 52.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.777 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.666 HG13 HD12 ' A' ' 287' ' ' ILE . 11.6 t -131.6 127.74 59.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.8 p -140.24 172.92 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.492 ' CZ ' HD13 ' A' ' 351' ' ' ILE . 4.3 m-85 . . . . . 0 C--N 1.332 -0.154 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.088 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.487 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 3.8 p-10 -86.45 -19.14 30.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 74.6 m -80.42 144.98 32.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.769 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.2 pt -123.36 168.33 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.764 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.664 ' HD2' HE22 ' A' ' 290' ' ' GLN . 0.6 OUTLIER -124.06 114.95 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.174 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -107.63 114.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.664 HE22 ' HD2' ' A' ' 288' ' ' PHE . 0.7 OUTLIER -112.74 144.18 42.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.678 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.51 4.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.731 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 296' ' ' VAL . 7.2 mt -60.51 -76.76 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.618 0.247 . . . . 0.0 110.743 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 114.3 77.72 0.77 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.392 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 43.93 30.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.632 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 293' ' ' GLY . 15.6 p30 -138.33 25.34 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.729 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 292' ' ' LEU . 21.5 t -68.17 83.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.7 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.845 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -126.44 147.99 49.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.588 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 324' ' ' LEU . 32.4 mm -68.54 -47.02 79.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.258 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -38.64 87.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.7 t -63.96 -40.28 96.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 297' ' ' THR . 54.6 t -74.9 -41.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.862 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.721 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.18 -29.93 68.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.837 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -74.11 -40.47 62.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.632 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -94.07 -21.83 18.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.806 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -105.33 38.13 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.02 19.11 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.305 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -36.45 8.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.301 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.0 tp -75.48 -30.1 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.465 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLY . . . . . 0.431 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -168.16 -167.38 28.73 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.91 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.69 116.71 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 305' ' ' PHE . 3.4 mt -76.81 124.02 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.313 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 321' ' ' MET . 23.9 mtmt -48.72 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.615 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.2 m -69.64 152.04 45.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.747 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.23 144.59 25.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.8 1.5 52.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.279 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.26 -32.1 7.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.845 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.401 ' OG1' ' CG ' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -107.39 -20.67 13.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.752 179.145 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.37 8.59 71.15 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.776 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.615 ' C ' HG23 ' A' ' 313' ' ' THR . 0.1 OUTLIER -125.12 167.42 16.3 Favored Pre-proline 0 C--O 1.224 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.721 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 66.8 Cg_exo -44.78 149.37 1.14 Allowed 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.708 2.272 . . . . 0.0 113.041 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 312' ' ' LYS . 36.7 mtp -101.94 121.56 42.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.835 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 339' ' ' VAL . 1.2 mt -143.25 138.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.0 OUTLIER -98.83 140.41 33.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.808 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.743 HD23 ' HB1' ' A' ' 337' ' ' ALA . 5.2 mt -126.7 142.61 51.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.034 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.665 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.22 136.5 15.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 0.0 111.236 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.743 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -157.88 153.02 25.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -102.67 145.83 29.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.428 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 322' ' ' ILE . 46.8 t -113.27 128.51 70.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.206 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 311' ' ' ILE . 59.7 p -97.57 124.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -102.06 154.87 18.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.69 -21.09 38.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -125.98 118.36 23.9 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.683 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.601 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.1 Cg_exo -41.31 -50.81 4.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.733 2.289 . . . . 0.0 112.983 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.3 Cg_endo -53.03 -30.54 49.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.956 1.771 . . . . 0.0 111.219 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 25.6 t -57.26 -44.92 84.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.97 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.35 -49.22 75.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.946 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.05 -49.97 73.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.003 0.43 . . . . 0.0 110.01 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.88 38.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.731 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.09 64.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.452 0.644 . . . . 0.0 109.382 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.5 mt -58.26 -35.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.158 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.17 -26.62 65.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.159 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.519 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -89.2 -68.01 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.334 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.621 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -75.64 -81.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.614 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.5 p-10 31.26 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.549 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 126.02 43.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.773 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.79 -157.2 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 27.7 tt0 -113.58 128.32 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.41 0.624 . . . . 0.0 111.518 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 304' ' ' TYR . 0.9 OUTLIER -112.46 101.66 9.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.957 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.7 t 55.43 26.55 8.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.068 0.461 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 94.66 24.83 16.89 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.74 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 73.5 m-80 -129.94 148.57 70.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.822 0.344 . . . . 0.0 111.848 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.07 121.71 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.479 2.119 . . . . 0.0 111.447 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 8.7 pt -112.33 -178.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.961 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.12 101.04 3.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.673 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.897 HG22 HG13 ' A' ' 289' ' ' VAL . 40.8 t -88.64 133.52 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 86.6 p -127.53 -179.89 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.195 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.693 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.8 p30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 29.5 p30 -58.41 -21.3 50.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.691 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 340' ' ' SER . 0.3 OUTLIER -84.56 143.04 29.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.836 HD12 ' CG1' ' A' ' 366' ' ' VAL . 2.0 pt -117.26 172.17 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.047 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 1.5 p90 -125.48 122.29 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.876 0.37 . . . . 0.0 111.459 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.963 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -104.34 114.86 45.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.242 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.423 ' NE2' ' CD1' ' A' ' 288' ' ' PHE . 0.0 OUTLIER -115.93 131.0 57.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.06 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 106.75 43.15 1.46 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.976 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.702 HD22 ' HD2' ' A' ' 359' ' ' PHE . 0.5 OUTLIER -85.67 -79.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.791 0.296 . . . . 0.0 110.678 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 136.39 -81.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.546 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.13 29.74 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.92 0.39 . . . . 0.0 110.575 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.409 ' ND2' ' CE1' ' A' ' 359' ' ' PHE . 0.2 OUTLIER -111.65 7.92 20.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.94 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.788 HG13 HD22 ' A' ' 324' ' ' LEU . 10.0 t -55.52 89.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.529 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -147.52 146.44 29.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.67 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.5 mm -71.43 -45.28 69.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.684 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.96 -43.09 84.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.073 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -40.0 82.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 297' ' ' THR . 54.2 t -73.58 -37.96 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.715 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.792 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.61 -34.52 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.36 -38.02 71.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.092 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -85.54 -20.91 28.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.714 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.867 ' CD2' HG21 ' A' ' 339' ' ' VAL . 0.6 OUTLIER -92.15 11.76 24.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 29.02 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.071 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -112.54 -33.8 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 7.8 tp -84.4 -31.8 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.71 -160.73 26.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.732 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.0 mt -92.85 134.63 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.562 0.22 . . . . 0.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.792 HD13 ' HA ' ' A' ' 302' ' ' ALA . 4.6 mt -92.93 134.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.378 0.608 . . . . 0.0 110.945 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.7 OUTLIER -48.56 100.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.411 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -76.21 154.25 35.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.523 ' CG ' ' HG1' ' A' ' 317' ' ' THR . 17.6 p30 -103.03 -178.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.018 0.437 . . . . 0.0 111.644 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.41 ' CD ' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -109.42 -12.46 14.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.172 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 -44.75 11.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.156 0.503 . . . . 0.0 109.999 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.523 ' HG1' ' CG ' ' A' ' 314' ' ' ASN . 8.5 p -106.37 -8.42 17.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.766 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 314' ' ' ASN . . . 61.23 17.39 52.36 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.671 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.559 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.7 168.03 14.32 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 120.776 0.322 . . . . 0.0 110.894 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.598 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 80.4 Cg_exo -44.54 161.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.988 2.459 . . . . 0.0 112.726 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -123.08 129.43 51.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.296 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 339' ' ' VAL . 3.7 mp -144.38 129.23 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.15 115.52 28.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.797 HD23 ' CB ' ' A' ' 337' ' ' ALA . 0.2 OUTLIER -121.56 148.77 44.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.776 179.876 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.18 140.55 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.62 0.247 . . . . 0.0 110.703 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.797 ' CB ' HD23 ' A' ' 324' ' ' LEU . . . -160.39 179.11 8.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.783 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 322' ' ' ILE . 69.4 p -129.91 136.47 49.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.406 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.867 HG21 ' CD2' ' A' ' 305' ' ' PHE . 0.4 OUTLIER -104.37 125.11 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.268 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 311' ' ' ILE . 3.1 p -94.56 140.07 30.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.047 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.557 ' CE2' HD13 ' A' ' 287' ' ' ILE . 32.2 m-85 -115.5 160.16 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 111.069 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -80.63 -18.15 49.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.25 116.87 20.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.609 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.7 Cg_exo -44.77 -50.52 8.34 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.653 2.235 . . . . 0.0 112.907 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.1 Cg_endo -54.58 -30.51 65.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.003 1.802 . . . . 0.0 111.401 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.9 t -58.67 -41.21 85.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.85 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.05 -50.1 71.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.949 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.4 OUTLIER -59.39 -50.64 73.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.175 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.56 -33.78 33.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.84 -48.33 63.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.433 0.635 . . . . 0.0 109.391 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.949 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.4 mt -56.87 -35.97 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.15 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -26.65 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.152 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.34 -68.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.054 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.533 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 5.1 m-85 -76.17 -79.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.483 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 354' ' ' PHE . 45.5 t0 21.44 51.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.439 0.462 . . . . 0.0 112.021 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 125.32 32.02 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.256 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -102.74 -162.87 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.087 0.443 . . . . 0.0 110.087 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 8.5 mt-10 -113.72 128.6 56.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.994 0.426 . . . . 0.0 111.866 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.74 ' HB2' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -102.79 101.72 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.266 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 41.0 t 60.01 28.38 17.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.486 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.32 -27.8 10.33 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.592 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 3.4 m120 -91.76 169.54 11.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.956 0.378 . . . . 0.0 110.64 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -93.34 137.18 1.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 112.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.74 HD13 ' HB2' ' A' ' 359' ' ' PHE . 23.3 pt -134.36 164.52 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 120.977 0.417 . . . . 0.0 111.804 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 100.53 5.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.963 HG22 HG13 ' A' ' 289' ' ' VAL . 19.5 t -90.02 118.66 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -140.53 -166.75 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.014 0.435 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 14.0 p30 -104.1 -25.15 13.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.491 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 58.9 m -70.52 116.23 10.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.659 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 36.8 pt -102.93 173.17 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.175 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.564 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.4 OUTLIER -122.46 107.69 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 364' ' ' ILE . 2.7 t -104.35 114.48 44.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.432 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 2.0 mp0 -116.78 130.5 56.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 364' ' ' ILE . . . 123.98 25.77 1.64 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.849 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 292' ' ' LEU . 4.9 mp -88.05 -104.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.94 -39.7 1.82 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.594 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.93 31.82 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.654 0.727 . . . . 0.0 112.036 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.711 HD21 ' HB3' ' A' ' 300' ' ' SER . 0.2 OUTLIER -162.51 -44.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 296' ' ' VAL . 14.7 t 26.48 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.639 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -164.48 145.2 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.101 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.749 HD12 HD21 ' A' ' 324' ' ' LEU . 1.2 mp -72.21 -42.1 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.998 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.44 -40.54 95.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' SER . . . . . 0.711 ' HB3' HD21 ' A' ' 295' ' ' ASN . 1.4 t -65.08 -43.99 90.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.468 . . . . 0.0 110.478 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 297' ' ' THR . 47.7 t -70.92 -40.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.353 0.597 . . . . 0.0 109.664 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 320' ' ' PRO . . . -68.18 -29.82 68.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.024 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -37.7 65.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.685 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.57 -24.79 15.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.769 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -93.27 7.98 42.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.081 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -95.56 22.41 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 111.076 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.21 -44.35 6.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.624 HG23 ' CE2' ' A' ' 341' ' ' PHE . 0.8 OUTLIER -70.94 -29.33 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.477 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.73 -170.52 35.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.943 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.29 113.85 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.689 0.281 . . . . 0.0 111.513 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 305' ' ' PHE . 1.1 mt -71.65 135.16 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 0.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 321' ' ' MET . 6.1 mmmt -65.37 91.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -67.33 171.02 6.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 111.043 178.381 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 316' ' ' LYS . 0.4 OUTLIER -103.35 116.34 32.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.354 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -8.26 0.16 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -83.27 -34.49 25.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.064 0.459 . . . . 0.0 110.59 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.614 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.5 OUTLIER -121.62 -23.48 5.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.338 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.84 23.43 52.78 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.908 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.614 ' HG2' HG21 ' A' ' 317' ' ' THR . 0.0 OUTLIER -118.57 138.1 25.49 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.884 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.681 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 4.8 Cg_exo -44.01 131.04 8.32 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.999 2.466 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -97.15 130.18 44.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.839 0.828 . . . . 0.0 112.929 -178.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.721 HD12 HG23 ' A' ' 298' ' ' ILE . 3.7 mt -143.14 140.22 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.428 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 6.2 t30 -98.8 148.38 23.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 298' ' ' ILE . 0.2 OUTLIER -154.42 128.17 8.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.943 0.401 . . . . 0.0 111.496 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.952 179.198 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.432 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 4.9 mp0 -130.16 132.16 45.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.502 0.191 . . . . 0.0 110.562 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -153.27 147.05 25.22 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.564 HG22 ' CD1' ' A' ' 288' ' ' PHE . 44.3 p -110.33 117.8 34.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.918 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.647 ' CG1' HD13 ' A' ' 311' ' ' ILE . 56.1 t -93.06 130.15 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.739 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 311' ' ' ILE . 9.1 t -96.72 133.62 41.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.907 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.624 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.0 m-85 -117.41 148.35 41.85 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -70.95 -34.32 71.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.49 109.45 60.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.28 -51.41 6.85 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.478 2.119 . . . . 0.0 112.496 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.3 Cg_endo -55.76 -30.58 76.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.945 1.763 . . . . 0.0 111.262 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -60.54 -44.21 96.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.659 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.65 -46.21 81.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.287 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.93 ' HA ' HD12 ' A' ' 351' ' ' ILE . 3.0 tppt? -60.16 -54.74 42.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.847 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.54 43.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.63 -49.68 57.28 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.93 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.9 mt -52.47 -36.66 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.763 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -58.38 -26.24 62.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.577 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.544 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.4 t90 -100.5 -68.6 0.8 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.688 ' HB2' HG21 ' A' ' 366' ' ' VAL . 47.2 m-85 -56.85 -74.48 0.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.4 p-10 9.35 59.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.973 0.796 . . . . 0.0 112.684 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.81 30.69 1.76 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.13 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.422 ' HG3' ' CG1' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -94.75 -164.45 1.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 7.7 mm-40 -119.4 129.38 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.621 -0.432 . . . . 0.0 112.122 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.678 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -86.09 101.05 12.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 40.5 30.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.358 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 140.49 -49.72 0.78 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.28 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.0 OUTLIER -89.7 171.1 9.26 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 117.207 0.504 . . . . 0.0 110.958 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -95.15 140.17 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.468 2.779 . . . . 0.0 112.153 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.678 HG21 ' CD1' ' A' ' 359' ' ' PHE . 5.1 pt -122.28 -179.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.865 0.364 . . . . 0.0 111.652 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.27 102.45 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.548 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' ' 354' ' ' PHE . 17.6 t -84.85 143.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.2 t -128.08 -168.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 351' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 9.9 p30 -63.9 -20.28 65.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 27.8 m -71.44 158.28 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 339' ' ' VAL . 10.2 pt -142.94 173.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.75 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -131.09 112.35 12.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.016 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 366' ' ' VAL . 0.5 OUTLIER -105.35 114.69 45.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.741 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 289' ' ' VAL . 1.1 mp0 -113.37 130.59 56.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.034 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.32 51.03 0.89 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.387 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -84.56 -73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.108 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.27 105.12 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.392 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.18 46.6 19.74 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 295' ' ' ASN . 0.1 OUTLIER -165.69 26.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 110.796 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.884 HG12 HD22 ' A' ' 324' ' ' LEU . 18.0 t -79.17 100.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.564 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -153.36 147.0 25.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.585 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.672 HD11 HD11 ' A' ' 324' ' ' LEU . 28.3 mm -70.93 -44.73 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.399 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.72 -39.19 87.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.7 t -68.22 -42.92 79.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.586 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 297' ' ' THR . 90.8 t -71.41 -40.01 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.564 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ALA . . . . . 0.557 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -29.9 68.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.832 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 4.4 m-20 -72.9 -38.73 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.721 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.81 -24.81 28.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.564 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 305' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 1.1 m-85 -85.67 1.13 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.769 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -89.75 12.81 15.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.622 0.248 . . . . 0.0 111.356 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.58 -45.11 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.043 0.449 . . . . 0.0 110.458 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ILE . . . . . 0.534 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -76.32 -36.64 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.26 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -171.78 -158.72 16.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.913 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.48 144.16 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.742 0.306 . . . . 0.0 111.536 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.557 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.2 mt -96.15 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.86 93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.42 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -71.74 152.57 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.421 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.827 HD22 ' HB2' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -107.74 110.9 22.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.806 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -8.52 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.827 ' HB2' HD22 ' A' ' 314' ' ' ASN . 15.1 mmtt -89.35 -25.7 21.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.994 0.426 . . . . 0.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.545 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 74.9 p -122.06 -24.03 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.56 16.0 76.72 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.692 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLN . . . . . 0.545 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.58 160.08 57.57 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 0.0 111.619 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 320' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 83.9 Cg_exo -50.5 156.9 3.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.776 2.317 . . . . 0.0 112.279 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.1 OUTLIER -121.35 122.94 40.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.224 0.535 . . . . 0.0 111.346 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 339' ' ' VAL . 47.9 mt -143.64 146.27 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.443 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.45 134.26 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.611 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.884 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -136.34 143.55 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.77 -179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.74 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -148.5 131.99 16.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.686 0.279 . . . . 0.0 111.216 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.04 133.38 7.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 111.765 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' THR . . . . . 0.75 HG22 ' CD1' ' A' ' 288' ' ' PHE . 20.4 p -91.91 130.38 37.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.15 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 322' ' ' ILE . 60.4 t -111.26 132.38 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.683 0.278 . . . . 0.0 111.217 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 286' ' ' THR . 2.5 p -100.44 139.21 36.44 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.812 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.96 161.16 14.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.03 -27.77 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.756 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.76 120.53 22.95 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.506 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' PRO . . . . . 0.577 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.9 Cg_exo -41.91 -51.62 4.46 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.832 2.355 . . . . 0.0 112.963 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 14.4 Cg_endo -56.61 -30.67 84.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.914 1.742 . . . . 0.0 111.466 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.1 t -62.34 -39.23 92.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -63.12 -48.33 78.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.38 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.956 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -61.73 -47.73 83.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.932 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.44 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.87 -31.96 63.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.97 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.09 67.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.8 mt -58.04 -35.46 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.943 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 348' ' ' LYS . 31.8 t70 -59.23 -26.46 64.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.6 t90 -101.97 -65.87 0.96 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 366' ' ' VAL . 20.5 m-85 -61.11 -74.89 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 354' ' ' PHE . 16.0 p-10 13.5 58.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.795 0.685 . . . . 0.0 112.345 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 113.27 35.02 1.68 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.727 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.23 -160.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 358' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.7 mm-40 -121.81 129.06 52.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 112.116 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' PHE . . . . . 0.55 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -83.95 100.9 11.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 18.6 p 39.31 31.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.209 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.8 -47.83 0.92 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.91 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.8 m-80 -88.13 170.99 10.21 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.989 0.395 . . . . 0.0 110.604 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -96.24 141.71 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.251 2.634 . . . . 0.0 112.386 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.8 pt -126.82 -178.91 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.35 100.93 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 354' ' ' PHE . 24.6 t -87.78 137.39 21.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.9 p -131.55 -165.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.963 0.411 . . . . 0.0 111.263 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' PHE . . . . . 0.403 ' CD2' HD13 ' A' ' 351' ' ' ILE . 6.8 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.063 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.771 0.32 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 60.62 66.16 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 8.5 t0 58.97 72.7 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -164.13 115.72 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.5 -17.63 19.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -96.87 27.46 3.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 111.121 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -44.95 110.92 0.26 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.367 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -47.26 -30.07 2.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.731 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 96.9 m -61.33 125.55 24.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 366' ' ' VAL . 40.2 pt -113.29 173.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.49 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.9 OUTLIER -126.36 112.98 16.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.266 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -107.01 122.48 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.626 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -128.89 129.98 46.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.018 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.57 46.76 0.52 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.3 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 359' ' ' PHE . 0.7 OUTLIER -86.29 -84.59 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.5 0.191 . . . . 0.0 110.83 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 105.64 90.6 2.18 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.269 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.592 ' HA ' HD12 ' A' ' 333' ' ' LEU . 3.1 mm-40 44.65 27.95 0.29 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.822 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 293' ' ' GLY . 17.9 p30 -142.31 -2.23 1.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.789 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.842 HG13 HD22 ' A' ' 333' ' ' LEU . 11.7 p -64.9 83.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.792 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -116.46 163.95 15.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.512 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.814 ' CD1' HD11 ' A' ' 324' ' ' LEU . 13.8 mm -71.29 -49.1 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 111.366 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -34.1 76.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.5 t -63.58 -44.13 94.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.819 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 339' ' ' VAL . 43.1 t -73.81 -38.44 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.401 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.747 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -67.92 -30.44 69.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.053 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.55 -41.79 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.498 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -93.18 -21.43 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.527 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -104.71 37.56 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.808 0.337 . . . . 0.0 111.326 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.92 17.04 9.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.177 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.05 -43.27 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 109.987 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 350' ' ' ALA . 0.6 OUTLIER -66.74 -35.56 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.5 -156.15 11.04 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.565 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 mt -101.93 134.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -89.18 139.66 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 110.035 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -48.15 91.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.945 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.421 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -70.79 147.12 49.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.415 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.536 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -97.35 157.86 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.425 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -89.44 -8.25 53.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -45.55 8.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.431 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 61.0 p -107.5 -7.43 16.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 314' ' ' ASN . . . 61.72 18.84 57.48 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.678 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 1.6 pt20 -124.5 163.69 35.04 Favored Pre-proline 0 C--O 1.227 -0.131 0 CA-C-O 120.677 0.275 . . . . 0.0 111.017 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.747 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 88.0 Cg_exo -46.86 154.55 1.05 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.789 2.326 . . . . 0.0 113.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.536 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -123.45 125.07 44.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.264 0.555 . . . . 0.0 110.959 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 338' ' ' THR . 2.7 mp -140.11 140.51 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -95.56 115.8 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.747 0.308 . . . . 0.0 110.29 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.814 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -108.26 116.77 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.553 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.918 HG22 HD23 ' A' ' 333' ' ' LEU . 9.9 p -120.89 156.37 32.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.63 145.12 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.799 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -110.23 -22.28 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.53 -46.33 55.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 5.2 t -99.27 -23.28 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.15 47.5 5.76 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.408 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -134.47 -165.27 1.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.605 0.24 . . . . 0.0 110.8 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.918 HD23 HG22 ' A' ' 326' ' ' THR . 7.5 mt -108.82 166.26 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.09 -39.16 9.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 105.78 27.77 5.59 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -151.09 131.86 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.433 0.158 . . . . 0.0 110.663 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.82 145.22 15.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 121.3 0.571 . . . . 0.0 112.298 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 322' ' ' ILE . 7.6 p -98.0 134.9 40.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.793 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.831 ' CG2' HG11 ' A' ' 301' ' ' VAL . 57.2 t -107.84 128.69 62.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.405 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 50.3 m -90.4 142.78 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.374 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 146.0 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 111.269 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -79.28 -17.94 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.14 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.8 111.03 27.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.554 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -49.07 -52.19 9.19 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.469 2.113 . . . . 0.0 112.877 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.1 Cg_endo -59.07 -30.67 93.9 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.873 1.715 . . . . 0.0 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 36.4 t -65.66 -34.72 78.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.688 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.29 97.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.81 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.882 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -62.66 -50.91 69.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.262 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.35 53.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.65 ' HA ' HD13 ' A' ' 308' ' ' ILE . . . -68.75 -48.0 64.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.305 0.574 . . . . 0.0 109.863 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.6 mt -57.44 -35.64 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.228 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -26.55 68.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.819 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.5 t90 -98.67 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.847 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 355' ' ' ASP . 60.6 m-85 -56.04 -74.17 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.562 ' C ' ' O ' ' A' ' 354' ' ' PHE . 22.6 t0 8.97 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.911 0.757 . . . . 0.0 111.624 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.02 22.35 4.25 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.259 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -78.72 -164.48 0.59 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.608 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 21.3 mm-40 -130.11 137.24 50.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 112.149 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.713 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -102.75 101.47 11.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.146 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.26 29.52 5.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.703 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 123.9 -37.9 2.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.443 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.0 OUTLIER -82.77 169.98 16.14 Favored Pre-proline 0 C--O 1.22 -0.474 0 CA-C-N 116.876 0.338 . . . . 0.0 110.659 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.76 144.46 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.441 2.761 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.713 HG21 ' HD2' ' A' ' 359' ' ' PHE . 3.6 pt -130.98 161.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-O 120.824 0.345 . . . . 0.0 111.667 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -130.42 100.95 5.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 287' ' ' ILE . 23.3 t -85.64 130.79 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 p -127.75 -177.27 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER -100.55 45.44 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.915 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 56.49 72.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 44.7 p -61.59 162.31 8.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.99 135.42 33.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.28 114.43 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -174.77 -171.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.85 -174.57 3.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 2.8 t80 63.65 84.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.41 112.5 5.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 60.74 53.36 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 167.23 115.01 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.7 -115.14 0.65 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.514 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -77.53 -51.07 6.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.14 -177.58 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 120.66 -19.57 9.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.645 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.8 166.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 111.097 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 163.63 69.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.551 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 62.22 -168.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.62 -32.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.96 98.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.021 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.28 -27.22 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.54 -35.23 6.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.526 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.489 ' O ' ' ND2' ' A' ' 285' ' ' ASN . 67.0 m-20 -66.51 166.96 11.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.009 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.0 OUTLIER 85.31 14.06 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.445 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.977 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 90.1 m -164.97 107.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.709 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.821 HD11 ' CE2' ' A' ' 305' ' ' PHE . 33.0 pt -92.75 170.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.172 0.51 . . . . 0.0 111.842 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.54 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.0 m-85 -119.75 110.92 17.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.553 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 339' ' ' VAL . 0.4 OUTLIER -103.15 119.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -128.31 130.03 47.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.533 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 126.26 20.18 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.154 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -71.19 -101.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 171.64 -100.44 0.15 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.139 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -131.95 33.55 3.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 296' ' ' VAL . 1.4 p30 -130.46 -51.66 1.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.137 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 296' ' ' VAL . 14.4 p -2.05 76.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.803 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -112.76 155.05 25.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.699 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.636 HG23 ' HB ' ' A' ' 322' ' ' ILE . 16.7 mt -61.12 -47.04 95.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -38.27 87.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -39.26 79.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.121 0.486 . . . . 0.0 110.484 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 297' ' ' THR . 87.2 t -73.41 -39.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.805 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.23 73.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.926 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -39.87 62.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.678 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -89.5 -21.64 22.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -102.19 30.09 4.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.142 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.3 19.36 17.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.159 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -101.83 -39.7 7.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 110.323 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -79.1 -38.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.119 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.99 -169.97 30.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.525 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.59 144.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 340' ' ' SER . 4.1 mp -93.48 131.83 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.144 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 25.7 mtmt -48.91 93.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.765 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -64.56 145.46 56.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.463 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.424 ' ND2' ' SD ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -75.89 162.19 28.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.346 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -104.95 -7.72 19.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -104.48 -35.69 7.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.999 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 314' ' ' ASN . 69.6 p -108.24 -9.57 15.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 313' ' ' THR . . . 60.51 14.72 36.35 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.718 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 159.18 52.41 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.984 0.392 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 76.6 Cg_exo -44.68 151.15 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.007 2.471 . . . . 0.0 112.86 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.424 ' SD ' ' ND2' ' A' ' 314' ' ' ASN . 29.9 mtm -108.11 119.15 38.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.391 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.636 ' HB ' HG23 ' A' ' 298' ' ' ILE . 4.8 mt -143.22 142.74 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.467 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -117.95 133.19 56.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 324' ' ' LEU . 0.1 OUTLIER -125.41 164.04 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.209 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.71 113.52 14.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.821 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.969 HG22 HD23 ' A' ' 333' ' ' LEU . 13.6 p -101.01 160.98 13.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.0 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.35 133.55 52.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.806 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.43 ' HD3' ' N ' ' A' ' 329' ' ' GLU . 0.0 OUTLIER -100.21 -7.19 24.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.43 ' N ' ' HD3' ' A' ' 328' ' ' ARG . 11.6 mt-10 -97.6 -36.68 10.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 110.747 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.4 t -110.86 -24.36 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 97.16 -22.7 39.35 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.408 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -176.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.382 . . . . 0.0 111.007 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.969 HD23 HG22 ' A' ' 326' ' ' THR . 1.1 mt -106.52 118.64 37.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.775 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -57.4 -21.2 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.353 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.655 ' O ' HD22 ' A' ' 292' ' ' LEU . . . 80.61 38.58 16.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.915 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -139.78 131.77 27.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.172 . . . . 0.0 110.866 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -162.65 145.54 11.01 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 121.089 0.471 . . . . 0.0 111.882 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.54 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 5.1 p -95.3 150.01 20.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.135 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.762 ' CG2' HG11 ' A' ' 301' ' ' VAL . 44.7 t -123.71 127.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 311' ' ' ILE . 91.4 p -84.32 153.21 23.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 3.5 m-85 -127.08 133.41 50.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.022 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -62.46 -22.19 66.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.942 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -127.98 116.72 20.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.758 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.5 Cg_exo -45.23 -51.05 8.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.664 2.243 . . . . 0.0 113.017 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.2 Cg_endo -59.55 -30.48 92.52 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.85 1.7 . . . . 0.0 111.159 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.37 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' A' ' 287' ' ' ILE . . . -58.64 -42.75 89.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.915 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.86 -55.96 21.53 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.527 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -48.32 -31.74 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.792 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.61 -47.74 65.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.428 0.632 . . . . 0.0 109.39 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -61.91 -36.52 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.073 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -26.42 68.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.325 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.533 ' CE3' ' CZ ' ' A' ' 354' ' ' PHE . 3.5 t90 -91.08 -68.5 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.533 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 2.5 m-85 -68.84 -77.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 33.8 t0 25.27 50.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.033 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.7 26.98 1.21 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.804 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.505 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -102.47 -156.19 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.347 0.574 . . . . 0.0 110.778 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.4 mt-10 -113.5 128.65 56.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.349 0.595 . . . . 0.0 112.192 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.5 OUTLIER -108.01 103.19 12.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.981 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.5 t 63.36 28.07 15.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.619 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 104.62 -14.06 50.29 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.799 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 4.0 m-80 -106.92 170.94 5.14 Favored Pre-proline 0 C--O 1.219 -0.503 0 CA-C-N 117.246 0.523 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 89.7 Cg_endo -92.1 139.14 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.82 2.346 . . . . 0.0 111.904 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.533 HG22 HD13 ' A' ' 292' ' ' LEU . 9.2 pt -132.33 172.78 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 106.16 4.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.772 ' CG1' HD12 ' A' ' 287' ' ' ILE . 14.4 t -84.45 139.54 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.813 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -122.43 -175.0 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 111.885 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER -103.43 40.27 1.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.635 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.977 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 61.14 108.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.208 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 63.7 p -74.16 133.29 42.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.63 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -42.92 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 373' ' ' ALA . 1.4 mtm-85 59.87 155.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 372' ' ' ARG . . . 177.33 45.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.25 55.97 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -177.07 56.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 45.0 t30 64.15 -77.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.29 148.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.857 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -134.64 -132.26 3.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.436 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.77 119.7 1.04 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 95.21 -175.4 33.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -97.32 -167.73 1.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.12 61.2 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.564 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -110.8 147.43 34.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.22 130.36 10.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.41 -1.217 . . . . 0.0 112.493 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.836 0.35 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -144.94 -178.32 5.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.18 94.88 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -149.22 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.433 ' O ' ' ND2' ' A' ' 285' ' ' ASN . 3.1 t -105.06 24.19 12.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.77 -26.96 68.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.431 ' OD1' ' CZ ' ' A' ' 368' ' ' PHE . 0.4 OUTLIER -73.47 122.19 21.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.221 0.534 . . . . 0.0 110.921 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 282' ' ' SER . 3.4 p30 166.08 -33.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.668 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 78.8 m -101.47 115.67 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.935 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 366' ' ' VAL . 9.2 pt -91.08 173.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 338' ' ' THR . 2.4 m-85 -130.34 108.37 9.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.122 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.596 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -99.82 114.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 35.8 mm-40 -119.91 130.62 54.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.422 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.86 ' C ' HD13 ' A' ' 292' ' ' LEU . . . 115.68 70.45 0.47 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.338 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.931 HD21 ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.83 -78.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.877 0.339 . . . . 0.0 110.12 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.93 -81.62 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.665 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 294' ' ' GLU . 8.6 tp10 -140.93 41.5 1.82 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.249 0.547 . . . . 0.0 110.13 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.13 14.56 2.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.32 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 1.061 HG12 HD23 ' A' ' 324' ' ' LEU . 1.6 t -77.38 95.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 111.612 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.817 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.07 151.52 52.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.301 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 324' ' ' LEU . 26.6 mm -65.21 -48.36 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.58 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.91 -35.11 79.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.761 0.315 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 55.2 m -70.89 -43.82 67.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.577 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -63.0 -29.78 71.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.165 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.6 -38.84 64.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.889 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 -22.36 18.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -93.22 5.26 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.06 23.93 6.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.89 -31.65 8.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 353' ' ' TRP . 1.8 tp -91.32 -39.39 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.767 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -150.96 -175.92 23.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.18 119.82 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 305' ' ' PHE . 73.5 mt -85.83 125.02 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.244 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -48.71 103.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -62.02 148.8 42.82 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.641 178.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.805 HD21 HG23 ' A' ' 317' ' ' THR . 0.1 OUTLIER -106.8 140.08 40.21 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.73 0.3 . . . . 0.0 110.525 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -5.34 47.13 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -29.16 17.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.805 HG23 HD21 ' A' ' 314' ' ' ASN . 28.9 p -122.13 -23.17 5.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 83.4 12.17 78.97 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.339 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.95 153.29 71.03 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.9 Cg_endo -44.79 153.24 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.048 2.499 . . . . 0.0 112.596 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.492 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 45.9 mtp -104.69 128.53 52.79 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 338' ' ' THR . 3.1 mt -140.22 141.56 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.938 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 6.1 m-80 -97.37 148.38 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 1.061 HD23 HG12 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -144.98 135.9 24.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.842 0.353 . . . . 0.0 111.483 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -80.35 87.81 5.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.127 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.534 HG22 HD23 ' A' ' 333' ' ' LEU . 15.6 p -83.43 167.73 17.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.397 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 330' ' ' THR . 0.6 OUTLIER -64.01 99.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.426 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.46 -76.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.266 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 327' ' ' ASP . 13.3 mt-10 -147.69 -26.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.717 HG23 ' H ' ' A' ' 332' ' ' LYS . 10.6 t -44.73 -29.67 0.81 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.821 0.343 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.19 20.86 71.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.003 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.717 ' H ' HG23 ' A' ' 330' ' ' THR . 0.3 OUTLIER -61.93 -25.8 67.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.568 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.876 HD22 HD22 ' A' ' 324' ' ' LEU . 2.2 mt 63.84 126.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.15 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.55 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 292' ' ' LEU . . . 171.11 -69.03 0.13 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.627 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.931 ' HA ' HD21 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -160.23 167.29 27.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 0.0 111.217 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -158.0 147.14 19.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.144 0.497 . . . . 0.0 111.741 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 322' ' ' ILE . 4.2 p -107.56 133.5 51.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.201 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 322' ' ' ILE . 49.8 t -100.91 124.29 54.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.3 p -94.67 112.16 23.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.199 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 311' ' ' ILE . 59.1 m-85 -91.27 159.46 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.953 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -88.91 -14.69 36.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -128.27 119.9 20.92 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.943 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.607 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.4 Cg_exo -47.56 -48.87 14.47 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.714 2.276 . . . . 0.0 113.027 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.9 Cg_endo -60.36 -30.6 91.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.858 1.705 . . . . 0.0 111.392 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -62.09 -34.91 77.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.645 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.542 ' HB3' ' CE1' ' A' ' 368' ' ' PHE . . . -59.71 -50.05 75.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.483 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 1.007 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -60.75 -45.8 92.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.956 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.5 34.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.63 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.49 -46.97 68.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 1.007 HD12 ' HA ' ' A' ' 348' ' ' LYS . 12.3 mt -59.64 -34.75 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.119 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -26.88 67.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.551 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.564 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.72 -68.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.049 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.39 -79.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.117 -177.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 37.6 t70 30.08 43.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 134.92 28.3 0.45 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.139 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -98.19 -163.6 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.9 pm0 -120.39 128.84 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.135 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.724 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.2 OUTLIER -82.88 101.45 11.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.243 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 45.91 29.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.281 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.27 -43.36 1.26 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.925 -1.131 . . . . 0.0 114.256 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.4 m120 -92.49 162.64 29.11 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-N 117.242 0.521 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 84.4 Cg_endo -85.93 141.85 7.48 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.135 2.557 . . . . 0.0 112.176 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.447 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 13.4 pt -124.77 177.6 4.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-O 121.105 0.479 . . . . 0.0 111.701 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -144.91 101.66 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.513 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 289' ' ' VAL . 25.7 t -84.76 135.17 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.053 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 m -136.85 172.61 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.428 . . . . 0.0 111.64 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -93.03 63.68 3.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.744 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 57.92 165.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 371' ' ' ARG . 47.9 m 57.96 165.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.013 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 370' ' ' THR . 0.0 OUTLIER -99.77 88.47 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -84.04 -65.82 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -78.99 139.83 38.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.002 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -138.43 138.44 38.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.45 31.08 20.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -122.07 139.23 53.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ARG . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 377' ' ' ARG . 0.0 OUTLIER -149.52 149.41 30.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 126.05 -179.64 16.16 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.597 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -111.5 56.74 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 144.04 112.95 0.86 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -94.21 -31.34 14.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 138.85 -31.2 2.41 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 112.04 19.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 0.0 110.927 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.69 -134.25 20.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.436 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.532 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.781 0.324 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.65 48.01 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.018 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -66.08 121.26 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -103.86 -70.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.948 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.14 28.62 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.8 115.53 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 347' ' ' ALA . 7.0 p30 -57.32 -21.74 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 369' ' ' ALA . 61.4 m -71.61 102.29 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 305' ' ' PHE . 13.7 pt -104.02 162.04 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.991 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.779 ' HB3' ' HB2' ' A' ' 369' ' ' ALA . 0.1 OUTLIER -125.22 127.54 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 112.202 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.821 HG13 HG22 ' A' ' 366' ' ' VAL . 1.7 t -107.12 117.5 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.401 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.482 ' OE1' ' CD2' ' A' ' 288' ' ' PHE . 1.3 mp0 -112.53 129.82 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.745 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.4 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 42.26 0.91 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.658 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 335' ' ' GLY . 0.4 OUTLIER -71.19 -78.6 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.522 0.201 . . . . 0.0 110.81 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.504 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 111.41 87.09 1.71 Allowed Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.172 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 43.68 30.31 0.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.684 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 293' ' ' GLY . 17.1 p30 -145.28 29.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.779 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.863 ' O ' HD13 ' A' ' 324' ' ' LEU . 2.5 t -75.43 72.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -116.57 146.87 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 322' ' ' ILE . 35.8 mt -69.31 -43.66 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.479 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.15 -42.93 88.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.899 0.38 . . . . 0.0 110.666 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.9 p -65.0 -41.27 95.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 110.697 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 85.5 t -71.21 -42.7 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.266 0.555 . . . . 0.0 109.733 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -63.25 -30.43 71.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.3 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -39.69 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.614 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -88.83 -24.33 22.6 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.614 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.632 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -94.14 19.1 9.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.662 0.268 . . . . 0.0 111.332 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.89 20.54 18.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 110.899 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -102.56 -39.36 7.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 tp -73.03 -34.98 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.05 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -167.25 -153.11 7.78 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.646 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -109.55 119.55 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.9 mt -71.77 130.66 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.1 OUTLIER -48.68 92.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.62 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -69.81 137.49 51.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.432 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' GLY . 2.6 t30 -73.98 128.26 35.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.194 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -5.9 56.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.074 0.464 . . . . 0.0 110.071 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.44 -40.69 7.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.452 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.3 OUTLIER -105.13 -11.12 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.906 -179.389 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.07 11.92 59.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.498 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.672 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.16 152.2 66.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.902 0.351 . . . . 0.0 111.336 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 80.8 Cg_exo -47.68 158.47 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.795 2.33 . . . . 0.0 112.476 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 37.2 mmm -119.13 119.09 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 111.119 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.83 HG23 ' O ' ' A' ' 338' ' ' THR . 59.6 mt -143.08 144.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.736 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 8.5 m120 -103.27 148.15 26.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 111.011 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 296' ' ' VAL . 3.6 mt -130.4 131.03 45.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.86 113.84 27.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.911 HG22 HD23 ' A' ' 333' ' ' LEU . 59.6 p -106.62 158.2 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.95 129.45 40.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.658 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.449 ' CD ' ' H ' ' A' ' 328' ' ' ARG . 0.0 OUTLIER -96.64 19.8 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.407 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.8 -41.57 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.8 p -110.68 -29.79 7.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 110.59 -24.65 16.93 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.82 -172.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 110.975 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.911 HD23 HG22 ' A' ' 326' ' ' THR . 1.7 mt -100.49 133.25 45.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.821 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -68.77 -21.76 64.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 292' ' ' LEU . . . 87.56 29.09 22.57 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.369 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 1.5 mt-10 -143.84 131.94 21.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.345 0.117 . . . . 0.0 110.8 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -144.15 167.45 22.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.159 0.504 . . . . 0.0 111.913 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 322' ' ' ILE . 1.3 p -121.12 145.84 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.198 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 322' ' ' ILE . 92.0 t -125.4 134.37 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 0.0 111.385 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 312' ' ' LYS . 59.2 p -98.37 131.02 45.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.016 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.44 147.81 29.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.2 OUTLIER -79.08 -9.54 59.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 116.58 15.49 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.62 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.9 Cg_exo -45.13 -50.27 9.05 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.579 2.186 . . . . 0.0 112.798 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.0 Cg_endo -54.71 -30.56 67.29 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.924 1.749 . . . . 0.0 111.484 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.4 t -59.03 -42.17 89.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.868 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 285' ' ' ASN . . . -56.86 -49.84 74.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 0.0 110.387 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.88 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.5 tppt? -61.98 -53.86 49.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.653 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.68 47.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.846 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.44 -47.92 65.93 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.88 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.7 mt -59.8 -36.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.66 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.166 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.514 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.16 -68.05 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.115 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.61 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -76.17 -80.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.1 p-10 26.62 45.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.399 0.437 . . . . 0.0 111.992 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.36 37.25 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.052 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.61 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -95.91 -155.99 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 13.4 mt-10 -113.27 128.27 56.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.62 . . . . 0.0 111.48 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.493 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -122.76 101.91 7.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.937 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 56.0 m 60.55 27.22 16.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 110.537 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.55 17.49 52.2 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 20.3 m-80 -129.28 164.37 39.87 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.869 0.366 . . . . 0.0 111.306 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 90.5 Cg_endo -89.55 132.54 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.816 2.344 . . . . 0.0 111.9 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 289' ' ' VAL . 20.4 pt -120.84 174.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.04 0.448 . . . . 0.0 111.992 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -139.39 100.95 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.728 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.821 HG22 HG13 ' A' ' 289' ' ' VAL . 26.0 t -97.64 115.92 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -140.54 -165.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.224 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -80.54 117.52 21.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' A' ' 288' ' ' PHE . . . -93.29 148.58 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.3 120.43 42.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -126.87 34.63 4.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 59.83 -87.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.979 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 42.95 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.632 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -122.07 94.53 4.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.972 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -142.94 -87.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 177.88 39.5 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.716 0.293 . . . . 0.0 110.711 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -178.58 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 153.21 -43.36 0.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.473 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 122.08 -92.68 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.501 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 113.5 29.85 2.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.518 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -111.34 31.17 6.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 0.0 110.818 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.7 80.5 1.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -124.91 127.29 46.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -92.65 -94.25 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.576 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 279' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.603 0.239 . . . . 0.0 111.156 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER 32.52 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.935 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -94.35 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -97.31 63.24 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.983 0.421 . . . . 0.0 110.811 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -41.08 11.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.45 17.29 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 285' ' ' ASN . 33.7 m120 -88.29 138.05 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.738 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 284' ' ' ASN . 6.4 p30 168.64 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.07 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 369' ' ' ALA . 90.7 m -104.84 95.33 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.996 HD12 HG13 ' A' ' 366' ' ' VAL . 50.3 pt -86.53 168.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.681 ' HD2' HG22 ' A' ' 338' ' ' THR . 31.4 m-85 -120.71 124.28 44.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.661 HG12 ' HB ' ' A' ' 364' ' ' ILE . 0.9 OUTLIER -109.73 114.65 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.886 178.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -116.53 130.66 56.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.017 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 363' ' ' PRO . . . 127.96 20.7 1.63 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.615 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.566 HD22 ' CD2' ' A' ' 359' ' ' PHE . 12.3 mt -66.76 -103.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.95 0.35 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.97 34.5 5.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -145.41 30.74 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.715 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.627 HG11 ' OG1' ' A' ' 326' ' ' THR . 2.5 t -74.97 81.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.582 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -146.6 146.27 30.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.704 HG23 ' HB ' ' A' ' 322' ' ' ILE . 15.4 mt -71.37 -43.39 73.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.15 -40.62 90.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.64 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.8 t -63.45 -41.05 98.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 297' ' ' THR . 43.9 t -74.12 -41.17 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.295 0.569 . . . . 0.0 109.95 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.12 -29.85 68.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -74.14 -39.59 63.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -92.41 -24.49 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -96.78 32.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.236 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -116.18 16.62 15.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.288 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -98.77 -42.19 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.455 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.6 tp -71.07 -32.6 48.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.24 -163.66 27.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.6 mt -100.64 141.84 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.534 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.1 mt -100.83 125.22 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.411 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.76 107.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -73.42 152.38 40.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.133 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.567 HD21 HG23 ' A' ' 317' ' ' THR . 0.2 OUTLIER -105.27 138.16 41.91 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.827 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -1.95 25.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -96.9 -26.51 15.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 110.481 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.567 HG23 HD21 ' A' ' 314' ' ' ASN . 68.6 p -121.33 -20.41 6.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.58 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 75.79 13.96 82.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.976 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.536 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.86 164.03 35.66 Favored Pre-proline 0 C--N 1.333 -0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.376 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.616 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 71.3 Cg_exo -44.7 155.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.76 2.307 . . . . 0.0 112.384 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.501 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 51.7 mtp -109.34 119.8 40.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 111.636 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.704 ' HB ' HG23 ' A' ' 298' ' ' ILE . 3.4 mt -142.83 145.19 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.977 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 11.6 t-20 -119.15 116.4 26.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.805 0.336 . . . . 0.0 110.934 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.7 130.28 56.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -109.07 91.79 3.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.66 ' HB ' HD23 ' A' ' 333' ' ' LEU . 69.7 p -147.01 165.17 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -62.47 148.27 46.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.417 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -104.92 -20.99 13.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 178.75 30.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.233 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 332' ' ' LYS . 5.3 t -116.54 -35.99 4.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 107.72 10.14 27.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.452 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.41 ' H ' HG23 ' A' ' 330' ' ' THR . 2.9 mmtp -69.73 -70.29 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.992 0.396 . . . . 0.0 110.825 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 326' ' ' THR . 1.9 mt 58.47 110.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.314 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 -15.96 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.906 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.516 ' H ' HG22 ' A' ' 326' ' ' THR . . . 57.8 47.77 86.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 290' ' ' GLN . 6.8 mt-10 -140.97 131.54 25.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.596 0.236 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -139.28 169.69 17.31 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.917 0.389 . . . . 0.0 111.275 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.681 HG22 ' HD2' ' A' ' 288' ' ' PHE . 20.0 p -128.05 126.38 41.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.572 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 322' ' ' ILE . 42.3 t -106.51 116.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.396 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 311' ' ' ILE . 20.4 m -80.68 152.96 28.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 5.5 m-85 -136.29 139.15 42.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 -26.29 65.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -124.16 116.03 27.31 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.589 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.2 Cg_exo -42.72 -51.12 5.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.773 2.315 . . . . 0.0 113.094 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.4 Cg_endo -53.66 -30.37 55.39 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.817 1.678 . . . . 0.0 111.131 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.4 t -57.7 -46.15 84.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.16 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -54.52 -39.63 67.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.618 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.892 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.3 tptp -64.91 -59.56 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.45 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -46.42 -30.71 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.758 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -50.25 52.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.469 0.652 . . . . 0.0 109.282 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.1 mt -59.48 -37.35 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.987 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.4 -26.3 66.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.946 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.4 t90 -98.9 -68.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 366' ' ' VAL . 8.1 m-85 -63.86 -76.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 12.7 p-10 19.88 55.49 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.99 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 120.92 17.73 4.08 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.3 OUTLIER -76.14 -161.4 0.18 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.672 0.272 . . . . 0.0 111.323 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 3.3 mt-10 -113.48 152.92 29.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 111.523 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -142.08 101.3 3.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.514 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p 49.82 27.41 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.88 0.371 . . . . 0.0 110.665 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.43 17.33 22.24 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.245 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 359' ' ' PHE . 27.6 m120 -129.3 152.2 79.09 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 121.002 0.429 . . . . 0.0 111.766 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.434 ' O ' ' HA3' ' A' ' 291' ' ' GLY . 90.7 Cg_endo -85.53 133.43 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.947 2.431 . . . . 0.0 111.451 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.661 ' HB ' HG12 ' A' ' 289' ' ' VAL . 5.1 pt -119.2 150.32 21.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.275 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 103.67 9.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.339 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.996 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -84.51 130.66 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.646 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.43 -174.45 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.701 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.671 ' CD2' HD13 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -107.06 35.3 3.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 288' ' ' PHE . . . 56.59 36.21 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.96 169.11 18.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.66 1.3 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 60.6 75.71 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.29 -171.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 375' ' ' PHE . 0.2 OUTLIER 79.36 -49.56 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.32 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 374' ' ' ASP . 0.2 OUTLIER 79.13 31.27 0.3 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.947 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.16 178.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.02 85.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.918 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 154.93 -81.18 0.17 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -128.89 -176.63 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.515 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 161.78 177.06 34.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.484 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 63.59 137.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -66.43 105.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -132.18 153.62 50.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 164.0 -115.24 0.64 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.504 179.925 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 43.37 74.84 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -101.06 36.15 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -100.53 33.2 2.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.48 -23.32 17.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -101.45 31.25 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.39 110.78 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.309 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 17.1 p30 -60.41 -23.6 64.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.677 HG22 ' CB ' ' A' ' 369' ' ' ALA . 28.4 m -70.13 139.56 52.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 366' ' ' VAL . 39.1 pt -122.44 164.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.608 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.2 OUTLIER -113.24 109.1 18.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.69 114.66 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 2.0 mp0 -113.74 130.54 56.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.5 47.89 1.09 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.873 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.878 HD12 HG22 ' A' ' 296' ' ' VAL . 7.1 mt -68.9 -70.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.723 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 102.79 77.48 1.22 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.632 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 42.01 31.53 0.24 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.42 29.29 2.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 110.512 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.918 HG12 HD22 ' A' ' 324' ' ' LEU . 4.6 t -69.29 86.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.862 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.88 146.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.228 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 322' ' ' ILE . 29.9 mm -70.88 -44.23 76.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.319 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.82 -43.1 84.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.782 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -41.59 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.7 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 297' ' ' THR . 72.6 t -72.05 -41.71 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.722 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -30.43 69.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.959 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.11 -35.37 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.845 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -88.71 -22.22 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.569 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 339' ' ' VAL . 1.2 m-85 -89.49 12.27 17.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 29.71 2.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.36 -35.51 5.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 349' ' ' ALA . 5.0 tp -80.04 -33.88 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.336 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.67 -150.62 9.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.823 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.47 129.18 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 302' ' ' ALA . 5.3 mt -84.34 125.9 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.05 0.452 . . . . 0.0 110.454 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -49.03 91.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.385 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -82.62 170.29 15.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.066 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.578 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -106.51 153.29 22.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -1.27 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.919 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 317' ' ' THR . 1.1 tptp -94.59 -47.38 6.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.607 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.561 HG23 ' HG3' ' A' ' 316' ' ' LYS . 58.4 p -104.62 -12.84 16.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.921 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.04 20.19 59.98 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.209 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.46 ' NE2' ' HB ' ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.88 154.23 70.86 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.322 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 73.2 Cg_exo -51.16 149.87 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.226 1.951 . . . . 0.0 111.745 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.578 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -118.53 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.439 0.638 . . . . 0.0 112.208 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -140.9 143.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.618 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.37 115.6 28.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -116.14 153.66 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -128.45 119.74 25.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.648 HG22 ' HB3' ' A' ' 333' ' ' LEU . 62.2 p -113.28 114.32 26.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.214 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 332' ' ' LYS . 0.9 OUTLIER -173.02 99.76 0.13 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.402 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.99 -41.35 3.19 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.511 ' C ' HG22 ' A' ' 330' ' ' THR . 49.0 mt-10 -152.49 12.84 0.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.261 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.511 HG22 ' C ' ' A' ' 329' ' ' GLU . 1.4 t 155.13 45.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.7 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 326' ' ' THR . . . 89.06 32.18 11.06 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.624 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 327' ' ' ASP . 1.3 mttp -92.83 124.26 36.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 111.775 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.828 HD13 ' H ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -46.28 118.17 1.83 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -96.62 30.24 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 49.66 53.22 22.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.659 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -148.29 131.26 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.777 0.322 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.06 170.33 22.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.066 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 322' ' ' ILE . 76.1 p -127.2 114.58 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 322' ' ' ILE . 48.7 t -94.82 117.04 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.1 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 312' ' ' LYS . 67.6 m -84.5 132.9 34.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.707 ' HE2' HD13 ' A' ' 287' ' ' ILE . 18.2 m-85 -104.95 142.62 34.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -19.5 62.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 346' ' ' SER . 0.7 OUTLIER -128.94 120.96 20.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.875 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -47.76 -48.63 15.43 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 113.069 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.8 Cg_endo -60.99 -30.63 90.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.858 1.705 . . . . 0.0 111.277 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -61.02 -32.6 72.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.372 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -61.68 -55.3 31.9 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.672 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -59.01 -43.33 91.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.166 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.38 -35.42 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.406 ' CA ' HG12 ' A' ' 308' ' ' ILE . . . -68.69 -49.35 59.66 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.429 0.633 . . . . 0.0 109.584 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -59.45 -36.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.135 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -62.68 -26.4 68.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.618 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.56 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.2 t90 -100.32 -68.13 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.175 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.529 ' O ' ' C ' ' A' ' 355' ' ' ASP . 23.2 m-85 -61.33 -77.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 354' ' ' PHE . 17.4 p-10 17.29 59.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.71 22.11 2.54 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.739 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.447 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -81.22 -165.61 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.63 0.215 . . . . 0.0 110.799 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.9 OUTLIER -124.38 129.67 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 111.861 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.82 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -89.72 101.46 14.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.064 178.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.85 29.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.24 -48.71 0.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.93 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -82.8 169.95 16.22 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 117.034 0.417 . . . . 0.0 110.636 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 87.4 Cg_endo -95.85 145.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 111.952 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.82 HG21 ' HD2' ' A' ' 359' ' ' PHE . 5.8 pt -127.37 -178.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.174 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -145.59 100.57 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 287' ' ' ILE . 21.7 t -87.43 128.41 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -140.2 -165.55 1.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -93.2 113.51 25.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.677 ' CB ' HG22 ' A' ' 286' ' ' THR . . . -69.96 175.19 4.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.74 -166.53 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.05 -41.55 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.53 -172.89 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.616 ' HB1' ' OD1' ' A' ' 376' ' ' ASN . . . -46.73 108.98 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.311 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -104.94 -31.32 9.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -58.24 -51.48 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ASN . . . . . 0.616 ' OD1' ' HB1' ' A' ' 373' ' ' ALA . 26.4 p30 -95.33 163.05 13.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.989 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -74.91 0.13 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.34 -138.68 13.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.559 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 139.3 79.91 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.409 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 161.77 -33.33 0.35 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.39 145.28 48.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 148.75 134.94 2.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.526 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.99 149.23 37.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 145.98 -108.67 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.527 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.463 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -169.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -141.08 87.86 2.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -144.93 119.96 10.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 21.6 p -105.01 -36.83 7.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -129.94 31.05 4.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.619 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 368' ' ' PHE . 2.2 t-20 -87.88 81.5 7.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.04 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER -123.44 -3.23 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.32 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.746 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 77.6 m -114.86 127.26 55.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 1.005 HD12 HG13 ' A' ' 366' ' ' VAL . 29.7 pt -108.45 167.87 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.633 ' CD1' HG22 ' A' ' 338' ' ' THR . 18.0 m-30 -122.59 114.83 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.261 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -105.69 114.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.398 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -108.88 130.55 55.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 119.65 55.56 0.25 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.684 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 296' ' ' VAL . 3.0 mm? -91.41 -77.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.749 0.309 . . . . 0.0 110.721 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.91 76.2 1.06 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.112 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 44.89 41.04 4.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 111.738 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -153.64 24.62 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.729 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 292' ' ' LEU . 4.0 t -73.89 88.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.519 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -116.63 146.54 42.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.793 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 54.2 mt -71.4 -43.49 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.443 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.44 -41.28 89.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.9 t -64.78 -43.4 93.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.725 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 297' ' ' THR . 59.6 t -72.98 -41.07 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.321 0.582 . . . . 0.0 109.649 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.1 -29.69 68.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.982 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -73.5 -39.03 65.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.608 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.86 -22.47 16.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.0 OUTLIER -95.56 2.37 54.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 21.5 ptmt -96.37 30.2 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.588 HE21 ' HH2' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -108.23 -34.31 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.11 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.459 HD13 ' HB2' ' A' ' 353' ' ' TRP . 0.8 OUTLIER -80.31 -41.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.244 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -146.58 -168.24 13.45 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.7 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.14 106.71 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 10.8 mt -72.39 129.49 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 109.929 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 92.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -65.99 138.94 58.15 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.782 177.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.1 OUTLIER -89.78 165.75 13.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.171 0.51 . . . . 0.0 111.96 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -102.57 -4.41 25.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.3 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.959 ' HD3' HG23 ' A' ' 317' ' ' THR . 0.0 OUTLIER -96.33 -40.81 8.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.75 179.041 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.959 HG23 ' HD3' ' A' ' 316' ' ' LYS . 12.1 p -106.13 -18.33 14.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.304 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.44 8.13 85.62 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.161 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.522 ' NE2' ' HB ' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.54 157.89 66.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.743 0.272 . . . . 0.0 111.022 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.635 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 1.1 Cg_endo -45.45 162.18 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.904 2.403 . . . . 0.0 112.617 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.515 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.84 130.37 56.67 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.686 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 339' ' ' VAL . 1.9 mp -143.22 140.02 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -105.23 115.82 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 296' ' ' VAL . 0.2 OUTLIER -108.87 150.35 27.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.278 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 336' ' ' GLU . 14.2 m-85 -92.29 101.81 14.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.74 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 333' ' ' LEU . 2.9 p -108.03 158.96 16.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.04 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -78.85 148.28 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 17.79 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -108.34 -40.78 5.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.933 0.397 . . . . 0.0 110.668 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 9.0 p -119.69 -7.58 10.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.163 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 69.46 32.63 71.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.372 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.53 154.22 25.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -102.27 147.58 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.509 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.02 90.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.54 -76.43 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.994 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -160.42 178.06 9.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.284 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -154.06 162.6 41.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.633 HG22 ' CD1' ' A' ' 288' ' ' PHE . 19.5 p -116.93 117.45 29.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.052 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 322' ' ' ILE . 50.8 t -92.73 123.06 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.586 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 311' ' ' ILE . 1.2 m -101.33 131.87 47.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 339' ' ' VAL . 26.8 m-85 -115.37 158.54 22.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.063 0.458 . . . . 0.0 111.268 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.9 6.81 37.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.08 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.32 121.81 7.91 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 50.5 Cg_exo -52.88 -47.75 25.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.68 2.253 . . . . 0.0 113.326 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.8 Cg_endo -60.7 -30.12 89.72 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.729 1.619 . . . . 0.0 111.048 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -40.54 81.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.973 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.45 -50.87 72.24 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.17 -50.87 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.778 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.44 -34.16 33.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' A' ' 305' ' ' PHE . . . -68.62 -46.81 68.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.421 0.629 . . . . 0.0 109.756 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.8 mt -58.69 -34.24 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.294 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.29 -26.8 68.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.796 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.588 ' HH2' HE21 ' A' ' 307' ' ' GLN . 1.2 t90 -87.07 -68.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 0.9 OUTLIER -77.63 -79.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.58 -176.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 28.74 45.7 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.799 0.333 . . . . 0.0 111.704 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 128.52 30.78 0.69 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -90.94 -160.32 0.71 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.51 0.195 . . . . 0.0 111.047 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 6.0 mp0 -113.36 153.13 29.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.291 0.567 . . . . 0.0 111.704 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.535 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.0 OUTLIER -136.98 101.12 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.319 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.6 m 46.73 28.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.81 18.75 14.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.118 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 359' ' ' PHE . 33.3 m120 -129.29 150.24 74.96 Favored Pre-proline 0 C--O 1.225 -0.186 0 CA-C-O 121.067 0.46 . . . . 0.0 111.71 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.93 127.83 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.766 2.311 . . . . 0.0 111.678 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 289' ' ' VAL . 6.1 pt -111.43 165.2 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.912 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.34 100.99 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 1.005 HG13 HD12 ' A' ' 287' ' ' ILE . 26.6 t -87.09 133.14 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 p -133.83 -176.49 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.653 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.55 ' CD1' ' OD1' ' A' ' 284' ' ' ASN . 26.6 m-85 -93.68 39.0 1.06 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 61.47 30.56 18.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.766 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.6 p -69.34 -162.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 74.31 134.51 0.05 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.989 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.4 -47.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.068 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -177.79 122.8 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.209 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.3 t70 58.22 -170.02 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 375' ' ' PHE . 0.1 OUTLIER -55.15 -178.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.65 160.57 14.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 161.86 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -58.84 89.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.392 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 76.98 -139.53 23.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.541 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 85.84 121.43 1.19 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -176.54 147.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -114.37 28.47 8.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -139.58 111.1 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 99.93 -89.12 0.83 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.398 -1.224 . . . . 0.0 112.533 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 58.59 176.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 282' ' ' SER . 5.1 m-20 -115.61 -85.89 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 56.09 -85.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.681 0.277 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 280' ' ' ASP . 10.0 t -104.93 -19.66 13.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.949 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -75.61 -22.39 56.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.081 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.77 119.14 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.729 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.721 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.0 OUTLIER -104.95 -28.41 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.4 m -64.82 145.13 56.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.846 HD12 HG13 ' A' ' 366' ' ' VAL . 23.5 pt -125.39 173.42 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -121.77 109.29 14.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -103.19 117.38 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.662 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.422 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -129.87 130.9 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.13 19.52 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.601 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 359' ' ' PHE . 39.6 mt -70.1 -101.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 159.08 -93.29 0.12 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.274 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -132.43 28.56 4.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.146 0.498 . . . . 0.0 110.136 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -122.09 -12.93 8.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.468 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.673 ' CG2' ' HB2' ' A' ' 337' ' ' ALA . 9.7 p -44.63 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -143.5 147.13 34.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.062 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.49 -47.37 93.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.712 0.291 . . . . 0.0 111.769 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.27 -39.47 89.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.2 t -68.44 -42.86 78.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 297' ' ' THR . 46.2 t -72.88 -38.82 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 109.625 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.38 -29.85 68.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.895 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.72 -40.54 66.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.812 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.2 -24.26 16.33 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.579 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.6 OUTLIER -95.72 33.13 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.901 0.381 . . . . 0.0 110.977 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.31 21.0 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -103.92 -40.39 6.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.285 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -72.28 -27.84 27.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.5 -165.92 32.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.705 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.58 134.94 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.462 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -94.68 127.73 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.422 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 321' ' ' MET . 14.7 mtmm -48.77 110.27 0.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -60.14 -179.64 0.11 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 315' ' ' LYS . 3.9 m-80 -95.98 -40.89 9.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 314' ' ' ASN . 0.2 OUTLIER 86.92 -31.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.411 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -41.23 11.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 67.0 p -100.23 -11.69 20.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.337 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 71.02 12.06 71.0 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.25 157.3 64.89 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.318 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 59.0 Cg_exo -44.59 161.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.259 2.64 . . . . 0.0 113.143 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 312' ' ' LYS . 21.5 mtp -120.67 124.65 45.72 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.585 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 301' ' ' VAL . 7.1 mt -142.52 137.07 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.947 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.555 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.6 t30 -96.49 147.97 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.172 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -144.28 153.04 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 111.165 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -108.99 103.43 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.5 p -95.72 151.8 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.97 116.08 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.666 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.32 3.11 37.17 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.412 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.83 -41.98 8.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 110.677 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 5.7 p -116.87 -20.96 9.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.16 -16.2 57.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -62.95 -176.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.023 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.16 171.53 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -121.45 -46.02 2.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 292' ' ' LEU . . . 118.99 19.43 4.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.065 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.422 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 8.3 mp0 -121.51 133.23 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.673 ' HB2' ' CG2' ' A' ' 296' ' ' VAL . . . -160.19 149.95 17.95 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 288' ' ' PHE . 17.7 p -108.6 127.74 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.547 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.593 ' CG2' HG11 ' A' ' 301' ' ' VAL . 65.1 t -99.27 128.01 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.929 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.2 m -87.05 153.02 21.86 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.483 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 346' ' ' SER . 4.0 m-85 -136.14 141.58 44.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 111.273 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -9.35 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.212 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.46 117.88 13.47 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.779 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.595 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 62.0 Cg_exo -49.73 -49.67 15.27 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.6 2.2 . . . . 0.0 113.041 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.7 Cg_endo -59.81 -30.53 92.17 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 121.791 1.661 . . . . 0.0 111.048 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -59.84 -35.09 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.88 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -62.02 -52.89 62.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.342 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.97 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -57.85 -46.48 84.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.095 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.52 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.71 -33.05 63.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.873 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 354' ' ' PHE . . . -68.65 -49.04 62.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 348' ' ' LYS . 15.9 mt -52.91 -34.52 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.946 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 348' ' ' LYS . 8.9 t0 -61.09 -26.71 67.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.931 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -102.89 -63.73 1.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.869 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.738 ' HB2' HG21 ' A' ' 366' ' ' VAL . 10.3 m-85 -66.26 -77.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.591 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 351' ' ' ILE . 30.5 t0 9.41 62.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 107.08 35.09 2.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.226 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.96 -156.38 0.54 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -125.7 128.9 48.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.109 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.702 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -89.41 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.842 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.58 28.39 0.76 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.655 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.04 -43.09 1.35 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.633 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 2.0 m-80 -81.83 169.99 16.7 Favored Pre-proline 0 C--O 1.22 -0.486 0 CA-C-N 116.974 0.387 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -97.88 142.05 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.514 2.81 . . . . 0.0 112.273 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 359' ' ' PHE . 3.4 pt -127.53 177.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.856 0.36 . . . . 0.0 111.512 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -145.03 101.61 3.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.752 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.846 HG13 HD12 ' A' ' 287' ' ' ILE . 61.2 t -88.92 138.15 19.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.761 0.315 . . . . 0.0 110.766 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.6 p -138.72 -164.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.331 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 5.2 m-85 -96.85 26.9 4.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.192 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 287' ' ' ILE . . . 33.86 49.29 0.27 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.288 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 371' ' ' ARG . 2.0 m -162.51 167.79 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.284 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 370' ' ' THR . 0.0 OUTLIER 62.01 117.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.964 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.5 mtt85 -118.23 60.35 0.79 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 62.28 75.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -61.36 171.14 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -177.0 -178.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -156.36 35.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.34 158.54 21.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.813 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.71 26.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 72.94 163.1 7.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.491 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -89.78 109.15 3.58 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -159.08 -54.44 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 111.077 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 56.24 72.86 0.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.555 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.0 mtm-85 -60.9 152.74 26.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.2 99.73 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.544 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.435 -1.203 . . . . 0.0 112.493 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.758 0.314 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.92 129.59 40.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -73.63 132.69 43.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -158.99 -178.12 7.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.2 m -83.83 -33.04 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -69.14 -35.32 76.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.404 ' HB2' ' CD2' ' A' ' 368' ' ' PHE . 1.8 m-80 48.83 89.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.2 OUTLIER -71.16 -37.02 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.765 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 71.4 m -90.57 136.63 32.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.763 HD12 HG13 ' A' ' 366' ' ' VAL . 6.1 pt -116.64 173.05 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CE2' ' CB ' ' A' ' 367' ' ' SER . 0.2 OUTLIER -135.66 120.99 19.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 111.051 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.774 ' CG1' HD12 ' A' ' 364' ' ' ILE . 1.0 OUTLIER -101.37 127.1 55.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.802 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.13 130.49 52.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.031 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.441 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 110.79 72.28 0.67 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.909 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -135.71 -87.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.46 115.27 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.301 -0.952 . . . . 0.0 114.141 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.737 ' HA ' HD23 ' A' ' 333' ' ' LEU . 6.4 mp0 53.59 32.77 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 8.48 0.77 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.39 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG13 ' A' ' 296' ' ' VAL . 13.7 p -77.98 95.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 112.232 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.895 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -136.4 146.81 46.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.083 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 322' ' ' ILE . 28.2 mm -64.98 -46.15 92.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.75 -41.82 87.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.901 0.382 . . . . 0.0 110.752 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.0 p -63.63 -41.65 98.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 297' ' ' THR . 34.1 t -73.56 -45.88 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -60.89 -29.96 69.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.564 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 28.4 t0 -74.3 -38.04 63.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.785 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.84 -21.82 20.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -91.89 11.42 24.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -96.5 24.05 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 111.079 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 -38.49 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.309 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 349' ' ' ALA . 3.3 tp -75.66 -39.54 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.179 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -176.04 -166.9 34.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.583 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.82 139.41 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.745 0.307 . . . . 0.0 111.685 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 2.1 mt -94.16 138.69 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -48.0 91.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.239 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -68.34 145.37 54.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.839 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.517 ' ND2' ' CG ' ' A' ' 321' ' ' MET . 1.4 m120 -78.62 170.96 15.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.343 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 -16.18 12.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.957 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -99.6 -36.17 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.91 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 57.9 p -109.12 -5.95 15.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.032 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 56.42 17.94 20.6 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.268 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -118.94 154.92 53.27 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.649 0.262 . . . . 0.0 110.817 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.504 ' HB3' ' CG2' ' A' ' 311' ' ' ILE . 68.1 Cg_exo -44.36 158.43 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.632 2.221 . . . . 0.0 112.712 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.5 OUTLIER -120.64 121.75 38.99 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.491 0.662 . . . . 0.0 111.674 -179.03 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 339' ' ' VAL . 2.3 mt -143.31 142.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.999 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 1.2 m-20 -103.19 148.5 25.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.138 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 296' ' ' VAL . 0.9 OUTLIER -152.82 147.53 26.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.892 0.377 . . . . 0.0 111.072 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.68 148.39 49.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -147.39 160.12 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.776 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.85 142.36 53.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.781 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 -22.45 12.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.207 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.38 -34.86 65.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 110.709 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.4 p -116.68 -19.37 9.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.94 28.42 50.28 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.11 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 128.6 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.663 0.268 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.854 ' H ' HD22 ' A' ' 333' ' ' LEU . 1.1 mm? -59.89 139.2 57.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.766 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -93.22 20.83 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.304 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.408 ' CA ' ' HG ' ' A' ' 292' ' ' LEU . . . 44.9 51.81 8.16 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.259 -0.496 . . . . 0.0 113.398 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 12.3 mt-10 -141.99 131.38 23.68 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.752 -0.264 . . . . 0.0 111.165 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -161.65 140.51 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.781 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 322' ' ' ILE . 19.1 p -100.33 131.54 46.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.357 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 322' ' ' ILE . 75.1 t -110.64 122.04 64.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.586 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 67.0 m -98.41 147.33 24.82 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.161 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 63.1 m-85 -121.68 152.21 39.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.07 45.79 0.28 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.647 0.26 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 343' ' ' ASP . 2.7 p30 165.14 125.98 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.481 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 71.4 Cg_exo -50.89 -48.86 18.92 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.613 2.209 . . . . 0.0 113.671 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.2 Cg_endo -57.29 -30.8 88.89 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.921 1.748 . . . . 0.0 112.04 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.412 ' CB ' ' OD1' ' A' ' 343' ' ' ASP . 40.2 t -61.14 -40.31 93.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.04 -51.75 66.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.989 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.932 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.44 -45.26 95.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.112 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.573 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.08 -34.25 63.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.537 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.51 -50.17 54.18 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.8 mt -55.74 -36.37 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.13 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.67 -26.59 67.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.744 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.52 ' CD1' ' CD2' ' A' ' 354' ' ' PHE . 1.3 t90 -82.41 -68.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.43 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.52 ' CD2' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.42 -78.54 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.536 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 31.13 51.11 0.12 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.86 22.09 1.84 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.096 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -84.63 -163.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.92 0.36 . . . . 0.0 110.093 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 10.8 mt-10 -119.17 130.87 55.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' A' ' 364' ' ' ILE . 0.1 OUTLIER -90.81 101.22 13.97 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.649 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 44.41 29.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.026 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.58 -48.72 0.92 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.94 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.8 OUTLIER -84.48 172.92 8.02 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 116.925 0.362 . . . . 0.0 110.668 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -94.1 145.02 1.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.218 2.612 . . . . 0.0 111.682 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.774 HD12 ' CG1' ' A' ' 289' ' ' VAL . 5.9 pt -116.69 178.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -148.28 100.89 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.068 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.763 HG13 HD12 ' A' ' 287' ' ' ILE . 23.7 t -96.44 131.08 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.517 ' CB ' ' CE2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -140.06 -164.0 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.923 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.776 ' CE1' HD13 ' A' ' 351' ' ' ILE . 3.7 m-85 -89.27 54.43 2.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.637 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 53.43 100.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.752 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 369' ' ' ALA . 0.2 OUTLIER 51.35 131.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.094 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ARG . . . . . 0.519 ' C ' ' HG3' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -74.84 -170.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.519 ' HG3' ' C ' ' A' ' 371' ' ' ARG . 0.0 OUTLIER 42.83 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.383 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.4 26.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.64 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.36 -170.74 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 66.9 159.78 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.31 151.21 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 153.34 44.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -97.44 139.46 14.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.557 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.76 68.63 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.3 m120 60.63 93.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.41 -128.34 6.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.01 178.24 4.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -136.73 -95.2 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.47 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -176.42 174.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -93.2 80.18 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -176.58 37.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.26 24.32 11.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.04 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -139.07 -35.14 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 62.74 67.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 5.5 p30 -102.14 -33.25 9.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.643 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 27.9 m -83.96 126.22 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.174 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.739 HD12 HG13 ' A' ' 366' ' ' VAL . 13.6 pt -95.92 173.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.344 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.758 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -130.37 109.76 10.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -98.18 114.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.6 OUTLIER -118.62 130.83 56.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.124 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.831 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 112.75 83.15 1.23 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.559 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 359' ' ' PHE . 1.9 mt -142.29 -78.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.828 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.21 -79.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.669 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.406 ' CG ' HD23 ' A' ' 333' ' ' LEU . 2.3 tt0 -149.52 31.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.17 -17.97 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.971 HG22 HD23 ' A' ' 324' ' ' LEU . 9.7 p -45.86 123.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.94 146.5 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.424 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.751 HG23 HD12 ' A' ' 322' ' ' ILE . 2.1 mp -64.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.151 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 18.5 pm0 -66.4 -34.76 78.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.121 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.0 m -73.65 -43.87 58.33 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.041 0.448 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 297' ' ' THR . 29.8 t -72.22 -36.4 55.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.338 0.589 . . . . 0.0 109.754 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.702 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.33 -29.76 68.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.946 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.05 -41.25 62.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.773 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -97.39 -20.64 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 311' ' ' ILE . 1.2 t80 -101.21 35.0 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.325 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 18.86 11.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -40.87 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -72.35 -32.41 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.358 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.419 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -161.08 -163.29 13.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.76 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.0 mt -111.08 115.69 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -75.86 125.34 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -48.65 115.34 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 111.985 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -75.79 150.98 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.482 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -104.94 130.72 53.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -4.23 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 7.1 mptt -81.72 -36.64 28.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.4 OUTLIER -118.8 -30.98 4.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.21 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 96.78 14.39 43.47 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.882 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.685 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.18 162.03 44.03 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.901 0.351 . . . . 0.0 110.798 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 89.1 Cg_exo -44.56 162.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.78 2.32 . . . . 0.0 112.431 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.457 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -122.42 128.08 50.47 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.384 0.611 . . . . 0.0 111.758 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.751 HD12 HG23 ' A' ' 298' ' ' ILE . 4.9 mt -141.84 137.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.646 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -99.1 141.14 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.614 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.971 HD23 HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -145.09 131.86 20.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 111.001 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 334' ' ' LYS . 9.8 m-30 -84.31 142.51 30.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 333' ' ' LEU . 1.3 p -147.85 152.65 37.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.12 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.861 ' HB3' HG22 ' A' ' 330' ' ' THR . 2.0 m-20 -80.44 148.29 30.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.387 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -43.11 -49.15 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.924 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -179.9 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.774 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.861 HG22 ' HB3' ' A' ' 327' ' ' ASP . 9.1 t -79.57 -21.34 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 126.27 -47.64 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.857 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 113.61 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 110.977 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.871 HD11 ' CG1' ' A' ' 296' ' ' VAL . 0.1 OUTLIER -99.37 25.86 6.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 110.778 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 336' ' ' GLU . 0.1 OUTLIER 40.02 96.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.17 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 292' ' ' LEU . . . -65.83 33.67 0.14 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.74 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 334' ' ' LYS . 0.0 OUTLIER -122.49 131.78 54.02 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -151.93 151.92 31.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.934 0.397 . . . . 0.0 111.965 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.758 HG22 ' CD1' ' A' ' 288' ' ' PHE . 22.3 p -106.05 126.4 52.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 322' ' ' ILE . 73.3 t -99.49 128.61 51.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.966 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 311' ' ' ILE . 83.5 p -85.44 152.45 23.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.53 148.71 52.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.64 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.52 -16.88 58.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.411 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.2 OUTLIER -136.28 120.33 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.001 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.21 -51.07 7.13 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.655 2.237 . . . . 0.0 112.952 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.1 Cg_endo -53.69 -30.5 56.33 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.975 1.783 . . . . 0.0 111.241 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.419 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 14.2 t -57.24 -42.0 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.898 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -55.85 -49.55 73.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.81 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.5 -53.02 61.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.5 18.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.97 -52.78 25.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.4 mt -54.7 -36.66 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.367 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -26.18 66.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.816 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.553 ' HE3' HD13 ' A' ' 308' ' ' ILE . 3.1 t90 -98.29 -68.4 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 2.3 m-85 -66.68 -74.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 354' ' ' PHE . 25.7 t0 14.04 62.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.41 19.62 3.12 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.933 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.48 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 5.4 mtpt -87.05 -165.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.952 0.376 . . . . 0.0 110.687 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.735 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -121.74 142.47 50.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.79 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -111.13 101.68 10.18 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.824 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.75 28.74 6.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 358' ' ' GLU . . . 116.32 -2.92 20.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.443 -0.885 . . . . 0.0 114.285 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.4 m120 -117.79 170.07 6.74 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 117.594 0.697 . . . . 0.0 110.67 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -96.06 141.85 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.491 2.794 . . . . 0.0 111.77 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.831 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.4 pt -128.85 168.58 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.052 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.155 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 100.94 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.739 HG13 HD12 ' A' ' 287' ' ' ILE . 21.2 t -84.85 131.84 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -135.12 -173.91 3.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.459 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 62.1 m-85 -90.67 54.24 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 47.02 73.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.942 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 371' ' ' ARG . 53.1 m 65.93 164.44 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ARG . . . . . 0.462 ' N ' HG22 ' A' ' 370' ' ' THR . 0.0 OUTLIER -148.81 135.65 19.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.116 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.21 107.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.59 173.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.036 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.42 44.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.8 -73.78 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -175.33 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -176.87 -66.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -155.15 110.19 0.44 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.17 144.48 3.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.1 -140.96 6.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.451 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.66 27.76 8.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.703 0.287 . . . . 0.0 110.855 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 56.39 27.72 53.96 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.536 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -124.38 111.6 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.01 -48.81 3.0 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.517 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.338 -1.257 . . . . 0.0 112.538 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.41 130.56 47.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.921 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -107.2 76.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -114.85 77.08 1.04 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 65.1 m -103.67 24.15 11.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -124.66 21.43 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.31 121.02 8.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 4.7 p30 -50.97 -25.87 5.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.479 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 84.8 m -72.55 117.91 14.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.575 HD12 ' CG1' ' A' ' 366' ' ' VAL . 46.0 pt -107.7 169.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.406 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 338' ' ' THR . 0.1 OUTLIER -134.0 122.4 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 111.094 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 366' ' ' VAL . 2.4 t -110.02 127.64 66.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.6 mp0 -111.87 130.67 55.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.046 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.6 33.62 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 295' ' ' ASN . 0.1 OUTLIER -59.71 -84.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.48 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 93.99 98.54 1.57 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.867 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.69 31.63 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.647 HD22 ' C ' ' A' ' 292' ' ' LEU . 16.7 p30 -144.34 31.21 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 324' ' ' LEU . 4.0 t -75.91 70.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -129.37 146.61 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.587 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 322' ' ' ILE . 26.3 mm -71.45 -43.05 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.447 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.46 -40.67 89.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -42.65 83.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 66.4 t -71.43 -40.11 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.68 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.24 -29.83 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.839 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -41.93 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.88 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -88.02 -24.8 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.61 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -97.43 30.54 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.121 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 306' ' ' LYS . 0.0 OUTLIER -114.77 1.81 14.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -85.4 -52.06 6.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.821 0.343 . . . . 0.0 111.144 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.602 HG21 ' CE2' ' A' ' 354' ' ' PHE . 0.7 OUTLIER -65.64 -28.19 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.0 -171.95 39.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.558 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.4 mt -97.62 144.14 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.68 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.8 mt -97.86 127.01 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 29.0 mtmt -49.75 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.651 0.263 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -86.48 155.56 20.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.875 0.845 . . . . 0.0 111.504 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.577 ' HB3' ' OG1' ' A' ' 317' ' ' THR . 1.0 OUTLIER -71.12 98.37 1.66 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.195 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.587 ' HD2' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -46.4 -16.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.546 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 314' ' ' ASN . 20.3 mttm -92.5 -38.01 12.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 314' ' ' ASN . 47.9 p -103.62 -3.11 25.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 57.32 17.68 25.84 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.448 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -118.61 139.34 26.9 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.942 0.371 . . . . 0.0 111.252 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.3 Cg_exo -45.45 147.2 2.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.536 2.158 . . . . 0.0 112.406 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.4 mtp -107.74 123.07 47.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.42 0.629 . . . . 0.0 112.137 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 338' ' ' THR . 2.6 mp -143.02 139.74 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.567 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.745 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 5.1 m-80 -99.25 147.54 25.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.226 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 337' ' ' ALA . 2.7 mt -128.08 150.22 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -118.89 139.94 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.6 HG22 HD23 ' A' ' 333' ' ' LEU . 16.6 p -125.59 176.07 7.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.041 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.639 ' HB3' HG22 ' A' ' 330' ' ' THR . 0.3 OUTLIER -62.85 148.69 46.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.09 -56.08 2.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.094 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -151.94 -31.03 0.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.651 HG23 ' H ' ' A' ' 332' ' ' LYS . 11.3 t -43.46 -29.89 0.5 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.652 0.263 . . . . 0.0 111.655 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.28 -27.65 12.25 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.826 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.651 ' H ' HG23 ' A' ' 330' ' ' THR . 0.4 OUTLIER -53.95 -174.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.6 HD23 HG22 ' A' ' 326' ' ' THR . 16.1 mt -127.4 135.35 50.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.971 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -63.87 -24.86 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.75 39.86 27.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 9.5 pt-20 -153.14 157.33 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.642 0.258 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -160.87 156.91 25.74 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 111.762 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 322' ' ' ILE . 2.0 p -103.48 136.9 42.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.055 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.626 HG22 HG12 ' A' ' 322' ' ' ILE . 55.6 t -112.06 130.52 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 311' ' ' ILE . 16.5 m -86.32 153.1 22.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.407 ' N ' ' HG3' ' A' ' 312' ' ' LYS . 2.6 m-85 -129.35 135.89 49.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 111.058 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.438 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 19.2 m-20 -63.29 -35.89 81.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.327 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.44 118.97 33.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.604 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.3 Cg_exo -42.42 -51.02 5.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.87 2.38 . . . . 0.0 112.701 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.4 Cg_endo -56.08 -30.62 79.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.963 1.775 . . . . 0.0 111.282 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.2 t -60.99 -40.74 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.582 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.32 -49.12 75.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.879 0.371 . . . . 0.0 110.468 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.2 tppt? -59.42 -54.94 40.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.637 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.87 -35.37 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.699 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 354' ' ' PHE . . . -68.95 -51.81 35.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.33 0.586 . . . . 0.0 109.458 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.1 mt -54.08 -39.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.728 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.19 -26.64 18.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.77 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.543 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.3 t90 -106.85 -68.45 0.89 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.477 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 366' ' ' VAL . 4.8 m-85 -59.1 -9.96 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 41.6 t0 -71.87 62.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.276 0.489 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 128.07 35.75 0.5 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.906 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 353' ' ' TRP . 36.4 mmtm -105.86 -173.83 2.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 5.7 mt-10 -116.66 133.1 56.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.134 0.492 . . . . 0.0 112.133 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.474 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -93.06 101.34 13.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.96 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 36.3 t 48.86 27.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.526 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.46 -45.01 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.737 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.9 OUTLIER -80.46 169.95 17.65 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 116.999 0.4 . . . . 0.0 111.037 -179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -94.63 145.16 1.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.397 2.731 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.4 pt -128.02 176.14 8.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.244 0.545 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -148.13 116.14 6.45 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.658 HG22 HG13 ' A' ' 289' ' ' VAL . 40.5 t -109.53 135.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.949 0.404 . . . . 0.0 111.875 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 p -140.67 -163.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.951 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -95.19 65.86 2.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 60.83 157.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.221 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 136.99 58.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.669 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -96.77 35.86 1.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.03 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.58 43.8 15.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.56 95.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.37 70.57 0.3 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -176.19 92.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.63 120.14 39.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -105.09 120.14 40.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.54 29.33 12.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -67.32 -59.86 6.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 142.51 -28.19 2.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -73.44 0.3 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.293 . . . . 0.0 110.949 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.96 -110.82 0.46 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.64 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 127.06 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -96.1 56.62 1.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.519 -1.156 . . . . 0.0 112.548 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -151.24 -176.89 5.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 281' ' ' ASN . 0.9 OUTLIER -61.19 -76.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.959 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 12.3 t-20 69.85 -60.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.396 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -42.38 -54.18 3.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.653 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.04 -35.46 2.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.284 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 368' ' ' PHE . 0.6 OUTLIER 54.43 104.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.03 -31.59 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.282 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.6 m -88.04 134.2 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 17.8 pt -110.79 173.38 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.476 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.73 ' HD1' HG22 ' A' ' 338' ' ' THR . 1.4 t80 -127.8 108.15 10.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 364' ' ' ILE . 2.1 t -104.5 114.81 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.5 mp0 -111.76 130.25 55.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 120.18 37.67 0.73 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.666 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.745 HD12 ' OD1' ' A' ' 295' ' ' ASN . 2.8 mm? -79.04 -89.1 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.557 0.218 . . . . 0.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.58 ' HA2' HD21 ' A' ' 333' ' ' LEU . . . 61.34 104.93 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.293 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 77.01 43.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.784 0.325 . . . . 0.0 111.37 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.745 ' OD1' HD12 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -168.45 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.79 HG22 HD13 ' A' ' 324' ' ' LEU . 8.7 p -19.06 94.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 301' ' ' VAL . 7.5 p -164.01 146.43 9.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.327 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.34 -42.27 74.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.986 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -43.15 86.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.9 p -65.03 -38.45 90.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 297' ' ' THR . 69.5 t -74.6 -40.62 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 109.729 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.26 -31.43 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.708 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -74.35 -36.12 63.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.893 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.18 -24.23 16.36 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -95.47 27.78 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 111.283 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 22.09 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.085 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -105.33 -28.83 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 350' ' ' ALA . 1.1 tp -83.91 -30.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -178.78 -162.33 28.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.4 mt -98.68 142.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.628 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 340' ' ' SER . 3.0 mp -98.43 136.11 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.569 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 321' ' ' MET . 2.7 mmtp -48.88 95.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -68.47 146.63 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.956 HD21 ' HG2' ' A' ' 321' ' ' MET . 0.2 OUTLIER -101.06 145.79 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 111.433 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -77.19 -7.59 56.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.904 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -83.16 -51.04 7.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.531 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 8.3 p -108.1 -7.31 16.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.526 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 313' ' ' THR . . . 67.63 15.69 66.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.393 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.9 164.37 23.89 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.807 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.523 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 57.7 Cg_exo -45.1 162.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.146 2.564 . . . . 0.0 113.456 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.956 ' HG2' HD21 ' A' ' 314' ' ' ASN . 17.4 mtm -123.29 118.68 28.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 339' ' ' VAL . 49.3 mt -141.56 149.98 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.346 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -114.14 148.03 37.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.79 HD13 HG22 ' A' ' 296' ' ' VAL . 2.1 mt -131.69 168.61 17.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.51 103.36 8.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 67.0 p -130.41 143.79 50.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -76.98 106.0 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 7.72 33.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.414 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.51 -38.43 14.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.609 HG23 ' HG3' ' A' ' 332' ' ' LYS . 0.0 OUTLIER -118.79 -37.52 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 120.84 29.35 1.54 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.965 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.609 ' HG3' HG23 ' A' ' 330' ' ' THR . 0.6 OUTLIER -100.22 -169.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 110.674 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.58 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.1 OUTLIER -140.51 128.8 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.503 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -69.48 -58.9 3.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.57 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 333' ' ' LEU . . . 115.49 28.89 2.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.0 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 2.3 mp0 -131.59 134.4 46.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.965 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -148.19 143.17 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.958 0.409 . . . . 0.0 111.447 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.73 HG22 ' HD1' ' A' ' 288' ' ' PHE . 17.4 p -109.53 119.55 39.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 322' ' ' ILE . 1.2 t -93.91 123.04 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.596 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -94.86 129.97 41.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.824 0.345 . . . . 0.0 110.86 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 339' ' ' VAL . 17.6 m-85 -109.71 150.26 28.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.57 -16.84 60.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 346' ' ' SER . 5.1 m-20 -126.35 116.46 23.31 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.682 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.615 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 78.1 Cg_exo -44.82 -50.82 8.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.35 2.034 . . . . 0.0 112.602 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 9.7 Cg_endo -53.16 -30.42 50.38 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.016 1.811 . . . . 0.0 111.041 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 12.4 t -55.82 -48.75 74.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -53.32 -44.86 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.926 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.846 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -58.37 -54.28 48.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.063 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.437 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -47.5 -39.0 15.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.786 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.72 -45.82 70.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.362 0.601 . . . . 0.0 109.761 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.9 mt -60.92 -32.39 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.433 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.67 -40.64 95.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.34 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.606 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -106.14 -45.54 4.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 356' ' ' GLY . 2.7 m-85 -59.22 -75.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.581 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.0 t0 1.04 63.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.211 0.944 . . . . 0.0 112.355 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 110.94 36.47 1.84 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.429 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.501 ' HD3' ' CD2' ' A' ' 354' ' ' PHE . 7.9 ptmt -97.83 -158.37 0.66 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.576 0.227 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 33.0 mt-10 -113.89 128.88 56.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.045 0.45 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -122.89 105.72 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.299 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.3 m 59.76 30.09 19.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.75 57.86 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.04 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 7.2 m-80 -129.27 167.01 21.45 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.832 0.316 . . . . 0.0 111.037 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 96.3 Cg_endo -90.36 128.8 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.924 2.416 . . . . 0.0 111.929 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 3.9 pt -124.68 168.58 17.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.599 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -139.1 102.42 4.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.068 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 354' ' ' PHE . 26.3 t -85.13 134.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.02 -173.12 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.99 0.424 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 2.7 m-85 -94.46 56.68 2.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.831 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 288' ' ' PHE . . . 52.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.975 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 372' ' ' ARG . 31.7 m 60.91 164.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.734 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 370' ' ' THR . 0.1 OUTLIER -115.48 -22.57 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.726 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.501 ' H ' HG22 ' A' ' 370' ' ' THR . 21.7 mmt-85 72.77 48.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.379 . . . . 0.0 110.815 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.35 109.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -177.56 178.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -134.2 39.05 3.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -98.02 83.09 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 62.17 119.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -177.88 167.12 37.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -64.99 158.33 45.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -148.84 -162.16 10.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.54 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.17 -61.68 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -60.98 98.08 0.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 151.27 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.823 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 106.04 28.41 5.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.455 -1.192 . . . . 0.0 112.503 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.857 0.361 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -175.63 3.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.661 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.92 99.56 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -177.23 -74.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.1 m -105.17 23.98 12.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -116.36 30.82 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.93 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.428 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.3 OUTLIER -170.32 118.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.099 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 20.8 p30 -99.39 -18.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.979 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 26.4 m -71.06 117.56 12.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.277 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.713 HD12 ' CG1' ' A' ' 366' ' ' VAL . 36.6 pt -105.15 164.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' ' 369' ' ' ALA . 0.1 OUTLIER -126.34 117.22 22.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.146 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 366' ' ' VAL . 1.0 OUTLIER -110.0 114.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.131 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 288' ' ' PHE . 47.6 mm-40 -112.58 132.77 54.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.056 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.679 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 75.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.767 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.848 HD21 ' CE2' ' A' ' 359' ' ' PHE . 1.6 mp -124.48 -76.41 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.667 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 126.17 65.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.194 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 44.25 30.36 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.61 4.64 4.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.254 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 292' ' ' LEU . 11.1 p -66.51 109.45 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.99 0.424 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -119.07 151.3 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.489 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.793 HD13 HD21 ' A' ' 324' ' ' LEU . 26.6 mm -63.18 -47.91 90.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.492 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.53 -42.18 87.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.8 p -65.81 -41.44 91.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.788 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 297' ' ' THR . 75.8 t -73.03 -40.51 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.14 -29.87 68.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.968 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -40.01 65.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.641 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.459 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.75 -22.46 29.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.42 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -90.12 7.13 39.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.423 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 14.86 15.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.644 0.259 . . . . 0.0 111.424 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.55 -31.98 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.489 HG23 ' CE2' ' A' ' 341' ' ' PHE . 2.6 tp -88.11 -35.84 8.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.341 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.18 -169.61 35.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.8 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 13.0 mt -92.76 144.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 111.665 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 340' ' ' SER . 3.2 mt -97.64 125.13 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.7 OUTLIER -52.72 91.66 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.338 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -80.96 167.18 20.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.242 0.544 . . . . 0.0 110.715 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.597 ' OD1' ' OG1' ' A' ' 317' ' ' THR . 0.4 OUTLIER -90.13 143.29 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.878 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -80.45 -3.18 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -94.44 -45.35 7.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.493 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 81.4 p -108.45 -4.63 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.93 43.24 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.368 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.34 144.17 31.21 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.319 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.1 Cg_exo -45.06 147.97 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.523 2.149 . . . . 0.0 112.068 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.46 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 6.7 mtp -114.23 125.55 54.04 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 112.046 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 338' ' ' THR . 74.4 mt -143.17 137.81 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.996 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.41 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.7 t30 -97.63 120.72 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.031 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.793 HD21 HD13 ' A' ' 298' ' ' ILE . 0.6 OUTLIER -110.07 149.8 29.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.0 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -105.06 148.2 27.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.767 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.635 ' HB ' HD23 ' A' ' 333' ' ' LEU . 0.2 OUTLIER -147.13 161.32 41.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -76.23 119.71 20.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -5.5 46.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.638 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -98.4 -69.31 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.1 p -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 77.55 60.24 2.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -134.69 -104.4 0.23 Allowed 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.979 -0.13 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.635 HD23 ' HB ' ' A' ' 326' ' ' THR . 85.8 mt -155.69 149.06 24.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.736 0.303 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -41.94 23.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 111.068 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 109.82 24.3 5.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.01 159.68 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.617 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -165.19 150.9 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 322' ' ' ILE . 56.3 p -95.59 128.34 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.654 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.585 ' CG2' HG11 ' A' ' 301' ' ' VAL . 82.0 t -107.39 134.45 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.841 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 311' ' ' ILE . 33.1 m -94.51 138.73 32.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.904 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.3 m-85 -115.51 142.45 46.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 111.547 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 1.4 t70 -65.43 -20.75 66.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.753 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -128.69 115.32 19.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.583 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 73.7 Cg_exo -47.24 -51.58 9.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.538 2.158 . . . . 0.0 112.683 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.1 Cg_endo -57.69 -30.86 90.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.981 1.787 . . . . 0.0 111.19 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -36.41 81.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.569 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -59.48 -44.54 93.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.658 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.899 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.89 -54.97 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.878 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.55 10.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.993 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.7 -49.33 59.8 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.439 0.638 . . . . 0.0 109.613 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.7 mt -56.39 -36.17 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.363 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.87 -26.85 65.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.1 t90 -86.78 -68.21 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.063 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' A' ' 355' ' ' ASP . 10.6 m-85 -69.65 -77.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.614 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.9 t70 21.16 55.51 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.473 0.483 . . . . 0.0 111.401 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.2 22.16 1.95 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.446 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -80.11 -165.61 0.87 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.737 0.303 . . . . 0.0 111.416 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -114.93 142.11 47.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.669 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.848 ' CE2' HD21 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -124.55 101.41 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.777 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.68 26.41 3.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.245 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 99.79 24.09 10.25 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.893 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 65.9 m-80 -129.95 153.65 81.03 Favored Pre-proline 0 C--O 1.225 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.776 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.02 136.01 8.98 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.577 2.185 . . . . 0.0 111.711 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.689 ' HB ' HG12 ' A' ' 289' ' ' VAL . 9.1 pt -130.47 154.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -124.87 100.74 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 289' ' ' VAL . 37.7 t -95.96 118.96 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.36 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.411 ' HA ' HG12 ' A' ' 351' ' ' ILE . 1.4 m -140.2 176.68 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.428 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 1.2 m-85 -70.13 110.17 5.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 288' ' ' PHE . . . -85.28 87.71 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.158 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.62 152.75 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.14 120.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.803 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -145.58 99.78 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 60.85 155.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.06 -177.03 4.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 66.59 172.32 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -144.61 -151.06 0.35 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.53 143.12 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.077 0 CA-C-O 120.858 0.361 . . . . 0.0 110.847 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 120.89 133.51 4.44 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.423 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 159.18 54.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.557 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -101.88 -40.81 2.6 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.409 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 58.26 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.522 0.201 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 45.83 82.77 0.03 OUTLIER Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 167.89 9.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 110.12 30.37 3.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.507 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.876 0.369 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 60.53 172.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.24 8.41 27.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.363 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.02 4.54 4.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.596 0.236 . . . . 0.0 111.54 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.6 t -105.1 24.12 12.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.688 0.28 . . . . 0.0 110.85 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.464 ' O ' ' ND2' ' A' ' 284' ' ' ASN . 20.3 m-20 -65.01 -35.03 79.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.6 OUTLIER 43.31 100.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.835 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 20.7 p30 -51.94 -28.38 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 369' ' ' ALA . 86.1 m -76.0 132.24 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 366' ' ' VAL . 37.0 pt -117.86 168.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' ' 338' ' ' THR . 1.5 m-30 -117.39 106.73 13.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -99.71 114.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 336' ' ' GLU . 0.7 OUTLIER -132.1 132.17 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.647 0.261 . . . . 0.0 111.48 -179.098 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.782 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 121.07 79.99 0.57 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.533 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -155.79 -90.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.801 -0.235 . . . . 0.0 111.116 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 292' ' ' LEU . . . 157.12 -92.5 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -126.0 28.07 6.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 297' ' ' THR . 0.8 OUTLIER -114.71 -14.48 12.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.04 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.748 HG22 HD22 ' A' ' 324' ' ' LEU . 9.8 p -52.24 88.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -128.88 147.16 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 322' ' ' ILE . 41.7 mt -61.21 -47.35 93.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.54 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -65.32 -39.36 92.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 24.7 p -68.59 -43.27 76.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.57 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 297' ' ' THR . 60.6 t -69.75 -37.84 74.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.495 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -68.71 -30.86 69.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -35.73 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -103.81 -19.94 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.654 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.8 OUTLIER -99.43 -15.28 18.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -83.46 7.4 17.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.419 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -51.93 6.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -59.81 -33.53 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.587 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -155.51 -177.84 29.15 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.251 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.84 105.86 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 302' ' ' ALA . 52.5 mt -71.93 130.16 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 1.0 OUTLIER -48.49 92.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -67.39 140.48 57.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.708 177.543 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -96.25 145.57 25.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 111.828 -179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -79.81 -4.12 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -90.57 -49.8 6.29 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.991 0.424 . . . . 0.0 110.197 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.2 p -104.98 -8.69 18.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.804 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 313' ' ' THR . . . 69.44 10.19 62.72 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 153.95 71.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 117.127 0.464 . . . . 0.0 110.99 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.7 Cg_endo -46.59 153.13 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.006 2.471 . . . . 0.0 112.77 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -105.03 120.96 42.77 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 111.262 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.73 HD12 HG23 ' A' ' 298' ' ' ILE . 4.0 mt -139.55 142.01 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.031 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 7.8 m120 -104.5 148.22 26.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 296' ' ' VAL . 0.5 OUTLIER -135.17 114.85 12.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.705 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 336' ' ' GLU . 7.5 m-30 -69.71 104.49 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.697 ' CG2' HD23 ' A' ' 333' ' ' LEU . 17.0 p -132.39 154.78 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.843 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -103.65 103.32 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -15.31 62.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.365 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -40.2 93.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.628 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 332' ' ' LYS . 1.9 t -124.62 8.27 8.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.114 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 58.8 24.71 57.93 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.546 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.649 ' HB2' HG23 ' A' ' 330' ' ' THR . 9.1 mmtm -104.42 133.88 48.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.914 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.697 HD23 ' CG2' ' A' ' 326' ' ' THR . 1.8 mp -93.22 149.16 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.792 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -95.69 21.7 8.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 50.62 50.73 35.57 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.504 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 290' ' ' GLN . 29.7 mt-10 -147.2 131.61 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.665 0.269 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.663 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -150.14 145.55 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.519 HG22 ' CE1' ' A' ' 288' ' ' PHE . 16.2 p -108.8 118.85 37.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.631 ' CG2' HG11 ' A' ' 301' ' ' VAL . 78.9 t -94.26 126.77 46.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.246 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.3 OUTLIER -95.72 121.93 37.95 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.876 0.37 . . . . 0.0 111.138 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.51 ' HE2' HD13 ' A' ' 287' ' ' ILE . 9.9 m-85 -96.48 155.44 16.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -25.86 40.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.644 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.7 117.05 22.6 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.581 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.8 Cg_exo -43.26 -51.43 5.79 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 113.107 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.3 Cg_endo -56.48 -30.63 82.95 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 121.956 1.771 . . . . 0.0 111.359 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.2 t -60.51 -37.63 81.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.883 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -60.15 -51.21 70.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -59.86 -43.01 94.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 110.056 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.29 62.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 308' ' ' ILE . . . -68.59 -48.04 65.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 348' ' ' LYS . 33.1 mt -52.46 -31.14 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.323 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -26.69 68.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -107.19 -61.93 1.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.514 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.571 ' CB ' HG21 ' A' ' 366' ' ' VAL . 66.3 m-85 -56.75 -74.85 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.029 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 354' ' ' PHE . 36.6 t0 2.94 65.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.046 0.841 . . . . 0.0 112.511 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 113.69 26.03 4.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.565 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -87.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 11.8 mm-40 -123.6 131.23 53.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.716 ' HZ ' HG22 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -91.63 101.41 14.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.144 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 33.9 t 45.77 29.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.13 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.25 -46.98 1.01 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.0 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.3 OUTLIER -84.85 169.67 15.8 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 116.991 0.395 . . . . 0.0 110.697 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -96.31 138.86 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.391 2.727 . . . . 0.0 112.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 291' ' ' GLY . 7.6 pt -116.97 -179.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 120.834 0.349 . . . . 0.0 111.426 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -148.31 100.51 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.01 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -86.92 128.03 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.708 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 92.5 p -140.51 -173.94 3.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.174 0.511 . . . . 0.0 112.048 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -83.28 106.2 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.35 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 286' ' ' THR . . . -35.81 111.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.205 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 11.9 t -107.4 -155.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.16 146.23 0.67 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.875 0.369 . . . . 0.0 111.374 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -176.9 4.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -114.3 153.22 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.933 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 375' ' ' PHE . 24.0 t70 -87.49 -89.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 374' ' ' ASP . 17.3 t80 178.86 51.83 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.829 0.347 . . . . 0.0 110.766 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 45.17 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.67 151.55 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -156.17 58.63 0.37 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 61.53 -161.42 26.85 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.448 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 83.92 -118.67 4.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.49 160.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 114.95 -72.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.559 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.48 121.63 44.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 79.92 -124.1 6.37 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.515 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.294 -1.281 . . . . 0.0 112.464 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 61.18 83.66 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -95.26 57.82 2.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.53 -164.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 368' ' ' PHE . 2.9 m -95.27 24.26 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.95 -10.81 6.31 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.695 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.788 ' OD1' ' HB2' ' A' ' 369' ' ' ALA . 0.1 OUTLIER -33.64 124.37 0.43 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -61.61 -18.22 58.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.79 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -73.53 106.16 5.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.675 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 16.2 pt -102.22 171.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.785 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.643 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.2 m-85 -125.33 113.54 17.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 366' ' ' VAL . 0.3 OUTLIER -102.35 114.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.223 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 30.9 mm-40 -111.6 130.76 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.351 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.634 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 114.08 81.45 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.348 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.3 OUTLIER -128.44 -74.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.737 ' O ' HD11 ' A' ' 333' ' ' LEU . . . 124.52 -76.24 0.38 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.108 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.837 ' HA ' HD21 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -144.21 28.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.919 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -116.28 -8.78 11.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.834 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.899 HG12 HD22 ' A' ' 333' ' ' LEU . 13.1 p -47.73 107.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.88 146.78 9.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.016 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.614 HG23 ' HB ' ' A' ' 322' ' ' ILE . 11.3 mt -63.75 -46.03 95.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.801 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -66.68 -41.93 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.358 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.3 p -67.08 -40.97 87.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -73.94 -38.16 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.233 0.539 . . . . 0.0 109.662 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.66 72.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.82 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -74.33 -35.65 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.001 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.22 -24.38 19.91 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -98.21 26.65 5.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.6 25.68 10.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.877 0.37 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -107.15 -44.19 4.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.402 HD13 ' HE3' ' A' ' 353' ' ' TRP . 1.7 tp -74.1 -28.35 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -174.68 -164.68 29.91 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.759 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.97 132.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mp -81.53 128.01 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 321' ' ' MET . 5.0 mtmp? -55.35 100.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.182 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.666 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.7 m -63.94 154.5 33.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.259 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.915 HD21 ' HG2' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.6 138.95 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 3.73 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.921 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -111.65 -20.92 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.292 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 -21.8 6.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.75 13.62 80.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.666 ' C ' HG23 ' A' ' 313' ' ' THR . 0.0 OUTLIER -124.43 162.63 41.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 93.1 Cg_exo -47.63 148.26 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.533 2.155 . . . . 0.0 112.152 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.915 ' HG2' HD21 ' A' ' 314' ' ' ASN . 72.0 mtp -101.33 114.71 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.667 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -143.26 139.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.8 OUTLIER -103.2 144.17 31.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 -179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.565 ' CD2' HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -136.9 144.96 43.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.42 114.14 20.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 17.4 p -103.09 169.98 8.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.22 115.1 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 110.792 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.02 26.03 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -112.36 -34.59 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 332' ' ' LYS . 5.9 t -129.2 -40.27 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 141.03 -26.13 2.5 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.467 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.529 ' H ' HG23 ' A' ' 330' ' ' THR . 10.6 mttt -58.4 -174.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.899 HD22 HG12 ' A' ' 296' ' ' VAL . 3.2 pp -125.28 138.35 54.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -53.03 -23.58 7.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.593 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 333' ' ' LEU . . . 78.65 39.24 21.99 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.013 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 11.3 pt-20 -152.35 144.95 24.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 111.006 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -155.26 141.72 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.25 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 3.7 p -92.1 138.83 31.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.706 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.667 HG22 HG12 ' A' ' 322' ' ' ILE . 90.4 t -116.89 127.75 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 311' ' ' ILE . 94.5 p -101.4 125.82 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.55 153.09 22.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 23.0 t0 -73.42 -26.49 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.326 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.96 111.16 48.25 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.954 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.6 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.4 Cg_exo -43.52 -51.04 6.38 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.53 2.153 . . . . 0.0 112.454 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.1 Cg_endo -55.35 -30.67 73.77 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.928 1.752 . . . . 0.0 111.149 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.7 t -58.98 -43.18 91.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.664 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.675 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -55.4 -49.79 71.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.958 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.33 -52.7 62.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.708 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.79 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.819 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.99 74.02 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.1 mt -61.72 -35.79 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.99 -26.34 67.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.6 t90 -96.52 -68.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.939 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 364' ' ' ILE . 16.3 m-85 -62.54 -74.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 354' ' ' PHE . 26.2 t70 11.86 63.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.811 0.694 . . . . 0.0 112.16 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 114.83 25.05 4.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.656 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 19.5 mmtt -87.54 -167.87 2.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -119.93 131.93 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 112.228 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -96.23 101.36 12.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.953 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.6 p 51.44 28.2 4.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.15 -42.49 1.55 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.28 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.3 m120 -78.05 172.32 10.15 Favored Pre-proline 0 C--O 1.221 -0.405 0 CA-C-N 116.667 0.233 . . . . 0.0 110.767 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -94.32 146.92 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.277 2.652 . . . . 0.0 112.054 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 354' ' ' PHE . 3.1 pt -123.59 171.26 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 111.822 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -148.29 104.02 3.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.807 HG22 HG13 ' A' ' 289' ' ' VAL . 37.0 t -91.39 139.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.04 -172.1 3.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -108.64 76.5 1.03 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.68 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.788 ' HB2' ' OD1' ' A' ' 284' ' ' ASN . . . 57.09 92.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.411 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 371' ' ' ARG . 0.2 OUTLIER 41.34 -161.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.44 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ARG . . . . . 0.596 ' H ' HG22 ' A' ' 370' ' ' THR . 14.4 mmp_? 63.06 133.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -93.66 59.04 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.74 167.05 2.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.014 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.71 -176.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.61 34.6 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.09 31.61 20.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.6 -172.3 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 133.97 107.13 0.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -59.57 -56.69 23.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.502 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 98.67 -59.48 0.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.43 -169.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 176.1 -116.53 0.57 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -110.42 114.26 27.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -77.47 -140.84 1.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.476 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 61.38 -176.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.07 49.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.233 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 284' ' ' ASN . 1.0 OUTLIER -58.69 125.55 23.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.543 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.5 p -105.4 -29.28 10.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.393 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.88 5.25 19.53 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.446 ' HA ' ' OD1' ' A' ' 281' ' ' ASN . 8.0 p30 45.45 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.171 0.51 . . . . 0.0 111.564 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -52.87 -34.55 55.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.603 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 99.6 m -62.07 97.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.666 HD12 HG13 ' A' ' 366' ' ' VAL . 43.5 pt -86.55 170.59 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -118.39 118.59 32.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 365' ' ' LYS . 0.2 OUTLIER -108.69 115.28 48.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.538 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -116.43 130.83 56.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.376 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.635 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 111.78 51.11 0.58 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.294 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.758 HD22 ' H ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -105.57 -83.55 0.51 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.905 0.352 . . . . 0.0 110.486 179.448 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.57 -50.14 2.83 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.214 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -107.75 40.0 1.81 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.186 0.493 . . . . 0.0 111.951 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -143.56 -42.28 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.039 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 296' ' ' VAL . 96.4 t 6.27 65.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.839 ' O ' HG23 ' A' ' 301' ' ' VAL . 39.4 p -161.92 145.58 12.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.731 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.732 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.2 mm -71.77 -40.3 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.15 -42.81 88.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.41 ' HB3' ' OG1' ' A' ' 297' ' ' THR . 21.6 p -63.18 -41.49 99.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.473 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 297' ' ' THR . 34.9 t -70.72 -47.67 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.728 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -62.62 -29.9 70.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.922 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.1 -40.67 71.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.756 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.69 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -88.83 9.99 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 20.99 13.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -102.32 -39.21 7.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.406 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.441 HD13 ' HE3' ' A' ' 353' ' ' TRP . 3.3 tp -76.81 -38.39 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.052 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -168.01 -162.97 21.12 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.528 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.6 mt -98.31 137.07 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.53 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -96.73 136.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 341' ' ' PHE . 4.1 mmtt -48.42 106.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.052 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -77.67 142.87 38.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.569 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.62 140.3 29.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 0.0 111.387 -179.031 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -77.86 -6.18 53.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.91 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -45.13 7.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.37 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 70.8 p -104.63 -8.25 19.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 63.95 14.22 55.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.235 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 2.1 pt20 -125.14 164.08 34.01 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 120.485 0.183 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.591 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 79.3 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.44 2.093 . . . . 0.0 112.299 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.569 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.64 125.1 51.29 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.569 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.717 HD13 ' HB ' ' A' ' 301' ' ' VAL . 4.6 mt -143.28 144.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.166 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.534 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.2 m-20 -110.34 147.84 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.703 0.287 . . . . 0.0 110.455 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.732 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -145.48 130.14 18.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.111 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 325' ' ' TYR . . . . . 0.402 ' HB2' ' CG ' ' A' ' 336' ' ' GLU . 51.2 m-85 -91.14 139.36 30.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.511 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 333' ' ' LEU . 63.1 p -146.19 174.8 11.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.55 147.99 31.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 328' ' ' ARG . 0.0 OUTLIER -111.15 15.85 21.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.409 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 330' ' ' THR . 0.2 OUTLIER -146.51 49.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.072 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 329' ' ' GLU . 1.0 OUTLIER 171.75 -35.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.99 -29.45 9.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.321 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -57.98 170.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 110.775 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 326' ' ' THR . 0.0 OUTLIER -108.57 -177.16 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -101.75 -28.93 12.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.401 ' C ' HD22 ' A' ' 292' ' ' LEU . . . 102.23 28.27 6.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.567 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 325' ' ' TYR . 0.6 OUTLIER -143.02 143.4 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.36 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -158.26 139.85 13.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.237 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 288' ' ' PHE . 11.9 p -97.61 134.15 41.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.561 HG22 HG11 ' A' ' 301' ' ' VAL . 95.0 t -112.0 126.06 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.522 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.899 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -86.18 153.26 22.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.467 ' CB ' ' ND2' ' A' ' 285' ' ' ASN . 4.5 m-85 -133.51 147.0 51.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.42 -33.22 48.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.65 118.07 41.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.648 0.261 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.565 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.5 Cg_exo -41.84 -51.69 4.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.876 2.384 . . . . 0.0 113.081 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.2 Cg_endo -55.6 -30.28 74.06 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.775 1.65 . . . . 0.0 111.089 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.8 t -56.64 -44.82 81.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.04 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.66 ' HB2' HD22 ' A' ' 285' ' ' ASN . . . -53.4 -50.34 65.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.63 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.943 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -63.9 -54.85 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.156 0.503 . . . . 0.0 109.749 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.92 14.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.539 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.58 -48.56 63.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.0 mt -58.93 -35.99 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.371 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -61.91 -26.2 68.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.242 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.6 t90 -94.37 -68.57 0.79 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.586 ' HB2' HG21 ' A' ' 366' ' ' VAL . 1.5 m-85 -69.79 -77.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.8 p-10 23.17 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.115 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.45 20.33 2.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.316 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.446 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 9.1 mtpp -87.02 -166.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.061 0.43 . . . . 0.0 110.472 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 13.3 mm-40 -120.02 128.91 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.419 . . . . 0.0 112.093 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HD2' HD12 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -84.2 100.84 11.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.743 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.49 31.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 142.51 -51.62 0.67 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.186 -1.006 . . . . 0.0 114.048 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.5 OUTLIER -89.16 171.61 8.7 Favored Pre-proline 0 C--O 1.218 -0.59 0 CA-C-N 117.008 0.404 . . . . 0.0 110.743 -179.255 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 358' ' ' GLU . 85.9 Cg_endo -95.48 143.36 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.308 2.672 . . . . 0.0 112.193 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.9 pt -132.03 170.06 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 111.978 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -132.62 150.92 52.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.777 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.666 HG13 HD12 ' A' ' 287' ' ' ILE . 11.6 t -131.6 127.74 59.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.8 p -140.24 172.92 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.492 ' CZ ' HD13 ' A' ' 351' ' ' ILE . 4.3 m-85 -86.28 55.5 3.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.088 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 59.44 84.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.14 120.21 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.16 127.77 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.712 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.61 -165.76 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -90.86 61.61 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.071 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 -75.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.92 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -178.92 150.79 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 57.43 -119.91 18.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 136.12 -51.36 0.81 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -131.19 -83.45 0.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.589 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.5 m120 63.71 137.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.87 0.367 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 99.18 -27.79 18.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 152.87 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -83.85 -27.97 36.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.551 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 61.43 -170.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -75.16 68.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.405 ' O ' ' CZ ' ' A' ' 368' ' ' PHE . 1.4 m120 -118.4 88.06 2.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 15.9 p -96.71 24.22 6.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.96 -28.25 62.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.992 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -123.17 119.19 29.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 3.8 p-10 -86.45 -19.14 30.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.843 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 74.6 m -80.42 144.98 32.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.769 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.2 pt -123.36 168.33 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.764 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.664 ' HD2' HE22 ' A' ' 290' ' ' GLN . 0.6 OUTLIER -124.06 114.95 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.174 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -107.63 114.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.664 HE22 ' HD2' ' A' ' 288' ' ' PHE . 0.7 OUTLIER -112.74 144.18 42.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.678 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.51 4.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.731 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 296' ' ' VAL . 7.2 mt -60.51 -76.76 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.618 0.247 . . . . 0.0 110.743 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.456 ' O ' ' ND2' ' A' ' 295' ' ' ASN . . . 114.3 77.72 0.77 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.392 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 43.93 30.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.632 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 293' ' ' GLY . 15.6 p30 -138.33 25.34 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.729 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 292' ' ' LEU . 21.5 t -68.17 83.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.7 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.845 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -126.44 147.99 49.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.588 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 324' ' ' LEU . 32.4 mm -68.54 -47.02 79.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.258 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -38.64 87.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.7 t -63.96 -40.28 96.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 297' ' ' THR . 54.6 t -74.9 -41.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.862 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.721 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.18 -29.93 68.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.837 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -74.11 -40.47 62.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.632 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -94.07 -21.83 18.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.806 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -105.33 38.13 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.02 19.11 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.305 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -36.45 8.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.301 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.0 tp -75.48 -30.1 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.465 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.431 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -168.16 -167.38 28.73 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.91 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.69 116.71 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 305' ' ' PHE . 3.4 mt -76.81 124.02 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.313 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 321' ' ' MET . 23.9 mtmt -48.72 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.615 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.2 m -69.64 152.04 45.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.747 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.23 144.59 25.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.8 1.5 52.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.279 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.26 -32.1 7.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.845 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.401 ' OG1' ' CG ' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -107.39 -20.67 13.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.752 179.145 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.37 8.59 71.15 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.776 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.615 ' C ' HG23 ' A' ' 313' ' ' THR . 0.1 OUTLIER -125.12 167.42 16.3 Favored Pre-proline 0 C--O 1.224 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.721 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 66.8 Cg_exo -44.78 149.37 1.14 Allowed 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.708 2.272 . . . . 0.0 113.041 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 312' ' ' LYS . 36.7 mtp -101.94 121.56 42.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.835 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 339' ' ' VAL . 1.2 mt -143.25 138.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.0 OUTLIER -98.83 140.41 33.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.808 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.743 HD23 ' HB1' ' A' ' 337' ' ' ALA . 5.2 mt -126.7 142.61 51.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.034 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -115.48 87.93 2.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.5 p -89.1 174.03 8.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 329' ' ' GLU . 11.5 m-20 -90.06 99.63 12.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 -83.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 327' ' ' ASP . 3.2 mt-10 167.58 31.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.88 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 8.8 t -96.23 -26.24 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.154 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.13 72.75 0.57 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.926 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 327' ' ' ASP . 2.8 mtpp -143.11 -46.32 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 110.758 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.3 mp 62.09 147.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.099 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -102.96 12.15 36.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.269 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 52.36 49.0 53.1 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.522 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.22 136.5 15.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 0.0 111.236 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.743 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -157.88 153.02 25.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -102.67 145.83 29.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.428 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 322' ' ' ILE . 46.8 t -113.27 128.51 70.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.206 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 311' ' ' ILE . 59.7 p -97.57 124.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -102.06 154.87 18.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.69 -21.09 38.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -125.98 118.36 23.9 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.683 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.601 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.1 Cg_exo -41.31 -50.81 4.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.733 2.289 . . . . 0.0 112.983 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.3 Cg_endo -53.03 -30.54 49.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.956 1.771 . . . . 0.0 111.219 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 25.6 t -57.26 -44.92 84.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.97 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.35 -49.22 75.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.946 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.05 -49.97 73.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.003 0.43 . . . . 0.0 110.01 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.88 38.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.731 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.09 64.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.452 0.644 . . . . 0.0 109.382 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.5 mt -58.26 -35.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.158 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.17 -26.62 65.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.159 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.519 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -89.2 -68.01 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.334 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.621 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -75.64 -81.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.614 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.5 p-10 31.26 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.549 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 126.02 43.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.773 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.79 -157.2 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 27.7 tt0 -113.58 128.32 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.41 0.624 . . . . 0.0 111.518 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 304' ' ' TYR . 0.9 OUTLIER -112.46 101.66 9.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.957 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.7 t 55.43 26.55 8.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.068 0.461 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 94.66 24.83 16.89 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.74 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 73.5 m-80 -129.94 148.57 70.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.822 0.344 . . . . 0.0 111.848 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.07 121.71 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.479 2.119 . . . . 0.0 111.447 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 8.7 pt -112.33 -178.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.961 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.12 101.04 3.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.673 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.897 HG22 HG13 ' A' ' 289' ' ' VAL . 40.8 t -88.64 133.52 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 86.6 p -127.53 -179.89 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.195 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -95.5 51.45 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.693 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.843 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 65.67 159.71 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.011 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -74.76 166.98 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.881 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.9 -172.95 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -116.55 -40.05 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 62.84 134.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 28.8 t70 60.04 164.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.12 -158.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 70.25 -78.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.08 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -153.48 -79.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 79.3 -152.21 35.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.35 75.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.424 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -89.31 -170.48 44.89 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.558 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.51 -167.62 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.311 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 157.65 -26.67 0.46 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.58 118.3 4.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.994 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.97 -94.82 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.485 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.53 155.85 34.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.84 -29.07 13.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 10.6 m120 61.58 21.43 12.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.055 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.3 m -104.98 23.52 13.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.057 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.32 31.12 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -115.81 87.4 2.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 29.5 p30 -58.41 -21.3 50.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.691 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.898 HG22 ' HB3' ' A' ' 369' ' ' ALA . 0.3 OUTLIER -84.56 143.04 29.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.836 HD12 ' CG1' ' A' ' 366' ' ' VAL . 2.0 pt -117.26 172.17 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.047 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 1.5 p90 -125.48 122.29 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.876 0.37 . . . . 0.0 111.459 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.963 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -104.34 114.86 45.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.242 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.423 ' NE2' ' CD1' ' A' ' 288' ' ' PHE . 0.0 OUTLIER -115.93 131.0 57.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.06 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 106.75 43.15 1.46 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.976 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.702 HD22 ' HD2' ' A' ' 359' ' ' PHE . 0.5 OUTLIER -85.67 -79.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.791 0.296 . . . . 0.0 110.678 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 136.39 -81.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.546 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.13 29.74 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.92 0.39 . . . . 0.0 110.575 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.409 ' ND2' ' CE1' ' A' ' 359' ' ' PHE . 0.2 OUTLIER -111.65 7.92 20.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.94 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.788 HG13 HD22 ' A' ' 324' ' ' LEU . 10.0 t -55.52 89.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.529 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -147.52 146.44 29.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.67 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.5 mm -71.43 -45.28 69.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.684 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.96 -43.09 84.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.073 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -40.0 82.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 297' ' ' THR . 54.2 t -73.58 -37.96 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.715 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.792 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.61 -34.52 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.36 -38.02 71.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.092 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -85.54 -20.91 28.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.714 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.867 ' CD2' HG21 ' A' ' 339' ' ' VAL . 0.6 OUTLIER -92.15 11.76 24.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 29.02 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.071 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -112.54 -33.8 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 7.8 tp -84.4 -31.8 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.71 -160.73 26.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.732 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.0 mt -92.85 134.63 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.562 0.22 . . . . 0.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.792 HD13 ' HA ' ' A' ' 302' ' ' ALA . 4.6 mt -92.93 134.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.378 0.608 . . . . 0.0 110.945 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.7 OUTLIER -48.56 100.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.411 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -76.21 154.25 35.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.523 ' CG ' ' HG1' ' A' ' 317' ' ' THR . 17.6 p30 -103.03 -178.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.018 0.437 . . . . 0.0 111.644 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.41 ' CD ' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -109.42 -12.46 14.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.172 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 -44.75 11.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.156 0.503 . . . . 0.0 109.999 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.523 ' HG1' ' CG ' ' A' ' 314' ' ' ASN . 8.5 p -106.37 -8.42 17.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.766 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 314' ' ' ASN . . . 61.23 17.39 52.36 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.671 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.559 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.7 168.03 14.32 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 120.776 0.322 . . . . 0.0 110.894 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.598 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 80.4 Cg_exo -44.54 161.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.988 2.459 . . . . 0.0 112.726 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -123.08 129.43 51.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.296 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 339' ' ' VAL . 3.7 mp -144.38 129.23 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.15 115.52 28.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.797 HD23 ' CB ' ' A' ' 337' ' ' ALA . 0.2 OUTLIER -121.56 148.77 44.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -101.22 130.33 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.412 ' CG2' HD12 ' A' ' 333' ' ' LEU . 13.8 p -132.92 145.59 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 118.75 7.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.755 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -7.6 59.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.451 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.17 -43.74 12.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 332' ' ' LYS . 10.0 t -112.72 -29.61 7.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.055 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.09 28.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.623 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.777 ' H ' HG23 ' A' ' 330' ' ' THR . 0.6 OUTLIER -57.22 135.36 56.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.888 0.375 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -61.95 149.19 41.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.785 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -76.71 -26.04 54.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 94.63 31.83 7.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -157.18 140.55 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.62 0.247 . . . . 0.0 110.703 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.797 ' CB ' HD23 ' A' ' 324' ' ' LEU . . . -160.39 179.11 8.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.783 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 322' ' ' ILE . 69.4 p -129.91 136.47 49.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.406 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.867 HG21 ' CD2' ' A' ' 305' ' ' PHE . 0.4 OUTLIER -104.37 125.11 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.268 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 311' ' ' ILE . 3.1 p -94.56 140.07 30.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.047 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.557 ' CE2' HD13 ' A' ' 287' ' ' ILE . 32.2 m-85 -115.5 160.16 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 111.069 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -80.63 -18.15 49.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.25 116.87 20.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.609 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.7 Cg_exo -44.77 -50.52 8.34 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.653 2.235 . . . . 0.0 112.907 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.1 Cg_endo -54.58 -30.51 65.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.003 1.802 . . . . 0.0 111.401 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.9 t -58.67 -41.21 85.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.85 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.05 -50.1 71.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.949 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.4 OUTLIER -59.39 -50.64 73.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.175 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.56 -33.78 33.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.84 -48.33 63.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.433 0.635 . . . . 0.0 109.391 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.949 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.4 mt -56.87 -35.97 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.15 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -26.65 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.152 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.34 -68.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.054 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.533 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 5.1 m-85 -76.17 -79.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.483 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 354' ' ' PHE . 45.5 t0 21.44 51.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.439 0.462 . . . . 0.0 112.021 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 125.32 32.02 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.256 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -102.74 -162.87 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.087 0.443 . . . . 0.0 110.087 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 8.5 mt-10 -113.72 128.6 56.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.994 0.426 . . . . 0.0 111.866 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.74 ' HB2' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -102.79 101.72 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.266 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 41.0 t 60.01 28.38 17.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.486 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.32 -27.8 10.33 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.592 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 3.4 m120 -91.76 169.54 11.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.956 0.378 . . . . 0.0 110.64 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -93.34 137.18 1.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 112.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.74 HD13 ' HB2' ' A' ' 359' ' ' PHE . 23.3 pt -134.36 164.52 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 120.977 0.417 . . . . 0.0 111.804 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 100.53 5.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.963 HG22 HG13 ' A' ' 289' ' ' VAL . 19.5 t -90.02 118.66 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -140.53 -166.75 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -72.94 113.06 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.898 ' HB3' HG22 ' A' ' 286' ' ' THR . . . -63.03 82.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.0 t -167.94 -172.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.66 120.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 99.25 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.986 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.86 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -161.12 -178.12 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.89 102.06 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -170.21 111.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -129.23 -70.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 82.23 -58.33 4.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.631 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.1 28.59 4.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 77.39 115.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -103.93 112.75 25.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 109.93 -56.51 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -68.75 149.92 48.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 104.42 -28.21 15.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.53 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.481 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.85 0.357 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.456 ' OE1' ' ND2' ' A' ' 281' ' ' ASN . 0.8 OUTLIER -86.77 157.45 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -85.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.456 ' ND2' ' OE1' ' A' ' 279' ' ' GLN . 1.1 m-80 46.69 77.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.765 0.317 . . . . 0.0 111.197 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 59.6 p -86.61 5.73 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -112.95 -9.34 13.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.632 0.254 . . . . 0.0 111.056 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 369' ' ' ALA . 0.0 OUTLIER -79.32 120.23 23.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.783 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 14.0 p30 -104.1 -25.15 13.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.491 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 58.9 m -70.52 116.23 10.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.659 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 36.8 pt -102.93 173.17 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.175 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.564 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.4 OUTLIER -122.46 107.69 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 364' ' ' ILE . 2.7 t -104.35 114.48 44.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.432 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 2.0 mp0 -116.78 130.5 56.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 364' ' ' ILE . . . 123.98 25.77 1.64 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.849 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 292' ' ' LEU . 4.9 mp -88.05 -104.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.94 -39.7 1.82 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.594 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.93 31.82 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.654 0.727 . . . . 0.0 112.036 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.711 HD21 ' HB3' ' A' ' 300' ' ' SER . 0.2 OUTLIER -162.51 -44.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.767 HG13 HG21 ' A' ' 326' ' ' THR . 14.7 t 26.48 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.639 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -164.48 145.2 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.101 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.749 HD12 HD21 ' A' ' 324' ' ' LEU . 1.2 mp -72.21 -42.1 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.998 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.44 -40.54 95.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.711 ' HB3' HD21 ' A' ' 295' ' ' ASN . 1.4 t -65.08 -43.99 90.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.468 . . . . 0.0 110.478 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 297' ' ' THR . 47.7 t -70.92 -40.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.353 0.597 . . . . 0.0 109.664 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 320' ' ' PRO . . . -68.18 -29.82 68.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.024 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -37.7 65.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.685 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.57 -24.79 15.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.769 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -93.27 7.98 42.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.081 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -95.56 22.41 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 111.076 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.21 -44.35 6.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.624 HG23 ' CE2' ' A' ' 341' ' ' PHE . 0.8 OUTLIER -70.94 -29.33 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.477 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.73 -170.52 35.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.943 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.29 113.85 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.689 0.281 . . . . 0.0 111.513 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 305' ' ' PHE . 1.1 mt -71.65 135.16 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 0.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 321' ' ' MET . 6.1 mmmt -65.37 91.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -67.33 171.02 6.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 111.043 178.381 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 316' ' ' LYS . 0.4 OUTLIER -103.35 116.34 32.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.354 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -8.26 0.16 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -83.27 -34.49 25.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.064 0.459 . . . . 0.0 110.59 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.614 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.5 OUTLIER -121.62 -23.48 5.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.338 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.84 23.43 52.78 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.908 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.614 ' HG2' HG21 ' A' ' 317' ' ' THR . 0.0 OUTLIER -118.57 138.1 25.49 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.884 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.681 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 4.8 Cg_exo -44.01 131.04 8.32 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.999 2.466 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -97.15 130.18 44.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.839 0.828 . . . . 0.0 112.929 -178.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.721 HD12 HG23 ' A' ' 298' ' ' ILE . 3.7 mt -143.14 140.22 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.428 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 6.2 t30 -98.8 148.38 23.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 298' ' ' ILE . 0.2 OUTLIER -154.42 128.17 8.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.943 0.401 . . . . 0.0 111.496 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -86.54 87.94 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.952 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.767 HG21 HG13 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -143.22 150.38 39.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.007 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 332' ' ' LYS . 0.4 OUTLIER -102.9 108.01 19.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.555 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.24 13.19 12.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.733 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -97.97 -40.57 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 111.134 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 6.4 t -127.2 -1.8 6.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.82 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.83 49.61 6.4 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.416 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 327' ' ' ASP . 0.3 OUTLIER -97.0 24.51 6.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 111.174 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.554 HD22 HG11 ' A' ' 296' ' ' VAL . 19.1 mt -32.62 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.762 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.41 -31.37 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 90.11 32.42 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.617 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.432 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 4.9 mp0 -130.16 132.16 45.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.502 0.191 . . . . 0.0 110.562 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -153.27 147.05 25.22 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.564 HG22 ' CD1' ' A' ' 288' ' ' PHE . 44.3 p -110.33 117.8 34.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.918 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.647 ' CG1' HD13 ' A' ' 311' ' ' ILE . 56.1 t -93.06 130.15 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.739 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 311' ' ' ILE . 9.1 t -96.72 133.62 41.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.907 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.624 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.0 m-85 -117.41 148.35 41.85 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -70.95 -34.32 71.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.49 109.45 60.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.28 -51.41 6.85 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.478 2.119 . . . . 0.0 112.496 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.3 Cg_endo -55.76 -30.58 76.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.945 1.763 . . . . 0.0 111.262 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -60.54 -44.21 96.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.659 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.65 -46.21 81.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.287 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.93 ' HA ' HD12 ' A' ' 351' ' ' ILE . 3.0 tppt? -60.16 -54.74 42.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.847 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.54 43.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.63 -49.68 57.28 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.93 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.9 mt -52.47 -36.66 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.763 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -58.38 -26.24 62.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.577 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.544 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.4 t90 -100.5 -68.6 0.8 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.688 ' HB2' HG21 ' A' ' 366' ' ' VAL . 47.2 m-85 -56.85 -74.48 0.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.4 p-10 9.35 59.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.973 0.796 . . . . 0.0 112.684 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.81 30.69 1.76 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.13 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.422 ' HG3' ' CG1' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -94.75 -164.45 1.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 7.7 mm-40 -119.4 129.38 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.621 -0.432 . . . . 0.0 112.122 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.678 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -86.09 101.05 12.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 40.5 30.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.358 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 140.49 -49.72 0.78 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.28 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.0 OUTLIER -89.7 171.1 9.26 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 117.207 0.504 . . . . 0.0 110.958 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -95.15 140.17 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.468 2.779 . . . . 0.0 112.153 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.678 HG21 ' CD1' ' A' ' 359' ' ' PHE . 5.1 pt -122.28 -179.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.865 0.364 . . . . 0.0 111.652 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.27 102.45 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.548 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' ' 354' ' ' PHE . 17.6 t -84.85 143.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.2 t -128.08 -168.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 351' ' ' ILE . 0.8 OUTLIER -121.2 65.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.614 ' HB2' ' OD1' ' A' ' 284' ' ' ASN . . . 63.23 177.06 0.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.455 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 -172.92 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 67.15 179.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.817 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -133.89 76.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.297 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 49.09 28.7 2.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 375' ' ' PHE . 1.9 t0 71.99 -146.97 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.216 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 375' ' ' PHE . 17.9 p90 42.26 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.385 0.612 . . . . 0.0 111.489 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 179.62 98.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.79 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -135.8 123.1 21.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 76.51 -104.49 1.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.524 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 61.93 51.99 53.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 115.14 170.55 16.34 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.435 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -100.35 -31.07 11.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 141.94 -163.5 26.97 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.45 150.7 41.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.953 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 163.7 131.21 1.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.418 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.358 -1.245 . . . . 0.0 112.475 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.793 0.33 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 60.81 -167.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.26 -30.56 62.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.76 87.82 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.4 t -71.9 -28.37 63.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 284' ' ' ASN . 25.7 m-20 -111.53 -2.37 15.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.412 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 283' ' ' ASP . 5.1 p30 48.98 108.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.71 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 9.9 p30 -63.9 -20.28 65.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 27.8 m -71.44 158.28 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.66 ' CA ' ' HB2' ' A' ' 369' ' ' ALA . 10.2 pt -142.94 173.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.75 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -131.09 112.35 12.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.016 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 366' ' ' VAL . 0.5 OUTLIER -105.35 114.69 45.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.741 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 289' ' ' VAL . 1.1 mp0 -113.37 130.59 56.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.034 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.32 51.03 0.89 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.387 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -84.56 -73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.108 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.27 105.12 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.392 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.18 46.6 19.74 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 295' ' ' ASN . 0.1 OUTLIER -165.69 26.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 110.796 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.884 HG12 HD22 ' A' ' 324' ' ' LEU . 18.0 t -79.17 100.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.564 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -153.36 147.0 25.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.585 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.672 HD11 HD11 ' A' ' 324' ' ' LEU . 28.3 mm -70.93 -44.73 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.399 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.72 -39.19 87.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.7 t -68.22 -42.92 79.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.586 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 297' ' ' THR . 90.8 t -71.41 -40.01 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.564 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.557 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -29.9 68.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.832 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 4.4 m-20 -72.9 -38.73 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.721 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.81 -24.81 28.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.564 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 305' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 1.1 m-85 -85.67 1.13 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.769 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -89.75 12.81 15.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.622 0.248 . . . . 0.0 111.356 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.58 -45.11 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.043 0.449 . . . . 0.0 110.458 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ILE . . . . . 0.534 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -76.32 -36.64 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.26 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -171.78 -158.72 16.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.913 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.48 144.16 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.742 0.306 . . . . 0.0 111.536 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.557 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.2 mt -96.15 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.86 93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.42 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -71.74 152.57 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.421 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.827 HD22 ' HB2' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -107.74 110.9 22.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.806 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -8.52 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.827 ' HB2' HD22 ' A' ' 314' ' ' ASN . 15.1 mmtt -89.35 -25.7 21.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.994 0.426 . . . . 0.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.545 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 74.9 p -122.06 -24.03 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.56 16.0 76.72 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.692 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLN . . . . . 0.545 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.58 160.08 57.57 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 0.0 111.619 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 320' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 83.9 Cg_exo -50.5 156.9 3.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.776 2.317 . . . . 0.0 112.279 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.1 OUTLIER -121.35 122.94 40.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.224 0.535 . . . . 0.0 111.346 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 339' ' ' VAL . 47.9 mt -143.64 146.27 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.443 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.45 134.26 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.611 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.884 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -136.34 143.55 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.77 -179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -111.18 119.52 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 20.7 p -136.67 148.94 47.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.27 115.27 17.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -15.84 37.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.59 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -72.58 -41.58 65.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 332' ' ' LYS . 6.0 t -104.17 -24.92 13.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.805 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.4 55.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.722 ' H ' HG23 ' A' ' 330' ' ' THR . 32.6 mmtm -82.21 -171.96 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.068 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.747 HD22 ' CG2' ' A' ' 296' ' ' VAL . 0.8 OUTLIER -142.77 161.25 38.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.816 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.64 12.7 20.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.441 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.455 ' H ' HD12 ' A' ' 333' ' ' LEU . . . 50.82 50.41 37.81 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.643 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -148.5 131.99 16.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.686 0.279 . . . . 0.0 111.216 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.04 133.38 7.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 111.765 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' THR . . . . . 0.75 HG22 ' CD1' ' A' ' 288' ' ' PHE . 20.4 p -91.91 130.38 37.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.15 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 322' ' ' ILE . 60.4 t -111.26 132.38 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.683 0.278 . . . . 0.0 111.217 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 286' ' ' THR . 2.5 p -100.44 139.21 36.44 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.812 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.96 161.16 14.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.03 -27.77 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.756 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.76 120.53 22.95 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.506 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' PRO . . . . . 0.577 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.9 Cg_exo -41.91 -51.62 4.46 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.832 2.355 . . . . 0.0 112.963 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 14.4 Cg_endo -56.61 -30.67 84.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.914 1.742 . . . . 0.0 111.466 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.1 t -62.34 -39.23 92.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -63.12 -48.33 78.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.38 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.956 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -61.73 -47.73 83.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.932 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.44 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.87 -31.96 63.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.97 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.09 67.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.8 mt -58.04 -35.46 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.943 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 348' ' ' LYS . 31.8 t70 -59.23 -26.46 64.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.6 t90 -101.97 -65.87 0.96 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 366' ' ' VAL . 20.5 m-85 -61.11 -74.89 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 354' ' ' PHE . 16.0 p-10 13.5 58.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.795 0.685 . . . . 0.0 112.345 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 113.27 35.02 1.68 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.727 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.23 -160.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.7 mm-40 -121.81 129.06 52.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 112.116 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' PHE . . . . . 0.55 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -83.95 100.9 11.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 18.6 p 39.31 31.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.209 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.8 -47.83 0.92 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.91 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.8 m-80 -88.13 170.99 10.21 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.989 0.395 . . . . 0.0 110.604 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -96.24 141.71 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.251 2.634 . . . . 0.0 112.386 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.8 pt -126.82 -178.91 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.35 100.93 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 354' ' ' PHE . 24.6 t -87.78 137.39 21.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.9 p -131.55 -165.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.963 0.411 . . . . 0.0 111.263 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' PHE . . . . . 0.403 ' CD2' HD13 ' A' ' 351' ' ' ILE . 6.8 m-85 -96.78 28.92 3.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.063 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.66 ' HB2' ' CA ' ' A' ' 287' ' ' ILE . . . 48.95 -176.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.1 t -171.31 -179.2 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 47.71 91.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.21 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -70.98 72.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.788 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -111.12 -177.67 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 28.5 t0 60.22 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 76.6 t80 60.11 87.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -119.04 -66.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -67.66 -50.77 56.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 146.42 -87.81 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -141.59 28.45 2.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 173.74 109.61 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.595 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.5 110.86 3.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.763 0.315 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -59.42 -160.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.22 135.74 52.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.81 -42.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.559 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.524 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.909 0.385 . . . . 0.0 111.367 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.26 -30.07 2.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 96.9 m -61.33 125.55 24.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 366' ' ' VAL . 40.2 pt -113.29 173.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.49 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.9 OUTLIER -126.36 112.98 16.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.266 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -107.01 122.48 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.626 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -128.89 129.98 46.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.018 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.57 46.76 0.52 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.3 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 359' ' ' PHE . 0.7 OUTLIER -86.29 -84.59 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.5 0.191 . . . . 0.0 110.83 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 105.64 90.6 2.18 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.269 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 44.65 27.95 0.29 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.822 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.8 OUTLIER -142.31 -2.23 1.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.789 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 296' ' ' VAL . 11.7 p -64.9 83.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.792 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -116.46 163.95 15.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.512 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.814 ' CD1' HD11 ' A' ' 324' ' ' LEU . 13.8 mm -71.29 -49.1 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 111.366 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -34.1 76.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.5 t -63.58 -44.13 94.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.819 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 339' ' ' VAL . 43.1 t -73.81 -38.44 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.401 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.747 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -67.92 -30.44 69.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.053 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.55 -41.79 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.498 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -93.18 -21.43 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.527 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -104.71 37.56 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.808 0.337 . . . . 0.0 111.326 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.92 17.04 9.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.177 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.05 -43.27 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 109.987 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 350' ' ' ALA . 0.6 OUTLIER -66.74 -35.56 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.5 -156.15 11.04 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.565 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 mt -101.93 134.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -89.18 139.66 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 110.035 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -48.15 91.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.945 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.421 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -70.79 147.12 49.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.415 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.536 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -97.35 157.86 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.425 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -89.44 -8.25 53.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -45.55 8.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.431 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 61.0 p -107.5 -7.43 16.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 314' ' ' ASN . . . 61.72 18.84 57.48 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.678 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.5 163.69 35.04 Favored Pre-proline 0 C--O 1.227 -0.131 0 CA-C-O 120.677 0.275 . . . . 0.0 111.017 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.747 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 88.0 Cg_exo -46.86 154.55 1.05 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.789 2.326 . . . . 0.0 113.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.536 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -123.45 125.07 44.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.264 0.555 . . . . 0.0 110.959 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 338' ' ' THR . 2.7 mp -140.11 140.51 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -95.56 115.8 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.747 0.308 . . . . 0.0 110.29 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.814 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.553 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -151.09 131.86 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.433 0.158 . . . . 0.0 110.663 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.82 145.22 15.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 121.3 0.571 . . . . 0.0 112.298 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 322' ' ' ILE . 7.6 p -98.0 134.9 40.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.793 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.831 ' CG2' HG11 ' A' ' 301' ' ' VAL . 57.2 t -107.84 128.69 62.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.405 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 50.3 m -90.4 142.78 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.374 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 146.0 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 111.269 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -79.28 -17.94 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.14 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.8 111.03 27.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.554 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -49.07 -52.19 9.19 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.469 2.113 . . . . 0.0 112.877 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.1 Cg_endo -59.07 -30.67 93.9 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.873 1.715 . . . . 0.0 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 36.4 t -65.66 -34.72 78.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.688 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.29 97.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.81 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.882 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -62.66 -50.91 69.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.262 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.35 53.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.65 ' HA ' HD13 ' A' ' 308' ' ' ILE . . . -68.75 -48.0 64.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.305 0.574 . . . . 0.0 109.863 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.6 mt -57.44 -35.64 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.228 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -26.55 68.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.819 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.5 t90 -98.67 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.847 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 355' ' ' ASP . 60.6 m-85 -56.04 -74.17 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.562 ' C ' ' O ' ' A' ' 354' ' ' PHE . 22.6 t0 8.97 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.911 0.757 . . . . 0.0 111.624 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.02 22.35 4.25 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.259 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -78.72 -164.48 0.59 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.608 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 21.3 mm-40 -130.11 137.24 50.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 112.149 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.713 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -102.75 101.47 11.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.146 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.26 29.52 5.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.703 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 123.9 -37.9 2.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.443 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.7 OUTLIER -82.77 169.98 16.14 Favored Pre-proline 0 C--O 1.22 -0.474 0 CA-C-N 116.876 0.338 . . . . 0.0 110.659 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.76 144.46 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.441 2.761 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.713 HG21 ' HD2' ' A' ' 359' ' ' PHE . 3.6 pt -130.98 161.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-O 120.824 0.345 . . . . 0.0 111.667 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -130.42 100.95 5.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 287' ' ' ILE . 23.3 t -85.64 130.79 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 p -127.75 -177.27 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.915 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.489 ' O ' ' ND2' ' A' ' 285' ' ' ASN . 13.8 m120 . . . . . 0 N--CA 1.458 -0.027 0 CA-C-O 120.621 0.248 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.0 OUTLIER 85.31 14.06 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.445 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 90.1 m -164.97 107.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.709 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.821 HD11 ' CE2' ' A' ' 305' ' ' PHE . 33.0 pt -92.75 170.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.172 0.51 . . . . 0.0 111.842 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.54 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.0 m-85 -119.75 110.92 17.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.553 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 339' ' ' VAL . 0.4 OUTLIER -103.15 119.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -128.31 130.03 47.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.533 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 126.26 20.18 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.154 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -71.19 -101.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 171.64 -100.44 0.15 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.139 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -131.95 33.55 3.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 296' ' ' VAL . 1.4 p-10 -130.46 -51.66 1.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.137 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 296' ' ' VAL . 14.4 p -2.05 76.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.803 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -112.76 155.05 25.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.699 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.636 HG23 ' HB ' ' A' ' 322' ' ' ILE . 16.7 mt -61.12 -47.04 95.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -38.27 87.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -39.26 79.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.121 0.486 . . . . 0.0 110.484 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 297' ' ' THR . 87.2 t -73.41 -39.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.805 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.23 73.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.926 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -39.87 62.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.678 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -89.5 -21.64 22.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -102.19 30.09 4.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.142 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.3 19.36 17.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.159 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -101.83 -39.7 7.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 110.323 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -79.1 -38.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.119 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.99 -169.97 30.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.525 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.59 144.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 340' ' ' SER . 4.1 mp -93.48 131.83 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.144 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 25.7 mtmt -48.91 93.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.765 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -64.56 145.46 56.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.463 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.491 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 5.8 m-20 -75.89 162.19 28.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.346 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -104.95 -7.72 19.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -104.48 -35.69 7.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.999 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 314' ' ' ASN . 69.6 p -108.24 -9.57 15.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 313' ' ' THR . . . 60.51 14.72 36.35 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.718 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 159.18 52.41 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.984 0.392 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 76.6 Cg_exo -44.68 151.15 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.007 2.471 . . . . 0.0 112.86 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.491 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 29.9 mtm -108.11 119.15 38.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.391 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.636 ' HB ' HG23 ' A' ' 298' ' ' ILE . 4.8 mt -143.22 142.74 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.467 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -117.95 133.19 56.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 324' ' ' LEU . 0.1 OUTLIER -125.41 164.04 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.209 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.821 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.655 ' O ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -139.78 131.77 27.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.172 . . . . 0.0 110.866 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -162.65 145.54 11.01 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 121.089 0.471 . . . . 0.0 111.882 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.54 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 5.1 p -95.3 150.01 20.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.135 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.762 ' CG2' HG11 ' A' ' 301' ' ' VAL . 44.7 t -123.71 127.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 311' ' ' ILE . 91.4 p -84.32 153.21 23.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 3.5 m-85 -127.08 133.41 50.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.022 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -62.46 -22.19 66.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.942 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -127.98 116.72 20.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.758 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.5 Cg_exo -45.23 -51.05 8.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.664 2.243 . . . . 0.0 113.017 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.2 Cg_endo -59.55 -30.48 92.52 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.85 1.7 . . . . 0.0 111.159 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.37 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' A' ' 287' ' ' ILE . . . -58.64 -42.75 89.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.915 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.86 -55.96 21.53 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.527 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -48.32 -31.74 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.792 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.61 -47.74 65.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.428 0.632 . . . . 0.0 109.39 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -61.91 -36.52 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.073 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -26.42 68.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.325 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.533 ' CE3' ' CZ ' ' A' ' 354' ' ' PHE . 3.5 t90 -91.08 -68.5 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.533 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 2.5 m-85 -68.84 -77.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 33.8 t0 25.27 50.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.033 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.7 26.98 1.21 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.804 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.505 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -102.47 -156.19 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.347 0.574 . . . . 0.0 110.778 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.4 mt-10 -113.5 128.65 56.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.349 0.595 . . . . 0.0 112.192 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.5 OUTLIER -108.01 103.19 12.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.981 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.5 t 63.36 28.07 15.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.619 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 104.62 -14.06 50.29 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.799 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 4.0 m-80 -106.92 170.94 5.14 Favored Pre-proline 0 C--O 1.219 -0.503 0 CA-C-N 117.246 0.523 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 89.7 Cg_endo -92.1 139.14 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.82 2.346 . . . . 0.0 111.904 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.533 HG22 HD13 ' A' ' 292' ' ' LEU . 9.2 pt -132.33 172.78 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 106.16 4.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.772 ' CG1' HD12 ' A' ' 287' ' ' ILE . 14.4 t -84.45 139.54 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.813 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -122.43 -175.0 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 111.885 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.447 ' CE1' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.431 ' OD1' ' CZ ' ' A' ' 368' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER 166.08 -33.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.668 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 78.8 m -101.47 115.67 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.935 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 366' ' ' VAL . 9.2 pt -91.08 173.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 338' ' ' THR . 2.4 m-85 -130.34 108.37 9.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.122 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.596 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -99.82 114.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 35.8 mm-40 -119.91 130.62 54.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.422 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.86 ' C ' HD13 ' A' ' 292' ' ' LEU . . . 115.68 70.45 0.47 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.338 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.931 HD21 ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.83 -78.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.877 0.339 . . . . 0.0 110.12 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.93 -81.62 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.665 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 294' ' ' GLU . 8.6 tp10 -140.93 41.5 1.82 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.249 0.547 . . . . 0.0 110.13 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -138.13 14.56 2.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.32 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 1.061 HG12 HD23 ' A' ' 324' ' ' LEU . 1.6 t -77.38 95.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 111.612 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.817 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.07 151.52 52.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.301 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 324' ' ' LEU . 26.6 mm -65.21 -48.36 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.58 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.91 -35.11 79.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.761 0.315 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 55.2 m -70.89 -43.82 67.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.577 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -63.0 -29.78 71.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.165 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.6 -38.84 64.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.889 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 -22.36 18.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -93.22 5.26 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.06 23.93 6.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.89 -31.65 8.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 353' ' ' TRP . 1.8 tp -91.32 -39.39 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.767 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -150.96 -175.92 23.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.18 119.82 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 305' ' ' PHE . 73.5 mt -85.83 125.02 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.244 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -48.71 103.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -62.02 148.8 42.82 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.641 178.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.805 HD21 HG23 ' A' ' 317' ' ' THR . 0.1 OUTLIER -106.8 140.08 40.21 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.73 0.3 . . . . 0.0 110.525 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -5.34 47.13 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -29.16 17.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.805 HG23 HD21 ' A' ' 314' ' ' ASN . 28.9 p -122.13 -23.17 5.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 83.4 12.17 78.97 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.339 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.95 153.29 71.03 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.9 Cg_endo -44.79 153.24 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.048 2.499 . . . . 0.0 112.596 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.492 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 45.9 mtp -104.69 128.53 52.79 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 338' ' ' THR . 3.1 mt -140.22 141.56 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.938 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 6.1 m-80 -97.37 148.38 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 1.061 HD23 HG12 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -144.98 135.9 24.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.842 0.353 . . . . 0.0 111.483 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.127 179.174 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.453 -0.221 0 N-CA-C 113.627 0.211 . . . . 0.0 113.627 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.931 ' HA ' HD21 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -160.23 167.29 27.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 0.0 111.217 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -158.0 147.14 19.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.144 0.497 . . . . 0.0 111.741 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 322' ' ' ILE . 4.2 p -107.56 133.5 51.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.201 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 322' ' ' ILE . 49.8 t -100.91 124.29 54.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.3 p -94.67 112.16 23.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.199 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 311' ' ' ILE . 59.1 m-85 -91.27 159.46 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.953 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -88.91 -14.69 36.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -128.27 119.9 20.92 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.943 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.607 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.4 Cg_exo -47.56 -48.87 14.47 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.714 2.276 . . . . 0.0 113.027 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.9 Cg_endo -60.36 -30.6 91.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.858 1.705 . . . . 0.0 111.392 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -62.09 -34.91 77.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.645 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.542 ' HB3' ' CE1' ' A' ' 368' ' ' PHE . . . -59.71 -50.05 75.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.483 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 1.007 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -60.75 -45.8 92.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.956 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.5 34.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.63 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.49 -46.97 68.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 1.007 HD12 ' HA ' ' A' ' 348' ' ' LYS . 12.3 mt -59.64 -34.75 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.119 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -26.88 67.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.551 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.564 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.72 -68.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.049 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.39 -79.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.117 -177.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 37.6 t70 30.08 43.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 134.92 28.3 0.45 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.139 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -98.19 -163.6 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.9 pm0 -120.39 128.84 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.135 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.724 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.2 OUTLIER -82.88 101.45 11.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.243 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 45.91 29.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.281 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.27 -43.36 1.26 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.925 -1.131 . . . . 0.0 114.256 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -92.49 162.64 29.11 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-N 117.242 0.521 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 84.4 Cg_endo -85.93 141.85 7.48 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.135 2.557 . . . . 0.0 112.176 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.447 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 13.4 pt -124.77 177.6 4.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-O 121.105 0.479 . . . . 0.0 111.701 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -144.91 101.66 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.513 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 289' ' ' VAL . 25.7 t -84.76 135.17 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.053 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 m -136.85 172.61 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.428 . . . . 0.0 111.64 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.744 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 347' ' ' ALA . 0.7 OUTLIER -57.32 -21.74 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 61.4 m -71.61 102.29 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 305' ' ' PHE . 13.7 pt -104.02 162.04 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.991 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 338' ' ' THR . 0.1 OUTLIER -125.22 127.54 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 112.202 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.821 HG13 HG22 ' A' ' 366' ' ' VAL . 1.7 t -107.12 117.5 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.401 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.482 ' OE1' ' CD2' ' A' ' 288' ' ' PHE . 1.3 mp0 -112.53 129.82 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.745 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.4 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 42.26 0.91 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.658 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 335' ' ' GLY . 0.4 OUTLIER -71.19 -78.6 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.522 0.201 . . . . 0.0 110.81 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 111.41 87.09 1.71 Allowed Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.172 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 43.68 30.31 0.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.684 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.28 29.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.863 ' O ' HD13 ' A' ' 324' ' ' LEU . 2.5 t -75.43 72.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -116.57 146.87 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 322' ' ' ILE . 35.8 mt -69.31 -43.66 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.479 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.15 -42.93 88.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.899 0.38 . . . . 0.0 110.666 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.9 p -65.0 -41.27 95.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 110.697 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 85.5 t -71.21 -42.7 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.266 0.555 . . . . 0.0 109.733 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -63.25 -30.43 71.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.3 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -39.69 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.614 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -88.83 -24.33 22.6 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.614 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.632 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -94.14 19.1 9.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.662 0.268 . . . . 0.0 111.332 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.89 20.54 18.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 110.899 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -102.56 -39.36 7.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 tp -73.03 -34.98 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.05 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -167.25 -153.11 7.78 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.646 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -109.55 119.55 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.9 mt -71.77 130.66 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.1 OUTLIER -48.68 92.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.62 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -69.81 137.49 51.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.432 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.5 OUTLIER -73.98 128.26 35.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.194 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -5.9 56.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.074 0.464 . . . . 0.0 110.071 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.44 -40.69 7.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.452 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.3 OUTLIER -105.13 -11.12 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.906 -179.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.07 11.92 59.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.498 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.672 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.16 152.2 66.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.902 0.351 . . . . 0.0 111.336 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 80.8 Cg_exo -47.68 158.47 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.795 2.33 . . . . 0.0 112.476 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.425 ' HG3' ' ND2' ' A' ' 314' ' ' ASN . 37.2 mmm -119.13 119.09 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 111.119 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.83 HG23 ' O ' ' A' ' 338' ' ' THR . 59.6 mt -143.08 144.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.736 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.2 m-80 -103.27 148.15 26.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 111.011 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 296' ' ' VAL . 3.6 mt -130.4 131.03 45.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 1.5 mt-10 -143.84 131.94 21.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.345 0.117 . . . . 0.0 110.8 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -144.15 167.45 22.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.159 0.504 . . . . 0.0 111.913 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 322' ' ' ILE . 1.3 p -121.12 145.84 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.198 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 322' ' ' ILE . 92.0 t -125.4 134.37 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 0.0 111.385 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 312' ' ' LYS . 59.2 p -98.37 131.02 45.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.016 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.44 147.81 29.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.2 OUTLIER -79.08 -9.54 59.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 116.58 15.49 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.62 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.9 Cg_exo -45.13 -50.27 9.05 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.579 2.186 . . . . 0.0 112.798 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.0 Cg_endo -54.71 -30.56 67.29 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.924 1.749 . . . . 0.0 111.484 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.4 t -59.03 -42.17 89.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.868 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 285' ' ' ASN . . . -56.86 -49.84 74.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 0.0 110.387 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.88 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.5 tppt? -61.98 -53.86 49.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.653 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.68 47.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.846 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.44 -47.92 65.93 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.88 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.7 mt -59.8 -36.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.66 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.166 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.514 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.16 -68.05 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.115 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.61 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -76.17 -80.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.1 p-10 26.62 45.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.399 0.437 . . . . 0.0 111.992 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.36 37.25 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.052 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.61 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -95.91 -155.99 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 13.4 mt-10 -113.27 128.27 56.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.62 . . . . 0.0 111.48 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.493 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -122.76 101.91 7.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.937 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 56.0 m 60.55 27.22 16.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 110.537 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.55 17.49 52.2 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 20.3 m-80 -129.28 164.37 39.87 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.869 0.366 . . . . 0.0 111.306 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 90.5 Cg_endo -89.55 132.54 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.816 2.344 . . . . 0.0 111.9 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 289' ' ' VAL . 20.4 pt -120.84 174.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.04 0.448 . . . . 0.0 111.992 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -139.39 100.95 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.728 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.821 HG22 HG13 ' A' ' 289' ' ' VAL . 26.0 t -97.64 115.92 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -140.54 -165.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.224 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 285' ' ' ASN . 33.7 m120 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.781 0.324 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 284' ' ' ASN . 6.4 p30 168.64 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.07 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 90.7 m -104.84 95.33 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.996 HD12 HG13 ' A' ' 366' ' ' VAL . 50.3 pt -86.53 168.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.681 ' HD2' HG22 ' A' ' 338' ' ' THR . 31.4 m-85 -120.71 124.28 44.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.661 HG12 ' HB ' ' A' ' 364' ' ' ILE . 0.9 OUTLIER -109.73 114.65 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.886 178.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -116.53 130.66 56.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.017 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 363' ' ' PRO . . . 127.96 20.7 1.63 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.615 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 295' ' ' ASN . 12.3 mt -66.76 -103.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.95 0.35 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.97 34.5 5.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.585 HD21 HD22 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.41 30.74 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.715 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.97 81.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.582 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -146.6 146.27 30.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.704 HG23 ' HB ' ' A' ' 322' ' ' ILE . 15.4 mt -71.37 -43.39 73.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.15 -40.62 90.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.64 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.8 t -63.45 -41.05 98.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 297' ' ' THR . 43.9 t -74.12 -41.17 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.295 0.569 . . . . 0.0 109.95 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.12 -29.85 68.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -74.14 -39.59 63.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -92.41 -24.49 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -96.78 32.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.236 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -116.18 16.62 15.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.288 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -98.77 -42.19 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.455 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.6 tp -71.07 -32.6 48.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.24 -163.66 27.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.6 mt -100.64 141.84 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.534 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.1 mt -100.83 125.22 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.411 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.76 107.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -73.42 152.38 40.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.133 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.567 HD21 HG23 ' A' ' 317' ' ' THR . 0.2 OUTLIER -105.27 138.16 41.91 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.827 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -1.95 25.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -96.9 -26.51 15.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 110.481 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.567 HG23 HD21 ' A' ' 314' ' ' ASN . 68.6 p -121.33 -20.41 6.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.58 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 75.79 13.96 82.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.976 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.536 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.86 164.03 35.66 Favored Pre-proline 0 C--N 1.333 -0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.376 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.616 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 71.3 Cg_exo -44.7 155.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.76 2.307 . . . . 0.0 112.384 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.501 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 51.7 mtp -109.34 119.8 40.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 111.636 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.704 ' HB ' HG23 ' A' ' 298' ' ' ILE . 3.4 mt -142.83 145.19 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.977 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 11.6 t-20 -119.15 116.4 26.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.805 0.336 . . . . 0.0 110.934 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.7 130.28 56.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 290' ' ' GLN . 6.8 mt-10 -140.97 131.54 25.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.596 0.236 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -139.28 169.69 17.31 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.917 0.389 . . . . 0.0 111.275 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.681 HG22 ' HD2' ' A' ' 288' ' ' PHE . 20.0 p -128.05 126.38 41.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.572 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 322' ' ' ILE . 42.3 t -106.51 116.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.396 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 311' ' ' ILE . 20.4 m -80.68 152.96 28.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 5.5 m-85 -136.29 139.15 42.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 -26.29 65.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -124.16 116.03 27.31 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.589 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.2 Cg_exo -42.72 -51.12 5.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.773 2.315 . . . . 0.0 113.094 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.4 Cg_endo -53.66 -30.37 55.39 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.817 1.678 . . . . 0.0 111.131 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.4 t -57.7 -46.15 84.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.16 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -54.52 -39.63 67.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.618 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.892 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.3 tptp -64.91 -59.56 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.45 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -46.42 -30.71 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.758 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -50.25 52.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.469 0.652 . . . . 0.0 109.282 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.1 mt -59.48 -37.35 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.987 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.4 -26.3 66.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.946 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.4 t90 -98.9 -68.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 366' ' ' VAL . 8.1 m-85 -63.86 -76.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 12.7 p-10 19.88 55.49 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.99 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 120.92 17.73 4.08 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.3 OUTLIER -76.14 -161.4 0.18 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.672 0.272 . . . . 0.0 111.323 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 3.3 mt-10 -113.48 152.92 29.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 111.523 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -142.08 101.3 3.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.514 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p 49.82 27.41 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.88 0.371 . . . . 0.0 110.665 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.43 17.33 22.24 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.245 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 359' ' ' PHE . 63.6 m-80 -129.3 152.2 79.09 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 121.002 0.429 . . . . 0.0 111.766 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.434 ' O ' ' HA3' ' A' ' 291' ' ' GLY . 90.7 Cg_endo -85.53 133.43 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.947 2.431 . . . . 0.0 111.451 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.661 ' HB ' HG12 ' A' ' 289' ' ' VAL . 5.1 pt -119.2 150.32 21.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.275 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 103.67 9.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.339 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.996 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -84.51 130.66 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.646 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.43 -174.45 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.701 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.671 ' CD2' HD13 ' A' ' 351' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.418 ' ND2' ' N ' ' A' ' 284' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.309 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 17.1 p30 -60.41 -23.6 64.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.4 m -70.13 139.56 52.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 366' ' ' VAL . 39.1 pt -122.44 164.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.608 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.2 OUTLIER -113.24 109.1 18.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.69 114.66 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 2.0 mp0 -113.74 130.54 56.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.5 47.89 1.09 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.873 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.878 HD12 HG22 ' A' ' 296' ' ' VAL . 7.1 mt -68.9 -70.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.723 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 102.79 77.48 1.22 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.632 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 42.01 31.53 0.24 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 29.29 2.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 110.512 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.918 HG12 HD22 ' A' ' 324' ' ' LEU . 4.6 t -69.29 86.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.862 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.88 146.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 322' ' ' ILE . 29.9 mm -70.88 -44.23 76.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.319 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.82 -43.1 84.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.782 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -41.59 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.7 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 297' ' ' THR . 72.6 t -72.05 -41.71 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.722 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -30.43 69.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.959 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.11 -35.37 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.845 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -88.71 -22.22 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.569 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 339' ' ' VAL . 1.2 m-85 -89.49 12.27 17.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 29.71 2.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.36 -35.51 5.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 349' ' ' ALA . 5.0 tp -80.04 -33.88 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.336 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.67 -150.62 9.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.823 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.47 129.18 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 302' ' ' ALA . 5.3 mt -84.34 125.9 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.05 0.452 . . . . 0.0 110.454 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -49.03 91.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.385 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -82.62 170.29 15.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.066 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.578 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -106.51 153.29 22.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -1.27 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.919 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 317' ' ' THR . 1.1 tptp -94.59 -47.38 6.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.607 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.561 HG23 ' HG3' ' A' ' 316' ' ' LYS . 58.4 p -104.62 -12.84 16.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.921 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.04 20.19 59.98 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.209 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.88 154.23 70.86 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 73.2 Cg_exo -51.16 149.87 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.226 1.951 . . . . 0.0 111.745 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.578 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -118.53 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.439 0.638 . . . . 0.0 112.208 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -140.9 143.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.618 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.37 115.6 28.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -116.14 153.66 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.847 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -148.29 131.26 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.777 0.322 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.06 170.33 22.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.066 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 322' ' ' ILE . 76.1 p -127.2 114.58 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 322' ' ' ILE . 48.7 t -94.82 117.04 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.1 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 312' ' ' LYS . 67.6 m -84.5 132.9 34.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.707 ' HE2' HD13 ' A' ' 287' ' ' ILE . 18.2 m-85 -104.95 142.62 34.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -19.5 62.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 346' ' ' SER . 0.7 OUTLIER -128.94 120.96 20.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.875 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -47.76 -48.63 15.43 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 113.069 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.8 Cg_endo -60.99 -30.63 90.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.858 1.705 . . . . 0.0 111.277 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -61.02 -32.6 72.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.372 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -61.68 -55.3 31.9 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.672 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -59.01 -43.33 91.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.166 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.38 -35.42 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.406 ' CA ' HG12 ' A' ' 308' ' ' ILE . . . -68.69 -49.35 59.66 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.429 0.633 . . . . 0.0 109.584 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -59.45 -36.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.135 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -62.68 -26.4 68.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.618 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.56 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.2 t90 -100.32 -68.13 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.175 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.529 ' O ' ' C ' ' A' ' 355' ' ' ASP . 23.2 m-85 -61.33 -77.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 354' ' ' PHE . 17.4 p-10 17.29 59.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.71 22.11 2.54 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.739 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.447 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -81.22 -165.61 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.63 0.215 . . . . 0.0 110.799 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.9 OUTLIER -124.38 129.67 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 111.861 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.82 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -89.72 101.46 14.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.064 178.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.85 29.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.24 -48.71 0.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.93 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -82.8 169.95 16.22 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 117.034 0.417 . . . . 0.0 110.636 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 87.4 Cg_endo -95.85 145.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 111.952 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.82 HG21 ' HD2' ' A' ' 359' ' ' PHE . 5.8 pt -127.37 -178.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.174 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -145.59 100.57 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 287' ' ' ILE . 21.7 t -87.43 128.41 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -140.2 -165.55 1.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 368' ' ' PHE . 2.2 t-20 . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.855 0.36 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER -123.44 -3.23 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.32 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.6 m -114.86 127.26 55.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 1.005 HD12 HG13 ' A' ' 366' ' ' VAL . 29.7 pt -108.45 167.87 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.633 ' CD1' HG22 ' A' ' 338' ' ' THR . 18.0 m-30 -122.59 114.83 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.261 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -105.69 114.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.398 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -108.88 130.55 55.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 119.65 55.56 0.25 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.684 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 296' ' ' VAL . 3.0 mm? -91.41 -77.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.749 0.309 . . . . 0.0 110.721 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.91 76.2 1.06 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.112 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 44.89 41.04 4.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 111.738 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.64 24.62 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.729 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 292' ' ' LEU . 4.0 t -73.89 88.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.519 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -116.63 146.54 42.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.793 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 54.2 mt -71.4 -43.49 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.443 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.44 -41.28 89.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.9 t -64.78 -43.4 93.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.725 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 297' ' ' THR . 59.6 t -72.98 -41.07 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.321 0.582 . . . . 0.0 109.649 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.1 -29.69 68.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.982 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -73.5 -39.03 65.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.608 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.86 -22.47 16.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.0 OUTLIER -95.56 2.37 54.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 21.5 ptmt -96.37 30.2 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -34.31 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.11 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.459 HD13 ' HB2' ' A' ' 353' ' ' TRP . 0.8 OUTLIER -80.31 -41.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.244 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -146.58 -168.24 13.45 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.7 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.14 106.71 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 10.8 mt -72.39 129.49 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 109.929 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 92.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -65.99 138.94 58.15 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.782 177.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.1 OUTLIER -89.78 165.75 13.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.171 0.51 . . . . 0.0 111.96 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -102.57 -4.41 25.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.3 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.959 ' HD3' HG23 ' A' ' 317' ' ' THR . 0.0 OUTLIER -96.33 -40.81 8.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.75 179.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.959 HG23 ' HD3' ' A' ' 316' ' ' LYS . 12.1 p -106.13 -18.33 14.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.304 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.44 8.13 85.62 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.161 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.54 157.89 66.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.743 0.272 . . . . 0.0 111.022 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.635 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 1.1 Cg_endo -45.45 162.18 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.904 2.403 . . . . 0.0 112.617 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.515 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.84 130.37 56.67 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.686 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 339' ' ' VAL . 1.9 mp -143.22 140.02 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -105.23 115.82 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 296' ' ' VAL . 0.2 OUTLIER -108.87 150.35 27.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.278 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 336' ' ' GLU . 14.2 m-85 . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.74 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.994 -0.042 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -160.42 178.06 9.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.284 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -154.06 162.6 41.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.633 HG22 ' CD1' ' A' ' 288' ' ' PHE . 19.5 p -116.93 117.45 29.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.052 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 322' ' ' ILE . 50.8 t -92.73 123.06 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.586 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 311' ' ' ILE . 1.2 m -101.33 131.87 47.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 339' ' ' VAL . 26.8 m-85 -115.37 158.54 22.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.063 0.458 . . . . 0.0 111.268 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.9 6.81 37.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.08 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.32 121.81 7.91 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 50.5 Cg_exo -52.88 -47.75 25.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.68 2.253 . . . . 0.0 113.326 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.8 Cg_endo -60.7 -30.12 89.72 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.729 1.619 . . . . 0.0 111.048 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -40.54 81.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.973 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.45 -50.87 72.24 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.17 -50.87 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.778 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.44 -34.16 33.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' A' ' 305' ' ' PHE . . . -68.62 -46.81 68.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.421 0.629 . . . . 0.0 109.756 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.8 mt -58.69 -34.24 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.294 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.29 -26.8 68.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.796 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.537 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.07 -68.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 0.9 OUTLIER -77.63 -79.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.58 -176.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 28.74 45.7 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.799 0.333 . . . . 0.0 111.704 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 128.52 30.78 0.69 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -90.94 -160.32 0.71 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.51 0.195 . . . . 0.0 111.047 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 6.0 mp0 -113.36 153.13 29.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.291 0.567 . . . . 0.0 111.704 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.535 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.0 OUTLIER -136.98 101.12 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.319 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.6 m 46.73 28.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.81 18.75 14.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.118 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 359' ' ' PHE . 72.0 m-80 -129.29 150.24 74.96 Favored Pre-proline 0 C--O 1.225 -0.186 0 CA-C-O 121.067 0.46 . . . . 0.0 111.71 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.93 127.83 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.766 2.311 . . . . 0.0 111.678 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 289' ' ' VAL . 6.1 pt -111.43 165.2 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.912 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.34 100.99 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 1.005 HG13 HD12 ' A' ' 287' ' ' ILE . 26.6 t -87.09 133.14 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 p -133.83 -176.49 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.653 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.55 ' CD1' ' OD1' ' A' ' 284' ' ' ASN . 26.6 m-85 . . . . . 0 C--O 1.233 0.188 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 121.014 0.435 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.721 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.0 OUTLIER -104.95 -28.41 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.4 m -64.82 145.13 56.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.846 HD12 HG13 ' A' ' 366' ' ' VAL . 23.5 pt -125.39 173.42 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -121.77 109.29 14.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -103.19 117.38 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.662 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.422 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -129.87 130.9 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.13 19.52 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.601 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 359' ' ' PHE . 39.6 mt -70.1 -101.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 159.08 -93.29 0.12 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.274 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -132.43 28.56 4.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.146 0.498 . . . . 0.0 110.136 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.09 -12.93 8.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.468 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.673 ' CG2' ' HB2' ' A' ' 337' ' ' ALA . 9.7 p -44.63 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -143.5 147.13 34.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.062 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.49 -47.37 93.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.712 0.291 . . . . 0.0 111.769 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.27 -39.47 89.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.2 t -68.44 -42.86 78.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 297' ' ' THR . 46.2 t -72.88 -38.82 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 109.625 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.38 -29.85 68.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.895 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.72 -40.54 66.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.812 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.2 -24.26 16.33 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.579 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.6 OUTLIER -95.72 33.13 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.901 0.381 . . . . 0.0 110.977 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.31 21.0 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -103.92 -40.39 6.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.285 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -72.28 -27.84 27.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.5 -165.92 32.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.705 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.58 134.94 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.462 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -94.68 127.73 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.422 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 321' ' ' MET . 14.7 mtmm -48.77 110.27 0.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -60.14 -179.64 0.11 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 315' ' ' LYS . 3.9 m-80 -95.98 -40.89 9.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 314' ' ' ASN . 0.2 OUTLIER 86.92 -31.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.411 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -41.23 11.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 67.0 p -100.23 -11.69 20.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.337 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 71.02 12.06 71.0 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 157.3 64.89 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.318 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 59.0 Cg_exo -44.59 161.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.259 2.64 . . . . 0.0 113.143 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 312' ' ' LYS . 21.5 mtp -120.67 124.65 45.72 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.585 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 301' ' ' VAL . 7.1 mt -142.52 137.07 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.947 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.555 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.6 t30 -96.49 147.97 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.172 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -144.28 153.04 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 111.165 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 179.734 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 120.525 -0.042 . . . . 0.0 113.065 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.422 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 8.3 mp0 -121.51 133.23 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.673 ' HB2' ' CG2' ' A' ' 296' ' ' VAL . . . -160.19 149.95 17.95 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 288' ' ' PHE . 17.7 p -108.6 127.74 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.547 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.593 ' CG2' HG11 ' A' ' 301' ' ' VAL . 65.1 t -99.27 128.01 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.929 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.2 m -87.05 153.02 21.86 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.483 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 346' ' ' SER . 4.0 m-85 -136.14 141.58 44.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 111.273 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -9.35 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.212 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.46 117.88 13.47 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.779 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.595 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 62.0 Cg_exo -49.73 -49.67 15.27 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.6 2.2 . . . . 0.0 113.041 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.7 Cg_endo -59.81 -30.53 92.17 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 121.791 1.661 . . . . 0.0 111.048 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -59.84 -35.09 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.88 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -62.02 -52.89 62.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.342 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.97 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -57.85 -46.48 84.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.095 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.52 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.71 -33.05 63.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.873 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 354' ' ' PHE . . . -68.65 -49.04 62.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 348' ' ' LYS . 15.9 mt -52.91 -34.52 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.946 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 348' ' ' LYS . 8.9 t0 -61.09 -26.71 67.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.931 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -102.89 -63.73 1.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.869 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.738 ' HB2' HG21 ' A' ' 366' ' ' VAL . 10.3 m-85 -66.26 -77.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.591 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 351' ' ' ILE . 30.5 t0 9.41 62.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 107.08 35.09 2.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.226 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.96 -156.38 0.54 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -125.7 128.9 48.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.109 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.702 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -89.41 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.842 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.58 28.39 0.76 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.655 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.04 -43.09 1.35 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.633 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 2.0 m-80 -81.83 169.99 16.7 Favored Pre-proline 0 C--O 1.22 -0.486 0 CA-C-N 116.974 0.387 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -97.88 142.05 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.514 2.81 . . . . 0.0 112.273 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 359' ' ' PHE . 3.4 pt -127.53 177.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.856 0.36 . . . . 0.0 111.512 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -145.03 101.61 3.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.752 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.846 HG13 HD12 ' A' ' 287' ' ' ILE . 61.2 t -88.92 138.15 19.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.761 0.315 . . . . 0.0 110.766 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.6 p -138.72 -164.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.331 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 5.2 m-85 . . . . . 0 C--N 1.333 -0.14 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.192 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.404 ' HB2' ' CD2' ' A' ' 368' ' ' PHE . 1.8 m-80 . . . . . 0 N--CA 1.462 0.155 0 CA-C-O 120.685 0.279 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.2 OUTLIER -71.16 -37.02 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 m -90.57 136.63 32.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.763 HD12 HG13 ' A' ' 366' ' ' VAL . 6.1 pt -116.64 173.05 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CE2' ' CB ' ' A' ' 367' ' ' SER . 0.2 OUTLIER -135.66 120.99 19.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 111.051 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.774 ' CG1' HD12 ' A' ' 364' ' ' ILE . 1.0 OUTLIER -101.37 127.1 55.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.802 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.13 130.49 52.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.031 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.441 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 110.79 72.28 0.67 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.909 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -135.71 -87.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.46 115.27 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.301 -0.952 . . . . 0.0 114.141 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 53.59 32.77 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 8.48 0.77 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.39 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG13 ' A' ' 296' ' ' VAL . 13.7 p -77.98 95.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 112.232 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.895 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -136.4 146.81 46.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.083 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 322' ' ' ILE . 28.2 mm -64.98 -46.15 92.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.75 -41.82 87.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.901 0.382 . . . . 0.0 110.752 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.0 p -63.63 -41.65 98.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 297' ' ' THR . 34.1 t -73.56 -45.88 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -60.89 -29.96 69.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.564 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 28.4 t0 -74.3 -38.04 63.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.785 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.84 -21.82 20.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -91.89 11.42 24.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -96.5 24.05 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 111.079 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 -38.49 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.309 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 349' ' ' ALA . 3.3 tp -75.66 -39.54 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.179 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -176.04 -166.9 34.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.583 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.82 139.41 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.745 0.307 . . . . 0.0 111.685 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 2.1 mt -94.16 138.69 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -48.0 91.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.239 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -68.34 145.37 54.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.839 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.455 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 8.4 m-20 -78.62 170.96 15.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.343 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 -16.18 12.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.957 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -99.6 -36.17 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.91 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 57.9 p -109.12 -5.95 15.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.032 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 56.42 17.94 20.6 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.268 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.94 154.92 53.27 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.649 0.262 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.504 ' HB3' ' CG2' ' A' ' 311' ' ' ILE . 68.1 Cg_exo -44.36 158.43 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.632 2.221 . . . . 0.0 112.712 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.5 OUTLIER -120.64 121.75 38.99 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.491 0.662 . . . . 0.0 111.674 -179.03 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 339' ' ' VAL . 2.3 mt -143.31 142.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.999 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 1.2 m-20 -103.19 148.5 25.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.138 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 296' ' ' VAL . 0.9 OUTLIER -152.82 147.53 26.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.892 0.377 . . . . 0.0 111.072 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 179.84 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.408 ' CA ' ' HG ' ' A' ' 292' ' ' LEU . . . . . . . . 0 CA--C 1.517 0.2 0 N-CA-C 113.398 0.119 . . . . 0.0 113.398 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 12.3 mt-10 -141.99 131.38 23.68 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.752 -0.264 . . . . 0.0 111.165 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -161.65 140.51 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.781 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 322' ' ' ILE . 19.1 p -100.33 131.54 46.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.357 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 322' ' ' ILE . 75.1 t -110.64 122.04 64.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.586 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 67.0 m -98.41 147.33 24.82 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.161 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 63.1 m-85 -121.68 152.21 39.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.07 45.79 0.28 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.647 0.26 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 343' ' ' ASP . 2.7 p30 165.14 125.98 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.481 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 71.4 Cg_exo -50.89 -48.86 18.92 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.613 2.209 . . . . 0.0 113.671 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.2 Cg_endo -57.29 -30.8 88.89 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.921 1.748 . . . . 0.0 112.04 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.412 ' CB ' ' OD1' ' A' ' 343' ' ' ASP . 40.2 t -61.14 -40.31 93.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.04 -51.75 66.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.989 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.932 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.44 -45.26 95.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.112 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.573 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.08 -34.25 63.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.537 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.51 -50.17 54.18 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.8 mt -55.74 -36.37 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.13 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.67 -26.59 67.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.744 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.52 ' CD1' ' CD2' ' A' ' 354' ' ' PHE . 1.3 t90 -82.41 -68.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.43 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.52 ' CD2' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.42 -78.54 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.536 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 31.13 51.11 0.12 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.86 22.09 1.84 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.096 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -84.63 -163.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.92 0.36 . . . . 0.0 110.093 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 10.8 mt-10 -119.17 130.87 55.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' A' ' 364' ' ' ILE . 0.1 OUTLIER -90.81 101.22 13.97 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.649 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 44.41 29.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.026 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.58 -48.72 0.92 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.94 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -84.48 172.92 8.02 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 116.925 0.362 . . . . 0.0 110.668 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -94.1 145.02 1.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.218 2.612 . . . . 0.0 111.682 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.774 HD12 ' CG1' ' A' ' 289' ' ' VAL . 5.9 pt -116.69 178.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -148.28 100.89 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.068 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.763 HG13 HD12 ' A' ' 287' ' ' ILE . 23.7 t -96.44 131.08 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . 0.517 ' CB ' ' CE2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -140.06 -164.0 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.923 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.776 ' CE1' HD13 ' A' ' 351' ' ' ILE . 3.7 m-85 . . . . . 0 CA--C 1.529 0.145 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.637 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 5.5 p30 -102.14 -33.25 9.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 27.9 m -83.96 126.22 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.174 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.739 HD12 HG13 ' A' ' 366' ' ' VAL . 13.6 pt -95.92 173.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.344 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.758 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -130.37 109.76 10.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -98.18 114.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -118.62 130.83 56.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.124 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.831 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 112.75 83.15 1.23 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.559 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 359' ' ' PHE . 1.9 mt -142.29 -78.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.828 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.21 -79.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.669 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -149.52 31.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.17 -17.97 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.971 HG22 HD23 ' A' ' 324' ' ' LEU . 9.7 p -45.86 123.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.94 146.5 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.424 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.751 HG23 HD12 ' A' ' 322' ' ' ILE . 2.1 mp -64.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.151 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 18.5 pm0 -66.4 -34.76 78.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.121 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.0 m -73.65 -43.87 58.33 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.041 0.448 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 297' ' ' THR . 29.8 t -72.22 -36.4 55.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.338 0.589 . . . . 0.0 109.754 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.702 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.33 -29.76 68.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.946 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.05 -41.25 62.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.773 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -97.39 -20.64 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 311' ' ' ILE . 1.2 t80 -101.21 35.0 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.325 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 18.86 11.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -40.87 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -72.35 -32.41 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.358 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.419 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -161.08 -163.29 13.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.76 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.0 mt -111.08 115.69 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -75.86 125.34 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -48.65 115.34 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 111.985 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -75.79 150.98 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.482 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -104.94 130.72 53.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -4.23 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 7.1 mptt -81.72 -36.64 28.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.4 OUTLIER -118.8 -30.98 4.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.21 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 96.78 14.39 43.47 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.882 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.685 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.18 162.03 44.03 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.901 0.351 . . . . 0.0 110.798 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 89.1 Cg_exo -44.56 162.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.78 2.32 . . . . 0.0 112.431 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.457 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -122.42 128.08 50.47 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.384 0.611 . . . . 0.0 111.758 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.751 HD12 HG23 ' A' ' 298' ' ' ILE . 4.9 mt -141.84 137.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.646 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -99.1 141.14 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.614 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.971 HD23 HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -145.09 131.86 20.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 111.001 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 292' ' ' LEU . . . . . . . . 0 CA--C 1.522 0.47 0 N-CA-C 112.74 -0.144 . . . . 0.0 112.74 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -122.49 131.78 54.02 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -151.93 151.92 31.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.934 0.397 . . . . 0.0 111.965 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.758 HG22 ' CD1' ' A' ' 288' ' ' PHE . 22.3 p -106.05 126.4 52.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 322' ' ' ILE . 73.3 t -99.49 128.61 51.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.966 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 311' ' ' ILE . 83.5 p -85.44 152.45 23.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.53 148.71 52.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.64 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.52 -16.88 58.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.411 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.2 OUTLIER -136.28 120.33 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.001 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.21 -51.07 7.13 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.655 2.237 . . . . 0.0 112.952 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.1 Cg_endo -53.69 -30.5 56.33 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.975 1.783 . . . . 0.0 111.241 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.419 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 14.2 t -57.24 -42.0 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.898 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -55.85 -49.55 73.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.81 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.5 -53.02 61.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.5 18.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.97 -52.78 25.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.4 mt -54.7 -36.66 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.367 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -26.18 66.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.816 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.553 ' HE3' HD13 ' A' ' 308' ' ' ILE . 3.1 t90 -98.29 -68.4 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 2.3 m-85 -66.68 -74.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 354' ' ' PHE . 25.7 t0 14.04 62.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.41 19.62 3.12 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.933 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.48 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 5.4 mtpt -87.05 -165.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.952 0.376 . . . . 0.0 110.687 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.735 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -121.74 142.47 50.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.79 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -111.13 101.68 10.18 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.824 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.75 28.74 6.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 358' ' ' GLU . . . 116.32 -2.92 20.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.443 -0.885 . . . . 0.0 114.285 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.3 m-80 -117.79 170.07 6.74 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 117.594 0.697 . . . . 0.0 110.67 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -96.06 141.85 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.491 2.794 . . . . 0.0 111.77 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.831 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.4 pt -128.85 168.58 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.052 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.155 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 100.94 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.739 HG13 HD12 ' A' ' 287' ' ' ILE . 21.2 t -84.85 131.84 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -135.12 -173.91 3.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.459 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 62.1 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.941 0.4 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 0.6 OUTLIER -50.97 -25.87 5.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.479 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 84.8 m -72.55 117.91 14.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.023 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.575 HD12 ' CG1' ' A' ' 366' ' ' VAL . 46.0 pt -107.7 169.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.406 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 338' ' ' THR . 0.1 OUTLIER -134.0 122.4 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 111.094 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 366' ' ' VAL . 2.4 t -110.02 127.64 66.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.6 mp0 -111.87 130.67 55.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.046 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.6 33.62 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.499 HD13 ' ND2' ' A' ' 295' ' ' ASN . 0.1 OUTLIER -59.71 -84.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 93.99 98.54 1.57 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.867 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.69 31.63 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.499 ' ND2' HD13 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -144.34 31.21 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 324' ' ' LEU . 4.0 t -75.91 70.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -129.37 146.61 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.587 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 322' ' ' ILE . 26.3 mm -71.45 -43.05 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.447 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.46 -40.67 89.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -42.65 83.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 66.4 t -71.43 -40.11 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.68 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.24 -29.83 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.839 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -41.93 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.88 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -88.02 -24.8 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.61 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -97.43 30.54 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.121 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 306' ' ' LYS . 0.0 OUTLIER -114.77 1.81 14.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -85.4 -52.06 6.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.821 0.343 . . . . 0.0 111.144 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.602 HG21 ' CE2' ' A' ' 354' ' ' PHE . 0.7 OUTLIER -65.64 -28.19 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.0 -171.95 39.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.558 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.4 mt -97.62 144.14 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.68 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.8 mt -97.86 127.01 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 29.0 mtmt -49.75 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.651 0.263 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -86.48 155.56 20.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.875 0.845 . . . . 0.0 111.504 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.577 ' HB3' ' OG1' ' A' ' 317' ' ' THR . 1.0 OUTLIER -71.12 98.37 1.66 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.195 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.587 ' HD2' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -46.4 -16.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.546 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 314' ' ' ASN . 20.3 mttm -92.5 -38.01 12.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 314' ' ' ASN . 47.9 p -103.62 -3.11 25.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 57.32 17.68 25.84 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.448 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -118.61 139.34 26.9 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.942 0.371 . . . . 0.0 111.252 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.3 Cg_exo -45.45 147.2 2.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.536 2.158 . . . . 0.0 112.406 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.4 mtp -107.74 123.07 47.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.42 0.629 . . . . 0.0 112.137 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 338' ' ' THR . 2.6 mp -143.02 139.74 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.567 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.745 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 5.1 m-80 -99.25 147.54 25.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.226 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 337' ' ' ALA . 2.7 mt -128.08 150.22 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 179.849 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 9.5 pt-20 -153.14 157.33 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.642 0.258 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -160.87 156.91 25.74 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 111.762 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 322' ' ' ILE . 2.0 p -103.48 136.9 42.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.055 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.626 HG22 HG12 ' A' ' 322' ' ' ILE . 55.6 t -112.06 130.52 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 311' ' ' ILE . 16.5 m -86.32 153.1 22.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.407 ' N ' ' HG3' ' A' ' 312' ' ' LYS . 2.6 m-85 -129.35 135.89 49.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 111.058 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.438 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 19.2 m-20 -63.29 -35.89 81.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.327 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.44 118.97 33.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.604 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.3 Cg_exo -42.42 -51.02 5.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.87 2.38 . . . . 0.0 112.701 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.4 Cg_endo -56.08 -30.62 79.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.963 1.775 . . . . 0.0 111.282 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.2 t -60.99 -40.74 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.582 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.32 -49.12 75.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.879 0.371 . . . . 0.0 110.468 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.2 tppt? -59.42 -54.94 40.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.637 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.87 -35.37 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.699 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 354' ' ' PHE . . . -68.95 -51.81 35.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.33 0.586 . . . . 0.0 109.458 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.1 mt -54.08 -39.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.728 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.19 -26.64 18.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.77 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.543 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.3 t90 -106.85 -68.45 0.89 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.477 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 366' ' ' VAL . 4.8 m-85 -59.1 -9.96 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 41.6 t0 -71.87 62.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.276 0.489 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 128.07 35.75 0.5 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.906 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 353' ' ' TRP . 36.4 mmtm -105.86 -173.83 2.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 5.7 mt-10 -116.66 133.1 56.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.134 0.492 . . . . 0.0 112.133 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.474 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -93.06 101.34 13.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.96 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 36.3 t 48.86 27.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.526 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.46 -45.01 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.737 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.9 OUTLIER -80.46 169.95 17.65 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 116.999 0.4 . . . . 0.0 111.037 -179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -94.63 145.16 1.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.397 2.731 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.4 pt -128.02 176.14 8.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.244 0.545 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -148.13 116.14 6.45 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.658 HG22 HG13 ' A' ' 289' ' ' VAL . 40.5 t -109.53 135.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.949 0.404 . . . . 0.0 111.875 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 p -140.67 -163.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.951 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.902 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 368' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.443 ' N ' ' ND2' ' A' ' 285' ' ' ASN . 0.1 OUTLIER -88.03 -31.59 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.282 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.6 m -88.04 134.2 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 17.8 pt -110.79 173.38 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.476 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.73 ' HD1' HG22 ' A' ' 338' ' ' THR . 1.4 t80 -127.8 108.15 10.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 364' ' ' ILE . 2.1 t -104.5 114.81 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.5 mp0 -111.76 130.25 55.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 120.18 37.67 0.73 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.666 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.895 HD12 ' ND2' ' A' ' 295' ' ' ASN . 2.8 mm? -79.04 -89.1 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.557 0.218 . . . . 0.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.34 104.93 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.293 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 77.01 43.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.784 0.325 . . . . 0.0 111.37 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.895 ' ND2' HD12 ' A' ' 292' ' ' LEU . 0.0 OUTLIER -168.45 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.79 HG22 HD13 ' A' ' 324' ' ' LEU . 8.7 p -19.06 94.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 301' ' ' VAL . 7.5 p -164.01 146.43 9.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.327 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.34 -42.27 74.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.986 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -43.15 86.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.9 p -65.03 -38.45 90.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 297' ' ' THR . 69.5 t -74.6 -40.62 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 109.729 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.26 -31.43 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.708 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -74.35 -36.12 63.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.893 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.18 -24.23 16.36 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -95.47 27.78 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 111.283 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 22.09 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.085 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -105.33 -28.83 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 350' ' ' ALA . 1.1 tp -83.91 -30.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -178.78 -162.33 28.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.4 mt -98.68 142.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.628 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 340' ' ' SER . 3.0 mp -98.43 136.11 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.569 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 321' ' ' MET . 2.7 mmtp -48.88 95.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -68.47 146.63 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.724 ' ND2' ' OG1' ' A' ' 317' ' ' THR . 0.1 OUTLIER -101.06 145.79 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 111.433 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -77.19 -7.59 56.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.904 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -83.16 -51.04 7.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.724 ' OG1' ' ND2' ' A' ' 314' ' ' ASN . 8.3 p -108.1 -7.31 16.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.526 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 313' ' ' THR . . . 67.63 15.69 66.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.393 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.467 ' H ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.9 164.37 23.89 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.807 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.523 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 57.7 Cg_exo -45.1 162.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.146 2.564 . . . . 0.0 113.456 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 17.4 mtm -123.29 118.68 28.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 339' ' ' VAL . 49.3 mt -141.56 149.98 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.346 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -114.14 148.03 37.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.79 HD13 HG22 ' A' ' 296' ' ' VAL . 2.1 mt -131.69 168.61 17.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 2.3 mp0 -131.59 134.4 46.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.965 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -148.19 143.17 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.958 0.409 . . . . 0.0 111.447 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.73 HG22 ' HD1' ' A' ' 288' ' ' PHE . 17.4 p -109.53 119.55 39.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 322' ' ' ILE . 1.2 t -93.91 123.04 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.596 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -94.86 129.97 41.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.824 0.345 . . . . 0.0 110.86 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 339' ' ' VAL . 17.6 m-85 -109.71 150.26 28.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.57 -16.84 60.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 346' ' ' SER . 5.1 m-20 -126.35 116.46 23.31 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.682 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.615 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 78.1 Cg_exo -44.82 -50.82 8.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.35 2.034 . . . . 0.0 112.602 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 9.7 Cg_endo -53.16 -30.42 50.38 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.016 1.811 . . . . 0.0 111.041 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 12.4 t -55.82 -48.75 74.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -53.32 -44.86 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.926 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.846 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -58.37 -54.28 48.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.063 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.437 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -47.5 -39.0 15.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.786 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.72 -45.82 70.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.362 0.601 . . . . 0.0 109.761 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.9 mt -60.92 -32.39 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.433 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.67 -40.64 95.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.34 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.606 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -106.14 -45.54 4.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 356' ' ' GLY . 2.7 m-85 -59.22 -75.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.581 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.0 t0 1.04 63.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.211 0.944 . . . . 0.0 112.355 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 110.94 36.47 1.84 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.429 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.501 ' HD3' ' CD2' ' A' ' 354' ' ' PHE . 7.9 ptmt -97.83 -158.37 0.66 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.576 0.227 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 33.0 mt-10 -113.89 128.88 56.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.045 0.45 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -122.89 105.72 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.299 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.3 m 59.76 30.09 19.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.75 57.86 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.04 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 7.2 m-80 -129.27 167.01 21.45 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.832 0.316 . . . . 0.0 111.037 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 96.3 Cg_endo -90.36 128.8 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.924 2.416 . . . . 0.0 111.929 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 3.9 pt -124.68 168.58 17.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.599 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -139.1 102.42 4.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.068 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 354' ' ' PHE . 26.3 t -85.13 134.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.02 -173.12 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.99 0.424 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 2.7 m-85 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.831 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.428 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.88 0.371 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 20.8 p30 -99.39 -18.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.979 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 26.4 m -71.06 117.56 12.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.277 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.713 HD12 ' CG1' ' A' ' 366' ' ' VAL . 36.6 pt -105.15 164.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.513 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -126.34 117.22 22.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.146 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 366' ' ' VAL . 1.0 OUTLIER -110.0 114.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.131 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 288' ' ' PHE . 47.6 mm-40 -112.58 132.77 54.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.056 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.679 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 75.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.767 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.848 HD21 ' CE2' ' A' ' 359' ' ' PHE . 1.6 mp -124.48 -76.41 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.667 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 126.17 65.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.194 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 44.25 30.36 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.61 4.64 4.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.254 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 292' ' ' LEU . 11.1 p -66.51 109.45 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.99 0.424 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -119.07 151.3 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.489 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.793 HD13 HD21 ' A' ' 324' ' ' LEU . 26.6 mm -63.18 -47.91 90.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.492 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.53 -42.18 87.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.8 p -65.81 -41.44 91.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.788 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 297' ' ' THR . 75.8 t -73.03 -40.51 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.14 -29.87 68.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.968 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -40.01 65.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.641 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.459 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.75 -22.46 29.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.42 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -90.12 7.13 39.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.423 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 14.86 15.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.644 0.259 . . . . 0.0 111.424 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.55 -31.98 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.489 HG23 ' CE2' ' A' ' 341' ' ' PHE . 2.6 tp -88.11 -35.84 8.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.341 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.18 -169.61 35.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.8 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 13.0 mt -92.76 144.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 111.665 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 340' ' ' SER . 3.2 mt -97.64 125.13 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.7 OUTLIER -52.72 91.66 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.338 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -80.96 167.18 20.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.242 0.544 . . . . 0.0 110.715 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.597 ' OD1' ' OG1' ' A' ' 317' ' ' THR . 0.4 OUTLIER -90.13 143.29 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.878 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -80.45 -3.18 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -94.44 -45.35 7.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.493 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 81.4 p -108.45 -4.63 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.93 43.24 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.368 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.451 HE22 HG21 ' A' ' 298' ' ' ILE . 0.0 OUTLIER -114.34 144.17 31.21 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.319 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.1 Cg_exo -45.06 147.97 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.523 2.149 . . . . 0.0 112.068 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.46 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 6.7 mtp -114.23 125.55 54.04 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 112.046 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 338' ' ' THR . 74.4 mt -143.17 137.81 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.996 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.41 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.7 t30 -97.63 120.72 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.031 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.793 HD21 HD13 ' A' ' 298' ' ' ILE . 0.6 OUTLIER -110.07 149.8 29.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.0 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.767 179.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.23 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.01 159.68 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.617 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -165.19 150.9 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 322' ' ' ILE . 56.3 p -95.59 128.34 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.654 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.585 ' CG2' HG11 ' A' ' 301' ' ' VAL . 82.0 t -107.39 134.45 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.841 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 311' ' ' ILE . 33.1 m -94.51 138.73 32.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.904 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.3 m-85 -115.51 142.45 46.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 111.547 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 1.4 t70 -65.43 -20.75 66.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.753 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -128.69 115.32 19.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.583 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 73.7 Cg_exo -47.24 -51.58 9.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.538 2.158 . . . . 0.0 112.683 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.1 Cg_endo -57.69 -30.86 90.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.981 1.787 . . . . 0.0 111.19 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -36.41 81.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.569 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -59.48 -44.54 93.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.658 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.899 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.89 -54.97 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.878 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.55 10.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.993 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.7 -49.33 59.8 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.439 0.638 . . . . 0.0 109.613 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.7 mt -56.39 -36.17 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.363 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.87 -26.85 65.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.1 t90 -86.78 -68.21 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.063 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' A' ' 355' ' ' ASP . 10.6 m-85 -69.65 -77.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.614 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.9 t70 21.16 55.51 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.473 0.483 . . . . 0.0 111.401 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.2 22.16 1.95 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.446 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -80.11 -165.61 0.87 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.737 0.303 . . . . 0.0 111.416 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -114.93 142.11 47.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.669 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.848 ' CE2' HD21 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -124.55 101.41 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.777 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.68 26.41 3.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.245 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 99.79 24.09 10.25 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.893 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 65.9 m-80 -129.95 153.65 81.03 Favored Pre-proline 0 C--O 1.225 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.776 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.02 136.01 8.98 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.577 2.185 . . . . 0.0 111.711 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.689 ' HB ' HG12 ' A' ' 289' ' ' VAL . 9.1 pt -130.47 154.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -124.87 100.74 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 289' ' ' VAL . 37.7 t -95.96 118.96 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.36 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . 0.411 ' HA ' HG12 ' A' ' 351' ' ' ILE . 1.4 m -140.2 176.68 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.428 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 1.2 m-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.981 0.419 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 20.7 p30 -51.94 -28.38 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 86.1 m -76.0 132.24 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 366' ' ' VAL . 37.0 pt -117.86 168.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' ' 338' ' ' THR . 1.5 m-30 -117.39 106.73 13.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -99.71 114.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -132.1 132.17 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.647 0.261 . . . . 0.0 111.48 -179.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.782 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 121.07 79.99 0.57 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.533 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -155.79 -90.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.801 -0.235 . . . . 0.0 111.116 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 292' ' ' LEU . . . 157.12 -92.5 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -126.0 28.07 6.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 297' ' ' THR . 0.8 OUTLIER -114.71 -14.48 12.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.04 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.748 HG22 HD22 ' A' ' 324' ' ' LEU . 9.8 p -52.24 88.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -128.88 147.16 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 322' ' ' ILE . 41.7 mt -61.21 -47.35 93.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.54 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -65.32 -39.36 92.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 24.7 p -68.59 -43.27 76.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.57 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 297' ' ' THR . 60.6 t -69.75 -37.84 74.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.495 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -68.71 -30.86 69.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -35.73 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -103.81 -19.94 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.654 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.8 OUTLIER -99.43 -15.28 18.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -83.46 7.4 17.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.419 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -51.93 6.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -59.81 -33.53 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.587 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -155.51 -177.84 29.15 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.251 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.84 105.86 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 302' ' ' ALA . 52.5 mt -71.93 130.16 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 1.0 OUTLIER -48.49 92.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -67.39 140.48 57.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.708 177.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -96.25 145.57 25.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 111.828 -179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -79.81 -4.12 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -90.57 -49.8 6.29 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.991 0.424 . . . . 0.0 110.197 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.2 p -104.98 -8.69 18.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.804 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 313' ' ' THR . . . 69.44 10.19 62.72 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 153.95 71.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 117.127 0.464 . . . . 0.0 110.99 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.7 Cg_endo -46.59 153.13 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.006 2.471 . . . . 0.0 112.77 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -105.03 120.96 42.77 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 111.262 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.73 HD12 HG23 ' A' ' 298' ' ' ILE . 4.0 mt -139.55 142.01 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.031 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.8 m-80 -104.5 148.22 26.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 296' ' ' VAL . 0.5 OUTLIER -135.17 114.85 12.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.705 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 336' ' ' GLU . 7.5 m-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 290' ' ' GLN . 29.7 mt-10 -147.2 131.61 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.665 0.269 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.663 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -150.14 145.55 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.519 HG22 ' CE1' ' A' ' 288' ' ' PHE . 16.2 p -108.8 118.85 37.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.631 ' CG2' HG11 ' A' ' 301' ' ' VAL . 78.9 t -94.26 126.77 46.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.246 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.3 OUTLIER -95.72 121.93 37.95 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.876 0.37 . . . . 0.0 111.138 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.51 ' HE2' HD13 ' A' ' 287' ' ' ILE . 9.9 m-85 -96.48 155.44 16.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -25.86 40.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.644 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.7 117.05 22.6 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.581 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.8 Cg_exo -43.26 -51.43 5.79 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 113.107 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.3 Cg_endo -56.48 -30.63 82.95 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 121.956 1.771 . . . . 0.0 111.359 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.2 t -60.51 -37.63 81.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.883 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -60.15 -51.21 70.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -59.86 -43.01 94.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 110.056 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.29 62.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 308' ' ' ILE . . . -68.59 -48.04 65.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 348' ' ' LYS . 33.1 mt -52.46 -31.14 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.323 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -26.69 68.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -107.19 -61.93 1.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.514 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.571 ' CB ' HG21 ' A' ' 366' ' ' VAL . 66.3 m-85 -56.75 -74.85 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.029 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 354' ' ' PHE . 36.6 t0 2.94 65.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.046 0.841 . . . . 0.0 112.511 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 113.69 26.03 4.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.565 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -87.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 11.8 mm-40 -123.6 131.23 53.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.716 ' HZ ' HG22 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -91.63 101.41 14.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.144 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 33.9 t 45.77 29.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.13 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.25 -46.98 1.01 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.0 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.3 OUTLIER -84.85 169.67 15.8 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 116.991 0.395 . . . . 0.0 110.697 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -96.31 138.86 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.391 2.727 . . . . 0.0 112.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 291' ' ' GLY . 7.6 pt -116.97 -179.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 120.834 0.349 . . . . 0.0 111.426 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -148.31 100.51 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.01 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -86.92 128.03 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.708 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 92.5 p -140.51 -173.94 3.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.174 0.511 . . . . 0.0 112.048 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.35 179.449 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -61.61 -18.22 58.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.79 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -73.53 106.16 5.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.675 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 16.2 pt -102.22 171.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.785 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.643 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.2 m-85 -125.33 113.54 17.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 366' ' ' VAL . 0.3 OUTLIER -102.35 114.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.223 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 30.9 mm-40 -111.6 130.76 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.351 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.634 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 114.08 81.45 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.348 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.3 OUTLIER -128.44 -74.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 124.52 -76.24 0.38 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.108 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.21 28.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.919 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.457 ' C ' ' ND2' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -116.28 -8.78 11.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.834 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 296' ' ' VAL . 13.1 p -47.73 107.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.88 146.78 9.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.016 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.614 HG23 ' HB ' ' A' ' 322' ' ' ILE . 11.3 mt -63.75 -46.03 95.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.801 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -66.68 -41.93 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.358 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.3 p -67.08 -40.97 87.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -73.94 -38.16 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.233 0.539 . . . . 0.0 109.662 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.66 72.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.82 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -74.33 -35.65 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.001 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.22 -24.38 19.91 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -98.21 26.65 5.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.6 25.68 10.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.877 0.37 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -107.15 -44.19 4.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.402 HD13 ' HE3' ' A' ' 353' ' ' TRP . 1.7 tp -74.1 -28.35 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -174.68 -164.68 29.91 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.759 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.97 132.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mp -81.53 128.01 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 321' ' ' MET . 5.0 mtmp? -55.35 100.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.182 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.666 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.7 m -63.94 154.5 33.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.259 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.6 138.95 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 3.73 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.921 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -111.65 -20.92 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.292 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.441 ' HB ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.27 -21.8 6.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.562 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.75 13.62 80.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.666 ' C ' HG23 ' A' ' 313' ' ' THR . 0.0 OUTLIER -124.43 162.63 41.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 93.1 Cg_exo -47.63 148.26 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.533 2.155 . . . . 0.0 112.152 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.405 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 72.0 mtp -101.33 114.71 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.667 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -143.26 139.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.8 OUTLIER -103.2 144.17 31.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 -179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.565 ' CD2' HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -136.9 144.96 43.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.017 179.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 11.3 pt-20 -152.35 144.95 24.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 111.006 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -155.26 141.72 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.25 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 3.7 p -92.1 138.83 31.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.706 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.667 HG22 HG12 ' A' ' 322' ' ' ILE . 90.4 t -116.89 127.75 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 311' ' ' ILE . 94.5 p -101.4 125.82 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.55 153.09 22.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 23.0 t0 -73.42 -26.49 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.326 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.96 111.16 48.25 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.954 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.6 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.4 Cg_exo -43.52 -51.04 6.38 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.53 2.153 . . . . 0.0 112.454 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.1 Cg_endo -55.35 -30.67 73.77 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.928 1.752 . . . . 0.0 111.149 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.7 t -58.98 -43.18 91.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.664 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.675 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -55.4 -49.79 71.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.958 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.33 -52.7 62.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.708 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.79 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.819 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.99 74.02 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.1 mt -61.72 -35.79 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.99 -26.34 67.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.6 t90 -96.52 -68.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.939 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 364' ' ' ILE . 16.3 m-85 -62.54 -74.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 354' ' ' PHE . 26.2 t70 11.86 63.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.811 0.694 . . . . 0.0 112.16 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 114.83 25.05 4.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.656 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 19.5 mmtt -87.54 -167.87 2.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -119.93 131.93 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 112.228 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -96.23 101.36 12.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.953 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.6 p 51.44 28.2 4.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.15 -42.49 1.55 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.28 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -78.05 172.32 10.15 Favored Pre-proline 0 C--O 1.221 -0.405 0 CA-C-N 116.667 0.233 . . . . 0.0 110.767 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -94.32 146.92 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.277 2.652 . . . . 0.0 112.054 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 354' ' ' PHE . 3.1 pt -123.59 171.26 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 111.822 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -148.29 104.02 3.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.807 HG22 HG13 ' A' ' 289' ' ' VAL . 37.0 t -91.39 139.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.04 -172.1 3.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 351' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.68 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.0 p30 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 121.171 0.51 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -52.87 -34.55 55.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.603 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 99.6 m -62.07 97.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.666 HD12 HG13 ' A' ' 366' ' ' VAL . 43.5 pt -86.55 170.59 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -118.39 118.59 32.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 365' ' ' LYS . 0.2 OUTLIER -108.69 115.28 48.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.538 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -116.43 130.83 56.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.376 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.635 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 111.78 51.11 0.58 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.294 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.758 HD22 ' H ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -105.57 -83.55 0.51 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.905 0.352 . . . . 0.0 110.486 179.448 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.57 -50.14 2.83 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.214 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -107.75 40.0 1.81 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.186 0.493 . . . . 0.0 111.951 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -143.56 -42.28 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.039 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 296' ' ' VAL . 96.4 t 6.27 65.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.839 ' O ' HG23 ' A' ' 301' ' ' VAL . 39.4 p -161.92 145.58 12.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.731 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.732 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.2 mm -71.77 -40.3 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.15 -42.81 88.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . 0.41 ' HB3' ' OG1' ' A' ' 297' ' ' THR . 21.6 p -63.18 -41.49 99.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.473 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 297' ' ' THR . 34.9 t -70.72 -47.67 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.728 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -62.62 -29.9 70.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.922 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.1 -40.67 71.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.756 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.69 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -88.83 9.99 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 20.99 13.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -102.32 -39.21 7.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.406 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.441 HD13 ' HE3' ' A' ' 353' ' ' TRP . 3.3 tp -76.81 -38.39 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.052 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -168.01 -162.97 21.12 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.528 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.6 mt -98.31 137.07 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.53 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -96.73 136.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 341' ' ' PHE . 4.1 mmtt -48.42 106.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.052 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -77.67 142.87 38.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.569 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.62 140.3 29.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 0.0 111.387 -179.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -77.86 -6.18 53.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.91 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -45.13 7.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.37 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 70.8 p -104.63 -8.25 19.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 63.95 14.22 55.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.235 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -125.14 164.08 34.01 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 120.485 0.183 . . . . 0.0 110.925 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.591 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 79.3 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.44 2.093 . . . . 0.0 112.299 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.569 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.64 125.1 51.29 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.569 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.717 HD13 ' HB ' ' A' ' 301' ' ' VAL . 4.6 mt -143.28 144.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.166 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.534 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.2 m-20 -110.34 147.84 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.703 0.287 . . . . 0.0 110.455 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.732 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -145.48 130.14 18.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.111 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . 0.402 ' HB2' ' CG ' ' A' ' 336' ' ' GLU . 51.2 m-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.511 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.401 ' C ' HD22 ' A' ' 292' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.567 -0.213 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 0.6 OUTLIER -143.02 143.4 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.36 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -158.26 139.85 13.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.237 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 288' ' ' PHE . 11.9 p -97.61 134.15 41.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.561 HG22 HG11 ' A' ' 301' ' ' VAL . 95.0 t -112.0 126.06 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.522 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.899 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -86.18 153.26 22.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.467 ' CB ' ' ND2' ' A' ' 285' ' ' ASN . 4.5 m-85 -133.51 147.0 51.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.42 -33.22 48.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.65 118.07 41.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.648 0.261 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.565 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.5 Cg_exo -41.84 -51.69 4.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.876 2.384 . . . . 0.0 113.081 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.2 Cg_endo -55.6 -30.28 74.06 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.775 1.65 . . . . 0.0 111.089 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.8 t -56.64 -44.82 81.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.04 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.66 ' HB2' HD22 ' A' ' 285' ' ' ASN . . . -53.4 -50.34 65.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.63 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.943 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -63.9 -54.85 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.156 0.503 . . . . 0.0 109.749 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.92 14.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.539 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.58 -48.56 63.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.0 mt -58.93 -35.99 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.371 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -61.91 -26.2 68.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.242 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.6 t90 -94.37 -68.57 0.79 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.586 ' HB2' HG21 ' A' ' 366' ' ' VAL . 1.5 m-85 -69.79 -77.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.8 p-10 23.17 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.115 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.45 20.33 2.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.316 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.446 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 9.1 mtpp -87.02 -166.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.061 0.43 . . . . 0.0 110.472 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 13.3 mm-40 -120.02 128.91 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.419 . . . . 0.0 112.093 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HD2' HD12 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -84.2 100.84 11.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.743 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.49 31.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 142.51 -51.62 0.67 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.186 -1.006 . . . . 0.0 114.048 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.4 OUTLIER -89.16 171.61 8.7 Favored Pre-proline 0 C--O 1.218 -0.59 0 CA-C-N 117.008 0.404 . . . . 0.0 110.743 -179.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 358' ' ' GLU . 85.9 Cg_endo -95.48 143.36 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.308 2.672 . . . . 0.0 112.193 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.9 pt -132.03 170.06 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 111.978 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -132.62 150.92 52.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.777 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.666 HG13 HD12 ' A' ' 287' ' ' ILE . 11.6 t -131.6 127.74 59.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.8 p -140.24 172.92 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.492 ' CZ ' HD13 ' A' ' 351' ' ' ILE . 4.3 m-85 . . . . . 0 C--N 1.332 -0.154 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.088 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.487 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.814 0.34 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 3.8 p-10 -86.45 -19.14 30.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 74.6 m -80.42 144.98 32.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.769 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.2 pt -123.36 168.33 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.764 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.6 OUTLIER -124.06 114.95 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.174 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -107.63 114.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -112.74 144.18 42.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.678 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.51 4.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.731 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 296' ' ' VAL . 7.2 mt -60.51 -76.76 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.618 0.247 . . . . 0.0 110.743 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.3 77.72 0.77 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.392 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 43.93 30.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.632 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.33 25.34 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.729 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 292' ' ' LEU . 21.5 t -68.17 83.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.7 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.845 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -126.44 147.99 49.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.588 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 324' ' ' LEU . 32.4 mm -68.54 -47.02 79.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.258 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -38.64 87.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.7 t -63.96 -40.28 96.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 297' ' ' THR . 54.6 t -74.9 -41.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.862 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.721 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.18 -29.93 68.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.837 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -74.11 -40.47 62.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.632 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -94.07 -21.83 18.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.806 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -105.33 38.13 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.02 19.11 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.305 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -36.45 8.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.301 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.0 tp -75.48 -30.1 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.465 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . 0.431 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -168.16 -167.38 28.73 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.91 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.69 116.71 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 305' ' ' PHE . 3.4 mt -76.81 124.02 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.313 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 321' ' ' MET . 23.9 mtmt -48.72 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.615 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.2 m -69.64 152.04 45.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.747 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.23 144.59 25.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.8 1.5 52.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.279 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.26 -32.1 7.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.845 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.401 ' OG1' ' CG ' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -107.39 -20.67 13.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.752 179.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.37 8.59 71.15 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.776 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.615 ' C ' HG23 ' A' ' 313' ' ' THR . 0.1 OUTLIER -125.12 167.42 16.3 Favored Pre-proline 0 C--O 1.224 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.721 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 66.8 Cg_exo -44.78 149.37 1.14 Allowed 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.708 2.272 . . . . 0.0 113.041 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 312' ' ' LYS . 36.7 mtp -101.94 121.56 42.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.835 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 339' ' ' VAL . 1.2 mt -143.25 138.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.0 OUTLIER -98.83 140.41 33.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.808 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.743 HD23 ' HB1' ' A' ' 337' ' ' ALA . 5.2 mt -126.7 142.61 51.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.034 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.22 136.5 15.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 0.0 111.236 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.743 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -157.88 153.02 25.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -102.67 145.83 29.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.428 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 322' ' ' ILE . 46.8 t -113.27 128.51 70.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.206 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 311' ' ' ILE . 59.7 p -97.57 124.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -102.06 154.87 18.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.69 -21.09 38.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -125.98 118.36 23.9 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.683 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.601 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.1 Cg_exo -41.31 -50.81 4.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.733 2.289 . . . . 0.0 112.983 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.3 Cg_endo -53.03 -30.54 49.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.956 1.771 . . . . 0.0 111.219 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 25.6 t -57.26 -44.92 84.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.97 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.35 -49.22 75.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.946 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.05 -49.97 73.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.003 0.43 . . . . 0.0 110.01 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.88 38.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.731 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.09 64.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.452 0.644 . . . . 0.0 109.382 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.5 mt -58.26 -35.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.158 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.17 -26.62 65.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.159 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.519 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -89.2 -68.01 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.334 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.621 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -75.64 -81.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.614 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.5 p-10 31.26 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.549 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 126.02 43.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.773 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.79 -157.2 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 27.7 tt0 -113.58 128.32 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.41 0.624 . . . . 0.0 111.518 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 304' ' ' TYR . 0.9 OUTLIER -112.46 101.66 9.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.957 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.7 t 55.43 26.55 8.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.068 0.461 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 94.66 24.83 16.89 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.74 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 73.5 m-80 -129.94 148.57 70.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.822 0.344 . . . . 0.0 111.848 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.07 121.71 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.479 2.119 . . . . 0.0 111.447 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 8.7 pt -112.33 -178.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.961 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.12 101.04 3.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.673 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.897 HG22 HG13 ' A' ' 289' ' ' VAL . 40.8 t -88.64 133.52 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 86.6 p -127.53 -179.89 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.195 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.693 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.8 p30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 29.5 p30 -58.41 -21.3 50.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.691 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 340' ' ' SER . 0.3 OUTLIER -84.56 143.04 29.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.836 HD12 ' CG1' ' A' ' 366' ' ' VAL . 2.0 pt -117.26 172.17 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.047 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 1.5 p90 -125.48 122.29 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.876 0.37 . . . . 0.0 111.459 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.963 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -104.34 114.86 45.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.242 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -115.93 131.0 57.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.06 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 106.75 43.15 1.46 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.976 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.702 HD22 ' HD2' ' A' ' 359' ' ' PHE . 0.5 OUTLIER -85.67 -79.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.791 0.296 . . . . 0.0 110.678 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 136.39 -81.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.546 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.13 29.74 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.92 0.39 . . . . 0.0 110.575 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -111.65 7.92 20.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.94 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.788 HG13 HD22 ' A' ' 324' ' ' LEU . 10.0 t -55.52 89.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.529 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -147.52 146.44 29.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.67 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.5 mm -71.43 -45.28 69.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.684 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.96 -43.09 84.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.073 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -40.0 82.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 297' ' ' THR . 54.2 t -73.58 -37.96 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.715 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.792 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.61 -34.52 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.36 -38.02 71.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.092 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -85.54 -20.91 28.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.714 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.867 ' CD2' HG21 ' A' ' 339' ' ' VAL . 0.6 OUTLIER -92.15 11.76 24.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 29.02 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.071 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -112.54 -33.8 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 7.8 tp -84.4 -31.8 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.71 -160.73 26.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.732 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.0 mt -92.85 134.63 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.562 0.22 . . . . 0.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.792 HD13 ' HA ' ' A' ' 302' ' ' ALA . 4.6 mt -92.93 134.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.378 0.608 . . . . 0.0 110.945 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.7 OUTLIER -48.56 100.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.411 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -76.21 154.25 35.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.523 ' CG ' ' HG1' ' A' ' 317' ' ' THR . 17.6 p30 -103.03 -178.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.018 0.437 . . . . 0.0 111.644 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.41 ' CD ' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -109.42 -12.46 14.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.172 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 -44.75 11.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.156 0.503 . . . . 0.0 109.999 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.523 ' HG1' ' CG ' ' A' ' 314' ' ' ASN . 8.5 p -106.37 -8.42 17.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.766 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 314' ' ' ASN . . . 61.23 17.39 52.36 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.671 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.559 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.7 168.03 14.32 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 120.776 0.322 . . . . 0.0 110.894 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.598 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 80.4 Cg_exo -44.54 161.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.988 2.459 . . . . 0.0 112.726 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -123.08 129.43 51.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.296 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 339' ' ' VAL . 3.7 mp -144.38 129.23 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.15 115.52 28.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.797 HD23 ' CB ' ' A' ' 337' ' ' ALA . 0.2 OUTLIER -121.56 148.77 44.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.776 179.876 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.413 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 8.8 pt-20 -157.18 140.55 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.62 0.247 . . . . 0.0 110.703 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.797 ' CB ' HD23 ' A' ' 324' ' ' LEU . . . -160.39 179.11 8.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.783 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 322' ' ' ILE . 69.4 p -129.91 136.47 49.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.406 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.867 HG21 ' CD2' ' A' ' 305' ' ' PHE . 0.4 OUTLIER -104.37 125.11 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.268 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 311' ' ' ILE . 3.1 p -94.56 140.07 30.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.047 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.557 ' CE2' HD13 ' A' ' 287' ' ' ILE . 32.2 m-85 -115.5 160.16 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 111.069 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -80.63 -18.15 49.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.25 116.87 20.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.609 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.7 Cg_exo -44.77 -50.52 8.34 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.653 2.235 . . . . 0.0 112.907 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.1 Cg_endo -54.58 -30.51 65.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.003 1.802 . . . . 0.0 111.401 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.9 t -58.67 -41.21 85.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.85 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.05 -50.1 71.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.949 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.4 OUTLIER -59.39 -50.64 73.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.175 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.56 -33.78 33.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.84 -48.33 63.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.433 0.635 . . . . 0.0 109.391 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.949 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.4 mt -56.87 -35.97 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.15 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -26.65 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.152 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.34 -68.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.054 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.533 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 5.1 m-85 -76.17 -79.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.483 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 354' ' ' PHE . 45.5 t0 21.44 51.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.439 0.462 . . . . 0.0 112.021 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 125.32 32.02 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.256 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -102.74 -162.87 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.087 0.443 . . . . 0.0 110.087 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 8.5 mt-10 -113.72 128.6 56.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.994 0.426 . . . . 0.0 111.866 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.74 ' HB2' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -102.79 101.72 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.266 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 41.0 t 60.01 28.38 17.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.486 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.32 -27.8 10.33 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.592 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 3.1 m-80 -91.76 169.54 11.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.956 0.378 . . . . 0.0 110.64 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -93.34 137.18 1.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 112.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.74 HD13 ' HB2' ' A' ' 359' ' ' PHE . 23.3 pt -134.36 164.52 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 120.977 0.417 . . . . 0.0 111.804 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 100.53 5.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.963 HG22 HG13 ' A' ' 289' ' ' VAL . 19.5 t -90.02 118.66 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -140.53 -166.75 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.014 0.435 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 14.0 p30 -104.1 -25.15 13.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.491 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 58.9 m -70.52 116.23 10.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.659 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 36.8 pt -102.93 173.17 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.175 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.564 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.4 OUTLIER -122.46 107.69 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 364' ' ' ILE . 2.7 t -104.35 114.48 44.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.432 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 2.0 mp0 -116.78 130.5 56.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 364' ' ' ILE . . . 123.98 25.77 1.64 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.849 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 295' ' ' ASN . 4.9 mp -88.05 -104.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.94 -39.7 1.82 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.594 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.93 31.82 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.654 0.727 . . . . 0.0 112.036 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.754 HD21 HD23 ' A' ' 292' ' ' LEU . 0.5 OUTLIER -162.51 -44.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.755 ' O ' HG12 ' A' ' 296' ' ' VAL . 14.7 t 26.48 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.639 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -164.48 145.2 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.101 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.751 HG21 HE22 ' A' ' 319' ' ' GLN . 1.2 mp -72.21 -42.1 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.998 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.44 -40.54 95.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.4 t -65.08 -43.99 90.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.468 . . . . 0.0 110.478 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 297' ' ' THR . 47.7 t -70.92 -40.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.353 0.597 . . . . 0.0 109.664 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 320' ' ' PRO . . . -68.18 -29.82 68.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.024 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -37.7 65.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.685 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.57 -24.79 15.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.769 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -93.27 7.98 42.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -95.56 22.41 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 111.076 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.21 -44.35 6.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.624 HG23 ' CE2' ' A' ' 341' ' ' PHE . 0.8 OUTLIER -70.94 -29.33 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.477 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.73 -170.52 35.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.943 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.29 113.85 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.689 0.281 . . . . 0.0 111.513 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 305' ' ' PHE . 1.1 mt -71.65 135.16 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 0.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 321' ' ' MET . 6.1 mmmt -65.37 91.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -67.33 171.02 6.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 111.043 178.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 316' ' ' LYS . 0.4 OUTLIER -103.35 116.34 32.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.354 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -8.26 0.16 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -83.27 -34.49 25.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.064 0.459 . . . . 0.0 110.59 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.614 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.5 OUTLIER -121.62 -23.48 5.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.338 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.84 23.43 52.78 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.908 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.751 HE22 HG21 ' A' ' 298' ' ' ILE . 2.7 pp0? -118.57 138.1 25.49 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.884 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.681 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 4.8 Cg_exo -44.01 131.04 8.32 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.999 2.466 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -97.15 130.18 44.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.839 0.828 . . . . 0.0 112.929 -178.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.721 HD12 HG23 ' A' ' 298' ' ' ILE . 3.7 mt -143.14 140.22 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.428 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 6.2 t30 -98.8 148.38 23.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 298' ' ' ILE . 0.2 OUTLIER -154.42 128.17 8.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.943 0.401 . . . . 0.0 111.496 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.952 179.198 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.432 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 4.9 mp0 -130.16 132.16 45.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.502 0.191 . . . . 0.0 110.562 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -153.27 147.05 25.22 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.564 HG22 ' CD1' ' A' ' 288' ' ' PHE . 44.3 p -110.33 117.8 34.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.918 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.647 ' CG1' HD13 ' A' ' 311' ' ' ILE . 56.1 t -93.06 130.15 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.739 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 311' ' ' ILE . 9.1 t -96.72 133.62 41.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.907 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.624 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.0 m-85 -117.41 148.35 41.85 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -70.95 -34.32 71.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.49 109.45 60.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.28 -51.41 6.85 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.478 2.119 . . . . 0.0 112.496 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.3 Cg_endo -55.76 -30.58 76.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.945 1.763 . . . . 0.0 111.262 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -60.54 -44.21 96.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.659 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.65 -46.21 81.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.287 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.93 ' HA ' HD12 ' A' ' 351' ' ' ILE . 3.0 tppt? -60.16 -54.74 42.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.847 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.54 43.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.63 -49.68 57.28 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.93 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.9 mt -52.47 -36.66 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.763 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -58.38 -26.24 62.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.577 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.544 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.4 t90 -100.5 -68.6 0.8 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.688 ' HB2' HG21 ' A' ' 366' ' ' VAL . 47.2 m-85 -56.85 -74.48 0.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.4 p-10 9.35 59.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.973 0.796 . . . . 0.0 112.684 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.81 30.69 1.76 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.13 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.422 ' HG3' ' CG1' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -94.75 -164.45 1.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 7.7 mm-40 -119.4 129.38 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.621 -0.432 . . . . 0.0 112.122 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.678 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -86.09 101.05 12.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 40.5 30.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.358 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 140.49 -49.72 0.78 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.28 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.0 OUTLIER -89.7 171.1 9.26 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 117.207 0.504 . . . . 0.0 110.958 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -95.15 140.17 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.468 2.779 . . . . 0.0 112.153 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.678 HG21 ' CD1' ' A' ' 359' ' ' PHE . 5.1 pt -122.28 -179.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.865 0.364 . . . . 0.0 111.652 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.27 102.45 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.548 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' ' 354' ' ' PHE . 17.6 t -84.85 143.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.2 t -128.08 -168.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 351' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 9.9 p30 -63.9 -20.28 65.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 27.8 m -71.44 158.28 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 339' ' ' VAL . 10.2 pt -142.94 173.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.75 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -131.09 112.35 12.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.016 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 366' ' ' VAL . 0.5 OUTLIER -105.35 114.69 45.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.741 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 289' ' ' VAL . 1.1 mp0 -113.37 130.59 56.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.034 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.32 51.03 0.89 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.387 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -84.56 -73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.108 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.27 105.12 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.392 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.18 46.6 19.74 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -165.69 26.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 110.796 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.884 HG12 HD22 ' A' ' 324' ' ' LEU . 18.0 t -79.17 100.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.564 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -153.36 147.0 25.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.585 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.672 HD11 HD11 ' A' ' 324' ' ' LEU . 28.3 mm -70.93 -44.73 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.399 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.72 -39.19 87.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.7 t -68.22 -42.92 79.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.586 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 297' ' ' THR . 90.8 t -71.41 -40.01 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.564 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ALA . . . . . 0.557 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -29.9 68.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.832 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 4.4 m-20 -72.9 -38.73 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.721 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.81 -24.81 28.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.564 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 1.1 m-85 -85.67 1.13 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.769 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -89.75 12.81 15.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.622 0.248 . . . . 0.0 111.356 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.58 -45.11 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.043 0.449 . . . . 0.0 110.458 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ILE . . . . . 0.534 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -76.32 -36.64 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.26 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -171.78 -158.72 16.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.913 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.48 144.16 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.742 0.306 . . . . 0.0 111.536 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.557 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.2 mt -96.15 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.86 93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.42 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -71.74 152.57 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.496 ' HB2' ' HG3' ' A' ' 321' ' ' MET . 0.7 OUTLIER -107.74 110.9 22.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.806 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -8.52 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 15.1 mmtt -89.35 -25.7 21.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.994 0.426 . . . . 0.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.545 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 74.9 p -122.06 -24.03 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.56 16.0 76.72 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.692 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLN . . . . . 0.545 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.58 160.08 57.57 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 0.0 111.619 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 83.9 Cg_exo -50.5 156.9 3.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.776 2.317 . . . . 0.0 112.279 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.1 OUTLIER -121.35 122.94 40.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.224 0.535 . . . . 0.0 111.346 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 339' ' ' VAL . 47.9 mt -143.64 146.27 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.443 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.45 134.26 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.611 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.884 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -136.34 143.55 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.77 -179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.74 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -148.5 131.99 16.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.686 0.279 . . . . 0.0 111.216 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.04 133.38 7.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 111.765 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' THR . . . . . 0.75 HG22 ' CD1' ' A' ' 288' ' ' PHE . 20.4 p -91.91 130.38 37.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.15 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 322' ' ' ILE . 60.4 t -111.26 132.38 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.683 0.278 . . . . 0.0 111.217 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 286' ' ' THR . 2.5 p -100.44 139.21 36.44 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.812 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.96 161.16 14.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.03 -27.77 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.756 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.76 120.53 22.95 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.506 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' PRO . . . . . 0.577 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.9 Cg_exo -41.91 -51.62 4.46 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.832 2.355 . . . . 0.0 112.963 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 14.4 Cg_endo -56.61 -30.67 84.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.914 1.742 . . . . 0.0 111.466 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.1 t -62.34 -39.23 92.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -63.12 -48.33 78.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.38 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.956 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -61.73 -47.73 83.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.932 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.44 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.87 -31.96 63.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.97 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.09 67.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.8 mt -58.04 -35.46 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.943 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 348' ' ' LYS . 31.8 t70 -59.23 -26.46 64.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.6 t90 -101.97 -65.87 0.96 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 366' ' ' VAL . 20.5 m-85 -61.11 -74.89 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 354' ' ' PHE . 16.0 p-10 13.5 58.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.795 0.685 . . . . 0.0 112.345 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 113.27 35.02 1.68 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.727 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.23 -160.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.7 mm-40 -121.81 129.06 52.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 112.116 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' PHE . . . . . 0.55 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -83.95 100.9 11.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 18.6 p 39.31 31.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.209 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.8 -47.83 0.92 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.91 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.8 m-80 -88.13 170.99 10.21 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.989 0.395 . . . . 0.0 110.604 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -96.24 141.71 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.251 2.634 . . . . 0.0 112.386 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.8 pt -126.82 -178.91 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.35 100.93 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 354' ' ' PHE . 24.6 t -87.78 137.39 21.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.9 p -131.55 -165.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.963 0.411 . . . . 0.0 111.263 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' PHE . . . . . 0.403 ' CD2' HD13 ' A' ' 351' ' ' ILE . 6.8 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.063 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.771 0.32 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 60.62 66.16 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 8.5 t0 58.97 72.7 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -164.13 115.72 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.5 -17.63 19.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -96.87 27.46 3.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 111.121 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -44.95 110.92 0.26 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.367 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.26 -30.07 2.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.731 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 96.9 m -61.33 125.55 24.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.631 HD12 HG13 ' A' ' 366' ' ' VAL . 40.2 pt -113.29 173.18 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.49 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.9 OUTLIER -126.36 112.98 16.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.266 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -107.01 122.48 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.626 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -128.89 129.98 46.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.018 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.57 46.76 0.52 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.3 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 359' ' ' PHE . 0.7 OUTLIER -86.29 -84.59 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.5 0.191 . . . . 0.0 110.83 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 105.64 90.6 2.18 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.269 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.592 ' HA ' HD12 ' A' ' 333' ' ' LEU . 3.1 mm-40 44.65 27.95 0.29 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.779 0.324 . . . . 0.0 111.822 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.8 OUTLIER -142.31 -2.23 1.13 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.789 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.842 HG13 HD22 ' A' ' 333' ' ' LEU . 11.7 p -64.9 83.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.047 0.451 . . . . 0.0 111.723 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.792 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -116.46 163.95 15.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.512 179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.814 ' CD1' HD11 ' A' ' 324' ' ' LEU . 13.8 mm -71.29 -49.1 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 111.366 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.19 -34.1 76.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 13.5 t -63.58 -44.13 94.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.819 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 339' ' ' VAL . 43.1 t -73.81 -38.44 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.401 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.747 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -67.92 -30.44 69.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.053 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.55 -41.79 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.498 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -93.18 -21.43 19.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.527 ' CE1' ' CE2' ' A' ' 354' ' ' PHE . 0.2 OUTLIER -104.71 37.56 2.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.808 0.337 . . . . 0.0 111.326 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.92 17.04 9.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.177 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -100.05 -43.27 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 0.0 109.987 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.65 HD13 ' HA ' ' A' ' 350' ' ' ALA . 0.6 OUTLIER -66.74 -35.56 75.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.5 -156.15 11.04 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.565 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.5 mt -101.93 134.75 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 0.0 111.693 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -89.18 139.66 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 110.035 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -48.15 91.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.945 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.421 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -70.79 147.12 49.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.415 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.536 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -97.35 157.86 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.906 0.384 . . . . 0.0 111.425 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 15.0 mmtm -89.44 -8.25 53.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.113 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.34 -45.55 8.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 110.431 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 61.0 p -107.5 -7.43 16.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.449 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 314' ' ' ASN . . . 61.72 18.84 57.48 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.678 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.5 163.69 35.04 Favored Pre-proline 0 C--O 1.227 -0.131 0 CA-C-O 120.677 0.275 . . . . 0.0 111.017 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.747 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 88.0 Cg_exo -46.86 154.55 1.05 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.789 2.326 . . . . 0.0 113.127 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.536 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -123.45 125.07 44.27 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.264 0.555 . . . . 0.0 110.959 179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.725 HG23 ' O ' ' A' ' 338' ' ' THR . 2.7 mp -140.11 140.51 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.264 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -95.56 115.8 27.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.747 0.308 . . . . 0.0 110.29 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.814 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -122.88 152.19 41.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.887 0.375 . . . . 0.0 110.957 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -108.26 116.77 32.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.553 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.918 HG22 HD23 ' A' ' 333' ' ' LEU . 9.9 p -120.89 156.37 32.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.63 145.12 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.799 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -110.23 -22.28 11.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.174 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.53 -46.33 55.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 5.2 t -99.27 -23.28 15.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 83.15 47.5 5.76 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.408 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -134.47 -165.27 1.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.605 0.24 . . . . 0.0 110.8 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.918 HD23 HG22 ' A' ' 326' ' ' THR . 7.5 mt -108.82 166.26 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 110.95 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -97.09 -39.16 9.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 105.78 27.77 5.59 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -151.09 131.86 14.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.433 0.158 . . . . 0.0 110.663 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.82 145.22 15.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 121.3 0.571 . . . . 0.0 112.298 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.725 ' O ' HG23 ' A' ' 322' ' ' ILE . 7.6 p -98.0 134.9 40.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.793 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.831 ' CG2' HG11 ' A' ' 301' ' ' VAL . 57.2 t -107.84 128.69 62.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.405 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.506 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 50.3 m -90.4 142.78 27.39 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.374 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -120.73 146.0 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 0.0 111.269 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -79.28 -17.94 53.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.14 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.8 111.03 27.49 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.554 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -49.07 -52.19 9.19 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.469 2.113 . . . . 0.0 112.877 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.1 Cg_endo -59.07 -30.67 93.9 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.873 1.715 . . . . 0.0 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 36.4 t -65.66 -34.72 78.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.688 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.29 97.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.81 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.882 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.6 OUTLIER -62.66 -50.91 69.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.262 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.35 53.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.003 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.65 ' HA ' HD13 ' A' ' 308' ' ' ILE . . . -68.75 -48.0 64.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.305 0.574 . . . . 0.0 109.863 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.6 mt -57.44 -35.64 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.228 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.27 -26.55 68.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.819 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.5 t90 -98.67 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.847 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 355' ' ' ASP . 60.6 m-85 -56.04 -74.17 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.562 ' C ' ' O ' ' A' ' 354' ' ' PHE . 22.6 t0 8.97 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.911 0.757 . . . . 0.0 111.624 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.02 22.35 4.25 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.259 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -78.72 -164.48 0.59 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.608 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 21.3 mm-40 -130.11 137.24 50.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.087 0.47 . . . . 0.0 112.149 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.713 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -102.75 101.47 11.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.146 179.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.26 29.52 5.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.703 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 123.9 -37.9 2.57 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.443 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.64 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.7 OUTLIER -82.77 169.98 16.14 Favored Pre-proline 0 C--O 1.22 -0.474 0 CA-C-N 116.876 0.338 . . . . 0.0 110.659 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -96.76 144.46 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.441 2.761 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.713 HG21 ' HD2' ' A' ' 359' ' ' PHE . 3.6 pt -130.98 161.5 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-O 120.824 0.345 . . . . 0.0 111.667 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -130.42 100.95 5.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.631 HG13 HD12 ' A' ' 287' ' ' ILE . 23.3 t -85.64 130.79 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.953 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 p -127.75 -177.27 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 348' ' ' LYS . 0.1 OUTLIER -100.55 45.44 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.915 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 56.49 72.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 44.7 p -61.59 162.31 8.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.99 135.42 33.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.28 114.43 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -174.77 -171.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.85 -174.57 3.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 2.8 t80 63.65 84.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.41 112.5 5.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 60.74 53.36 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 167.23 115.01 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.52 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.7 -115.14 0.65 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.514 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -77.53 -51.07 6.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.14 -177.58 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 120.66 -19.57 9.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.645 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.8 166.46 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 111.097 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 163.63 69.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.029 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.551 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.802 0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 62.22 -168.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.62 -32.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -43.96 98.8 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.021 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.28 -27.22 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.54 -35.23 6.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.526 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.489 ' O ' ' ND2' ' A' ' 285' ' ' ASN . 13.8 m120 -66.51 166.96 11.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.009 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 284' ' ' ASN . 0.0 OUTLIER 85.31 14.06 0.19 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.445 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.977 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 90.1 m -164.97 107.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.709 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.821 HD11 ' CE2' ' A' ' 305' ' ' PHE . 33.0 pt -92.75 170.0 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.172 0.51 . . . . 0.0 111.842 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.54 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.0 m-85 -119.75 110.92 17.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.553 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 339' ' ' VAL . 0.4 OUTLIER -103.15 119.25 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.922 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -128.31 130.03 47.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.533 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 126.26 20.18 2.03 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.154 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -71.19 -101.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 171.64 -100.44 0.15 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.139 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -131.95 33.55 3.93 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.517 ' O ' ' C ' ' A' ' 296' ' ' VAL . 1.4 p-10 -130.46 -51.66 1.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.137 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 296' ' ' VAL . 14.4 p -2.05 76.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.803 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -112.76 155.05 25.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.699 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.636 HG23 ' HB ' ' A' ' 322' ' ' ILE . 16.7 mt -61.12 -47.04 95.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.225 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -38.27 87.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.746 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -39.26 79.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.121 0.486 . . . . 0.0 110.484 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 297' ' ' THR . 87.2 t -73.41 -39.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.805 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -64.13 -32.23 73.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.926 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.54 -39.87 62.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.678 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.532 ' CZ ' ' CE1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -89.5 -21.64 22.85 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.821 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -102.19 30.09 4.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.142 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.3 19.36 17.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.159 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -101.83 -39.7 7.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.091 0.472 . . . . 0.0 110.323 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -79.1 -38.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.119 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -165.99 -169.97 30.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.525 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.59 144.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 340' ' ' SER . 4.1 mp -93.48 131.83 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.144 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 25.7 mtmt -48.91 93.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.765 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -64.56 145.46 56.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.463 179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.491 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 5.8 m-20 -75.89 162.19 28.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.346 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -104.95 -7.72 19.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.619 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -104.48 -35.69 7.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.999 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 314' ' ' ASN . 69.6 p -108.24 -9.57 15.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 313' ' ' THR . . . 60.51 14.72 36.35 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.718 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 159.18 52.41 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.984 0.392 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 76.6 Cg_exo -44.68 151.15 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.007 2.471 . . . . 0.0 112.86 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.491 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 29.9 mtm -108.11 119.15 38.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.391 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.636 ' HB ' HG23 ' A' ' 298' ' ' ILE . 4.8 mt -143.22 142.74 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.467 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -117.95 133.19 56.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.618 ' N ' HD23 ' A' ' 324' ' ' LEU . 0.1 OUTLIER -125.41 164.04 21.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.209 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -130.71 113.52 14.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.821 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.969 HG22 HD23 ' A' ' 333' ' ' LEU . 13.6 p -101.01 160.98 13.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.0 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.35 133.55 52.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.806 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.43 ' HD3' ' N ' ' A' ' 329' ' ' GLU . 0.0 OUTLIER -100.21 -7.19 24.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.43 ' N ' ' HD3' ' A' ' 328' ' ' ARG . 11.6 mt-10 -97.6 -36.68 10.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.947 0.403 . . . . 0.0 110.747 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.4 t -110.86 -24.36 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 97.16 -22.7 39.35 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.408 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -176.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.901 0.382 . . . . 0.0 111.007 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.969 HD23 HG22 ' A' ' 326' ' ' THR . 1.1 mt -106.52 118.64 37.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.775 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt -57.4 -21.2 34.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.353 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.655 ' O ' HD22 ' A' ' 292' ' ' LEU . . . 80.61 38.58 16.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.915 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -139.78 131.77 27.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.857 -0.172 . . . . 0.0 110.866 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -162.65 145.54 11.01 Favored 'General case' 0 C--N 1.335 -0.051 0 CA-C-O 121.089 0.471 . . . . 0.0 111.882 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.54 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 5.1 p -95.3 150.01 20.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.135 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.762 ' CG2' HG11 ' A' ' 301' ' ' VAL . 44.7 t -123.71 127.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 311' ' ' ILE . 91.4 p -84.32 153.21 23.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.05 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 3.5 m-85 -127.08 133.41 50.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.022 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.454 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -62.46 -22.19 66.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.942 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -127.98 116.72 20.56 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.758 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.5 Cg_exo -45.23 -51.05 8.24 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.664 2.243 . . . . 0.0 113.017 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.2 Cg_endo -59.55 -30.48 92.52 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.85 1.7 . . . . 0.0 111.159 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -38.37 89.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.897 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' A' ' 287' ' ' ILE . . . -58.64 -42.75 89.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.874 0.368 . . . . 0.0 110.694 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.915 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.86 -55.96 21.53 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.527 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -48.32 -31.74 6.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.792 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.61 -47.74 65.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.428 0.632 . . . . 0.0 109.39 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.915 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -61.91 -36.52 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.073 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.93 -26.42 68.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.325 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.533 ' CE3' ' CZ ' ' A' ' 354' ' ' PHE . 3.5 t90 -91.08 -68.5 0.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.533 ' CZ ' ' CE3' ' A' ' 353' ' ' TRP . 2.5 m-85 -68.84 -77.87 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 33.8 t0 25.27 50.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.033 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.7 26.98 1.21 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.804 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.505 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.6 OUTLIER -102.47 -156.19 0.55 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.347 0.574 . . . . 0.0 110.778 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.4 mt-10 -113.5 128.65 56.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.349 0.595 . . . . 0.0 112.192 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.642 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.5 OUTLIER -108.01 103.19 12.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.981 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 29.5 t 63.36 28.07 15.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.619 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 104.62 -14.06 50.29 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.799 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.661 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 4.0 m-80 -106.92 170.94 5.14 Favored Pre-proline 0 C--O 1.219 -0.503 0 CA-C-N 117.246 0.523 . . . . 0.0 110.328 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 89.7 Cg_endo -92.1 139.14 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.82 2.346 . . . . 0.0 111.904 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.533 HG22 HD13 ' A' ' 292' ' ' LEU . 9.2 pt -132.33 172.78 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.21 106.16 4.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.786 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.772 ' CG1' HD12 ' A' ' 287' ' ' ILE . 14.4 t -84.45 139.54 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.813 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.9 t -122.43 -175.0 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 0.0 111.885 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.447 ' CE1' ' ND2' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -103.43 40.27 1.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.635 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.977 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 61.14 108.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.208 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 63.7 p -74.16 133.29 42.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.63 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -42.92 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.273 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 373' ' ' ALA . 1.4 mtm-85 59.87 155.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 372' ' ' ARG . . . 177.33 45.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.25 55.97 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -177.07 56.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 45.0 t30 64.15 -77.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.008 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.29 148.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.857 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -134.64 -132.26 3.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.436 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.77 119.7 1.04 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 95.21 -175.4 33.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -97.32 -167.73 1.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -58.24 -28.12 61.2 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.564 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 4.8 ttm-85 -110.8 147.43 34.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -106.22 130.36 10.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.41 -1.217 . . . . 0.0 112.493 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.836 0.35 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -144.94 -178.32 5.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.18 94.88 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -149.22 37.31 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.1 t -105.06 24.19 12.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.77 -26.96 68.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.431 ' OD1' ' CZ ' ' A' ' 368' ' ' PHE . 0.4 OUTLIER -73.47 122.19 21.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.221 0.534 . . . . 0.0 110.921 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER 166.08 -33.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.668 -179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 78.8 m -101.47 115.67 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.935 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 366' ' ' VAL . 9.2 pt -91.08 173.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 338' ' ' THR . 2.4 m-85 -130.34 108.37 9.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.122 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.596 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -99.82 114.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 35.8 mm-40 -119.91 130.62 54.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.422 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.86 ' C ' HD13 ' A' ' 292' ' ' LEU . . . 115.68 70.45 0.47 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.236 -0.983 . . . . 0.0 114.338 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.931 HD21 ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.83 -78.28 0.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.877 0.339 . . . . 0.0 110.12 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.93 -81.62 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.665 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 294' ' ' GLU . 8.6 tp10 -140.93 41.5 1.82 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.249 0.547 . . . . 0.0 110.13 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -138.13 14.56 2.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.32 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 1.061 HG12 HD23 ' A' ' 324' ' ' LEU . 1.6 t -77.38 95.64 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.864 0.364 . . . . 0.0 111.612 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.817 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.07 151.52 52.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.301 179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 324' ' ' LEU . 26.6 mm -65.21 -48.36 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.58 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.91 -35.11 79.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.761 0.315 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 55.2 m -70.89 -43.82 67.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.577 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -63.0 -29.78 71.09 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.165 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.6 -38.84 64.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.889 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.38 -22.36 18.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.857 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -93.22 5.26 52.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.06 23.93 6.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.782 0.325 . . . . 0.0 111.092 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -105.89 -31.65 8.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.47 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' A' ' 353' ' ' TRP . 1.8 tp -91.32 -39.39 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.767 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -150.96 -175.92 23.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.18 119.82 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 305' ' ' PHE . 73.5 mt -85.83 125.02 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.244 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 0.7 OUTLIER -48.71 103.75 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -62.02 148.8 42.82 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.641 178.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.805 HD21 HG23 ' A' ' 317' ' ' THR . 0.1 OUTLIER -106.8 140.08 40.21 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.73 0.3 . . . . 0.0 110.525 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -5.34 47.13 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -29.16 17.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.805 HG23 HD21 ' A' ' 314' ' ' ASN . 28.9 p -122.13 -23.17 5.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 83.4 12.17 78.97 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.339 -178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.95 153.29 71.03 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.939 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.9 Cg_endo -44.79 153.24 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.048 2.499 . . . . 0.0 112.596 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.492 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 45.9 mtp -104.69 128.53 52.79 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.353 0.597 . . . . 0.0 111.7 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 338' ' ' THR . 3.1 mt -140.22 141.56 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.938 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 6.1 m-80 -97.37 148.38 23.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 1.061 HD23 HG12 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -144.98 135.9 24.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.842 0.353 . . . . 0.0 111.483 -179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -80.35 87.81 5.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.127 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.534 HG22 HD23 ' A' ' 333' ' ' LEU . 15.6 p -83.43 167.73 17.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.397 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 330' ' ' THR . 0.6 OUTLIER -64.01 99.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.426 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.46 -76.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.266 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 327' ' ' ASP . 13.3 mt-10 -147.69 -26.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.717 HG23 ' H ' ' A' ' 332' ' ' LYS . 10.6 t -44.73 -29.67 0.81 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.821 0.343 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.19 20.86 71.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.003 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.717 ' H ' HG23 ' A' ' 330' ' ' THR . 0.3 OUTLIER -61.93 -25.8 67.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.568 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.876 HD22 HD22 ' A' ' 324' ' ' LEU . 2.2 mt 63.84 126.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.15 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.55 84.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 292' ' ' LEU . . . 171.11 -69.03 0.13 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 119.881 -1.152 . . . . 0.0 113.627 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.931 ' HA ' HD21 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -160.23 167.29 27.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.323 . . . . 0.0 111.217 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.697 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -158.0 147.14 19.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.144 0.497 . . . . 0.0 111.741 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 322' ' ' ILE . 4.2 p -107.56 133.5 51.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.201 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 322' ' ' ILE . 49.8 t -100.91 124.29 54.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.066 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.3 p -94.67 112.16 23.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.199 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 311' ' ' ILE . 59.1 m-85 -91.27 159.46 16.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.953 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -88.91 -14.69 36.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -128.27 119.9 20.92 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.943 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.607 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.4 Cg_exo -47.56 -48.87 14.47 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.714 2.276 . . . . 0.0 113.027 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.9 Cg_endo -60.36 -30.6 91.34 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.858 1.705 . . . . 0.0 111.392 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -62.09 -34.91 77.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.645 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.542 ' HB3' ' CE1' ' A' ' 368' ' ' PHE . . . -59.71 -50.05 75.35 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.483 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 1.007 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -60.75 -45.8 92.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.956 179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.5 34.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.63 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.49 -46.97 68.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 1.007 HD12 ' HA ' ' A' ' 348' ' ' LYS . 12.3 mt -59.64 -34.75 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.119 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -26.88 67.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.551 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.564 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.72 -68.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.049 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.39 -79.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.117 -177.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 351' ' ' ILE . 37.6 t70 30.08 43.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.967 0.413 . . . . 0.0 111.496 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 134.92 28.3 0.45 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.139 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.1 OUTLIER -98.19 -163.6 1.06 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.9 pm0 -120.39 128.84 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.247 -0.581 . . . . 0.0 112.135 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.724 ' CD2' HD12 ' A' ' 292' ' ' LEU . 0.2 OUTLIER -82.88 101.45 11.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.243 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 45.91 29.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.281 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.27 -43.36 1.26 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 119.925 -1.131 . . . . 0.0 114.256 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -92.49 162.64 29.11 Favored Pre-proline 0 C--O 1.215 -0.715 0 CA-C-N 117.242 0.521 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 84.4 Cg_endo -85.93 141.85 7.48 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.135 2.557 . . . . 0.0 112.176 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.447 ' CG2' ' HB2' ' A' ' 359' ' ' PHE . 13.4 pt -124.77 177.6 4.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-O 121.105 0.479 . . . . 0.0 111.701 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -144.91 101.66 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.513 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.596 HG22 HG13 ' A' ' 289' ' ' VAL . 25.7 t -84.76 135.17 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.053 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 m -136.85 172.61 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.998 0.428 . . . . 0.0 111.64 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -93.03 63.68 3.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.744 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 57.92 165.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 371' ' ' ARG . 47.9 m 57.96 165.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.013 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 370' ' ' THR . 0.0 OUTLIER -99.77 88.47 3.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.752 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 -84.04 -65.82 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -78.99 139.83 38.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.002 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -138.43 138.44 38.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.45 31.08 20.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -122.07 139.23 53.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 377' ' ' ARG . 0.0 OUTLIER -149.52 149.41 30.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 126.05 -179.64 16.16 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.597 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -111.5 56.74 0.45 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.416 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 144.04 112.95 0.86 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -94.21 -31.34 14.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 138.85 -31.2 2.41 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.54 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 112.04 19.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.749 0.309 . . . . 0.0 110.927 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.69 -134.25 20.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.436 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.405 -1.219 . . . . 0.0 112.532 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.781 0.324 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.56 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -92.65 48.01 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.018 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -66.08 121.26 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -103.86 -70.12 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.948 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.14 28.62 1.52 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.8 115.53 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 347' ' ' ALA . 0.7 OUTLIER -57.32 -21.74 37.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.489 ' O ' ' HB3' ' A' ' 369' ' ' ALA . 61.4 m -71.61 102.29 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.069 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 305' ' ' PHE . 13.7 pt -104.02 162.04 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.991 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.779 ' HB3' ' HB2' ' A' ' 369' ' ' ALA . 0.1 OUTLIER -125.22 127.54 46.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.585 0.707 . . . . 0.0 112.202 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.821 HG13 HG22 ' A' ' 366' ' ' VAL . 1.7 t -107.12 117.5 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.401 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.482 ' OE1' ' CD2' ' A' ' 288' ' ' PHE . 1.3 mp0 -112.53 129.82 56.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.745 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.4 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 42.26 0.91 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.658 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 335' ' ' GLY . 0.4 OUTLIER -71.19 -78.6 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.522 0.201 . . . . 0.0 110.81 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 111.41 87.09 1.71 Allowed Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.172 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 43.68 30.31 0.35 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.834 0.35 . . . . 0.0 111.684 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.28 29.43 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.863 ' O ' HD13 ' A' ' 324' ' ' LEU . 2.5 t -75.43 72.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -116.57 146.87 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 322' ' ' ILE . 35.8 mt -69.31 -43.66 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.479 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.15 -42.93 88.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.899 0.38 . . . . 0.0 110.666 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 9.9 p -65.0 -41.27 95.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.2 0.524 . . . . 0.0 110.697 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 85.5 t -71.21 -42.7 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.266 0.555 . . . . 0.0 109.733 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -63.25 -30.43 71.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.3 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -39.69 62.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.614 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.493 ' CE1' ' CE2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -88.83 -24.33 22.6 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.614 -179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.632 ' CE2' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -94.14 19.1 9.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.662 0.268 . . . . 0.0 111.332 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.89 20.54 18.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.853 0.359 . . . . 0.0 110.899 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -102.56 -39.36 7.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 5.0 tp -73.03 -34.98 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.05 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -167.25 -153.11 7.78 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.646 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -109.55 119.55 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.9 mt -71.77 130.66 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.1 OUTLIER -48.68 92.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.62 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -69.81 137.49 51.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.432 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.5 OUTLIER -73.98 128.26 35.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.194 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -5.9 56.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.074 0.464 . . . . 0.0 110.071 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.44 -40.69 7.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.452 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.672 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.3 OUTLIER -105.13 -11.12 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.906 -179.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 67.07 11.92 59.43 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.498 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.672 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.16 152.2 66.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.902 0.351 . . . . 0.0 111.336 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 80.8 Cg_exo -47.68 158.47 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.795 2.33 . . . . 0.0 112.476 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.425 ' HG3' ' ND2' ' A' ' 314' ' ' ASN . 37.2 mmm -119.13 119.09 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 111.119 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.83 HG23 ' O ' ' A' ' 338' ' ' THR . 59.6 mt -143.08 144.81 23.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.736 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.2 m-80 -103.27 148.15 26.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 111.011 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.863 HD13 ' O ' ' A' ' 296' ' ' VAL . 3.6 mt -130.4 131.03 45.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.86 113.84 27.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.911 HG22 HD23 ' A' ' 333' ' ' LEU . 59.6 p -106.62 158.2 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.95 129.45 40.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.658 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.449 ' CD ' ' H ' ' A' ' 328' ' ' ARG . 0.0 OUTLIER -96.64 19.8 11.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.407 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.8 -41.57 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 15.8 p -110.68 -29.79 7.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 110.59 -24.65 16.93 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.521 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -56.82 -172.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 110.975 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.911 HD23 HG22 ' A' ' 326' ' ' THR . 1.7 mt -100.49 133.25 45.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.821 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -68.77 -21.76 64.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.559 ' O ' HD22 ' A' ' 292' ' ' LEU . . . 87.56 29.09 22.57 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.369 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 1.5 mt-10 -143.84 131.94 21.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.345 0.117 . . . . 0.0 110.8 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -144.15 167.45 22.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.159 0.504 . . . . 0.0 111.913 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 322' ' ' ILE . 1.3 p -121.12 145.84 47.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.198 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 322' ' ' ILE . 92.0 t -125.4 134.37 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.721 0.296 . . . . 0.0 111.385 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 312' ' ' LYS . 59.2 p -98.37 131.02 45.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.016 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.44 147.81 29.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 0.2 OUTLIER -79.08 -9.54 59.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.21 116.58 15.49 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.003 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.62 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.9 Cg_exo -45.13 -50.27 9.05 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.579 2.186 . . . . 0.0 112.798 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.0 Cg_endo -54.71 -30.56 67.29 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.924 1.749 . . . . 0.0 111.484 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 19.4 t -59.03 -42.17 89.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.868 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 285' ' ' ASN . . . -56.86 -49.84 74.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.033 0.444 . . . . 0.0 110.387 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.88 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.5 tppt? -61.98 -53.86 49.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.653 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.51 -31.68 47.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.846 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.44 -47.92 65.93 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.88 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.7 mt -59.8 -36.72 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.66 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.166 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.514 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.16 -68.05 0.75 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.115 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.61 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -76.17 -80.74 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -177.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.1 p-10 26.62 45.02 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.399 0.437 . . . . 0.0 111.992 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.36 37.25 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.052 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.61 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -95.91 -155.99 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 13.4 mt-10 -113.27 128.27 56.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.401 0.62 . . . . 0.0 111.48 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.493 ' CE2' ' CE1' ' A' ' 304' ' ' TYR . 0.6 OUTLIER -122.76 101.91 7.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.937 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 56.0 m 60.55 27.22 16.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 110.537 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 90.55 17.49 52.2 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.018 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.42 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 20.3 m-80 -129.28 164.37 39.87 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.869 0.366 . . . . 0.0 111.306 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 90.5 Cg_endo -89.55 132.54 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.816 2.344 . . . . 0.0 111.9 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 289' ' ' VAL . 20.4 pt -120.84 174.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.04 0.448 . . . . 0.0 111.992 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -139.39 100.95 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.728 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.821 HG22 HG13 ' A' ' 289' ' ' VAL . 26.0 t -97.64 115.92 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.454 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -140.54 -165.03 1.84 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.224 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -80.54 117.52 21.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.924 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.779 ' HB2' ' HB3' ' A' ' 288' ' ' PHE . . . -93.29 148.58 21.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -107.3 120.43 42.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -126.87 34.63 4.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.9 mtp85 59.83 -87.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.979 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 42.95 91.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.753 0.311 . . . . 0.0 111.632 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -122.07 94.53 4.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.972 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -142.94 -87.61 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.87 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 177.88 39.5 0.0 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.716 0.293 . . . . 0.0 110.711 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -178.58 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 153.21 -43.36 0.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.473 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 122.08 -92.68 0.49 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.501 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 113.5 29.85 2.81 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.518 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -111.34 31.17 6.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.802 0.334 . . . . 0.0 110.818 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.7 80.5 1.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -124.91 127.29 46.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.762 0.315 . . . . 0.0 110.947 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -92.65 -94.25 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.576 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 279' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.603 0.239 . . . . 0.0 111.156 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER 32.52 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.935 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -94.35 42.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.146 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -97.31 63.24 1.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.983 0.421 . . . . 0.0 110.811 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -41.08 11.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.841 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.45 17.29 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 285' ' ' ASN . 33.7 m120 -88.29 138.05 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.738 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 284' ' ' ASN . 6.4 p30 168.64 -32.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.07 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 369' ' ' ALA . 90.7 m -104.84 95.33 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.996 HD12 HG13 ' A' ' 366' ' ' VAL . 50.3 pt -86.53 168.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.681 ' HD2' HG22 ' A' ' 338' ' ' THR . 31.4 m-85 -120.71 124.28 44.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.384 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.661 HG12 ' HB ' ' A' ' 364' ' ' ILE . 0.9 OUTLIER -109.73 114.65 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.886 178.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -116.53 130.66 56.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.017 -179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 363' ' ' PRO . . . 127.96 20.7 1.63 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.615 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 295' ' ' ASN . 12.3 mt -66.76 -103.63 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 -74.95 0.35 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.97 34.5 5.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.585 HD21 HD22 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -145.41 30.74 1.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.715 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.627 HG11 ' OG1' ' A' ' 326' ' ' THR . 2.5 t -74.97 81.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.582 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -146.6 146.27 30.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.906 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.704 HG23 ' HB ' ' A' ' 322' ' ' ILE . 15.4 mt -71.37 -43.39 73.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -66.15 -40.62 90.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.64 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.8 t -63.45 -41.05 98.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 297' ' ' THR . 43.9 t -74.12 -41.17 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.295 0.569 . . . . 0.0 109.95 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.12 -29.85 68.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -74.14 -39.59 63.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.506 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -92.41 -24.49 18.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.649 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.3 OUTLIER -96.78 32.83 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.236 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -116.18 16.62 15.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.288 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -98.77 -42.19 7.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.455 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.6 tp -71.07 -32.6 48.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.24 -163.66 27.28 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.6 mt -100.64 141.84 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.534 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.1 mt -100.83 125.22 54.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.411 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -48.76 107.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.529 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -73.42 152.38 40.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.133 178.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.567 HD21 HG23 ' A' ' 317' ' ' THR . 0.2 OUTLIER -105.27 138.16 41.91 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.928 0.394 . . . . 0.0 110.827 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.17 -1.95 25.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -96.9 -26.51 15.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 110.481 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.567 HG23 HD21 ' A' ' 314' ' ' ASN . 68.6 p -121.33 -20.41 6.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.58 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 75.79 13.96 82.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.976 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.536 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.86 164.03 35.66 Favored Pre-proline 0 C--N 1.333 -0.113 0 CA-C-O 120.746 0.308 . . . . 0.0 111.376 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.616 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 71.3 Cg_exo -44.7 155.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.76 2.307 . . . . 0.0 112.384 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.501 ' CG ' ' HB2' ' A' ' 314' ' ' ASN . 51.7 mtp -109.34 119.8 40.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 111.636 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.704 ' HB ' HG23 ' A' ' 298' ' ' ILE . 3.4 mt -142.83 145.19 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.977 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 11.6 t-20 -119.15 116.4 26.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.805 0.336 . . . . 0.0 110.934 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.7 130.28 56.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -109.07 91.79 3.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.66 ' HB ' HD23 ' A' ' 333' ' ' LEU . 69.7 p -147.01 165.17 30.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -62.47 148.27 46.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.417 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -104.92 -20.99 13.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 178.75 30.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.233 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 332' ' ' LYS . 5.3 t -116.54 -35.99 4.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.568 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 107.72 10.14 27.33 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.452 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.41 ' H ' HG23 ' A' ' 330' ' ' THR . 2.9 mmtp -69.73 -70.29 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.992 0.396 . . . . 0.0 110.825 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 326' ' ' THR . 1.9 mt 58.47 110.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.314 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 -15.96 19.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.906 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.516 ' H ' HG22 ' A' ' 326' ' ' THR . . . 57.8 47.77 86.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 290' ' ' GLN . 6.8 mt-10 -140.97 131.54 25.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.596 0.236 . . . . 0.0 111.234 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -139.28 169.69 17.31 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.917 0.389 . . . . 0.0 111.275 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.681 HG22 ' HD2' ' A' ' 288' ' ' PHE . 20.0 p -128.05 126.38 41.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.572 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' A' ' 322' ' ' ILE . 42.3 t -106.51 116.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.396 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.7 ' O ' HG23 ' A' ' 311' ' ' ILE . 20.4 m -80.68 152.96 28.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.404 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 5.5 m-85 -136.29 139.15 42.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 -26.29 65.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.113 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -124.16 116.03 27.31 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.801 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.589 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.2 Cg_exo -42.72 -51.12 5.5 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.773 2.315 . . . . 0.0 113.094 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.4 Cg_endo -53.66 -30.37 55.39 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.817 1.678 . . . . 0.0 111.131 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.4 t -57.7 -46.15 84.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.16 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.75 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -54.52 -39.63 67.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.618 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.892 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.3 tptp -64.91 -59.56 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.45 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -46.42 -30.71 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.758 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -50.25 52.43 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.469 0.652 . . . . 0.0 109.282 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.1 mt -59.48 -37.35 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.987 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -60.4 -26.3 66.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.946 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.4 t90 -98.9 -68.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.582 ' HB2' HG21 ' A' ' 366' ' ' VAL . 8.1 m-85 -63.86 -76.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 12.7 p-10 19.88 55.49 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.99 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 120.92 17.73 4.08 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.563 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.3 OUTLIER -76.14 -161.4 0.18 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.672 0.272 . . . . 0.0 111.323 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 3.3 mt-10 -113.48 152.92 29.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.123 0.487 . . . . 0.0 111.523 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.566 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -142.08 101.3 3.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.514 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 16.9 p 49.82 27.41 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.88 0.371 . . . . 0.0 110.665 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.43 17.33 22.24 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.245 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 359' ' ' PHE . 63.6 m-80 -129.3 152.2 79.09 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 121.002 0.429 . . . . 0.0 111.766 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.434 ' O ' ' HA3' ' A' ' 291' ' ' GLY . 90.7 Cg_endo -85.53 133.43 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.947 2.431 . . . . 0.0 111.451 178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.661 ' HB ' HG12 ' A' ' 289' ' ' VAL . 5.1 pt -119.2 150.32 21.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.115 0.483 . . . . 0.0 112.275 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.91 103.67 9.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.339 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.996 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -84.51 130.66 35.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.646 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.43 -174.45 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.701 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.671 ' CD2' HD13 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -107.06 35.3 3.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 288' ' ' PHE . . . 56.59 36.21 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.96 169.11 18.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.66 1.3 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.495 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 43.9 mmm-85 60.6 75.71 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.29 -171.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.991 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.407 ' O ' ' CB ' ' A' ' 375' ' ' PHE . 0.2 OUTLIER 79.36 -49.56 0.41 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.32 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 374' ' ' ASP . 0.2 OUTLIER 79.13 31.27 0.3 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.947 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.16 178.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.02 85.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.918 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 154.93 -81.18 0.17 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -128.89 -176.63 14.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.515 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 161.78 177.06 34.52 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.484 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 63.59 137.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -66.43 105.82 1.42 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.5 tpt85 -132.18 153.62 50.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 164.0 -115.24 0.64 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.504 179.925 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 43.37 74.84 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -101.06 36.15 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -100.53 33.2 2.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.832 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.48 -23.32 17.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -101.45 31.25 3.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.418 ' ND2' ' N ' ' A' ' 284' ' ' ASN . 0.1 OUTLIER -44.39 110.78 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.309 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 17.1 p30 -60.41 -23.6 64.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.997 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.677 HG22 ' CB ' ' A' ' 369' ' ' ALA . 28.4 m -70.13 139.56 52.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.966 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 366' ' ' VAL . 39.1 pt -122.44 164.86 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.608 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.2 OUTLIER -113.24 109.1 18.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.69 114.66 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 2.0 mp0 -113.74 130.54 56.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.5 47.89 1.09 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.873 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.878 HD12 HG22 ' A' ' 296' ' ' VAL . 7.1 mt -68.9 -70.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.723 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 102.79 77.48 1.22 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.632 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 42.01 31.53 0.24 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.42 29.29 2.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.246 0.546 . . . . 0.0 110.512 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.918 HG12 HD22 ' A' ' 324' ' ' LEU . 4.6 t -69.29 86.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.862 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -133.88 146.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.346 179.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 322' ' ' ILE . 29.9 mm -70.88 -44.23 76.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.319 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.82 -43.1 84.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.782 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -41.59 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.7 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 297' ' ' THR . 72.6 t -72.05 -41.71 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.722 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -30.43 69.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.959 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.11 -35.37 64.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.845 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.512 ' CE1' ' CD2' ' A' ' 305' ' ' PHE . 0.1 OUTLIER -88.71 -22.22 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.569 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 339' ' ' VAL . 1.2 m-85 -89.49 12.27 17.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.67 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 29.71 2.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.888 0.375 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.36 -35.51 5.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 349' ' ' ALA . 5.0 tp -80.04 -33.88 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.336 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.67 -150.62 9.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.823 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -101.47 129.18 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.73 0.3 . . . . 0.0 111.447 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.722 HD13 ' HA ' ' A' ' 302' ' ' ALA . 5.3 mt -84.34 125.9 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.05 0.452 . . . . 0.0 110.454 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 340' ' ' SER . 0.0 OUTLIER -49.03 91.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.385 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -82.62 170.29 15.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.066 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.578 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -106.51 153.29 22.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -1.27 51.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.919 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.561 ' HG3' HG23 ' A' ' 317' ' ' THR . 1.1 tptp -94.59 -47.38 6.55 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.607 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.561 HG23 ' HG3' ' A' ' 316' ' ' LYS . 58.4 p -104.62 -12.84 16.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.921 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 62.04 20.19 59.98 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.209 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.88 154.23 70.86 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 120.667 0.27 . . . . 0.0 110.322 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 73.2 Cg_exo -51.16 149.87 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.226 1.951 . . . . 0.0 111.745 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.578 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -118.53 128.62 54.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.439 0.638 . . . . 0.0 112.208 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -140.9 143.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.618 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.37 115.6 28.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -116.14 153.66 31.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -128.45 119.74 25.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.847 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.648 HG22 ' HB3' ' A' ' 333' ' ' LEU . 62.2 p -113.28 114.32 26.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.214 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 332' ' ' LYS . 0.9 OUTLIER -173.02 99.76 0.13 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.402 179.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.99 -41.35 3.19 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.511 ' C ' HG22 ' A' ' 330' ' ' THR . 49.0 mt-10 -152.49 12.84 0.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.261 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.511 HG22 ' C ' ' A' ' 329' ' ' GLU . 1.4 t 155.13 45.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.7 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 326' ' ' THR . . . 89.06 32.18 11.06 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.624 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 327' ' ' ASP . 1.3 mttp -92.83 124.26 36.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 111.775 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.828 HD13 ' H ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -46.28 118.17 1.83 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -96.62 30.24 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 49.66 53.22 22.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.659 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -148.29 131.26 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.777 0.322 . . . . 0.0 111.331 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.06 170.33 22.29 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.066 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 322' ' ' ILE . 76.1 p -127.2 114.58 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.331 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 322' ' ' ILE . 48.7 t -94.82 117.04 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.1 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 312' ' ' LYS . 67.6 m -84.5 132.9 34.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.479 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.707 ' HE2' HD13 ' A' ' 287' ' ' ILE . 18.2 m-85 -104.95 142.62 34.46 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.858 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.85 -19.5 62.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 346' ' ' SER . 0.7 OUTLIER -128.94 120.96 20.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.875 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 72.0 Cg_exo -47.76 -48.63 15.43 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.713 2.275 . . . . 0.0 113.069 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 19.8 Cg_endo -60.99 -30.63 90.22 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.858 1.705 . . . . 0.0 111.277 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 343' ' ' ASP . 0.0 OUTLIER -61.02 -32.6 72.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.372 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 341' ' ' PHE . . . -61.68 -55.3 31.9 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.672 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.883 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -59.01 -43.33 91.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.166 179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.38 -35.42 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.406 ' CA ' HG12 ' A' ' 308' ' ' ILE . . . -68.69 -49.35 59.66 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.429 0.633 . . . . 0.0 109.584 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 348' ' ' LYS . 6.9 mt -59.45 -36.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.135 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -62.68 -26.4 68.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.618 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.56 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.2 t90 -100.32 -68.13 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.175 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.529 ' O ' ' C ' ' A' ' 355' ' ' ASP . 23.2 m-85 -61.33 -77.21 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 354' ' ' PHE . 17.4 p-10 17.29 59.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.71 22.11 2.54 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.739 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.447 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -81.22 -165.61 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.63 0.215 . . . . 0.0 110.799 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.9 OUTLIER -124.38 129.67 51.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 111.861 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.82 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -89.72 101.46 14.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.064 178.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.85 29.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.24 -48.71 0.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.224 -0.989 . . . . 0.0 113.93 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -82.8 169.95 16.22 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 117.034 0.417 . . . . 0.0 110.636 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 357' ' ' LYS . 87.4 Cg_endo -95.85 145.55 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.44 2.76 . . . . 0.0 111.952 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.82 HG21 ' HD2' ' A' ' 359' ' ' PHE . 5.8 pt -127.37 -178.84 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.174 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -145.59 100.57 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 287' ' ' ILE . 21.7 t -87.43 128.41 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.9 t -140.2 -165.55 1.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -93.2 113.51 25.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.819 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.677 ' CB ' HG22 ' A' ' 286' ' ' THR . . . -69.96 175.19 4.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.74 -166.53 1.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.05 -41.55 28.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.421 . . . . 0.0 110.729 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.53 -172.89 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.681 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.616 ' HB1' ' OD1' ' A' ' 376' ' ' ASN . . . -46.73 108.98 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.311 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -104.94 -31.32 9.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -58.24 -51.48 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . 0.616 ' OD1' ' HB1' ' A' ' 373' ' ' ALA . 26.4 p30 -95.33 163.05 13.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.989 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -74.91 0.13 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 100.34 -138.68 13.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.559 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 139.3 79.91 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.409 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 161.77 -33.33 0.35 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -60.39 145.28 48.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 148.75 134.94 2.46 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.526 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.99 149.23 37.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.855 0.359 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 145.98 -108.67 0.47 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.527 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.463 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.773 0.32 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -169.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -141.08 87.86 2.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -144.93 119.96 10.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.098 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 21.6 p -105.01 -36.83 7.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -129.94 31.05 4.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.619 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.55 ' OD1' ' CD1' ' A' ' 368' ' ' PHE . 2.2 t-20 -87.88 81.5 7.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.04 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.404 ' OD1' ' CD ' ' A' ' 344' ' ' PRO . 0.7 OUTLIER -123.44 -3.23 8.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.32 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.746 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 77.6 m -114.86 127.26 55.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 1.005 HD12 HG13 ' A' ' 366' ' ' VAL . 29.7 pt -108.45 167.87 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.633 ' CD1' HG22 ' A' ' 338' ' ' THR . 18.0 m-30 -122.59 114.83 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.261 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -105.69 114.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.398 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -108.88 130.55 55.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 119.65 55.56 0.25 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.684 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 296' ' ' VAL . 3.0 mm? -91.41 -77.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.749 0.309 . . . . 0.0 110.721 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.91 76.2 1.06 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.112 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 44.89 41.04 4.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.882 0.372 . . . . 0.0 111.738 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.64 24.62 0.52 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.729 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 292' ' ' LEU . 4.0 t -73.89 88.2 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.519 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.778 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -116.63 146.54 42.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.793 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 54.2 mt -71.4 -43.49 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.443 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -66.44 -41.28 89.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.735 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.9 t -64.78 -43.4 93.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.725 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 297' ' ' THR . 59.6 t -72.98 -41.07 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.321 0.582 . . . . 0.0 109.649 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.589 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.1 -29.69 68.68 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.982 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -73.5 -39.03 65.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.608 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.86 -22.47 16.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.541 ' CZ ' ' CE2' ' A' ' 354' ' ' PHE . 1.0 OUTLIER -95.56 2.37 54.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 21.5 ptmt -96.37 30.2 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.187 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -34.31 6.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.11 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.459 HD13 ' HB2' ' A' ' 353' ' ' TRP . 0.8 OUTLIER -80.31 -41.34 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.244 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -146.58 -168.24 13.45 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.7 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.14 106.71 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 10.8 mt -72.39 129.49 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 109.929 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 92.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -65.99 138.94 58.15 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.782 177.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.1 OUTLIER -89.78 165.75 13.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.171 0.51 . . . . 0.0 111.96 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -102.57 -4.41 25.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.3 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.959 ' HD3' HG23 ' A' ' 317' ' ' THR . 0.0 OUTLIER -96.33 -40.81 8.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.75 179.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.959 HG23 ' HD3' ' A' ' 316' ' ' LYS . 12.1 p -106.13 -18.33 14.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.304 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 76.44 8.13 85.62 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.161 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.54 157.89 66.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.743 0.272 . . . . 0.0 111.022 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.635 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 1.1 Cg_endo -45.45 162.18 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.904 2.403 . . . . 0.0 112.617 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.515 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.84 130.37 56.67 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.686 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 339' ' ' VAL . 1.9 mp -143.22 140.02 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -105.23 115.82 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.772 0.32 . . . . 0.0 111.098 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 296' ' ' VAL . 0.2 OUTLIER -108.87 150.35 27.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.278 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 336' ' ' GLU . 14.2 m-85 -92.29 101.81 14.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.74 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 333' ' ' LEU . 2.9 p -108.03 158.96 16.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.04 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -78.85 148.28 32.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 17.79 18.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.179 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -108.34 -40.78 5.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.933 0.397 . . . . 0.0 110.668 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 9.0 p -119.69 -7.58 10.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.163 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 69.46 32.63 71.66 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.372 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.53 154.22 25.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 111.045 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -102.27 147.58 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.509 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.02 90.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.339 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.54 -76.43 0.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.329 -0.938 . . . . 0.0 112.994 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -160.42 178.06 9.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.284 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 296' ' ' VAL . . . -154.06 162.6 41.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.212 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.633 HG22 ' CD1' ' A' ' 288' ' ' PHE . 19.5 p -116.93 117.45 29.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.052 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 322' ' ' ILE . 50.8 t -92.73 123.06 44.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.586 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 311' ' ' ILE . 1.2 m -101.33 131.87 47.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 339' ' ' VAL . 26.8 m-85 -115.37 158.54 22.3 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.063 0.458 . . . . 0.0 111.268 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.9 6.81 37.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.08 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.32 121.81 7.91 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.714 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.602 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 50.5 Cg_exo -52.88 -47.75 25.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.68 2.253 . . . . 0.0 113.326 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.8 Cg_endo -60.7 -30.12 89.72 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 121.729 1.619 . . . . 0.0 111.048 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -40.54 81.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.973 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.45 -50.87 72.24 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.17 -50.87 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.778 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.44 -34.16 33.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.072 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.481 ' HB1' ' CE1' ' A' ' 305' ' ' PHE . . . -68.62 -46.81 68.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.421 0.629 . . . . 0.0 109.756 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.8 mt -58.69 -34.24 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.294 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.29 -26.8 68.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.796 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.537 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -87.07 -68.18 0.77 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.541 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 0.9 OUTLIER -77.63 -79.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.58 -176.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 28.74 45.7 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.799 0.333 . . . . 0.0 111.704 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 128.52 30.78 0.69 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.485 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.481 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -90.94 -160.32 0.71 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.51 0.195 . . . . 0.0 111.047 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 6.0 mp0 -113.36 153.13 29.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.291 0.567 . . . . 0.0 111.704 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.535 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.0 OUTLIER -136.98 101.12 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.319 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.6 m 46.73 28.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.413 . . . . 0.0 110.787 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.81 18.75 14.69 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.118 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 359' ' ' PHE . 72.0 m-80 -129.29 150.24 74.96 Favored Pre-proline 0 C--O 1.225 -0.186 0 CA-C-O 121.067 0.46 . . . . 0.0 111.71 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.93 127.83 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.766 2.311 . . . . 0.0 111.678 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.562 ' HB ' HG12 ' A' ' 289' ' ' VAL . 6.1 pt -111.43 165.2 6.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.912 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.34 100.99 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 1.005 HG13 HD12 ' A' ' 287' ' ' ILE . 26.6 t -87.09 133.14 30.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.034 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 17.9 p -133.83 -176.49 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.653 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.55 ' CD1' ' OD1' ' A' ' 284' ' ' ASN . 26.6 m-85 -93.68 39.0 1.06 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 61.47 30.56 18.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.924 0.393 . . . . 0.0 110.766 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.6 p -69.34 -162.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 5.0 ttm-85 74.31 134.51 0.05 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.989 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.4 -47.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.068 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -177.79 122.8 0.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.209 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.3 t70 58.22 -170.02 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.954 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 375' ' ' PHE . 0.1 OUTLIER -55.15 -178.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.109 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.65 160.57 14.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 161.86 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -58.84 89.6 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.392 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 76.98 -139.53 23.6 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.541 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 85.84 121.43 1.19 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -176.54 147.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -114.37 28.47 8.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.442 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -139.58 111.1 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 99.93 -89.12 0.83 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.398 -1.224 . . . . 0.0 112.533 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 58.59 176.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 282' ' ' SER . 5.1 m-20 -115.61 -85.89 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 56.09 -85.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.681 0.277 . . . . 0.0 110.877 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 280' ' ' ASP . 10.0 t -104.93 -19.66 13.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.949 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -75.61 -22.39 56.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.081 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.77 119.14 5.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.729 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.721 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.0 OUTLIER -104.95 -28.41 11.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 4.4 m -64.82 145.13 56.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.512 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.846 HD12 HG13 ' A' ' 366' ' ' VAL . 23.5 pt -125.39 173.42 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.618 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -121.77 109.29 14.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.936 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.813 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -103.19 117.38 48.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.662 179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.422 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -129.87 130.9 45.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.218 -179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 123.13 19.52 2.91 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.601 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 359' ' ' PHE . 39.6 mt -70.1 -101.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 159.08 -93.29 0.12 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.274 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -132.43 28.56 4.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.146 0.498 . . . . 0.0 110.136 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.09 -12.93 8.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.468 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.673 ' CG2' ' HB2' ' A' ' 337' ' ' ALA . 9.7 p -44.63 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.7 OUTLIER -143.5 147.13 34.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.062 178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 19.5 mt -61.49 -47.37 93.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.712 0.291 . . . . 0.0 111.769 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.27 -39.47 89.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 12.2 t -68.44 -42.86 78.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 297' ' ' THR . 46.2 t -72.88 -38.82 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.291 0.567 . . . . 0.0 109.625 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.38 -29.85 68.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.895 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.72 -40.54 66.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.812 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.2 -24.26 16.33 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.579 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.6 OUTLIER -95.72 33.13 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.901 0.381 . . . . 0.0 110.977 -179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.31 21.0 12.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -103.92 -40.39 6.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.285 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 349' ' ' ALA . 1.0 OUTLIER -72.28 -27.84 27.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.262 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.5 -165.92 32.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.705 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.8 mt -99.58 134.94 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.462 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -94.68 127.73 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.422 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 321' ' ' MET . 14.7 mtmm -48.77 110.27 0.33 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -60.14 -179.64 0.11 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 315' ' ' LYS . 3.9 m-80 -95.98 -40.89 9.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 314' ' ' ASN . 0.2 OUTLIER 86.92 -31.08 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.411 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -41.23 11.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 67.0 p -100.23 -11.69 20.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.337 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 71.02 12.06 71.0 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.42 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.25 157.3 64.89 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.943 0.401 . . . . 0.0 111.318 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 59.0 Cg_exo -44.59 161.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.259 2.64 . . . . 0.0 113.143 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 312' ' ' LYS . 21.5 mtp -120.67 124.65 45.72 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.585 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 301' ' ' VAL . 7.1 mt -142.52 137.07 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.947 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.555 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.6 t30 -96.49 147.97 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.172 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.54 ' HB3' HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -144.28 153.04 41.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.995 0.426 . . . . 0.0 111.165 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -108.99 103.43 12.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 30.5 p -95.72 151.8 19.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.039 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.97 116.08 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.666 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.32 3.11 37.17 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.412 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.83 -41.98 8.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 110.677 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 5.7 p -116.87 -20.96 9.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.311 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.16 -16.2 57.24 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.502 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -62.95 -176.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.023 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 54.4 mt -92.16 171.53 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -121.45 -46.02 2.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.934 0.397 . . . . 0.0 110.915 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 292' ' ' LEU . . . 118.99 19.43 4.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.065 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.422 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 8.3 mp0 -121.51 133.23 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.673 ' HB2' ' CG2' ' A' ' 296' ' ' VAL . . . -160.19 149.95 17.95 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.618 HG22 ' CD1' ' A' ' 288' ' ' PHE . 17.7 p -108.6 127.74 54.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.547 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.593 ' CG2' HG11 ' A' ' 301' ' ' VAL . 65.1 t -99.27 128.01 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.929 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 311' ' ' ILE . 18.2 m -87.05 153.02 21.86 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.483 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 346' ' ' SER . 4.0 m-85 -136.14 141.58 44.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 111.273 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.53 -9.35 59.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.212 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -134.46 117.88 13.47 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.779 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.595 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 62.0 Cg_exo -49.73 -49.67 15.27 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.6 2.2 . . . . 0.0 113.041 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 18.7 Cg_endo -59.81 -30.53 92.17 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 121.791 1.661 . . . . 0.0 111.048 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 341' ' ' PHE . 0.1 OUTLIER -59.84 -35.09 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.88 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -62.02 -52.89 62.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.342 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.97 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -57.85 -46.48 84.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.095 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.52 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.71 -33.05 63.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.873 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.479 ' HB1' ' CE2' ' A' ' 354' ' ' PHE . . . -68.65 -49.04 62.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.97 HD12 ' HA ' ' A' ' 348' ' ' LYS . 15.9 mt -52.91 -34.52 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.946 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 348' ' ' LYS . 8.9 t0 -61.09 -26.71 67.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.931 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.576 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -102.89 -63.73 1.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.869 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.738 ' HB2' HG21 ' A' ' 366' ' ' VAL . 10.3 m-85 -66.26 -77.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.591 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 351' ' ' ILE . 30.5 t0 9.41 62.0 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 107.08 35.09 2.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.226 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.96 -156.38 0.54 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.2 OUTLIER -125.7 128.9 48.52 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.109 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.702 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -89.41 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.842 178.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.58 28.39 0.76 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.655 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.04 -43.09 1.35 Allowed Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.633 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 2.0 m-80 -81.83 169.99 16.7 Favored Pre-proline 0 C--O 1.22 -0.486 0 CA-C-N 116.974 0.387 . . . . 0.0 110.778 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -97.88 142.05 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.514 2.81 . . . . 0.0 112.273 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 359' ' ' PHE . 3.4 pt -127.53 177.25 6.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.856 0.36 . . . . 0.0 111.512 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -145.03 101.61 3.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.752 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.846 HG13 HD12 ' A' ' 287' ' ' ILE . 61.2 t -88.92 138.15 19.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.761 0.315 . . . . 0.0 110.766 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.6 p -138.72 -164.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.331 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.475 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 5.2 m-85 -96.85 26.9 4.27 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.192 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 287' ' ' ILE . . . 33.86 49.29 0.27 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.288 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 371' ' ' ARG . 2.0 m -162.51 167.79 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.284 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 370' ' ' THR . 0.0 OUTLIER 62.01 117.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.964 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 30.5 mtt85 -118.23 60.35 0.79 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 62.28 75.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -61.36 171.14 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -177.0 -178.48 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -156.36 35.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.34 158.54 21.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.813 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 94.04 -164.71 26.28 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 72.94 163.1 7.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.491 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -89.78 109.15 3.58 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.487 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -159.08 -54.44 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.349 . . . . 0.0 111.077 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 56.24 72.86 0.51 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.555 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.0 mtm-85 -60.9 152.74 26.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -163.2 99.73 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.544 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.435 -1.203 . . . . 0.0 112.493 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.758 0.314 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.92 129.59 40.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.026 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -73.63 132.69 43.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -158.99 -178.12 7.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.2 m -83.83 -33.04 24.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -69.14 -35.32 76.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.404 ' HB2' ' CD2' ' A' ' 368' ' ' PHE . 1.8 m-80 48.83 89.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 0.2 OUTLIER -71.16 -37.02 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.969 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.765 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 71.4 m -90.57 136.63 32.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.945 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.763 HD12 HG13 ' A' ' 366' ' ' VAL . 6.1 pt -116.64 173.05 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.766 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.517 ' CE2' ' CB ' ' A' ' 367' ' ' SER . 0.2 OUTLIER -135.66 120.99 19.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 111.051 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.774 ' CG1' HD12 ' A' ' 364' ' ' ILE . 1.0 OUTLIER -101.37 127.1 55.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.802 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -125.13 130.49 52.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.031 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.441 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 110.79 72.28 0.67 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.909 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.493 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -135.71 -87.92 0.34 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 96.46 115.27 3.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.301 -0.952 . . . . 0.0 114.141 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.737 ' HA ' HD23 ' A' ' 333' ' ' LEU . 6.4 mp0 53.59 32.77 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.78 8.48 0.77 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.39 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG13 ' A' ' 296' ' ' VAL . 13.7 p -77.98 95.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.218 0.533 . . . . 0.0 112.232 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.895 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -136.4 146.81 46.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.083 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 322' ' ' ILE . 28.2 mm -64.98 -46.15 92.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -66.75 -41.82 87.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.901 0.382 . . . . 0.0 110.752 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.0 p -63.63 -41.65 98.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.819 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 297' ' ' THR . 34.1 t -73.56 -45.88 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -60.89 -29.96 69.88 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.564 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 28.4 t0 -74.3 -38.04 63.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.785 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.84 -21.82 20.44 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.2 OUTLIER -91.89 11.42 24.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -96.5 24.05 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.844 0.354 . . . . 0.0 111.079 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -104.95 -38.49 6.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.08 0.467 . . . . 0.0 110.309 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.573 HD11 ' O ' ' A' ' 349' ' ' ALA . 3.3 tp -75.66 -39.54 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.179 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 308' ' ' ILE . . . -176.04 -166.9 34.12 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.583 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.82 139.41 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.745 0.307 . . . . 0.0 111.685 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.504 ' CG2' ' HB3' ' A' ' 320' ' ' PRO . 2.1 mt -94.16 138.69 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -48.0 91.47 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.239 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -68.34 145.37 54.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.018 0.437 . . . . 0.0 110.839 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.455 ' ND2' ' HG2' ' A' ' 321' ' ' MET . 8.4 m-20 -78.62 170.96 15.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.343 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.97 -16.18 12.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.957 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -99.6 -36.17 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.91 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 57.9 p -109.12 -5.95 15.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.032 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 56.42 17.94 20.6 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.268 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.94 154.92 53.27 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.649 0.262 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.504 ' HB3' ' CG2' ' A' ' 311' ' ' ILE . 68.1 Cg_exo -44.36 158.43 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.632 2.221 . . . . 0.0 112.712 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.5 OUTLIER -120.64 121.75 38.99 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.491 0.662 . . . . 0.0 111.674 -179.03 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 339' ' ' VAL . 2.3 mt -143.31 142.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.999 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 1.2 m-20 -103.19 148.5 25.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.138 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 296' ' ' VAL . 0.9 OUTLIER -152.82 147.53 26.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.892 0.377 . . . . 0.0 111.072 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -126.68 148.39 49.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.673 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 333' ' ' LEU . 0.0 OUTLIER -147.39 160.12 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.776 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -69.85 142.36 53.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.781 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.11 -22.45 12.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.207 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -73.38 -34.86 65.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 110.709 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.4 p -116.68 -19.37 9.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 79.94 28.42 50.28 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.11 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 128.6 54.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.663 0.268 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.854 ' H ' HD22 ' A' ' 333' ' ' LEU . 1.1 mm? -59.89 139.2 57.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.766 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -93.22 20.83 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.304 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.408 ' CA ' ' HG ' ' A' ' 292' ' ' LEU . . . 44.9 51.81 8.16 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.259 -0.496 . . . . 0.0 113.398 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 290' ' ' GLN . 12.3 mt-10 -141.99 131.38 23.68 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.752 -0.264 . . . . 0.0 111.165 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 323' ' ' ASN . . . -161.65 140.51 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.781 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 322' ' ' ILE . 19.1 p -100.33 131.54 46.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.357 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 322' ' ' ILE . 75.1 t -110.64 122.04 64.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.586 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 312' ' ' LYS . 67.0 m -98.41 147.33 24.82 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.161 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 347' ' ' ALA . 63.1 m-85 -121.68 152.21 39.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -75.07 45.79 0.28 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.647 0.26 . . . . 0.0 111.477 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 343' ' ' ASP . 2.7 p30 165.14 125.98 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.481 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.605 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 71.4 Cg_exo -50.89 -48.86 18.92 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.613 2.209 . . . . 0.0 113.671 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.2 Cg_endo -57.29 -30.8 88.89 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.921 1.748 . . . . 0.0 112.04 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.412 ' CB ' ' OD1' ' A' ' 343' ' ' ASP . 40.2 t -61.14 -40.31 93.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.517 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.04 -51.75 66.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.989 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.932 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.44 -45.26 95.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 0.0 110.112 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.573 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -55.08 -34.25 63.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.537 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.51 -50.17 54.18 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.932 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.8 mt -55.74 -36.37 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.13 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.67 -26.59 67.12 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.744 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.52 ' CD1' ' CD2' ' A' ' 354' ' ' PHE . 1.3 t90 -82.41 -68.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.43 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.52 ' CD2' ' CD1' ' A' ' 353' ' ' TRP . 0.3 OUTLIER -82.42 -78.54 0.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.536 -177.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.588 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.8 p-10 31.13 51.11 0.12 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.86 22.09 1.84 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.096 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -84.63 -163.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.92 0.36 . . . . 0.0 110.093 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 10.8 mt-10 -119.17 130.87 55.75 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.518 ' HB2' ' CG2' ' A' ' 364' ' ' ILE . 0.1 OUTLIER -90.81 101.22 13.97 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.649 178.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.1 p 44.41 29.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.026 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 135.58 -48.72 0.92 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.94 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.6 OUTLIER -84.48 172.92 8.02 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 116.925 0.362 . . . . 0.0 110.668 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -94.1 145.02 1.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.218 2.612 . . . . 0.0 111.682 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.774 HD12 ' CG1' ' A' ' 289' ' ' VAL . 5.9 pt -116.69 178.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.861 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -148.28 100.89 3.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.068 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.763 HG13 HD12 ' A' ' 287' ' ' ILE . 23.7 t -96.44 131.08 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.517 ' CB ' ' CE2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -140.06 -164.0 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.902 0.382 . . . . 0.0 111.923 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.776 ' CE1' HD13 ' A' ' 351' ' ' ILE . 3.7 m-85 -89.27 54.43 2.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.637 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 53.43 100.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.752 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 369' ' ' ALA . 0.2 OUTLIER 51.35 131.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.094 179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . 0.519 ' C ' ' HG3' ' A' ' 372' ' ' ARG . 0.0 OUTLIER -74.84 -170.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.519 ' HG3' ' C ' ' A' ' 371' ' ' ARG . 0.0 OUTLIER 42.83 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.383 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -130.04 121.4 26.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.64 93.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.36 -170.74 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 66.9 159.78 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.31 151.21 26.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 153.34 44.23 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.544 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -97.44 139.46 14.49 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.557 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.76 68.63 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.3 m120 60.63 93.75 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -106.41 -128.34 6.03 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.463 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.01 178.24 4.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -136.73 -95.2 0.41 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.53 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.47 179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.936 0.398 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -176.42 174.18 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -93.2 80.18 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.998 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -176.58 37.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.26 24.32 11.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.04 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -139.07 -35.14 0.57 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.74 67.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.232 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 5.5 p30 -102.14 -33.25 9.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.054 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.643 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 27.9 m -83.96 126.22 32.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.174 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.739 HD12 HG13 ' A' ' 366' ' ' VAL . 13.6 pt -95.92 173.09 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.977 0.418 . . . . 0.0 111.344 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.758 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -130.37 109.76 10.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.83 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -98.18 114.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -118.62 130.83 56.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.124 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.831 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 112.75 83.15 1.23 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.559 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.46 ' CD2' ' CD2' ' A' ' 359' ' ' PHE . 1.9 mt -142.29 -78.23 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.615 0.245 . . . . 0.0 110.828 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 134.21 -79.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.669 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.406 ' CG ' HD23 ' A' ' 333' ' ' LEU . 2.3 tt0 -149.52 31.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.17 -17.97 10.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.971 HG22 HD23 ' A' ' 324' ' ' LEU . 9.7 p -45.86 123.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.94 146.5 9.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.424 179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.751 HG23 HD12 ' A' ' 322' ' ' ILE . 2.1 mp -64.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.151 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 18.5 pm0 -66.4 -34.76 78.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.121 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 3.0 m -73.65 -43.87 58.33 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.041 0.448 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.838 HG23 ' O ' ' A' ' 297' ' ' THR . 29.8 t -72.22 -36.4 55.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.338 0.589 . . . . 0.0 109.754 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.702 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.33 -29.76 68.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.946 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.05 -41.25 62.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.773 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -97.39 -20.64 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 311' ' ' ILE . 1.2 t80 -101.21 35.0 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.325 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 18.86 11.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.299 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -40.87 7.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.405 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -72.35 -32.41 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.358 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.419 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -161.08 -163.29 13.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.76 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.0 mt -111.08 115.69 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.702 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.2 mt -75.86 125.34 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -48.65 115.34 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 111.985 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -75.79 150.98 37.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.482 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -104.94 130.72 53.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.622 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -4.23 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 314' ' ' ASN . 7.1 mptt -81.72 -36.64 28.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.278 0.561 . . . . 0.0 109.914 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 319' ' ' GLN . 0.4 OUTLIER -118.8 -30.98 4.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.21 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 96.78 14.39 43.47 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.882 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.685 ' H ' HG22 ' A' ' 317' ' ' THR . 0.0 OUTLIER -124.18 162.03 44.03 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.901 0.351 . . . . 0.0 110.798 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 89.1 Cg_exo -44.56 162.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.78 2.32 . . . . 0.0 112.431 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.457 ' CG ' ' HB3' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -122.42 128.08 50.47 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.384 0.611 . . . . 0.0 111.758 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.751 HD12 HG23 ' A' ' 298' ' ' ILE . 4.9 mt -141.84 137.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.646 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.1 OUTLIER -99.1 141.14 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.614 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.971 HD23 HG22 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -145.09 131.86 20.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.851 0.358 . . . . 0.0 111.001 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 334' ' ' LYS . 9.8 m-30 -84.31 142.51 30.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.782 HG22 ' HB2' ' A' ' 333' ' ' LEU . 1.3 p -147.85 152.65 37.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.12 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.861 ' HB3' HG22 ' A' ' 330' ' ' THR . 2.0 m-20 -80.44 148.29 30.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.387 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -43.11 -49.15 6.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.924 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -179.9 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.774 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.861 HG22 ' HB3' ' A' ' 327' ' ' ASP . 9.1 t -79.57 -21.34 45.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 126.27 -47.64 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.857 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.55 113.61 3.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.849 0.357 . . . . 0.0 110.977 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.871 HD11 ' CG1' ' A' ' 296' ' ' VAL . 0.1 OUTLIER -99.37 25.86 6.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.282 0.563 . . . . 0.0 110.778 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 336' ' ' GLU . 0.1 OUTLIER 40.02 96.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.17 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 292' ' ' LEU . . . -65.83 33.67 0.14 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.74 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 334' ' ' LYS . 0.0 OUTLIER -122.49 131.78 54.02 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -151.93 151.92 31.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.934 0.397 . . . . 0.0 111.965 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.758 HG22 ' CD1' ' A' ' 288' ' ' PHE . 22.3 p -106.05 126.4 52.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.64 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 322' ' ' ILE . 73.3 t -99.49 128.61 51.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.966 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.679 ' O ' HG23 ' A' ' 311' ' ' ILE . 83.5 p -85.44 152.45 23.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.909 0.385 . . . . 0.0 111.474 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.53 148.71 52.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.64 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.52 -16.88 58.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.411 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.2 OUTLIER -136.28 120.33 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.001 -179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.606 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.21 -51.07 7.13 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.655 2.237 . . . . 0.0 112.952 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.1 Cg_endo -53.69 -30.5 56.33 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.975 1.783 . . . . 0.0 111.241 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.419 ' OG ' ' HA3' ' A' ' 309' ' ' GLY . 14.2 t -57.24 -42.0 80.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.898 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -55.85 -49.55 73.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.744 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.81 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.5 -53.02 61.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.5 18.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.97 -52.78 25.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.81 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.4 mt -54.7 -36.66 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.367 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -26.18 66.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.816 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.553 ' HE3' HD13 ' A' ' 308' ' ' ILE . 3.1 t90 -98.29 -68.4 0.8 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 305' ' ' PHE . 2.3 m-85 -66.68 -74.95 0.1 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 354' ' ' PHE . 25.7 t0 14.04 62.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.41 19.62 3.12 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.933 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.48 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 5.4 mtpt -87.05 -165.2 1.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.952 0.376 . . . . 0.0 110.687 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.735 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.0 OUTLIER -121.74 142.47 50.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.79 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.2 OUTLIER -111.13 101.68 10.18 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.824 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.75 28.74 6.64 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 358' ' ' GLU . . . 116.32 -2.92 20.49 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.443 -0.885 . . . . 0.0 114.285 178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.735 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.3 m-80 -117.79 170.07 6.74 Favored Pre-proline 0 C--O 1.218 -0.596 0 CA-C-N 117.594 0.697 . . . . 0.0 110.67 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -96.06 141.85 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.491 2.794 . . . . 0.0 111.77 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.831 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.4 pt -128.85 168.58 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.052 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.155 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.49 100.94 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.739 HG13 HD12 ' A' ' 287' ' ' ILE . 21.2 t -84.85 131.84 33.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -135.12 -173.91 3.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.16 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.459 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 62.1 m-85 -90.67 54.24 2.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 47.02 73.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.942 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 371' ' ' ARG . 53.1 m 65.93 164.44 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . 0.462 ' N ' HG22 ' A' ' 370' ' ' THR . 0.0 OUTLIER -148.81 135.65 19.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.116 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.21 107.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.59 173.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.036 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.42 44.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.8 -73.78 0.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -175.33 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -176.87 -66.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -155.15 110.19 0.44 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.558 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.17 144.48 3.92 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.424 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.1 -140.96 6.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.451 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.66 27.76 8.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.703 0.287 . . . . 0.0 110.855 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 56.39 27.72 53.96 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.536 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -124.38 111.6 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.01 -48.81 3.0 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.517 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.338 -1.257 . . . . 0.0 112.538 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.659 0.266 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.41 130.56 47.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.921 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -107.2 76.09 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -114.85 77.08 1.04 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 65.1 m -103.67 24.15 11.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -124.66 21.43 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.31 121.02 8.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 0.6 OUTLIER -50.97 -25.87 5.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.479 179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 84.8 m -72.55 117.91 14.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.575 HD12 ' CG1' ' A' ' 366' ' ' VAL . 46.0 pt -107.7 169.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.406 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 338' ' ' THR . 0.1 OUTLIER -134.0 122.4 22.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.134 0.493 . . . . 0.0 111.094 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 366' ' ' VAL . 2.4 t -110.02 127.64 66.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.412 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.6 mp0 -111.87 130.67 55.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.046 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 116.6 33.62 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.499 HD13 ' ND2' ' A' ' 295' ' ' ASN . 0.1 OUTLIER -59.71 -84.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 93.99 98.54 1.57 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.867 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 43.69 31.63 0.48 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.499 ' ND2' HD13 ' A' ' 292' ' ' LEU . 0.9 OUTLIER -144.34 31.21 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.523 HG12 HD22 ' A' ' 324' ' ' LEU . 4.0 t -75.91 70.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.524 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -129.37 146.61 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.587 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 322' ' ' ILE . 26.3 mm -71.45 -43.05 72.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.447 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.46 -40.67 89.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -42.65 83.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 297' ' ' THR . 66.4 t -71.43 -40.11 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.68 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.24 -29.83 68.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.839 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -41.93 68.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.88 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HE1' HG13 ' A' ' 301' ' ' VAL . 0.8 OUTLIER -88.02 -24.8 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.61 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -97.43 30.54 2.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.121 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 306' ' ' LYS . 0.0 OUTLIER -114.77 1.81 14.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -85.4 -52.06 6.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.821 0.343 . . . . 0.0 111.144 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.602 HG21 ' CE2' ' A' ' 354' ' ' PHE . 0.7 OUTLIER -65.64 -28.19 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -175.0 -171.95 39.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.558 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 4.4 mt -97.62 144.14 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.68 HD13 ' HA ' ' A' ' 302' ' ' ALA . 2.8 mt -97.86 127.01 50.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 340' ' ' SER . 29.0 mtmt -49.75 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.651 0.263 . . . . 0.0 110.735 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -86.48 155.56 20.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.875 0.845 . . . . 0.0 111.504 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.577 ' HB3' ' OG1' ' A' ' 317' ' ' THR . 1.0 OUTLIER -71.12 98.37 1.66 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.195 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.587 ' HD2' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -46.4 -16.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.546 178.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 314' ' ' ASN . 20.3 mttm -92.5 -38.01 12.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.665 0.269 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 314' ' ' ASN . 47.9 p -103.62 -3.11 25.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 57.32 17.68 25.84 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.448 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -118.61 139.34 26.9 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.942 0.371 . . . . 0.0 111.252 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.3 Cg_exo -45.45 147.2 2.79 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.536 2.158 . . . . 0.0 112.406 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.4 mtp -107.74 123.07 47.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.42 0.629 . . . . 0.0 112.137 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 338' ' ' THR . 2.6 mp -143.02 139.74 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.567 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.745 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 5.1 m-80 -99.25 147.54 25.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.805 0.336 . . . . 0.0 111.226 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.708 HD23 ' CB ' ' A' ' 337' ' ' ALA . 2.7 mt -128.08 150.22 50.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -118.89 139.94 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.6 HG22 HD23 ' A' ' 333' ' ' LEU . 16.6 p -125.59 176.07 7.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.041 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.639 ' HB3' HG22 ' A' ' 330' ' ' THR . 0.3 OUTLIER -62.85 148.69 46.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.09 -56.08 2.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.094 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -151.94 -31.03 0.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.651 HG23 ' H ' ' A' ' 332' ' ' LYS . 11.3 t -43.46 -29.89 0.5 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.652 0.263 . . . . 0.0 111.655 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.28 -27.65 12.25 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.826 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.651 ' H ' HG23 ' A' ' 330' ' ' THR . 0.4 OUTLIER -53.95 -174.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.879 0.371 . . . . 0.0 111.094 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.6 HD23 HG22 ' A' ' 326' ' ' THR . 16.1 mt -127.4 135.35 50.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.971 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -63.87 -24.86 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.015 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 76.75 39.86 27.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.541 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.449 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 9.5 pt-20 -153.14 157.33 40.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.642 0.258 . . . . 0.0 110.994 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -160.87 156.91 25.74 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 111.762 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.801 ' O ' HG23 ' A' ' 322' ' ' ILE . 2.0 p -103.48 136.9 42.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.055 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.626 HG22 HG12 ' A' ' 322' ' ' ILE . 55.6 t -112.06 130.52 65.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 311' ' ' ILE . 16.5 m -86.32 153.1 22.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.407 ' N ' ' HG3' ' A' ' 312' ' ' LYS . 2.6 m-85 -129.35 135.89 49.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.746 0.308 . . . . 0.0 111.058 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.438 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 19.2 m-20 -63.29 -35.89 81.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.327 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.44 118.97 33.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.11 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.604 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.3 Cg_exo -42.42 -51.02 5.28 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.87 2.38 . . . . 0.0 112.701 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.4 Cg_endo -56.08 -30.62 79.62 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.963 1.775 . . . . 0.0 111.282 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.2 t -60.99 -40.74 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.582 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.32 -49.12 75.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.879 0.371 . . . . 0.0 110.468 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' A' ' 351' ' ' ILE . 4.2 tppt? -59.42 -54.94 40.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.637 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.87 -35.37 23.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.699 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 354' ' ' PHE . . . -68.95 -51.81 35.72 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.33 0.586 . . . . 0.0 109.458 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.1 mt -54.08 -39.22 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.728 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.19 -26.64 18.15 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.77 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.543 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.3 t90 -106.85 -68.45 0.89 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.477 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 366' ' ' VAL . 4.8 m-85 -59.1 -9.96 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 351' ' ' ILE . 41.6 t0 -71.87 62.85 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 118.276 0.489 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 128.07 35.75 0.5 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.906 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 353' ' ' TRP . 36.4 mmtm -105.86 -173.83 2.39 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 5.7 mt-10 -116.66 133.1 56.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.134 0.492 . . . . 0.0 112.133 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.474 ' HD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -93.06 101.34 13.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.96 179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 36.3 t 48.86 27.57 1.64 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.526 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 129.46 -45.01 1.17 Allowed Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.737 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.589 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.9 OUTLIER -80.46 169.95 17.65 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 116.999 0.4 . . . . 0.0 111.037 -179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -94.63 145.16 1.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.397 2.731 . . . . 0.0 112.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 6.4 pt -128.02 176.14 8.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.244 0.545 . . . . 0.0 112.434 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.4 mmmm -148.13 116.14 6.45 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.658 HG22 HG13 ' A' ' 289' ' ' VAL . 40.5 t -109.53 135.99 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.949 0.404 . . . . 0.0 111.875 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.4 p -140.67 -163.07 1.46 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.951 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -95.19 65.86 2.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.959 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 60.83 157.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.221 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.37 136.99 58.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.669 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -96.77 35.86 1.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.03 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.58 43.8 15.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.953 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.56 95.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.196 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.37 70.57 0.3 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -176.19 92.85 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.63 120.14 39.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -105.09 120.14 40.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 91.54 29.33 12.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.47 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -67.32 -59.86 6.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 142.51 -28.19 2.2 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 -73.44 0.3 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.714 0.293 . . . . 0.0 110.949 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 152.96 -110.82 0.46 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.64 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 127.06 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -96.1 56.62 1.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.497 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.519 -1.156 . . . . 0.0 112.548 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.698 0.285 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -151.24 -176.89 5.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 281' ' ' ASN . 0.9 OUTLIER -61.19 -76.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.959 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 12.3 t-20 69.85 -60.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.396 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -42.38 -54.18 3.91 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.653 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.04 -35.46 2.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.284 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 368' ' ' PHE . 0.6 OUTLIER 54.43 104.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 0.0 111.273 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.443 ' N ' ' ND2' ' A' ' 285' ' ' ASN . 0.1 OUTLIER -88.03 -31.59 19.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.282 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.6 m -88.04 134.2 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.487 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 17.8 pt -110.79 173.38 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.476 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.73 ' HD1' HG22 ' A' ' 338' ' ' THR . 1.4 t80 -127.8 108.15 10.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.804 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 364' ' ' ILE . 2.1 t -104.5 114.81 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 1.5 mp0 -111.76 130.25 55.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 120.18 37.67 0.73 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.666 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.895 HD12 ' ND2' ' A' ' 295' ' ' ASN . 2.8 mm? -79.04 -89.1 0.05 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.557 0.218 . . . . 0.0 110.505 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.58 ' HA2' HD21 ' A' ' 333' ' ' LEU . . . 61.34 104.93 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.293 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 77.01 43.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.784 0.325 . . . . 0.0 111.37 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.895 ' ND2' HD12 ' A' ' 292' ' ' LEU . 0.0 OUTLIER -168.45 -37.78 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.778 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.79 HG22 HD13 ' A' ' 324' ' ' LEU . 8.7 p -19.06 94.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.78 ' O ' HG23 ' A' ' 301' ' ' VAL . 7.5 p -164.01 146.43 9.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.327 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 20.0 mt -71.34 -42.27 74.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.986 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -43.15 86.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.75 0.31 . . . . 0.0 111.115 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 6.9 p -65.03 -38.45 90.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 297' ' ' THR . 69.5 t -74.6 -40.62 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.276 0.56 . . . . 0.0 109.729 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.26 -31.43 70.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.708 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -74.35 -36.12 63.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.893 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.505 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.18 -24.23 16.36 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 0.1 OUTLIER -95.47 27.78 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 111.283 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.13 22.09 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.085 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -105.33 -28.83 10.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.615 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.567 HG21 ' HB2' ' A' ' 350' ' ' ALA . 1.1 tp -83.91 -30.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -178.78 -162.33 28.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.575 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.4 mt -98.68 142.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.628 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 340' ' ' SER . 3.0 mp -98.43 136.11 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.569 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 321' ' ' MET . 2.7 mmtp -48.88 95.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 318' ' ' GLY . 0.2 OUTLIER -68.47 146.63 52.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.724 ' ND2' ' OG1' ' A' ' 317' ' ' THR . 0.1 OUTLIER -101.06 145.79 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 111.433 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -77.19 -7.59 56.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.904 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -83.16 -51.04 7.85 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.438 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.724 ' OG1' ' ND2' ' A' ' 314' ' ' ASN . 8.3 p -108.1 -7.31 16.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.526 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 313' ' ' THR . . . 67.63 15.69 66.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.393 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.467 ' H ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.9 164.37 23.89 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.935 0.398 . . . . 0.0 111.807 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.523 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 57.7 Cg_exo -45.1 162.09 0.09 OUTLIER 'Trans proline' 0 N--CA 1.472 0.214 0 C-N-CA 123.146 2.564 . . . . 0.0 113.456 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 312' ' ' LYS . 17.4 mtm -123.29 118.68 28.1 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 339' ' ' VAL . 49.3 mt -141.56 149.98 19.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.346 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -114.14 148.03 37.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.664 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.79 HD13 HG22 ' A' ' 296' ' ' VAL . 2.1 mt -131.69 168.61 17.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.51 103.36 8.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.901 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 67.0 p -130.41 143.79 50.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.659 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -76.98 106.0 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 7.72 33.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.414 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.51 -38.43 14.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.609 HG23 ' HG3' ' A' ' 332' ' ' LYS . 0.0 OUTLIER -118.79 -37.52 3.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 120.84 29.35 1.54 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.965 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.609 ' HG3' HG23 ' A' ' 330' ' ' THR . 0.6 OUTLIER -100.22 -169.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.341 . . . . 0.0 110.674 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.58 HD21 ' HA2' ' A' ' 293' ' ' GLY . 0.1 OUTLIER -140.51 128.8 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.503 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -69.48 -58.9 3.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.57 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 333' ' ' LEU . . . 115.49 28.89 2.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.0 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 2.3 mp0 -131.59 134.4 46.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.965 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.647 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -148.19 143.17 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.958 0.409 . . . . 0.0 111.447 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.73 HG22 ' HD1' ' A' ' 288' ' ' PHE . 17.4 p -109.53 119.55 39.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.754 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 322' ' ' ILE . 1.2 t -93.91 123.04 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.596 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.9 OUTLIER -94.86 129.97 41.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.824 0.345 . . . . 0.0 110.86 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 339' ' ' VAL . 17.6 m-85 -109.71 150.26 28.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.95 0.405 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.57 -16.84 60.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 346' ' ' SER . 5.1 m-20 -126.35 116.46 23.31 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.682 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.615 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 78.1 Cg_exo -44.82 -50.82 8.08 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.35 2.034 . . . . 0.0 112.602 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 9.7 Cg_endo -53.16 -30.42 50.38 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.016 1.811 . . . . 0.0 111.041 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 12.4 t -55.82 -48.75 74.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -53.32 -44.86 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.926 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.846 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -58.37 -54.28 48.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.063 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.437 ' O ' HD11 ' A' ' 308' ' ' ILE . . . -47.5 -39.0 15.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.786 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.72 -45.82 70.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.362 0.601 . . . . 0.0 109.761 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 348' ' ' LYS . 7.9 mt -60.92 -32.39 52.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.433 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -61.67 -40.64 95.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.34 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.606 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.0 OUTLIER -106.14 -45.54 4.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -178.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.608 ' O ' ' N ' ' A' ' 356' ' ' GLY . 2.7 m-85 -59.22 -75.83 0.05 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.581 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.0 t0 1.04 63.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.211 0.944 . . . . 0.0 112.355 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 110.94 36.47 1.84 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.429 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.501 ' HD3' ' CD2' ' A' ' 354' ' ' PHE . 7.9 ptmt -97.83 -158.37 0.66 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.576 0.227 . . . . 0.0 110.837 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 33.0 mt-10 -113.89 128.88 56.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.045 0.45 . . . . 0.0 111.036 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.505 ' CZ ' ' CE1' ' A' ' 304' ' ' TYR . 0.2 OUTLIER -122.89 105.72 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.299 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.3 m 59.76 30.09 19.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.75 57.86 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.04 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 7.2 m-80 -129.27 167.01 21.45 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.832 0.316 . . . . 0.0 111.037 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 362' ' ' ASN . 96.3 Cg_endo -90.36 128.8 1.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.924 2.416 . . . . 0.0 111.929 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 3.9 pt -124.68 168.58 17.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.897 0.38 . . . . 0.0 111.599 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -139.1 102.42 4.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.068 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 354' ' ' PHE . 26.3 t -85.13 134.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.02 -173.12 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.99 0.424 . . . . 0.0 111.437 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.457 ' CE1' ' CD1' ' A' ' 351' ' ' ILE . 2.7 m-85 -94.46 56.68 2.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.831 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 288' ' ' PHE . . . 52.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.975 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 372' ' ' ARG . 31.7 m 60.91 164.36 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.734 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 370' ' ' THR . 0.1 OUTLIER -115.48 -22.57 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.726 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.501 ' H ' HG22 ' A' ' 370' ' ' THR . 21.7 mmt-85 72.77 48.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.895 0.379 . . . . 0.0 110.815 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.35 109.7 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -177.56 178.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -134.2 39.05 3.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -98.02 83.09 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.978 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 62.17 119.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -177.88 167.12 37.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -64.99 158.33 45.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -148.84 -162.16 10.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.54 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.17 -61.68 0.2 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.852 0.358 . . . . 0.0 110.877 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -60.98 98.08 0.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 151.27 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.823 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 106.04 28.41 5.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.481 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.455 -1.192 . . . . 0.0 112.503 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.857 0.361 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -175.63 3.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.661 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.92 99.56 3.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.077 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -177.23 -74.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.1 m -105.17 23.98 12.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -116.36 30.82 7.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.93 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.428 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.3 OUTLIER -170.32 118.84 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.099 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 344' ' ' PRO . 20.8 p30 -99.39 -18.1 17.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.979 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 26.4 m -71.06 117.56 12.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.277 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.713 HD12 ' CG1' ' A' ' 366' ' ' VAL . 36.6 pt -105.15 164.34 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' ' 369' ' ' ALA . 0.1 OUTLIER -126.34 117.22 22.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.114 0.483 . . . . 0.0 111.146 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 366' ' ' VAL . 1.0 OUTLIER -110.0 114.84 48.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.131 -179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.475 ' CG ' ' CE2' ' A' ' 288' ' ' PHE . 47.6 mm-40 -112.58 132.77 54.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.056 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.679 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 113.25 75.46 0.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.767 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.848 HD21 ' CE2' ' A' ' 359' ' ' PHE . 1.6 mp -124.48 -76.41 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.673 0.273 . . . . 0.0 110.667 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 126.17 65.39 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.194 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 44.25 30.36 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.61 4.64 4.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.254 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.696 ' HB ' HD22 ' A' ' 292' ' ' LEU . 11.1 p -66.51 109.45 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.99 0.424 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -119.07 151.3 38.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.489 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.793 HD13 HD21 ' A' ' 324' ' ' LEU . 26.6 mm -63.18 -47.91 90.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.492 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -66.53 -42.18 87.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.73 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 27.8 p -65.81 -41.44 91.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.788 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 297' ' ' THR . 75.8 t -73.03 -40.51 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.14 -29.87 68.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.968 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -40.01 65.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.641 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.459 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.75 -22.46 29.65 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.42 -179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -90.12 7.13 39.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.423 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 14.86 15.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.644 0.259 . . . . 0.0 111.424 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.55 -31.98 9.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.489 HG23 ' CE2' ' A' ' 341' ' ' PHE . 2.6 tp -88.11 -35.84 8.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.341 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -173.18 -169.61 35.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.8 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 13.0 mt -92.76 144.15 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 111.665 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 340' ' ' SER . 3.2 mt -97.64 125.13 50.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 342' ' ' ASP . 0.7 OUTLIER -52.72 91.66 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.338 -179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -80.96 167.18 20.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.242 0.544 . . . . 0.0 110.715 179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.597 ' OD1' ' OG1' ' A' ' 317' ' ' THR . 0.4 OUTLIER -90.13 143.29 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.878 -178.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -80.45 -3.18 48.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.617 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -94.44 -45.35 7.48 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.493 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 314' ' ' ASN . 81.4 p -108.45 -4.63 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.969 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.93 43.24 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.368 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.451 HE22 HG21 ' A' ' 298' ' ' ILE . 0.0 OUTLIER -114.34 144.17 31.21 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.319 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 87.1 Cg_exo -45.06 147.97 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.523 2.149 . . . . 0.0 112.068 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.46 ' HG2' ' ND2' ' A' ' 314' ' ' ASN . 6.7 mtp -114.23 125.55 54.04 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 112.046 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 338' ' ' THR . 74.4 mt -143.17 137.81 26.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.996 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.41 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.7 t30 -97.63 120.72 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.758 0.313 . . . . 0.0 111.031 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.793 HD21 HD13 ' A' ' 298' ' ' ILE . 0.6 OUTLIER -110.07 149.8 29.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.0 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -105.06 148.2 27.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.767 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.635 ' HB ' HD23 ' A' ' 333' ' ' LEU . 0.2 OUTLIER -147.13 161.32 41.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.012 0.434 . . . . 0.0 110.838 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -76.23 119.71 20.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.12 -5.5 46.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.638 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -98.4 -69.31 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 3.1 p -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.767 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 77.55 60.24 2.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.448 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -134.69 -104.4 0.23 Allowed 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.979 -0.13 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.635 HD23 ' HB ' ' A' ' 326' ' ' THR . 85.8 mt -155.69 149.06 24.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.736 0.303 . . . . 0.0 110.814 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.4 -41.94 23.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 111.068 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 109.82 24.3 5.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.01 159.68 35.05 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.617 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -165.19 150.9 9.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 322' ' ' ILE . 56.3 p -95.59 128.34 42.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.654 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.585 ' CG2' HG11 ' A' ' 301' ' ' VAL . 82.0 t -107.39 134.45 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.841 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 311' ' ' ILE . 33.1 m -94.51 138.73 32.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.904 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.3 m-85 -115.51 142.45 46.7 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.976 0.417 . . . . 0.0 111.547 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 1.4 t70 -65.43 -20.75 66.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.753 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -128.69 115.32 19.36 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.564 0.221 . . . . 0.0 111.339 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.583 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 73.7 Cg_exo -47.24 -51.58 9.25 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.538 2.158 . . . . 0.0 112.683 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 17.1 Cg_endo -57.69 -30.86 90.39 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 121.981 1.787 . . . . 0.0 111.19 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.06 -36.41 81.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.569 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.595 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -59.48 -44.54 93.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.658 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.899 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.3 OUTLIER -61.89 -54.97 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.878 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.62 -33.55 10.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.993 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.7 -49.33 59.8 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.439 0.638 . . . . 0.0 109.613 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.899 HD12 ' HA ' ' A' ' 348' ' ' LYS . 11.7 mt -56.39 -36.17 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.363 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.87 -26.85 65.34 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.241 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.532 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.1 t90 -86.78 -68.21 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.063 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.515 ' O ' ' C ' ' A' ' 355' ' ' ASP . 10.6 m-85 -69.65 -77.8 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.614 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 354' ' ' PHE . 29.9 t70 21.16 55.51 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.473 0.483 . . . . 0.0 111.401 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 125.2 22.16 1.95 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.446 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -80.11 -165.61 0.87 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.737 0.303 . . . . 0.0 111.416 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -114.93 142.11 47.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.582 . . . . 0.0 111.669 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.848 ' CE2' HD21 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -124.55 101.41 7.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.287 -0.869 . . . . 0.0 108.777 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.68 26.41 3.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.026 0.441 . . . . 0.0 110.245 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 99.79 24.09 10.25 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.893 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 65.9 m-80 -129.95 153.65 81.03 Favored Pre-proline 0 C--O 1.225 -0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 111.776 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.02 136.01 8.98 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.577 2.185 . . . . 0.0 111.711 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.689 ' HB ' HG12 ' A' ' 289' ' ' VAL . 9.1 pt -130.47 154.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -124.87 100.74 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.193 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 289' ' ' VAL . 37.7 t -95.96 118.96 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.36 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.411 ' HA ' HG12 ' A' ' 351' ' ' ILE . 1.4 m -140.2 176.68 8.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.428 ' CD1' ' ND2' ' A' ' 284' ' ' ASN . 1.2 m-85 -70.13 110.17 5.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 288' ' ' PHE . . . -85.28 87.71 7.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.158 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.62 152.75 43.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.14 120.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.803 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -145.58 99.78 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 60.85 155.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.06 -177.03 4.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 66.59 172.32 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -144.61 -151.06 0.35 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.53 143.12 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.077 0 CA-C-O 120.858 0.361 . . . . 0.0 110.847 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 120.89 133.51 4.44 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.423 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 159.18 54.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.557 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -101.88 -40.81 2.6 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.409 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 58.26 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.522 0.201 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 45.83 82.77 0.03 OUTLIER Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 167.89 9.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.947 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 110.12 30.37 3.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.507 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.876 0.369 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 60.53 172.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -108.24 8.41 27.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.363 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.02 4.54 4.89 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.596 0.236 . . . . 0.0 111.54 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.6 t -105.1 24.12 12.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.688 0.28 . . . . 0.0 110.85 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -65.01 -35.03 79.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.965 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 12.0 p30 43.31 100.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 344' ' ' PRO . 20.7 p30 -51.94 -28.38 16.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.643 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 369' ' ' ALA . 86.1 m -76.0 132.24 40.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.639 HD12 HG13 ' A' ' 366' ' ' VAL . 37.0 pt -117.86 168.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' ' 338' ' ' THR . 1.5 m-30 -117.39 106.73 13.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.523 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -99.71 114.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -132.1 132.17 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.647 0.261 . . . . 0.0 111.48 -179.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.782 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 121.07 79.99 0.57 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.533 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -155.79 -90.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.801 -0.235 . . . . 0.0 111.116 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 292' ' ' LEU . . . 157.12 -92.5 0.13 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.118 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -126.0 28.07 6.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 297' ' ' THR . 0.8 OUTLIER -114.71 -14.48 12.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.04 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.748 HG22 HD22 ' A' ' 324' ' ' LEU . 9.8 p -52.24 88.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.825 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -128.88 147.16 50.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.572 179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.73 HG23 HD12 ' A' ' 322' ' ' ILE . 41.7 mt -61.21 -47.35 93.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.54 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -65.32 -39.36 92.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 24.7 p -68.59 -43.27 76.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.57 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 297' ' ' THR . 60.6 t -69.75 -37.84 74.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.495 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.757 ' HA ' HD12 ' A' ' 311' ' ' ILE . . . -68.71 -30.86 69.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -35.73 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -103.81 -19.94 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.654 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.8 OUTLIER -99.43 -15.28 18.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -83.46 7.4 17.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.419 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -51.93 6.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.459 HD12 ' HE3' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -59.81 -33.53 52.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.587 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -155.51 -177.84 29.15 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.251 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 5.0 mt -97.84 105.86 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 302' ' ' ALA . 52.5 mt -71.93 130.16 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 320' ' ' PRO . 1.0 OUTLIER -48.49 92.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -67.39 140.48 57.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.708 177.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.504 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -96.25 145.57 25.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 0.0 111.828 -179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -79.81 -4.12 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -90.57 -49.8 6.29 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.991 0.424 . . . . 0.0 110.197 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.2 p -104.98 -8.69 18.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.804 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.448 ' C ' HG22 ' A' ' 313' ' ' THR . . . 69.44 10.19 62.72 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 153.95 71.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 117.127 0.464 . . . . 0.0 110.99 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 1.7 Cg_endo -46.59 153.13 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.006 2.471 . . . . 0.0 112.77 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.504 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -105.03 120.96 42.77 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.337 0.589 . . . . 0.0 111.262 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.73 HD12 HG23 ' A' ' 298' ' ' ILE . 4.0 mt -139.55 142.01 33.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.031 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.451 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 3.8 m-80 -104.5 148.22 26.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.717 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 296' ' ' VAL . 0.5 OUTLIER -135.17 114.85 12.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.705 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 336' ' ' GLU . 7.5 m-30 -69.71 104.49 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.697 ' CG2' HD23 ' A' ' 333' ' ' LEU . 17.0 p -132.39 154.78 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.843 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -103.65 103.32 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.928 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -15.31 62.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.365 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -40.2 93.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.034 0.445 . . . . 0.0 110.628 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 332' ' ' LYS . 1.9 t -124.62 8.27 8.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.114 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 58.8 24.71 57.93 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.546 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.649 ' HB2' HG23 ' A' ' 330' ' ' THR . 9.1 mmtm -104.42 133.88 48.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.914 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.697 HD23 ' CG2' ' A' ' 326' ' ' THR . 1.8 mp -93.22 149.16 21.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.792 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -95.69 21.7 8.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.135 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 50.62 50.73 35.57 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.504 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.457 ' HG2' ' HB3' ' A' ' 290' ' ' GLN . 29.7 mt-10 -147.2 131.61 17.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.665 0.269 . . . . 0.0 111.211 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.663 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -150.14 145.55 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.0 111.409 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.519 HG22 ' CE1' ' A' ' 288' ' ' PHE . 16.2 p -108.8 118.85 37.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.96 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.631 ' CG2' HG11 ' A' ' 301' ' ' VAL . 78.9 t -94.26 126.77 46.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.246 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.3 OUTLIER -95.72 121.93 37.95 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.876 0.37 . . . . 0.0 111.138 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.51 ' HE2' HD13 ' A' ' 287' ' ' ILE . 9.9 m-85 -96.48 155.44 16.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -25.86 40.52 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.644 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.7 117.05 22.6 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.581 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.8 Cg_exo -43.26 -51.43 5.79 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.717 2.278 . . . . 0.0 113.107 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 13.3 Cg_endo -56.48 -30.63 82.95 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 121.956 1.771 . . . . 0.0 111.359 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.2 t -60.51 -37.63 81.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.883 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.637 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -60.15 -51.21 70.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -59.86 -43.01 94.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 110.056 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.29 62.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 308' ' ' ILE . . . -68.59 -48.04 65.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 348' ' ' LYS . 33.1 mt -52.46 -31.14 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.323 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -26.69 68.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.596 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 0.6 OUTLIER -107.19 -61.93 1.48 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.514 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.571 ' CB ' HG21 ' A' ' 366' ' ' VAL . 66.3 m-85 -56.75 -74.85 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.029 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 354' ' ' PHE . 36.6 t0 2.94 65.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.046 0.841 . . . . 0.0 112.511 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 113.69 26.03 4.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.565 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -87.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 11.8 mm-40 -123.6 131.23 53.57 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.716 ' HZ ' HG22 ' A' ' 301' ' ' VAL . 0.1 OUTLIER -91.63 101.41 14.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.144 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 33.9 t 45.77 29.03 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.13 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 134.25 -46.98 1.01 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.0 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.3 OUTLIER -84.85 169.67 15.8 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 116.991 0.395 . . . . 0.0 110.697 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -96.31 138.86 0.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.391 2.727 . . . . 0.0 112.392 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 291' ' ' GLY . 7.6 pt -116.97 -179.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-O 120.834 0.349 . . . . 0.0 111.426 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -148.31 100.51 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.01 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.639 HG13 HD12 ' A' ' 287' ' ' ILE . 23.1 t -86.92 128.03 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.708 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 92.5 p -140.51 -173.94 3.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.174 0.511 . . . . 0.0 112.048 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -83.28 106.2 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.35 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 286' ' ' THR . . . -35.81 111.61 0.14 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.205 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 11.9 t -107.4 -155.38 0.55 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -44.16 146.23 0.67 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.875 0.369 . . . . 0.0 111.374 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -176.9 4.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -114.3 153.22 30.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.933 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 375' ' ' PHE . 24.0 t70 -87.49 -89.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 374' ' ' ASP . 17.3 t80 178.86 51.83 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.829 0.347 . . . . 0.0 110.766 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 45.17 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.22 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.67 151.55 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -156.17 58.63 0.37 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.469 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 61.53 -161.42 26.85 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.448 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 83.92 -118.67 4.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.56 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.49 160.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.952 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 114.95 -72.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.559 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.48 121.63 44.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.957 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 79.92 -124.1 6.37 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.515 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.294 -1.281 . . . . 0.0 112.464 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 61.18 83.66 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -95.26 57.82 2.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.53 -164.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.822 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 368' ' ' PHE . 2.9 m -95.27 24.26 5.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.228 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.95 -10.81 6.31 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.695 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.788 ' OD1' ' HB2' ' A' ' 369' ' ' ALA . 0.1 OUTLIER -33.64 124.37 0.43 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -61.61 -18.22 58.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.79 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 87.7 m -73.53 106.16 5.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.675 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 16.2 pt -102.22 171.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.785 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.643 ' CZ ' HG21 ' A' ' 338' ' ' THR . 4.2 m-85 -125.33 113.54 17.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.807 HG13 HG22 ' A' ' 366' ' ' VAL . 0.3 OUTLIER -102.35 114.39 41.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.784 0.326 . . . . 0.0 110.223 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.427 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 30.9 mm-40 -111.6 130.76 55.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.351 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.634 ' C ' HD23 ' A' ' 292' ' ' LEU . . . 114.08 81.45 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.348 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 359' ' ' PHE . 0.3 OUTLIER -128.44 -74.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.737 ' O ' HD11 ' A' ' 333' ' ' LEU . . . 124.52 -76.24 0.38 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.108 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.837 ' HA ' HD21 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -144.21 28.4 1.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.9 0.381 . . . . 0.0 110.919 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.457 ' C ' ' ND2' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -116.28 -8.78 11.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.834 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.899 HG12 HD22 ' A' ' 333' ' ' LEU . 13.1 p -47.73 107.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.0 OUTLIER -163.88 146.78 9.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.016 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.614 HG23 ' HB ' ' A' ' 322' ' ' ILE . 11.3 mt -63.75 -46.03 95.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.801 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -66.68 -41.93 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.853 0.358 . . . . 0.0 110.874 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 16.3 p -67.08 -40.97 87.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 297' ' ' THR . 60.7 t -73.94 -38.16 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.233 0.539 . . . . 0.0 109.662 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.66 72.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.82 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -74.33 -35.65 63.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.001 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 305' ' ' PHE . 0.0 OUTLIER -91.22 -24.38 19.91 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.62 ' HD2' HG11 ' A' ' 339' ' ' VAL . 0.2 OUTLIER -98.21 26.65 5.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.394 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.6 25.68 10.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.877 0.37 . . . . 0.0 110.75 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -107.15 -44.19 4.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.402 HD13 ' HE3' ' A' ' 353' ' ' TRP . 1.7 tp -74.1 -28.35 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -174.68 -164.68 29.91 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.759 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.97 132.0 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 320' ' ' PRO . 3.4 mp -81.53 128.01 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 321' ' ' MET . 5.0 mtmp? -55.35 100.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.182 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.666 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.7 m -63.94 154.5 33.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.259 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.6 138.95 31.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 3.73 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.921 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -111.65 -20.92 11.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.292 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.441 ' HB ' ' ND2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -120.27 -21.8 6.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.562 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 73.75 13.62 80.4 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.666 ' C ' HG23 ' A' ' 313' ' ' THR . 0.0 OUTLIER -124.43 162.63 41.16 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 93.1 Cg_exo -47.63 148.26 5.92 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.533 2.155 . . . . 0.0 112.152 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.405 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 72.0 mtp -101.33 114.71 28.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.667 HG12 HG22 ' A' ' 339' ' ' VAL . 3.3 mt -143.26 139.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.044 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.508 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 0.8 OUTLIER -103.2 144.17 31.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.892 0.377 . . . . 0.0 110.932 -179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.565 ' CD2' HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -136.9 144.96 43.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -121.42 114.14 20.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.017 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 17.4 p -103.09 169.98 8.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.22 115.1 24.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 110.792 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.02 26.03 4.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -112.36 -34.59 5.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 332' ' ' LYS . 5.9 t -129.2 -40.27 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.022 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 141.03 -26.13 2.5 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.467 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.529 ' H ' HG23 ' A' ' 330' ' ' THR . 10.6 mttt -58.4 -174.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.899 HD22 HG12 ' A' ' 296' ' ' VAL . 3.2 pp -125.28 138.35 54.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.717 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -53.03 -23.58 7.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.593 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 333' ' ' LEU . . . 78.65 39.24 21.99 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.013 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 11.3 pt-20 -152.35 144.95 24.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 111.006 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -155.26 141.72 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.25 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 3.7 p -92.1 138.83 31.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.706 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.667 HG22 HG12 ' A' ' 322' ' ' ILE . 90.4 t -116.89 127.75 74.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 311' ' ' ILE . 94.5 p -101.4 125.82 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.598 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.55 153.09 22.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.951 0.405 . . . . 0.0 111.182 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 312' ' ' LYS . 23.0 t0 -73.42 -26.49 60.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.326 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.96 111.16 48.25 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.954 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.6 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 84.4 Cg_exo -43.52 -51.04 6.38 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.53 2.153 . . . . 0.0 112.454 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.1 Cg_endo -55.35 -30.67 73.77 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.928 1.752 . . . . 0.0 111.149 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 7.7 t -58.98 -43.18 91.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.664 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.675 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -55.4 -49.79 71.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.958 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -62.33 -52.7 62.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.708 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.46 -29.79 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.819 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.36 -44.99 74.02 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 348' ' ' LYS . 8.1 mt -61.72 -35.79 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -60.99 -26.34 67.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.535 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 2.6 t90 -96.52 -68.27 0.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.939 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 364' ' ' ILE . 16.3 m-85 -62.54 -74.34 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.536 ' C ' ' O ' ' A' ' 354' ' ' PHE . 26.2 t70 11.86 63.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.811 0.694 . . . . 0.0 112.16 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 114.83 25.05 4.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.656 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 354' ' ' PHE . 19.5 mmtt -87.54 -167.87 2.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 0.1 OUTLIER -119.93 131.93 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.0 112.228 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -96.23 101.36 12.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.953 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 19.6 p 51.44 28.2 4.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.15 -42.49 1.55 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.28 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.1 m-80 -78.05 172.32 10.15 Favored Pre-proline 0 C--O 1.221 -0.405 0 CA-C-N 116.667 0.233 . . . . 0.0 110.767 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -94.32 146.92 1.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.277 2.652 . . . . 0.0 112.054 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.859 HD11 ' HB3' ' A' ' 354' ' ' PHE . 3.1 pt -123.59 171.26 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 111.822 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -148.29 104.02 3.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.807 HG22 HG13 ' A' ' 289' ' ' VAL . 37.0 t -91.39 139.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.04 -172.1 3.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.283 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.617 ' CD1' HD11 ' A' ' 351' ' ' ILE . 0.2 OUTLIER -108.64 76.5 1.03 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.68 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.788 ' HB2' ' OD1' ' A' ' 284' ' ' ASN . . . 57.09 92.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.411 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 371' ' ' ARG . 0.2 OUTLIER 41.34 -161.47 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.44 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . 0.596 ' H ' HG22 ' A' ' 370' ' ' THR . 14.4 mmp_? 63.06 133.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -93.66 59.04 2.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.74 167.05 2.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.014 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.71 -176.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -108.61 34.6 3.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.09 31.61 20.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.6 -172.3 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 133.97 107.13 0.96 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -59.57 -56.69 23.59 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.502 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 98.67 -59.48 0.9 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.549 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.43 -169.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 176.1 -116.53 0.57 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -110.42 114.26 27.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -77.47 -140.84 1.39 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.453 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.476 179.95 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.868 0.366 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 61.38 -176.91 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.07 49.58 0.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.233 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 284' ' ' ASN . 1.0 OUTLIER -58.69 125.55 23.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.543 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.5 p -105.4 -29.28 10.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.393 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.88 5.25 19.53 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.446 ' HA ' ' OD1' ' A' ' 281' ' ' ASN . 8.0 p30 45.45 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.171 0.51 . . . . 0.0 111.564 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.66 HD22 ' HB2' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -52.87 -34.55 55.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.603 179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 99.6 m -62.07 97.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.666 HD12 HG13 ' A' ' 366' ' ' VAL . 43.5 pt -86.55 170.59 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -118.39 118.59 32.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.295 -179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 365' ' ' LYS . 0.2 OUTLIER -108.69 115.28 48.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.538 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -116.43 130.83 56.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.376 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.635 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 111.78 51.11 0.58 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.294 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.758 HD22 ' H ' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -105.57 -83.55 0.51 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.905 0.352 . . . . 0.0 110.486 179.448 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 76.57 -50.14 2.83 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.214 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -107.75 40.0 1.81 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.186 0.493 . . . . 0.0 111.951 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' A' ' 296' ' ' VAL . 0.0 OUTLIER -143.56 -42.28 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.039 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 296' ' ' VAL . 96.4 t 6.27 65.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.839 ' O ' HG23 ' A' ' 301' ' ' VAL . 39.4 p -161.92 145.58 12.25 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.988 0.423 . . . . 0.0 110.731 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.732 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.2 mm -71.77 -40.3 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.862 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.15 -42.81 88.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.41 ' HB3' ' OG1' ' A' ' 297' ' ' THR . 21.6 p -63.18 -41.49 99.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.0 110.473 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 297' ' ' THR . 34.9 t -70.72 -47.67 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.728 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -62.62 -29.9 70.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.922 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.1 -40.67 71.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.756 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -89.42 -27.25 20.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.69 -179.34 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' A' ' 287' ' ' ILE . 0.1 OUTLIER -88.83 9.99 22.7 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 20.99 13.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.757 0.313 . . . . 0.0 111.131 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -102.32 -39.21 7.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.406 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.441 HD13 ' HE3' ' A' ' 353' ' ' TRP . 3.3 tp -76.81 -38.39 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.052 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -168.01 -162.97 21.12 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.528 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.6 mt -98.31 137.07 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.53 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.899 HG23 ' O ' ' A' ' 340' ' ' SER . 3.8 mt -96.73 136.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 341' ' ' PHE . 4.1 mmtt -48.42 106.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.052 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -77.67 142.87 38.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.898 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.569 ' OD1' ' CG ' ' A' ' 321' ' ' MET . 0.0 OUTLIER -93.62 140.3 29.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 0.0 111.387 -179.031 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -77.86 -6.18 53.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.91 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.39 -45.13 7.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.37 . . . . 0.0 110.412 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 70.8 p -104.63 -8.25 19.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 314' ' ' ASN . . . 63.95 14.22 55.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.235 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.408 ' HB2' ' HD2' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -125.14 164.08 34.01 Favored Pre-proline 0 N--CA 1.456 -0.138 0 CA-C-O 120.485 0.183 . . . . 0.0 110.925 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.591 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 79.3 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.44 2.093 . . . . 0.0 112.299 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.569 ' CG ' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -116.64 125.1 51.29 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.569 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.717 HD13 ' HB ' ' A' ' 301' ' ' VAL . 4.6 mt -143.28 144.62 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.166 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.534 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.2 m-20 -110.34 147.84 33.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.703 0.287 . . . . 0.0 110.455 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.732 HD11 ' CD1' ' A' ' 298' ' ' ILE . 0.0 OUTLIER -145.48 130.14 18.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.111 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . 0.402 ' HB2' ' CG ' ' A' ' 336' ' ' GLU . 51.2 m-85 -91.14 139.36 30.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.511 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 333' ' ' LEU . 63.1 p -146.19 174.8 11.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.55 147.99 31.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 328' ' ' ARG . 0.0 OUTLIER -111.15 15.85 21.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.409 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 330' ' ' THR . 0.2 OUTLIER -146.51 49.46 1.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.072 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 329' ' ' GLU . 1.0 OUTLIER 171.75 -35.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.99 -29.45 9.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.321 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -57.98 170.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 110.775 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.662 ' HB3' HG22 ' A' ' 326' ' ' THR . 0.0 OUTLIER -108.57 -177.16 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -101.75 -28.93 12.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.401 ' C ' HD22 ' A' ' 292' ' ' LEU . . . 102.23 28.27 6.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.567 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 0.6 OUTLIER -143.02 143.4 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 111.36 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 323' ' ' ASN . . . -158.26 139.85 13.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.237 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.765 HG22 ' CE1' ' A' ' 288' ' ' PHE . 11.9 p -97.61 134.15 41.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.561 HG22 HG11 ' A' ' 301' ' ' VAL . 95.0 t -112.0 126.06 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.522 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.899 ' O ' HG23 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -86.18 153.26 22.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.467 ' CB ' ' ND2' ' A' ' 285' ' ' ASN . 4.5 m-85 -133.51 147.0 51.59 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.42 -33.22 48.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -114.65 118.07 41.64 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.648 0.261 . . . . 0.0 110.788 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.565 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 81.5 Cg_exo -41.84 -51.69 4.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.876 2.384 . . . . 0.0 113.081 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.2 Cg_endo -55.6 -30.28 74.06 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.775 1.65 . . . . 0.0 111.089 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.8 t -56.64 -44.82 81.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.04 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.66 ' HB2' HD22 ' A' ' 285' ' ' ASN . . . -53.4 -50.34 65.37 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.63 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.943 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -63.9 -54.85 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.156 0.503 . . . . 0.0 109.749 178.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -50.05 -31.92 14.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.539 ' HB1' ' HE1' ' A' ' 305' ' ' PHE . . . -68.58 -48.56 63.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.0 mt -58.93 -35.99 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.371 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -61.91 -26.2 68.03 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.242 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 3.6 t90 -94.37 -68.57 0.79 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.586 ' HB2' HG21 ' A' ' 366' ' ' VAL . 1.5 m-85 -69.79 -77.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.8 p-10 23.17 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.115 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 122.45 20.33 2.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.316 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.446 ' HD2' ' CD1' ' A' ' 353' ' ' TRP . 9.1 mtpp -87.02 -166.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.061 0.43 . . . . 0.0 110.472 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 13.3 mm-40 -120.02 128.91 53.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.979 0.419 . . . . 0.0 112.093 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.613 ' HD2' HD12 ' A' ' 292' ' ' LEU . 0.1 OUTLIER -84.2 100.84 11.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.743 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.49 31.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 142.51 -51.62 0.67 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.186 -1.006 . . . . 0.0 114.048 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.4 OUTLIER -89.16 171.61 8.7 Favored Pre-proline 0 C--O 1.218 -0.59 0 CA-C-N 117.008 0.404 . . . . 0.0 110.743 -179.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 358' ' ' GLU . 85.9 Cg_endo -95.48 143.36 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.308 2.672 . . . . 0.0 112.193 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.9 pt -132.03 170.06 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 121.014 0.435 . . . . 0.0 111.978 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -132.62 150.92 52.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.777 179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.666 HG13 HD12 ' A' ' 287' ' ' ILE . 11.6 t -131.6 127.74 59.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 111.363 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 1.8 p -140.24 172.92 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.492 ' CZ ' HD13 ' A' ' 351' ' ' ILE . 4.3 m-85 -86.28 55.5 3.57 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.088 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 59.44 84.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.14 120.21 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.344 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.16 127.77 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.712 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.61 -165.76 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -90.86 61.61 4.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.071 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 -75.93 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.53 114.54 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.92 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 17.3 tpp85 -178.92 150.79 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 57.43 -119.91 18.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.654 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 136.12 -51.36 0.81 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -131.19 -83.45 0.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.589 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.5 m120 63.71 137.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.87 0.367 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 99.18 -27.79 18.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.79 152.87 47.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -83.85 -27.97 36.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.551 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 61.43 -170.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -75.16 68.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.405 ' O ' ' CZ ' ' A' ' 368' ' ' PHE . 1.4 m120 -118.4 88.06 2.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 15.9 p -96.71 24.22 6.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.96 -28.25 62.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.992 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.487 ' ND2' ' CD1' ' A' ' 368' ' ' PHE . 0.2 OUTLIER -123.17 119.19 29.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.114 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 3.8 p-10 -86.45 -19.14 30.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.843 ' O ' ' HB2' ' A' ' 369' ' ' ALA . 74.6 m -80.42 144.98 32.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.769 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 305' ' ' PHE . 36.2 pt -123.36 168.33 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.764 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 338' ' ' THR . 0.6 OUTLIER -124.06 114.95 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.174 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.897 HG13 HG22 ' A' ' 366' ' ' VAL . 0.1 OUTLIER -107.63 114.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -112.74 144.18 42.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.678 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.51 4.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.731 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.844 HD12 HG22 ' A' ' 296' ' ' VAL . 7.2 mt -60.51 -76.76 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.618 0.247 . . . . 0.0 110.743 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.3 77.72 0.77 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.392 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 43.93 30.79 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.853 0.358 . . . . 0.0 111.632 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.33 25.34 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.729 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.844 HG22 HD12 ' A' ' 292' ' ' LEU . 21.5 t -68.17 83.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.7 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.845 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.2 OUTLIER -126.44 147.99 49.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.588 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.572 HD13 HD21 ' A' ' 324' ' ' LEU . 32.4 mm -68.54 -47.02 79.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.258 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -38.64 87.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 11.7 t -63.96 -40.28 96.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 297' ' ' THR . 54.6 t -74.9 -41.25 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.862 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.721 ' HB1' ' HG2' ' A' ' 320' ' ' PRO . . . -68.18 -29.93 68.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.837 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -74.11 -40.47 62.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.632 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.519 ' CZ ' ' CE2' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -94.07 -21.83 18.89 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.806 ' O ' HD11 ' A' ' 311' ' ' ILE . 0.2 OUTLIER -105.33 38.13 2.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.712 0.291 . . . . 0.0 111.406 -179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -123.02 19.11 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.305 179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.64 -36.45 8.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.301 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 3.0 tp -75.48 -30.1 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.465 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.431 ' HA3' ' OG ' ' A' ' 346' ' ' SER . . . -168.16 -167.38 28.73 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.91 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.69 116.71 49.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 305' ' ' PHE . 3.4 mt -76.81 124.02 34.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.313 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 321' ' ' MET . 23.9 mtmt -48.72 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.615 HG23 ' C ' ' A' ' 319' ' ' GLN . 1.2 m -69.64 152.04 45.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.747 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 319' ' ' GLN . 0.0 OUTLIER -93.23 144.59 25.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.8 1.5 52.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.279 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.26 -32.1 7.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.845 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.401 ' OG1' ' CG ' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -107.39 -20.67 13.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.752 179.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 72.37 8.59 71.15 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.776 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.615 ' C ' HG23 ' A' ' 313' ' ' THR . 0.1 OUTLIER -125.12 167.42 16.3 Favored Pre-proline 0 C--O 1.224 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.465 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.721 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 66.8 Cg_exo -44.78 149.37 1.14 Allowed 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.708 2.272 . . . . 0.0 113.041 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.472 ' N ' ' O ' ' A' ' 312' ' ' LYS . 36.7 mtp -101.94 121.56 42.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.835 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 339' ' ' VAL . 1.2 mt -143.25 138.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 337' ' ' ALA . 1.0 OUTLIER -98.83 140.41 33.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.808 -179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.743 HD23 ' HB1' ' A' ' 337' ' ' ALA . 5.2 mt -126.7 142.61 51.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.034 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -115.48 87.93 2.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 77.5 p -89.1 174.03 8.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 329' ' ' GLU . 11.5 m-20 -90.06 99.63 12.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.799 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 -83.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.438 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 327' ' ' ASP . 3.2 mt-10 167.58 31.04 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.88 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 8.8 t -96.23 -26.24 15.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 0.0 110.154 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 114.13 72.75 0.57 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.926 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 327' ' ' ASP . 2.8 mtpp -143.11 -46.32 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 110.758 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 4.3 mp 62.09 147.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.099 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -102.96 12.15 36.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.269 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 52.36 49.0 53.1 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.522 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.22 136.5 15.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 0.0 111.236 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.743 ' HB1' HD23 ' A' ' 324' ' ' LEU . . . -157.88 153.02 25.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.085 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -102.67 145.83 29.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.428 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.712 HG22 HG12 ' A' ' 322' ' ' ILE . 46.8 t -113.27 128.51 70.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.206 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 311' ' ' ILE . 59.7 p -97.57 124.54 41.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -102.06 154.87 18.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.69 -21.09 38.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.261 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' SER . 0.6 OUTLIER -125.98 118.36 23.9 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.683 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.601 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 91.1 Cg_exo -41.31 -50.81 4.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.733 2.289 . . . . 0.0 112.983 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 10.3 Cg_endo -53.03 -30.54 49.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.956 1.771 . . . . 0.0 111.219 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 343' ' ' ASP . 25.6 t -57.26 -44.92 84.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.97 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.35 -49.22 75.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.946 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.7 OUTLIER -62.05 -49.97 73.87 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.003 0.43 . . . . 0.0 110.01 179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.91 -33.88 38.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.731 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.09 64.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.452 0.644 . . . . 0.0 109.382 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.946 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.5 mt -58.26 -35.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.158 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.17 -26.62 65.84 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.159 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.519 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.2 t90 -89.2 -68.01 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.334 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.621 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 4.1 m-85 -75.64 -81.2 0.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.614 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 10.5 p-10 31.26 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.549 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 126.02 43.36 0.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.773 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.79 -157.2 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 357' ' ' LYS . 27.7 tt0 -113.58 128.32 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.41 0.624 . . . . 0.0 111.518 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.519 ' CE2' ' CZ ' ' A' ' 304' ' ' TYR . 0.9 OUTLIER -112.46 101.66 9.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.957 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 1.7 t 55.43 26.55 8.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.068 0.461 . . . . 0.0 110.247 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 94.66 24.83 16.89 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.74 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 73.5 m-80 -129.94 148.57 70.14 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.822 0.344 . . . . 0.0 111.848 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.07 121.71 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.479 2.119 . . . . 0.0 111.447 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 290' ' ' GLN . 8.7 pt -112.33 -178.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.961 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.12 101.04 3.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.673 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.897 HG22 HG13 ' A' ' 289' ' ' VAL . 40.8 t -88.64 133.52 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.934 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 86.6 p -127.53 -179.89 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.195 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 347' ' ' ALA . 0.1 OUTLIER -95.5 51.45 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.693 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.843 ' HB2' ' O ' ' A' ' 286' ' ' THR . . . 65.67 159.71 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.011 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -74.76 166.98 22.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.881 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.9 -172.95 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -116.55 -40.05 3.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 62.84 134.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.156 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 28.8 t70 60.04 164.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.815 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.12 -158.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 70.25 -78.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.08 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -153.48 -79.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.714 0.292 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 79.3 -152.21 35.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.492 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.35 75.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.424 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -89.31 -170.48 44.89 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.558 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.51 -167.62 2.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.752 0.311 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 157.65 -26.67 0.46 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.58 118.3 4.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.994 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 179.97 -94.82 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.485 -179.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.789 0.328 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.53 155.85 34.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.84 -29.07 13.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.996 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 10.6 m120 61.58 21.43 12.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.055 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.3 m -104.98 23.52 13.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.057 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -99.32 31.12 3.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -115.81 87.4 2.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 29.5 p30 -58.41 -21.3 50.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.691 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.898 HG22 ' HB3' ' A' ' 369' ' ' ALA . 0.3 OUTLIER -84.56 143.04 29.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.0 0.428 . . . . 0.0 110.909 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.836 HD12 ' CG1' ' A' ' 366' ' ' VAL . 2.0 pt -117.26 172.17 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.047 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 288' ' ' PHE . 1.5 p90 -125.48 122.29 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.876 0.37 . . . . 0.0 111.459 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.963 HG13 HG22 ' A' ' 366' ' ' VAL . 0.2 OUTLIER -104.34 114.86 45.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.242 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -115.93 131.0 57.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.06 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 106.75 43.15 1.46 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.976 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.702 HD22 ' HD2' ' A' ' 359' ' ' PHE . 0.5 OUTLIER -85.67 -79.74 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.791 0.296 . . . . 0.0 110.678 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 136.39 -81.5 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.546 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.13 29.74 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.92 0.39 . . . . 0.0 110.575 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 292' ' ' LEU . 0.0 OUTLIER -111.65 7.92 20.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.94 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.788 HG13 HD22 ' A' ' 324' ' ' LEU . 10.0 t -55.52 89.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.529 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -147.52 146.44 29.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.033 178.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.67 ' CD1' HD11 ' A' ' 324' ' ' LEU . 19.5 mm -71.43 -45.28 69.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.684 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.96 -43.09 84.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.073 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -40.0 82.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 297' ' ' THR . 54.2 t -73.58 -37.96 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.715 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.792 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.61 -34.52 75.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.103 179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -71.36 -38.02 71.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.092 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.488 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -85.54 -20.91 28.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.714 -179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.867 ' CD2' HG21 ' A' ' 339' ' ' VAL . 0.6 OUTLIER -92.15 11.76 24.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 29.02 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.322 . . . . 0.0 111.071 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -112.54 -33.8 6.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.918 0.39 . . . . 0.0 110.646 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . . . . . . . . . 7.8 tp -84.4 -31.8 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.311 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 179.71 -160.73 26.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.732 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 6.0 mt -92.85 134.63 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.562 0.22 . . . . 0.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.792 HD13 ' HA ' ' A' ' 302' ' ' ALA . 4.6 mt -92.93 134.18 31.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.378 0.608 . . . . 0.0 110.945 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 321' ' ' MET . 0.7 OUTLIER -48.56 100.83 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.411 -178.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.2 OUTLIER -76.21 154.25 35.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.523 ' CG ' ' HG1' ' A' ' 317' ' ' THR . 17.6 p30 -103.03 -178.86 3.79 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.018 0.437 . . . . 0.0 111.644 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.41 ' CD ' ' N ' ' A' ' 315' ' ' LYS . 0.0 OUTLIER -109.42 -12.46 14.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.172 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.92 -44.75 11.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.156 0.503 . . . . 0.0 109.999 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.523 ' HG1' ' CG ' ' A' ' 314' ' ' ASN . 8.5 p -106.37 -8.42 17.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.766 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 314' ' ' ASN . . . 61.23 17.39 52.36 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.671 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.559 ' HG2' ' N ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -124.7 168.03 14.32 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 120.776 0.322 . . . . 0.0 110.894 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.598 ' HG2' ' HB1' ' A' ' 302' ' ' ALA . 80.4 Cg_exo -44.54 161.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.988 2.459 . . . . 0.0 112.726 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 312' ' ' LYS . 0.4 OUTLIER -123.08 129.43 51.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.296 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.848 HG12 HG23 ' A' ' 339' ' ' VAL . 3.7 mp -144.38 129.23 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.467 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -93.15 115.52 28.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.797 HD23 ' CB ' ' A' ' 337' ' ' ALA . 0.2 OUTLIER -121.56 148.77 44.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.867 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -101.22 130.33 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.412 ' CG2' HD12 ' A' ' 333' ' ' LEU . 13.8 p -132.92 145.59 51.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.98 118.75 7.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.755 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -7.6 59.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.451 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -86.17 -43.74 12.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.788 0.328 . . . . 0.0 110.934 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 332' ' ' LYS . 10.0 t -112.72 -29.61 7.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.055 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 107.75 -22.09 28.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.623 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.777 ' H ' HG23 ' A' ' 330' ' ' THR . 0.6 OUTLIER -57.22 135.36 56.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.888 0.375 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 333' ' ' LEU . 0.0 OUTLIER -61.95 149.19 41.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.785 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -76.71 -26.04 54.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.398 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 94.63 31.83 7.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.337 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.413 ' HB2' ' NE2' ' A' ' 290' ' ' GLN . 8.8 pt-20 -157.18 140.55 15.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.62 0.247 . . . . 0.0 110.703 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.797 ' CB ' HD23 ' A' ' 324' ' ' LEU . . . -160.39 179.11 8.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.1 0.476 . . . . 0.0 111.783 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 322' ' ' ILE . 69.4 p -129.91 136.47 49.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.406 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.867 HG21 ' CD2' ' A' ' 305' ' ' PHE . 0.4 OUTLIER -104.37 125.11 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.268 -179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 311' ' ' ILE . 3.1 p -94.56 140.07 30.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.047 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.557 ' CE2' HD13 ' A' ' 287' ' ' ILE . 32.2 m-85 -115.5 160.16 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 111.069 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -80.63 -18.15 49.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.25 116.87 20.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.609 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.7 Cg_exo -44.77 -50.52 8.34 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.653 2.235 . . . . 0.0 112.907 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 11.1 Cg_endo -54.58 -30.51 65.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.003 1.802 . . . . 0.0 111.401 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.9 t -58.67 -41.21 85.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.85 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -56.05 -50.1 71.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.857 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.949 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.4 OUTLIER -59.39 -50.64 73.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.175 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.56 -33.78 33.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.792 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.84 -48.33 63.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.433 0.635 . . . . 0.0 109.391 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.949 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.4 mt -56.87 -35.97 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.15 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -26.65 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.152 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 354' ' ' PHE . 1.1 t90 -85.34 -68.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.054 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.533 ' HB3' ' HG2' ' A' ' 357' ' ' LYS . 5.1 m-85 -76.17 -79.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.483 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 354' ' ' PHE . 45.5 t0 21.44 51.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.439 0.462 . . . . 0.0 112.021 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 125.32 32.02 0.81 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.256 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -102.74 -162.87 0.95 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.087 0.443 . . . . 0.0 110.087 179.344 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 8.5 mt-10 -113.72 128.6 56.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.994 0.426 . . . . 0.0 111.866 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.74 ' HB2' HD13 ' A' ' 364' ' ' ILE . 0.6 OUTLIER -102.79 101.72 11.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.266 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 41.0 t 60.01 28.38 17.91 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.486 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.32 -27.8 10.33 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.592 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 3.1 m-80 -91.76 169.54 11.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.956 0.378 . . . . 0.0 110.64 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -93.34 137.18 1.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 112.071 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.74 HD13 ' HB2' ' A' ' 359' ' ' PHE . 23.3 pt -134.36 164.52 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 120.977 0.417 . . . . 0.0 111.804 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 100.53 5.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.963 HG22 HG13 ' A' ' 289' ' ' VAL . 19.5 t -90.02 118.66 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.035 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.441 ' HA ' HG12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -140.53 -166.75 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -72.94 113.06 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.705 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.898 ' HB3' HG22 ' A' ' 286' ' ' THR . . . -63.03 82.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.0 t -167.94 -172.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.66 120.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 99.25 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.986 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -97.87 31.86 2.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -161.12 -178.12 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.89 102.06 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -170.21 111.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -129.23 -70.41 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 82.23 -58.33 4.96 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.631 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 109.1 28.59 4.36 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 77.39 115.08 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.439 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -103.93 112.75 25.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 109.93 -56.51 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -68.75 149.92 48.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 104.42 -28.21 15.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.53 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.481 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.85 0.357 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.77 157.45 19.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -85.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.865 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.69 77.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.765 0.317 . . . . 0.0 111.197 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 59.6 p -86.61 5.73 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -112.95 -9.34 13.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.632 0.254 . . . . 0.0 111.056 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 369' ' ' ALA . 0.0 OUTLIER -79.32 120.23 23.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.014 0.435 . . . . 0.0 110.783 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 14.0 p30 -104.1 -25.15 13.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.491 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 58.9 m -70.52 116.23 10.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.659 ' CG2' ' HB1' ' A' ' 347' ' ' ALA . 36.8 pt -102.93 173.17 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.175 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.564 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.4 OUTLIER -122.46 107.69 12.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 364' ' ' ILE . 2.7 t -104.35 114.48 44.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.957 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.432 ' HG3' ' CG ' ' A' ' 336' ' ' GLU . 2.0 mp0 -116.78 130.5 56.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.86 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 364' ' ' ILE . . . 123.98 25.77 1.64 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.849 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 295' ' ' ASN . 4.9 mp -88.05 -104.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.94 -39.7 1.82 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.594 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.93 31.82 1.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.654 0.727 . . . . 0.0 112.036 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.754 HD21 HD23 ' A' ' 292' ' ' LEU . 0.5 OUTLIER -162.51 -44.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.56 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.767 HG13 HG21 ' A' ' 326' ' ' THR . 14.7 t 26.48 72.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.639 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -164.48 145.2 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.101 179.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.751 HG21 HE22 ' A' ' 319' ' ' GLN . 1.2 mp -72.21 -42.1 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.998 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.44 -40.54 95.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.4 t -65.08 -43.99 90.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.468 . . . . 0.0 110.478 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 297' ' ' THR . 47.7 t -70.92 -40.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.353 0.597 . . . . 0.0 109.664 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 320' ' ' PRO . . . -68.18 -29.82 68.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.024 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.4 -37.7 65.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.685 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.427 ' CE1' ' CZ ' ' A' ' 359' ' ' PHE . 0.0 OUTLIER -96.57 -24.79 15.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.769 ' HB3' HD11 ' A' ' 311' ' ' ILE . 0.1 OUTLIER -93.27 7.98 42.15 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 302' ' ' ALA . 0.0 OUTLIER -95.56 22.41 7.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 111.076 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -99.21 -44.35 6.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.624 HG23 ' CE2' ' A' ' 341' ' ' PHE . 0.8 OUTLIER -70.94 -29.33 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.477 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -170.73 -170.52 35.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.943 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 3.8 mt -96.29 113.85 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.689 0.281 . . . . 0.0 111.513 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 305' ' ' PHE . 1.1 mt -71.65 135.16 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.028 0.442 . . . . 0.0 111.239 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 321' ' ' MET . 6.1 mmmt -65.37 91.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 320' ' ' PRO . 0.0 OUTLIER -67.33 171.02 6.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 111.043 178.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 316' ' ' LYS . 0.4 OUTLIER -103.35 116.34 32.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.354 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -8.26 0.16 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.593 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -83.27 -34.49 25.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.064 0.459 . . . . 0.0 110.59 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.614 HG21 ' HG2' ' A' ' 319' ' ' GLN . 0.5 OUTLIER -121.62 -23.48 5.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.338 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 83.84 23.43 52.78 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.908 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.751 HE22 HG21 ' A' ' 298' ' ' ILE . 2.7 pp0? -118.57 138.1 25.49 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.884 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.681 ' HB3' ' HB ' ' A' ' 311' ' ' ILE . 4.8 Cg_exo -44.01 131.04 8.32 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.999 2.466 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.0 OUTLIER -97.15 130.18 44.44 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.839 0.828 . . . . 0.0 112.929 -178.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.721 HD12 HG23 ' A' ' 298' ' ' ILE . 3.7 mt -143.14 140.22 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.428 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 337' ' ' ALA . 6.2 t30 -98.8 148.38 23.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 298' ' ' ILE . 0.2 OUTLIER -154.42 128.17 8.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.943 0.401 . . . . 0.0 111.496 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -86.54 87.94 7.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.952 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.767 HG21 HG13 ' A' ' 296' ' ' VAL . 0.2 OUTLIER -143.22 150.38 39.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.007 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 332' ' ' LYS . 0.4 OUTLIER -102.9 108.01 19.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.555 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.24 13.19 12.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.733 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -97.97 -40.57 8.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 111.134 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 6.4 t -127.2 -1.8 6.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.82 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 78.83 49.61 6.4 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.416 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 327' ' ' ASP . 0.3 OUTLIER -97.0 24.51 6.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 111.174 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.554 HD22 HG11 ' A' ' 296' ' ' VAL . 19.1 mt -32.62 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.762 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.41 -31.37 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 90.11 32.42 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.617 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.432 ' CG ' ' HG3' ' A' ' 290' ' ' GLN . 4.9 mp0 -130.16 132.16 45.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.502 0.191 . . . . 0.0 110.562 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.47 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -153.27 147.05 25.22 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.564 HG22 ' CD1' ' A' ' 288' ' ' PHE . 44.3 p -110.33 117.8 34.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.918 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.647 ' CG1' HD13 ' A' ' 311' ' ' ILE . 56.1 t -93.06 130.15 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.739 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.683 ' O ' HG23 ' A' ' 311' ' ' ILE . 9.1 t -96.72 133.62 41.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.907 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.624 ' CE2' HG23 ' A' ' 308' ' ' ILE . 3.0 m-85 -117.41 148.35 41.85 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.816 0.341 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -70.95 -34.32 71.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 0.0 111.328 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.49 109.45 60.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 87.5 Cg_exo -44.28 -51.41 6.85 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.478 2.119 . . . . 0.0 112.496 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 12.3 Cg_endo -55.76 -30.58 76.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.945 1.763 . . . . 0.0 111.262 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 8.4 t -60.54 -44.21 96.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.659 ' HB1' ' CG2' ' A' ' 287' ' ' ILE . . . -56.65 -46.21 81.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.287 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.93 ' HA ' HD12 ' A' ' 351' ' ' ILE . 3.0 tppt? -60.16 -54.74 42.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.847 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.69 -32.54 43.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.039 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 308' ' ' ILE . . . -68.63 -49.68 57.28 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.93 HD12 ' HA ' ' A' ' 348' ' ' LYS . 9.9 mt -52.47 -36.66 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.763 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -58.38 -26.24 62.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.577 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.544 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.4 t90 -100.5 -68.6 0.8 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.96 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.688 ' HB2' HG21 ' A' ' 366' ' ' VAL . 47.2 m-85 -56.85 -74.48 0.05 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 351' ' ' ILE . 11.4 p-10 9.35 59.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.973 0.796 . . . . 0.0 112.684 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 354' ' ' PHE . . . 117.81 30.69 1.76 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.13 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.422 ' HG3' ' CG1' ' A' ' 364' ' ' ILE . 0.0 OUTLIER -94.75 -164.45 1.17 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 7.7 mm-40 -119.4 129.38 54.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.621 -0.432 . . . . 0.0 112.122 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.678 ' CD1' HG21 ' A' ' 364' ' ' ILE . 0.3 OUTLIER -86.09 101.05 12.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.041 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 40.5 30.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.358 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 140.49 -49.72 0.78 Allowed Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.006 -1.092 . . . . 0.0 114.28 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 0.0 OUTLIER -89.7 171.1 9.26 Favored Pre-proline 0 C--O 1.218 -0.555 0 CA-C-N 117.207 0.504 . . . . 0.0 110.958 -179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -95.15 140.17 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.468 2.779 . . . . 0.0 112.153 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.678 HG21 ' CD1' ' A' ' 359' ' ' PHE . 5.1 pt -122.28 -179.16 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.865 0.364 . . . . 0.0 111.652 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.27 102.45 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.548 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.688 HG21 ' HB2' ' A' ' 354' ' ' PHE . 17.6 t -84.85 143.28 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 0.0 111.087 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.2 t -128.08 -168.23 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.474 ' HD1' HD11 ' A' ' 351' ' ' ILE . 0.8 OUTLIER -121.2 65.0 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.614 ' HB2' ' OD1' ' A' ' 284' ' ' ASN . . . 63.23 177.06 0.15 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.455 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.71 -172.92 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 11.5 mtp-105 67.15 179.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.817 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -133.89 76.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.429 . . . . 0.0 111.297 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . 49.09 28.7 2.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.982 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . 0.49 ' O ' ' CD1' ' A' ' 375' ' ' PHE . 1.9 t0 71.99 -146.97 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.216 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . 0.54 ' CG ' ' O ' ' A' ' 375' ' ' PHE . 17.9 p90 42.26 85.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.385 0.612 . . . . 0.0 111.489 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 179.62 98.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.79 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -135.8 123.1 21.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.834 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 76.51 -104.49 1.87 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.524 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 61.93 51.99 53.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 115.14 170.55 16.34 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.435 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -100.35 -31.07 11.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 141.94 -163.5 26.97 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.45 150.7 41.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.852 0.358 . . . . 0.0 110.953 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 163.7 131.21 1.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.418 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.358 -1.245 . . . . 0.0 112.475 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.793 0.33 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 60.81 -167.38 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.759 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -56.26 -30.56 62.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.76 87.82 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.4 t -71.9 -28.37 63.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.117 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 284' ' ' ASN . 25.7 m-20 -111.53 -2.37 15.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.412 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 283' ' ' ASP . 5.1 p30 48.98 108.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.229 0.538 . . . . 0.0 111.71 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 347' ' ' ALA . 9.9 p30 -63.9 -20.28 65.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 340' ' ' SER . 27.8 m -71.44 158.28 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.66 ' CA ' ' HB2' ' A' ' 369' ' ' ALA . 10.2 pt -142.94 173.24 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.75 ' CD1' HG22 ' A' ' 338' ' ' THR . 0.1 OUTLIER -131.09 112.35 12.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.016 -179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 366' ' ' VAL . 0.5 OUTLIER -105.35 114.69 45.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.741 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.417 ' NE2' ' O ' ' A' ' 289' ' ' VAL . 1.1 mp0 -113.37 130.59 56.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.034 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.705 ' O ' HG22 ' A' ' 364' ' ' ILE . . . 105.32 51.03 0.89 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.387 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 296' ' ' VAL . 0.3 OUTLIER -84.56 -73.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.817 0.341 . . . . 0.0 110.108 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 79.27 105.12 0.23 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.917 -0.659 . . . . 0.0 114.392 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 48.18 46.6 19.74 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.51 ' CG ' ' O ' ' A' ' 295' ' ' ASN . 0.0 OUTLIER -165.69 26.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.34 0.591 . . . . 0.0 110.796 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.884 HG12 HD22 ' A' ' 324' ' ' LEU . 18.0 t -79.17 100.07 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.564 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.754 ' O ' HG23 ' A' ' 301' ' ' VAL . 0.6 OUTLIER -153.36 147.0 25.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.585 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.672 HD11 HD11 ' A' ' 324' ' ' LEU . 28.3 mm -70.93 -44.73 75.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.399 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.72 -39.19 87.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 8.7 t -68.22 -42.92 79.07 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.586 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 297' ' ' THR . 90.8 t -71.41 -40.01 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.283 0.563 . . . . 0.0 109.564 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.557 ' HA ' HD13 ' A' ' 311' ' ' ILE . . . -68.46 -29.9 68.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.832 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 306' ' ' LYS . 4.4 m-20 -72.9 -38.73 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.721 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.525 ' CE2' ' CZ ' ' A' ' 359' ' ' PHE . 0.1 OUTLIER -84.81 -24.81 28.5 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.564 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 301' ' ' VAL . 1.1 m-85 -85.67 1.13 50.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.769 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 303' ' ' ASP . 0.0 OUTLIER -89.75 12.81 15.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.622 0.248 . . . . 0.0 111.356 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.58 -45.11 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.043 0.449 . . . . 0.0 110.458 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ILE . . . . . 0.534 HD13 ' HE3' ' A' ' 353' ' ' TRP . 2.1 tp -76.32 -36.64 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.26 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . -171.78 -158.72 16.46 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.913 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.48 144.16 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.742 0.306 . . . . 0.0 111.536 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.557 HD13 ' HA ' ' A' ' 302' ' ' ALA . 3.2 mt -96.15 138.91 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.86 93.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.42 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 319' ' ' GLN . 0.7 OUTLIER -71.74 152.57 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.496 ' HB2' ' HG3' ' A' ' 321' ' ' MET . 0.7 OUTLIER -107.74 110.9 22.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.133 0.492 . . . . 0.0 110.806 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -8.52 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 314' ' ' ASN . 15.1 mmtt -89.35 -25.7 21.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.994 0.426 . . . . 0.0 110.547 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.545 ' OG1' ' HG3' ' A' ' 319' ' ' GLN . 74.9 p -122.06 -24.03 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 80.56 16.0 76.72 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.692 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLN . . . . . 0.545 ' HG3' ' OG1' ' A' ' 317' ' ' THR . 0.0 OUTLIER -125.58 160.08 57.57 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-O 120.862 0.363 . . . . 0.0 111.619 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 313' ' ' THR . 83.9 Cg_exo -50.5 156.9 3.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.776 2.317 . . . . 0.0 112.279 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 314' ' ' ASN . 0.1 OUTLIER -121.35 122.94 40.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.224 0.535 . . . . 0.0 111.346 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 339' ' ' VAL . 47.9 mt -143.64 146.27 21.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.443 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.45 134.26 55.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.611 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.884 HD22 HG12 ' A' ' 296' ' ' VAL . 0.0 OUTLIER -136.34 143.55 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.77 -179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -111.18 119.52 39.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.74 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 333' ' ' LEU . 20.7 p -136.67 148.94 47.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.27 115.27 17.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.701 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -15.84 37.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.59 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -72.58 -41.58 65.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.969 0.414 . . . . 0.0 110.74 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 332' ' ' LYS . 6.0 t -104.17 -24.92 13.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.805 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.4 55.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.722 ' H ' HG23 ' A' ' 330' ' ' THR . 32.6 mmtm -82.21 -171.96 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.855 0.36 . . . . 0.0 111.068 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.747 HD22 ' CG2' ' A' ' 296' ' ' VAL . 0.8 OUTLIER -142.77 161.25 38.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.816 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.64 12.7 20.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.441 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.455 ' H ' HD12 ' A' ' 333' ' ' LEU . . . 50.82 50.41 37.81 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.643 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -148.5 131.99 16.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.686 0.279 . . . . 0.0 111.216 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 324' ' ' LEU . . . -159.04 133.38 7.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.931 0.396 . . . . 0.0 111.765 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' THR . . . . . 0.75 HG22 ' CD1' ' A' ' 288' ' ' PHE . 20.4 p -91.91 130.38 37.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.15 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 322' ' ' ILE . 60.4 t -111.26 132.38 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.683 0.278 . . . . 0.0 111.217 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 286' ' ' THR . 2.5 p -100.44 139.21 36.44 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.812 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.96 161.16 14.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.03 -27.77 35.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.756 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.76 120.53 22.95 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.506 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' PRO . . . . . 0.577 ' N ' ' HD2' ' A' ' 345' ' ' PRO . 82.9 Cg_exo -41.91 -51.62 4.46 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.832 2.355 . . . . 0.0 112.963 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 344' ' ' PRO . 14.4 Cg_endo -56.61 -30.67 84.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.914 1.742 . . . . 0.0 111.466 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 3.1 t -62.34 -39.23 92.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.021 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 285' ' ' ASN . . . -63.12 -48.33 78.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.91 0.386 . . . . 0.0 110.38 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.956 ' HA ' HD12 ' A' ' 351' ' ' ILE . 0.0 OUTLIER -61.73 -47.73 83.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.932 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.44 ' HA ' ' HE2' ' A' ' 348' ' ' LYS . . . -55.87 -31.96 63.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.97 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -47.09 67.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ILE . . . . . 0.956 HD12 ' HA ' ' A' ' 348' ' ' LYS . 10.8 mt -58.04 -35.46 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.943 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 348' ' ' LYS . 31.8 t70 -59.23 -26.46 64.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' TRP . . . . . 0.545 ' CD1' ' C ' ' A' ' 353' ' ' TRP . 1.6 t90 -101.97 -65.87 0.96 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' PHE . . . . . 0.62 ' HB2' HG21 ' A' ' 366' ' ' VAL . 20.5 m-85 -61.11 -74.89 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.1 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 354' ' ' PHE . 16.0 p-10 13.5 58.31 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.795 0.685 . . . . 0.0 112.345 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 364' ' ' ILE . . . 113.27 35.02 1.68 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.727 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 354' ' ' PHE . 0.0 OUTLIER -98.23 -160.79 0.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 362' ' ' ASN . 1.7 mm-40 -121.81 129.06 52.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 112.116 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' PHE . . . . . 0.55 ' CD2' HG21 ' A' ' 364' ' ' ILE . 0.1 OUTLIER -83.95 100.9 11.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.042 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 18.6 p 39.31 31.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.209 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 137.8 -47.83 0.92 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.91 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 358' ' ' GLU . 1.8 m-80 -88.13 170.99 10.21 Favored Pre-proline 0 C--O 1.218 -0.563 0 CA-C-N 116.989 0.395 . . . . 0.0 110.604 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -96.24 141.71 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.251 2.634 . . . . 0.0 112.386 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 291' ' ' GLY . 3.8 pt -126.82 -178.91 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.35 100.93 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 354' ' ' PHE . 24.6 t -87.78 137.39 21.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.933 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.9 p -131.55 -165.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.963 0.411 . . . . 0.0 111.263 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' PHE . . . . . 0.403 ' CD2' HD13 ' A' ' 351' ' ' ILE . 6.8 m-85 -96.78 28.92 3.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.063 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.66 ' HB2' ' CA ' ' A' ' 287' ' ' ILE . . . 48.95 -176.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 9.1 t -171.31 -179.2 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.029 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 47.71 91.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.21 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -70.98 72.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.788 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -111.12 -177.67 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ASP . . . . . . . . . . . . . 28.5 t0 60.22 92.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' PHE . . . . . . . . . . . . . 76.6 t80 60.11 87.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -119.04 -66.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -67.66 -50.77 56.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . 146.42 -87.81 0.16 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.525 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -141.59 28.45 2.31 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 173.74 109.61 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.595 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.5 110.86 3.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.763 0.315 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -59.42 -160.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.519 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.22 135.74 52.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -169.81 -42.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.559 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.524 179.98 . . . . . . . . 0 0 . 1 stop_ save_